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Evidence linking maternal antenatal depression with an increased risk of altered 
biological and behavioral outcomes in offspring is substantial. However, knowledge 
concerning the underlying mechanisms is strikingly less advanced. The current 
dissertation addresses this gap by adopting a multi-systems approach and 
prospectively investigating three main biological pathways, involving stress and 
inflammation, possibly underlying the effects of maternal antenatal depression on 
infants’ early development, taking into account the potential buffering role of postnatal 
maternal care.  
One-hundred-ten healthy pregnant women, together with their offspring, were studied 
from late pregnancy to three months after delivery as part of the Effects of Depression 
on Infants (EDI) Study. In Chapter 3, cross-sectional associations between maternal 
depressive symptoms and stress-related biology in late pregnancy and soon after 
delivery were examined. Chapters 4 and 5 investigated the prospective associations 
between antenatal variations in maternal depressive symptoms, stress and 
inflammation and infant behavioral and biological outcomes at birth (Chapter 4) and 3 
months after delivery (Chapter 5). Lastly, Chapter 6 explored the moderating role of 
maternal caregiving in the association between prenatal maternal influences and 3-
month-olds’ bio-behavioral outcomes.  
Current findings indicate that antenatal depressive symptoms are associated with an 
altered diurnal cortisol pattern and heightened inflammation in late pregnancy and 
independently predict 3-month-olds’ negative affectivity. Additionally, this thesis 
provides evidence that variations in maternal stress-related biology during pregnancy 
are associated with offspring physiological and behavioural outcomes and that the 
impact of antenatal maternal cortisol on infant cortisol stress reactivity may be 
moderated by maternal sensitive caregiving. Despite the fact that replication of these 
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findings in larger and different samples is needed, our results are in keeping with the 
hypothesis that maternal antenatal stress exerts a programming effect on offspring 
bio-behavioral development and that the impact partially depends on the quality of the 
























Caring for our children is caring for the future of our society. It is estimated that 250 
million children younger than five years old are at risk of not reaching their full 
developmental potential and there is increasing realisation that the roots of abnormal 
bio-behavioral functioning can often be traced early in life. It is therefore essential for 
the future well-being of our society that we thoroughly understand the factors that can 
affect child development from conception to toddlerhood, as this represents a unique 
window of opportunity for a “good start in life”.  
In the last decades, a tremendous amount has been learnt about the negative long-
term influences of maternal depression during pregnancy on child development. 
However, research in humans has not yet successfully demonstrated how maternal 
antenatal depression is “communicated” to the fetus and might affect its development.  
The “Effects of Depression on Infants” (EDI) Study was conceived to address this gap 
by prospectively investigating three stress-related biological pathways, possibly 
underlying the association between maternal antenatal depression and infant 
outcomes, in a sample of 110 women and infants. 
Findings indicated that maternal antenatal depressive symptoms and variations in 
stress-biology are associated with offspring’s bio-behavioral outcomes and that a 
postnatal sensitive rearing environment can reverse some of these effects. These are 
promising and largely unexplored areas for future scientific endeavours. Findings will 
be disseminated to the scientific community through scientific publications. 
Furthermore, they have important clinical implications. Indeed, although prevalence 
estimates suggest that up to 30% of pregnant women experience depressive 
symptoms, they are mostly undetected by health practitioners with possible negative 
consequences for both women and their children. The EDI Study was an occasion to 
open dialogue between researchers and both health professionals working with 
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pregnant women and the public, on the importance of maternal perinatal psychological 
health, thus fostering closer connections between research and practice. Although 
there is still a long way to go before maternal psychological health during pregnancy 
can be addressed as fully as any other medical aspects of antenatal care, the EDI 
study promotes awareness, at least at local level, about the importance of maternal 
emotional state during pregnancy. Furthermore, our findings underline the role of a 
sensitive caregiver in buffering some effects of prenatal risk exposure, thus extending 
the window of opportunities for preventive interventions beyond the first nine months of 
life and suggesting that the quality of maternal caregiving should be a major target for 
intervention. If the current findings are replicated, they suggest that researchers and 
clinicians should join their efforts to find the best way to effectively identify women 
experiencing antenatal depressive symptoms and provide them with accessible and 
effective antenatal and postnatal treatment in order to help all mothers and babies 
have the best start in life.  
Lastly, the EDI study constituted a unique opportunity to critically extend an existing 
collaboration between UCL and the Scientific Institute Medea in Italy, which, besides 
promoting scientific exchange, created the basis for a long-lasting network to 
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Chapter 1: Introduction  
 
Early problems in behavioural, cognitive and physiological regulation in infancy 
may represent vulnerability factors for the development of later psychopathology 
(Schlotz & Phillips, 2009). An important step toward the early identification and 
treatment of children at risk is the understanding of potential pathways that may lead 
to early deficits in regulatory capacities. The last decades have seen a growing 
appreciation for the roles of environmental exposures in shaping brain development 
and influencing later risk for psychopathology, with increasing attention directed 
toward prenatal exposures (Grossman et al., 2003). Indeed, the rapid fetal growth and 
brain development occurring across gestation make the fetus particularly vulnerable to 
any insults and changes in the intrauterine environment, with possibly long-term 
consequences (Gluckman, 2008). This has led to the hypothesis that stress or 
psychological distress experienced by the mother during pregnancy, including major 
life events or psychiatric disturbances such as depression, can induce alterations in 
the intrauterine environment that in turn can affect fetal development and later risk for 
lifetime physical and mental health problems (Maccari et al., 2017, Weinstock, 2005). 
Since this hypothesis has been proposed, many prospective studies have provided 
evidence of an association between maternal stress or distress during pregnancy and 
long-term altered behavioral and physiological outcomes in the offspring (reviewed in 
Van den Bergh et al., 2017b). However, research in humans has not yet successfully 
demonstrated how maternal antenatal stress is “communicated” to the fetus and might 
affect its development. The current dissertation focuses on symptoms of psychological 
distress, particularly depression, during pregnancy and investigates three main 
biological pathways, involving the two main stress response systems and the 
inflammatory response system, possibly underlying the effects of maternal antenatal 
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depressive symptoms on infants’ early development, taking into account the role of 
postnatal maternal care.  
This chapter begins by delineating the theoretical foundation of the 
Developmental Origins of Health and Disease (DOHaD) hypothesis and summarizing 
illustrative evidence. Then the focus of interest is restricted on the effects of maternal 
depression on child development and empirical evidence for it as well as critical 
conceptual and methodological issues is reviewed. In the second half of this chapter, 
possible biological mechanisms underlying the effects of antenatal depression on fetal 
development involving the Hypothalamic-Pituitary-Adrenal (HPA) axis, the 
Sympathetic Nervous System (SNS) and the inflammatory response system (IRS) are 
examined. For each of these, a brief overview of system functioning and of the main 
pregnancy-related changes these systems undergo is provided, jointly with a 
description of what is known about associations with perinatal depressive 
symptomatology. Finally, possible mechanisms of fetal programming by stress and 
inflammatory response systems are proposed and available evidence for these are 
reviewed.  
 
1.1 The Developmental Origins of Health and Disease (DOHaD) hypothesis  
The notion that maternal health during pregnancy may affect the developing 
child has a long lineage across cultures and is strongly embedded in folk psychology. 
Over the last decades, this belief has attracted considerable research interest and 
several models have been proposed such as, the ‘Fetal programming hypothesis’ 
(Seckl & Holmes, 2007), the ‘Developmental programming hypothesis’ (Barker, 2004, 
Langley-Evans, 2006), and the ‘Developmental Origins of Health and Disease 
(DOHaD) hypothesis’ (Wahdwa et al., 2009; Hanson & Gluckman, 2008). Despite 
some differences, all these models emphasize fetal plasticity and share the basic idea 
that intrauterine exposure to an altered environment, characterized for example by 
high levels of glucocorticoids, either synthetic or endogenous, or by nutrient 
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restrictions, during sensitive windows of development might alter the structure and/or 
function of fetal biological systems, influencing later health and susceptibility to 
disease (Gluckman, 2008; Hanson & Gluckman, 2014; Seckl & Holmes, 2007; Van 
den Bergh, 2011). More specifically, antenatal exposure to environmental challenges 
has been hypothesized to affect the fetal set-point of the stress response systems as 
well as induce changes in proteins and neurotransmitters involved in fetal brain 
development and function (McGowan & Matthews, 2018; Wyrwoll & Holmes, 2012).  
These prenatally-induced changes are thought to heighten the offspring’s susceptibility 
to later physical and mental health problems which, in interaction with genetic and 
postnatal environmental factors, will determine ultimate individual outcomes (Schlotz 
and Phillips, 2009). 
 
1.1.1 Epidemiological studies  
Although the notion that early-life exposures can significantly impact 
subsequent development has a long-standing tradition in psychology (e.g. Lorenz, 
1935; Watson & Rayner, 1920), the greatest impetus to the emergence of the fetal 
programming hypothesis came from the original work of David Barker and colleagues. 
Barker and collaborators, from the late 1980s onward, conducted a series of 
epidemiological studies demonstrating an association between nutrition early in life 
and health problems in adulthood (Barker, 1995; Barker & Osmond, 1986). In 
particular, they showed that low birthweight was associated with a higher prevalence 
of a number of adult diseases such as type 2 diabetes (Hales & Barker, 1992), heart 
disease (Barker, 1997), hypertension (Barker & Osmond, 1988) and metabolic 
syndrome (Barker, 1995). Based on this evidence, Barker suggested that prenatal 
exposure to malnutrition, substance use or poverty, could affect fetal development and 
these alterations, in turn, could confer a higher risk for certain diseases in later life in a 
process that he described as “fetal programming”. Despite the fact that birth weight 
was only a proxy of prenatal development and that later meta-analyses challenged 
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some of his results (e.g. Huxley, Neil, & Collins, 2002), Barker’s original work 
inaugurated a wave of research on the effects of prenatal experiences on health and 
risk for disease across the lifespan. In addition, while the initial focus was exclusively 
on the role of the intra-uterine environment for offspring’s later outcomes, life 
experiences occurring during periods of high developmental plasticity, such as the 
early postnatal period, as well as possible pre-conception and intergenerational 
influences, were later included in the DOHaD hypothesis.  
Independently of the work on fetal malnutrition, accumulating evidence in 
support for the fetal programming hypothesis came from studies highlighting a link 
between prenatal exposure to toxic agents, such as smoking, alcohol, radiation, lead 
and methyl mercury, and later adverse outcomes in the offspring (e.g. Thayer et al., 
2012; Grandjean & Landrigan, 2014). Additionally, these studies showed that timing 
and severity of the exposure during gestation influence the nature and degree of these 
effects (e.g. Eberhart-Phillips, Frederick, Baron, & Mascola, 1993), providing further 
support for the notion that sensitive periods exist during fetal development, when 
specific biological structures and systems, usually undergoing rapid developmental 
change at that given point, are particularly vulnerable to environmental influences. 
 
1.1.2 The effects of antenatal maternal stress: observational studies  
In the last decades, mounting evidence has indicated that stress experienced 
by the mother during pregnancy is another powerful environmental factor that could be 
involved in fetal programming (reviewed in Talge, Neal, & Glover, 2007; Glover, 2011; 
Van den Bergh et al., 2017). This includes maternal exposure to negative life events or 
bereavement, self-reports of daily hassles, conflictual relationship with the partner, 
anxiety and depressive symptoms. In particular, several independent prospective 
studies in humans showed an association between maternal antenatal distress and 
altered child outcomes in several domains such as: 1) poor birth outcomes, including 
an higher risk of preterm delivery and smaller size at birth (e.g. Copper et al., 1996; 
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Dole et al., 2003); 2) regulation and sleep problems (e.g. Gerardin et al., 2011; 
Pacheco & Figueiredo, 2012; Räikkönen et al., 2015); 3) poor cognitive outcomes 
(Tarabulsy et al., 2014 meta-analytical findings) and, to a lesser extent, motor 
outcomes (Lin et al., 2017; Gerardin et al., 2011); 4) mixed-handedness during 
childhood (Glover et al., 2004); 5) altered behavioral stress reactivity (Davis et al., 
2011) and more “difficult” and fearful temperament (e.g. Madigan et al., 2018; 
Braithwaite et al., 2017; Bergman et al., 2007); 6) behavioral problems in childhood 
and adolescence (Madigan et al., 2018 meta-analytical findings), including 
externalizing (e.g. O’Donnell et al., 2014; Leis et al., 2014; Loomans et al., 2011), 
internalizing (e.g. Capron et al., 2015, Gerardin et al., 2011), social behavioral 
problems (Loomans et al., 2011) and autistic traits (Rijlaarsdam et al., 2017); 7) 
neuroendocrine alterations, including an altered pattern of cortisol stress reactivity (K. 
A. Grant et al., 2009), an altered diurnal cortisol rhythm (e.g. O’Connor et al., 2005; 
O’Donnell et al., 2013; Van Den Bergh, et al., 2008) and altered autonomic stress 
reactivity (Nancy Aaron Jones et al., 1998); 8) brain structural and functional 
alterations such as cortical thinning (Sandman et al., 2015; Lebel et al., 2016), altered 
patterns of connectivity of the amygdala (Qiu et al., 2015; Favaro et al., 2015), 
microstructural brain changes from the neonatal period to age 9 years (reviewed in 
Franke et al., in press). 
The magnitude of these effects varies widely across studies and appears to 
depend on infant’s age and gender, as well as on the type of maternal stress 
measured and gestational time window. Additionally, studies vary considerably for 
sample size and methods of assessment and analyses. Nonetheless, despite all 
methodological variations, findings collectively support the notion that maternal stress 
during pregnancy is a non-specific risk factor for negative outcomes during childhood. 
However, the observational design of these studies does not enable to rule out the 
contribution of factors, such as genetic, postnatal environmental factors or potential 
third variables (e.g. maternal smoking), that might confound the observed 
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associations, thus limiting the possibility to draw causal inferences and really establish 
whether fetal programming is occurring.  
 
1.1.3 The effects of antenatal maternal stress: animal studies  
Animal research has allowed for further investigation of the direct effects of 
prenatal experiences on offspring development in experimentally controlled settings. 
Animal experiments offer several advantages, including shorter life spans and 
breeding cycles as well as the possibility to control the intensity, duration and timing of 
the stressor (Maccari et al., 2003; Weinstock, 2008). Additionally, as stress 
experiences during pregnancy might induce changes in early maternal care in the 
postnatal period, which might in turn also influence offspring development, cross-
fostering procedures can be adopted in animal models that allow researchers to 
disentangle the contribution of prenatal factors versus postnatal rearing effects on 
offspring development. 
The majority of studies on the effects of prenatal stress on brain development 
has been conducted in rat strains providing, to date, the most comprehensive 
information on the behavioural, morphological and histological effects of prenatal 
stress (Boersma & Tamashiro, 2015; Weinstock, 2017). Several protocols have been 
employed to induce stress in pregnant dams including drugs administration, infections, 
hormonal manipulations, undernutrition, noise and sleep deprivation, and physical or 
social stressors that induce strong psychoneuroendocrine responses in the mothers 
(e.g. Mastorci et al., 2009; Bock et al., 2011; Muhammad & Kolb, 2011; Mychasiuk, 
Gibb, & Kolb, 2011). Taken together, this body of research shows that exposure to 
prenatal stress has a long-lasting impact on the physiological and behavioral 
development of the resulting offspring (Frasch et al., 2018) and provides a possible 
biological basis for prenatal stress-induced behavioral and physiological alterations in 
offspring. In particular, exposure to different stressors in late pregnancy has been 
found to alter offspring neurogenesis and brain morphology and this, in turn, appears 
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to affect offspring behavior (Charil et al., 2010; Mastorci et al., 2009; Weinstock, 2001). 
In addition, offspring of prenatally stressed dams are characterized by lower birth 
weight, impaired stress reactivity, learning and memory, motor delay, alterations in 
neurotransmitter pathways including dopaminergic, gabaergic and glutamate systems 
(reviewed in Frasch et al., 2018). In adulthood, prenatal stress exposed offspring show 
diminished propensity for social interactions, increased anxiety and depressive-like 
behaviors, altered sexual behaviors and gonadal dysfunction (Darnaudery & Maccari, 
2008; Weinstock, 2008; Yaka et al., 2007; Yang et al., 2006).  
Because animal models allow the duration and timing of prenatal stress to be 
controlled, they allow us to differentiate the effect of prenatal stress at different stages 
of development. Evidence to date suggests that the characteristics of the behavioral 
alterations associated with antenatal stress depends on the gestational timing of 
maternal stress (Frasch et al., 2018). In particular, it has been shown that fetal brain 
development is characterized by a sequence of vulnerability time windows during 
which specific organ systems are developing and that specific cellular events and 
neuronal systems in fetal brains can be affected by environmental stress depending on 
the time of exposure (Weinstock, 2007).  
Lastly, animal models have provided evidence that prenatal stress-related 
vulnerability can be transmitted across generations, so that the effects of prenatal 
stress exposure on the phenotype are apparent also in subsequent generations of 
offspring that were not exposed to environmental stressors at any time (Aiken & 
Ozanne, 2014; Heard & Martienssen, 2014). Despite the mechanisms underlying 
transgenerational transmission being far from elucidated, some have argued that they 
may involve transmission of epigenetic information across generation (Skinner, 2014).  
 
1.1.4 The effects of antenatal maternal stress: natural disasters studies 
While in human studies rigorous experimental control is difficult to achieve, as 
pregnant women cannot be randomized to different stress conditions, research on the 
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consequences of major stressful events, such as wars or natural disasters, in humans 
are natural experiments that allow for an approximation of the randomization adopted 
in animal studies. This body of research gives additional support to the notion that 
stressful events occurring during prenatal life are associated with altered outcomes in 
childhood and beyond.  
Early research into the consequences of prenatal exposure to the Dutch 
Hunger Winter of 1944–1945 revealed that offspring of women who were pregnant 
during the famine showed lower birth weight and impaired glucose tolerance in 
adulthood, as compared with the unexposed group of individuals born in the year 
before or conceived in the year after the famine (Ravelli et al., 1998). Additionally, 
associations between conception during the famine and both a higher rate of neural 
tube defects such as spina bifida and anencephaly (Brown & Susser, 1997) and a 
higher risk of schizophrenia in adulthood (Susser, Hoek, & Brown, 1998), as compared 
to the unexposed cohorts, were reported. Similar associations were found in studies 
on the consequences of a famine in China, suggesting an impact of severe caloric 
restriction during pregnancy on offspring’s later risk for schizophrenia (Song, Wang, & 
Hu, 2009). Kinney and colleagues (2008) conducted historical analyses exploring the 
impact of prenatal exposure to several severe storms in Louisiana on autism risk by 
examining changes in prevalence rates before and after the exposure. The authors 
reported a significant increase in autism rates after prenatal exposure to the storms 
(from a prevalence of 5 per 10,000 births to 13 per 10,000 births) and highlights a role 
of storm severity and timing of exposure in predicting the risk for psychopathology.  
The first prospective study on natural disaster was Project Ice Storm in Canada 
(King et al., 2012). This study found that prenatal exposure to the worst natural 
disaster in Canadian history significantly affected outcomes in the resulting offspring in 
nearly every developmental domain examined. In particular, researchers were able to 
differentiate between the objective severity of stress exposure (for example greater 
loss or changes) and woman’s perceived stress (King et al., 2015) and showed that 
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greater objective stress exposure was associated with poor birth outcomes  
(Dancause et al., 2011), increased obesity risk in preschool (Dancause et al., 2012) 
and school age (King et al., 2012), more difficult temperament (Laplante, Brunet, & 
King, 2016), poorer cognitive and language development  (Laplante et al., 2004) and 
poorer bilateral coordination and visual motor integration (Cao et al., 2014), with 
effects depending on timing of exposure and baby’s gender (King et al., 2012; 
Dancause et al., 2011). Additionally, maternal perceived stress (and to a lesser extent, 
objective exposure) was found to influence fingerprint asymmetry (King et al., 2009), 
autism traits (Walder et al., 2014) and childhood asthma in girls (Turcotte-Tremblay et 
al., 2014). Interestingly, the severity of objective exposure and subjective distress in 
response to the storm were found to interact to predict child outcomes so that the 
poorer outcomes were found in children of women who showed a mismatch between 
objective and subjective exposure (i.e. high objective stress versus low subjective 
distress or low objective stress versus high subjective distress; King et al., 2012).  
Similarly, results from the QF2011 Queensland Flood Study in Australia 
showed an association between higher levels of objective flood exposure and both 
problem-solving skills at 6 months of age (Simcock et al., 2018) and lower cognitive 
and motor scores at 16 months of age, especially when the flood occurred in late 
gestation (Moss et al., 2017). Additionally, infant’s socio-emotional development was 
lower the later in gestation they were exposed to the flood and the greater maternal 
objective exposure (Simcock et al., 2017). 
The effects of acute disasters have also been studied. For example, it was 
found that exposure to the Chernobyl disaster in the second or third trimester of 
pregnancy was associated with an increased prevalence of depressive and attention 
deficit and hyperactivity disorder (ADHD) symptoms in adolescence in the offspring 
(Huizink et al., 2007). Work on infants prenatally exposed to the World Trade Center 
Attacks (Yehuda et al., 2005) showed decreased salivary cortisol levels in infants of 
mothers who developed posttraumatic stress disorder (PTSD) in response to the 
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attacks, as compared to infants of exposed mothers who did not develop PTSD. 
Additionally, effects were most apparent when the exposure occurred in the third 
trimester of pregnancy.  
Collectively these studies represent a unique opportunity to quasi-
experimentally investigate the impact of stress exposure upon offspring outcomes. 
However, results are still likely to be confounded by several factors. For example, the 
association between calorific restriction or malnutrition during pregnancy in wartime 
and later offspring outcomes is confounded as the population was clearly exposed to 
considerable stress and significant life changes in addition to malnutrition. Additionally, 
depending on the characteristics of the disaster under examination, the proportion of 
population affected by it might vary, thus leading to considerable variability in sample 
sizes, as well as in the severity of stress exposures (Harville, Xiong, & Buekens, 
2010). Similarly, the measurement of such exposure varies widely across studies, 
ranging from exposure defined simply by being resident in an area affected by the 
disaster (e.g. Xiong et al., 2008) to more formal assessment of maternal perception of 
stress or mental health (e.g. Engel et al., 2005). Furthermore, duration and timing of 
the effects are confounded, as women who experience the event at an earlier stage of 
pregnancy are affected by it and its consequences for a greater proportion of the 
gestation than those later exposed (O’ Connor et al., 2014). Lastly, direct replication of 
the results is difficult and findings are not likely to generalize to different forms of 
stress experienced by pregnant women such as more normative chronic stress 
conditions. 
 
1.1.5 Evolutionary significance  
It is important to note that a strong evolutionary connotation is inherent in the 
fetal programming or DOHaD hypotheses. In particular, early alterations in fetal 
biological systems are thought to represent fetal adaptations to the intra-uterine 
environment that are triggered by maternal signals, such as nutrient restriction or 
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stress hormones, and are thought to serve the function of preparing the developing 
fetus for optimal functioning in the postnatal environment (e.g. Bateson et al., 2004; 
Ellis & Del Giudice, 2018; Gluckman, 2008; Glover, 2011). Whether such adjustments, 
based on prenatal maternal hormonal cues, will be dysfunctional rather than adaptive 
in later life is thought to depend on how they suit actual characteristics of the postnatal 
environment (Monaghan & Haussmann, 2015). 
Hales and Barker (1992) first proposed the “Thrifty phenotype” hypothesis, 
according to which cardiovascular and metabolic alterations associated with prenatal 
exposure to adversity (e.g. stress, undernutrition, higher levels of glucocorticoids) 
constitute an organism’s anticipatory preparations to conditions of reduced nutrient 
supply and/or the increased metabolic demands of postnatal life. Later, this was 
further extended within the predictive-adaptive-response (PAR) model (Gluckman, 
Hanson, & Spencer, 2005), also known as the weather-forecasting model (Bateson et 
al., 2004) or developmental match/mismatch hypothesis (Gluckman, Hanson, & 
Beedle, 2007), which questions the initial disease/dysfunction emphasis of fetal 
programming models and proposes that under certain conditions, prenatally stressed 
individuals may have an adaptive advantage if they have to cope with stress later in 
development, while they might have an increased risk for disease in a non-stressful 
postnatal environment (Gluckman et al., 2005). Thus, it is the mismatch between 
prenatal and postnatal environments that render offspring stressed in utero more 
susceptible to the development of physical and mental problems later in life. In this 
vein, the effects of maternal antenatal stress on fetal stress reactivity might be 
adaptive in that they help the offspring succeeding in an environment characterized by 
high levels of stress. However, the fetal stress-induced adjustments might prove to be 
dysfunctional in a non-stressful postnatal environment.  
The majority of studies investigating the consequences of discordance 
between prenatal and postnatal environments have been limited to prenatal nutritional 
adversity and provide support for the PAR model. For instance, offspring of dams 
33 
 
exposed to nutrient restriction during pregnancy showed an excessive weight increase 
and atypical percentage of body fat, if they received ad libitum food postnatally (Desai 
et al., 2005). Similarly, increasing the discrepancy between prenatal and postnatal 
nutrition enhanced the risk for altered cardiovascular function in sheep (Cleal et al., 
2007), while children provided with adequate nutrition after being exposed to 
nutritional restriction in utero have an increased risk of developing metabolic diseases 
in later life (Metcalfe & Monaghan, 2001).  
To our knowledge, only two studies have tested the predictions of the PAR 
model on neurodevelopmental outcomes in humans and provided mixed results. 
Specifically, Sandman and colleagues (2012) reported improved motor and mental 
development across the first year of life among infants whose mothers experienced 
high depressive symptoms both prenatally and postnatally, while infants prenatally 
exposed to maternal depression did not benefit from maternal postpartum euthymia, in 
line with the PAR model predictions. However, Grant and colleagues (2009) found that 
children exposed to synthetic glucocorticoids during pregnancy showed impaired 
memory performance if they were reared in a postnatal environment at high 
psychosocial risk, in line with a vulnerability-stress model. More empirical work is 
clearly needed, however these findings highlights the fact that, although the notion of 
fetal programming is often related to adverse developmental outcomes, pathology is 
not inherent to this concept (Schwartz & Morrison, 2005). 
 
1.1.6 Defining the risk phenotype 
During pregnancy women can be exposed to several endogenous and 
exogenous challenges that may represent a threat to their health and wellbeing and be 
subjectively perceived as unpleasant or distressing (Glover, 2014). Prenatal stress is 
an all-encompassing term for a wide range of exposures, varying from very severe to 
mild, that has been investigated and was found to be associated with later child 
developmental outcomes (reviewed in Van den Bergh et al., 2017). These include 
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exposure to major life events, such as natural disasters or wars, bereavement, marital 
conflict, symptoms of depression and anxiety as well as clinically diagnosed mood or 
anxiety disorders, pregnancy-specific anxiety and daily hassles. Taken together, 
available findings suggest that the “prenatal risk” phenotype is fairly broad and that the 
programming effects of antenatal stress on fetal development are not limited to 
extreme levels of stress or severe maternal disturbance and are not unique to clinical 
samples. Rather, the effects of antenatal maternal stress appear to occur across the 
whole spectrum of stress exposures and symptom severity that women all around the 
world might experience at some time during their pregnancies (reviewed in Talge et 
al., 2007; Van Den Bergh et al., 2017). A fairly linear or dose-response relationship 
across the range between prenatal stress and child outcomes has often been reported 
(e.g. MacKinnon et al., 2018; Kingston et al., 2018; O’Connor et al., 2002), suggesting 
that prenatal maternal distress might have a detectable impact even at subclinical 
levels and that maternal mental health should be considered a population health issue 
(O’Donnell & Meaney, 2017). Nevertheless, it has been hypothesized that some 
outcomes, such as a higher risk of schizophrenia, might be observed only in offspring 
prenatally exposed to severe stress experiences, such as the death of a close relative 
(Khashan et al., 2008). Additionally, it has also been shown that mild levels of 
antenatal maternal stress might actually promote, rather than adversely affect, 
offspring’s development, as highlighted in a study showing a positive association 
between prenatal maternal distress and infants’ mental and motor development 
(DiPietro et al., 2006). Some researchers proposed that the association between 
maternal prenatal stress and children’s outcomes might be U-shaped, with mild to 
moderate levels of maternal distress during pregnancy actually promoting fetal 
development in healthy samples and being associated with more optimal outcomes, as 
compared to too little or too much prenatal maternal stress (Fernandes et al., 2014; 
DiPietro et al., 2006; Davis et al., 2017). 
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While a wide range of prenatal stress measures has been found to be 
associated with child outcomes, it has been shown that the significance and 
magnitude of the observed associations varies according to the prenatal maternal 
measure investigated. For example pregnancy-specific stress, such as fear of bearing 
a handicapped child, rather than daily hassles or anxiety symptoms, has been found to 
be significantly associated with infants’ cortisol reactivity in some studies (Tollenaar et 
al., 2011; Gutteling, De Weerth, & Buitelaar, 2005).  
While methodological heterogeneity among studies might account for different 
findings, discrepancies still reflect the poor understanding of the mechanisms 
underlying the effects of prenatal maternal distress on child development that might 
also explain why a significant association with child outcomes is sometimes detected 
for one stress measure but not another. For example, one potential source of 
confusion is the assumption that different forms of maternal antenatal stress share the 
same distress-linked biological alterations, such as increased glucocorticoid levels, 
which might not be always the case. The field of prenatal stress in humans suffers 
from a lack of specificity and imprecision in the definition and operationalization of 
prenatal maternal stress and, in turn, of the underlying biological mechanisms that 
might link maternal distress during pregnancy to altered child outcomes (O’Donnell & 
Meaney, 2017; O’Connor, Monk, & Fitelson, 2014). Recent reviews have called for 
more research into the effects of specific maternal conditions on specific 
neurodevelopmental outcomes and for more studies integrating subjective and 
objective measures of maternal stress and investigating their effects on child 
development (Graignic-Philippe et al., 2014; O’Donnell & Meaney, 2017). For the 
purposes of the current thesis, the prenatal risk phenotype is narrowed and both 
psychological (i.e. depressive symptoms) and neuroendocrine (i.e. stress and 
inflammatory markers) measures of maternal antenatal stress experience are 
included. Furthermore, as anxiety symptoms are often found in comorbidity with 
depression (Dindo et al., 2017; Falah-Hassani, Shiri, & Dennis, 2017), in order to 
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evaluate the specificity of the associations investigated, measures of maternal anxiety 
will be included. In addition, studying a low risk community sample of pregnant women 
allows to limit confounding influences of additional risk factors associated with 
psychosocial adversity (e.g. teenage motherhood, unemployment, financial problems 
etc.). We believe that a clear and unambiguous definition of the type of stress 
measured both in terms of psychological construct, magnitude of exposure (i.e. how 
much distress can significantly affect offspring development) and biological 
underpinnings is pivotal in order to bring the field of fetal programming a step forward. 
The rationale for focusing on depressive symptomatology experience during 
pregnancy include: 1) the significant prevalence of such symptoms during pregnancy 
and after delivery (e.g. Woody et al., 2017); 2) a considerable body of findings 
suggesting an association between maternal antenatal depressive symptoms and an 
increased risk for altered outcomes in the offspring (e.g. Gentile et al., 2017); 3) the 
great wealth of evidence suggesting specific associations between depressive 
symptomatology and altered functioning of biological systems that might be involved in 
fetal programming (e.g. Knorr et al., 2010; Miller & Raison, 2016; Vreeburg, Sophie; 
Hoogendijk, 2009). Points 1) and 2) will be further discussed in what follows, while 
point 3) will be extensively examined in section 1.4. 
 
1.2 The effects of antenatal maternal depression on child development 
 
1.2.1 Maternal depression during the perinatal period  
The perinatal period, encompassing both gestation and childbirth, is inevitably 
accompanied by physiological, psychological and social challenges and it is a time of 
high risk for new onset or re-lapse of mental disorders (Johnson et al., 2012). In 
particular, depression, a leading cause of the disease burden for women of 
childbearing age, is one of the most common complications during the perinatal period 
in developed countries (Woody et al., 2017; Dimidjian & Goodman, 2009). 
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Historically, maternal mental health in the postpartum period has attracted 
greater attention both from researchers and clinicians as compared to the antenatal 
period; however, prevalence estimates do not justify this bias. Between 7 and 12.7% 
of women in high-income countries experience a major depressive disorder during the 
gestational period (Woody et al., 2017; Melville et al., 2010; Gavin et al., 2005; Banti et 
al., 2011) and between 7 and 13.6% in the first year post-partum (Banti et al., 2011; 
Gavin et al., 2005, Woody et al., 2017). In addition, depressive symptoms affect up to 
30% of women during the perinatal period, with significant variation in prevalence rates 
depending on time and method of assessment (Banti et al. 2011; Le Strat et al., 2011; 
Verreault et al., 2014; Waldie et al., 2015). Antenatal depression has been shown to 
represent one of the strongest risk factors for postnatal depression (Underwood et al., 
2016; Robertson et al., 2004; Norhayati et al., 2015), with only a minority of women 
experiencing depression for the first time in the postpartum period (e.g. Verrault et al., 
2014). 
The clinical features of depression during pregnancy are essentially identical to 
those appearing in other life periods and include persistent feelings of sadness and/or 
loss of interest in things once pleasurable, as well as emotional problems, such as 
feeling worthless or guilty, difficulty concentrating or decision-making, suicidal 
thoughts, and somatic complaints, such as change in appetite, sleep and physical 
activity. However, some of these symptoms overlap with the changes that accompany 
pregnancy and are often misattributed to gestation, both by women and clinicians, and 
therefore often go unrecognized (Marcus & Heringhausen, 2009). In addition, a 
widespread stigma associated with mental illness, particularly occurring during a time 
that is expected to be one of the most joyful in a woman’s life, make it difficult for 
women to report. Thus, although a considerable proportion of women experience 
mental health problems across gestation, only a small portion is detected and receive 
mental health treatment (Andersson et al., 2006; Goodman & Tyer-Viola, 2010), 
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indicating that adequate screening instruments and assessment procedures are still 
lacking or poorly implemented.  
Anxiety is often found in comorbidity with depression during the perinatal 
period (e.g. Dindo et al., 2017; Lancaster et al., 2010; Biaggi et al., 2016), with a 
prevalence rate of around 10% antenatally and 8% postnatally for anxiety and 
depressive symptoms, while 4.1% during pregnancy and 6.6% postnatally for 
comorbid anxiety and mood disorder, according to recent meta-analytical estimates 
(Falah-Hassani et al., 2017), potentially exacerbating negative outcomes both in 
women (Fichter et al., 2010) and their children (Field et al., 2011; although see Leis et 
al., 2014 for contradictory results).  
As will be further discussed in section 1.4, the background of neuroendocrine 
changes occurring during pregnancy and after delivery has been held responsible for 
increasing women’s vulnerability to developing depression during the peripartum 
period (e.g. Corwin & Pajer, 2008). However, perinatal depression has a multi-factorial 
aetiology and, although hormonal and immune alterations are thought to play a role, 
genetic vulnerability, life experiences, stress and psychosocial factors all contribute to 
determine individual risk (Leigh & Milgrom, 2008; Lancaster et al., 2010). Concerning 
the latter ones, the factors most consistently related to maternal depression both 
during pregnancy and after delivery are a personal and family history of psychiatric 
illness, lack of social or partner support, adverse life events, negative attitude towards 
pregnancy or unplanned/unwanted pregnancy and pregnancy complications (reviewed 
in Norhayati et al., 2015 and Biaggi et al., 2016). 
 
1.2.2 Antenatal maternal depression and offspring outcomes  
Several prospective studies have now demonstrated that, if left untreated, 
maternal depression during pregnancy is associated with an increased risk for several 
adverse pregnancy-related outcomes and behavioural, cognitive, emotional and 
neurophysiological outcomes in the offspring (reviewed in Gentile et al., 2015; Glover 
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et al., 2014). Despite great variations among studies in terms of gestational timing, 
assessment of maternal depression and which outcome is evaluated, the vast majority 
of findings converge to suggest that maternal antenatal depression influences, or at 
least is associated with, fetal development, resulting in altered offspring outcomes that 
are summarized in what follows.  
 
1.2.2.1 Pregnancy and fetal outcomes 
There is considerable evidence that maternal depression during gestation is 
associated with poorer maternal health and pregnancy outcomes. In particular, 
maternal depression have been associated with unhealthy life style during pregnancy, 
including increased alcohol or substance use, smoking, inadequate diet and weight 
gain (Marcus, 2009). Additionally, antenatally depressed women are more likely to 
access antenatal care services late and less frequently, to miss regular scans (Kim et 
al., 2006; Redshaw & Henderson, 2013), to experience greater fear of childbirth and to 
show a preference for elective caesarean section (Andersson et al., 2004). Maternal 
depression has also been shown to relate to a heightened risk for medical 
complications during pregnancy, such as hypertension, preeclampsia, gestational 
diabetes and severe forms of hyperemesis gravidarum (e.g. Qiu et al., 2009; Alder et 
al., 2007; Kozhimannil, Pereira, & Harlow, 2009; Kurki et al., 2000), and is associated 
with prolonged sick leave (Gentile et al., 2017).  
Recent systematic reviews and meta-analyses indicate that maternal 
depression during pregnancy is related to a modest but significantly greater risk of 
preterm delivery (Staneva et al., 2015; Alder et al., 2007; Grote et al., 2010; Szegda et 
al., 2014) and low-birth weight (Alder et al., 2007; Grote et al., 2010; Jarde et al., 
2016). Nonetheless, findings vary widely depending on timing of assessment, with 
greater effects observed in mid-late pregnancy as compared to earlier exposure, and 
operationalisation of maternal depression, with stronger effects for categorical clinical 
diagnosis of depression, rather than continuous measure of depressive symptoms.  
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Few studies have directly examined the impact of antenatal depressive 
symptomatology on fetal behaviour and physiology. Generally, a greater amount of 
fetal activity in foetuses of depressed pregnant women as compared to a control group 
of non-depressed women has been reported (Emory & Dieter, 2006; Dieter et al., 
2001; Field, Diego, & Hernandez-Reif, 2004). In contrast, the association between 
maternal antenatal depression and fetal heart rate baseline and reactivity is less 
consistent. Allister and colleagues (2001) found a significant association between 
maternal depression and both fetal heart rate and reactivity to external stimuli, with 
foetuses antenatally exposed to maternal depression showing a higher baseline heart 
rate, and a slower and reduced responsivity to an external vibroacustic stimulus. 
Similarly, lower fetal heart rate during stimulation (Emory and Dieter, 2006) and lower 
heart rate variability in response to a familiar speech stimulus (Figueiredo et al., 2017) 
have been reported in fetuses of prenatally depressed women. In contrast, Monk and 
colleagues (2004) reported no differences in baseline fetal heart rate according to 
women’s psychiatric condition, however foetuses of depressed women showed a 
larger increase in fetal rate in response to a laboratory challenge (i.e. mothers 
completing a Stroop Task), independent of women’s cardiorespiratory activity. Taken 
together, findings seem suggestive of an association between maternal 
symptomatology and offspring’s behaviour and physiological reactivity even before 
birth, although the limited number of available studies and considerable differences in 
assessment procedures and timing of assessment, do not allow to draw firm 
conclusions.  
 
1.2.2.2 Neurodevelopment and psychomotor development  
Infants of prenatally depressed mother have been observed to obtain lower 
scores on the Brazelton Neonatal Behavioural Assessment Scale (NBAS; Brazelton & 
Nugent, 1995), indicating less neonatal neurobehavioral maturity (Osborne et al., 
2018; Field et al., 2004; Lundy et al., 1999; Pacheco & Figueiredo, 2012; Figuereido et 
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al., 2017). Negative effects of maternal depression during pregnancy were also seen 
on infants’ attentiveness and responsiveness to faces and voices, as early as the 
neonatal period (reviewed in Field, Diego, & Hernandez-Reif, 2009), and on infants 
early regulatory behaviors and sleep problems (Diego et al., 2004; Gerardin et al., 
2011; Pacheco and Figuereido, 2012; Räikkönen et al., 2015).  
Findings of an association between maternal depression during pregnancy and 
infants’ psychomotor development are controversial. In particular, a significant 
association between maternal antenatal depression and lower cognitive development 
independent of postnatal depression has been reported at 18 months of age (Koutra et 
al., 2013), 24-30 months of age (Lin et al., 2017) and in a large sample of 8 years-old 
children of the Avon Longitudinal Study of Parents and Children (ALSPAC) in the UK 
(Evans et al., 2012). However, a subsequent analyses of data from the ALSPAC 
sample showed no direct effect of maternal antenatal depression on children cognitive 
functioning at 8 years of age, while the effects of maternal depressive symptoms 
during pregnancy were mediated by a poor maternal prenatal nutrition, which in turn 
predicted reduced cognitive function (Barker et al., 2013). In addition, a positive 
association between maternal depression assessed in mid-pregnancy and children 
motor and mental development at 2 years of age, after controlling for several 
covariates including postnatal depression has also been reported (DiPietro et al., 
2006). Furthermore, Sandman and colleagues (2012) reported greater cognitive and 
motor development scores in 3-6 month old infants of prenatally and postnatally 
depressed mothers or in infants of never-depressed mother, as compared to infants 
where prenatal and postnatal symptomatology were discordant (i.e. high prenatal 
depression versus low postnatal depression or low prenatal depression versus high 
postnatal depression), suggesting that it is the continuity in prenatal and postnatal 
environment that might confer an advantage for infants’ development, consistent with 
the PAR model. Lastly, a number of studies failed to detect any significant association 
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between maternal antenatal depression and child psychomotor development (Osborne 
et al., 2018; Santucci et al., 2014; Tse et al., 2010).  
 
1.2.2.3 Temperament and behavioural reactivity 
Most evidence points to an association between maternal antenatal depression 
and caregiver-reports measures of infants’ early temperamental traits, and in particular 
difficult temperament and negative affectivity (e.g. Rode & Kiel, 2016; Nomura et al., 
2014; Davis et al., 2007; Rouse & Goodman, 2014) between 2 and 6 months of age, 
after accounting for postnatal depression. However, null associations have also been 
reported (Rothenberger et al., 2011; Braithwaite et al., 2017; Werner et al., 2013; 
Kantonen et al., 2015). Furthermore, the majority of studies conducted on children 
aged 24-36 months failed to detect any significant effect of prenatal symptomatology 
(Lin et al., 2017; Bekkhus et al., 2011; Blair et al., 2011; though not all, Stroustrup et 
al., 2016).  
Very few studies examined the association between maternal depressive 
symptoms during pregnancy and observational measures of infants’ temperament and 
behavioral reactivity and these yielded mixed findings. Maternal depressive symptoms 
during pregnancy, but not postnatally, have been found to predict either greater (Davis 
& Schetter, 2004; Werner et al., 2007) or lower (Rothenberg et al., 2011) infant 
behavioral reactivity to novelty at 4-5 months of age, although non-significant 
associations have also been reported (Werner et al., 2013a). Moreover, Davis and 
colleagues (2011) found maternal depression in mid-late pregnancy to predict a slower 
behavioural recovery after the heel-stick soon after birth, while Swales and colleagues 
(2018) reported no effects of antenatal depression on pre-schoolers behavioural 






1.2.2.4 Emotional and behavioural problems  
Maternal antenatal depression is considered a risk factor for children’s socio-
emotional development and mental health. Several observational studies have now 
provided evidence for a significant association between prenatal depressive symptoms 
and children’s increased risk for attention and behavioural problems, internalizing and 
externalizing disorders and psychopathology from 1 to 10 years of age (Barker et al., 
2011; Luoma et al., 2001; Leis et al., 2014; Nulman et al., 2012; Gerardin et al., 2011; 
Lahti et al., 2017), after controlling for postnatal symptomatology. However, in a study 
by Leech and colleagues (2006) the association between prenatal depression and 
children’s depression and anxiety symptoms was no longer significant after accounting 
for postnatal predictors of children’s mental health. Similarly, in a large combined 
dataset from the Generation R and ALSPAC studies, the association between 
antenatal maternal depression and child inattention problems at 3-4 years of age was 
strongly attenuated (and in Generation R sample became non-significant) when 
postnatal depressive symptoms were taken into account (Van Batenburg-Eddes et al., 
2013). In addition, gender differences and timing effects in the association between 
prenatal maternal depression and anxiety and child behavioural problems have been 
reported (de Bruijn, van Bakel, & van Baar, 2009), with significant association early in 
pregnancy for boys, while later in pregnancy for girls. A recent meta-analyses by 
Madigan and colleagues (2018) including 73 studies showed that maternal depression 
during pregnancy is associated with children socio-emotional problems (i.e. difficult 
temperament, behavioral problems, behavioral dysregulation). In particular, children 
prenatally exposed to maternal depression were 1.5-2 times at greater risk of 
experiencing behavioral problems as compared to unexposed children. The effects 
were stronger for clinical depression as compared to self-reported symptoms and for 
children from socio-economic disadvantaged families. However, it is important to note 
that meta-analytic work only estimates the overall unadjusted effect size, and was not 
able to control for relevant covariates. 
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Available evidence suggests that the relationship between maternal antenatal 
depression and offspring psychopathology might persist into adolescence and 
adulthood. In a study based on the large dataset from the ALSPAC study maternal 
prenatal depression or anxiety was found to predict persistently higher behavioral and 
emotional problems from 4 to 13 years of age, independent of postnatal mood, with no 
attenuation of the effects into adolescence (O’Donnell et al., 2014). In addition, a 
higher risk for depression (Pawlby et al., 2009; Pearson et al., 2013), anxiety and co-
morbid anxiety and depression (Capron et al., 2015) in young adults aged 16-25 
prenatally exposed to maternal depression, independently of postnatal depression, 
has been reported. Similarly, findings from a large cohort of 3,099 mother–offspring 
pairs from the Mater University Study of Pregnancy in Australia showed that high 
levels of depressive symptoms in pregnancy predicted higher levels of internalizing 
problems at 14 years (Betts et al., 2014), internalizing and externalizing behavioral 
problems and greater self-reported symptoms at 21 years of age (Betts et al., 2015). In 
addition, exposure to maternal depression during pregnancy has been associated with 
a greater risk for conduct disorders and violent acts at 16 years of age (Hay et al., 
2010), after controlling for postnatal symptoms and parents’ antisocial behaviors, and 
with greater offspring externalizing, but not internalizing, problems at age 16 
(Korhonen et al., 2014).    
Gender effects in the association between antenatal depression and emotional 
problems have been reported also in adolescence, with Hay and colleagues (2008) 
and Quarini and colleagues (2016) showing significant and stronger associations in 
girls, as compared to boys. Furthermore, some studies showed that antenatal 
depression alone did not increase the risk of developing psychopathology in 
adolescence, while the exposure to both antenatal depression and childhood 
maltreatment (but not maltreatment alone) increased around 12 times the risk for a 
depressive or conduct disorder (Pawlby et al., 2011; Plant et al., 2013). 
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To sum up, mounting evidence points to a significant association between 
maternal antenatal depression and attention, emotional and behavioral problems in the 
offspring from early childhood to adulthood, although postnatal factors, including 
postnatal maternal depression, appear to account for some of the effects in a number 
of reports (e.g. Hay et al., 2010, Leech et al., 2006; Van Batenburg-Eddes et al., 
2013). 
 
1.2.2.5 Stress-related physiology and inflammation 
The fetal programming hypothesis proposes that maternal prenatal stress 
might alter the development of fetal biological systems and this in turn might be 
associated with altered behavioural and physiological outcomes later in life (Talge et 
al., 2007). In particular, it has been hypothesized that maternal antenatal stress might 
influence child development and increased later vulnerability for physical and mental 
health problems by altering the developing fetal stress response systems and immune 
system (Seckl & Holmes, 2007; Van den Bergh et al., 2017). A number of studies have 
assessed the effects of maternal antenatal depression on offspring stress-related 
physiology and, more specifically, on the functioning of the two main components of 
the stress response system, namely the Hypothalamic-Pituitary-Adrenal (HPA) axis 
and the Autonomic Nervous System (ANS). 
Several studies reported higher baseline cortisol levels in infants of prenatally 
depressed women (e.g. Brennan et al., 2008; Diego et al., 2004; Lundy et al., 1999; 
Osborne et al., 2018). Few prospective studies have evaluated samples of older 
children and these have found lower basal cortisol levels in children prenatally 
exposed to maternal depression (Laurent et al., 2013; Stonawsky et al., 2019), thus 
possibly suggesting that age-dependent effects might exist (Essex et al., 2011). This is 
also in line with the notion that, as part of an allostatic process, the “costs” associated 
with chronic HPA-axis activation may lead over time to an exhausted and down-
regulated HPA-axis, with a reduced cortisol output (Miller et al., 2007). While this has 
46 
 
been well-demonstrated in children and adults with a history of maltreatment (Fries et 
al., 2008; Miller et al., 2007), it still need to be empirically investigated in children 
exposed to maternal depression early in life.  
Evidence concerning an association between in utero exposure to maternal 
depression and children’s cortisol reactivity to stressors is inconsistent. Either positive 
(i.e. greater reactivity, e.g. Brennan et al., 2008; Swales et al., 2018) or negative (i.e. 
blunted reactivity, e.g.  Vedhara et al., 2012; Waters et al., 2013) or even U-Shaped 
(i.e. greater reactivity in infants exposed to the highest and lowest levels of maternal 
depression,  Fernandes et al., 2014) associations have been reported, while a number 
of studies failed to detect any significant associations (Azar et al., 2007; Davis et al., 
2011; Werner et al., 2013). In addition, two studies reported that maternal antenatal 
depression predicted heightened cortisol levels in girls but not in boys (De Brujin et al., 
2009; Giesbrecht et al., 2017), while recent findings by Osborne and colleagues 
(2018) showed greater cortisol response to inoculation in infants prenatally exposed to 
maternal depression at 12 months, but not at 2 months, suggesting that both infants’ 
gender and age might play a role in the association. Two recent investigations 
reported an association between maternal depression during pregnancy and greater 
infant cortisol reactivity, possibly mediated by epigenetic mechanisms involving, 
respectively, methylation of NR3C1 gene (Oberlander et al., 2008) and methylation of 
placental 11β-HSD2 (Stroud et al., 2016). 
To date, only two prospective studies have evaluated the association between 
maternal prenatal depression and offspring’s cortisol physiology at older ages. Data on 
a large sample from the ALSPAC study showed that maternal depression in late 
pregnancy was significantly associated with an alteration of cortisol diurnal patterning, 
as indexed by a reduced cortisol awakening response (CAR, O’Donnell et al., 2013). 
In contrast, a recent study, based on a smaller sample, provided no evidence for an 
association between maternal prenatal depression and CAR in 25 year olds adults 
(Plant et al., 2016). 
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Evidence concerning the functioning of the ANS in children prenatally exposed 
to maternal depression are scarce. Increased norepinephrine (noradrenaline) and 
decreased dopamine levels soon after birth have been found in infants of prenatally 
depressed women (Lundy et al., 1999, Field et al., 2004) and in newborns of women 
depressed both prenatally and postnatally (Diego et al., 2004). Cardiac measures of 
ANS functioning have been evaluated in a handful of studies. Lower Respiratory Sinus 
Arrhythmia (RSA), an index of Parasympathetic Nervous System (PNS) activity, in 
newborns of mothers with depressive symptoms in late gestation have been reported 
in an early study (Jones et al., 1997). However, no associations between maternal 
negative emotionality (measured by combining anxiety- and depression-related 
variables) both in early and late pregnancy and infant RSA were reported in a different 
study  (Ponirakis, Susman, & Stifter, 1998). In addition, no associations between 
maternal antenatal depression and infants’ heart rate variability have been reported at 
4 months (Kaplan, Evans, & Monk, 2009) and 14 months of age (Dieter et al., 2008). 
Similarly, in a large sample of mother-child dyads from the Generation-R study, no 
significant associations were found between maternal depressive symptoms at 16 
gestational weeks and preschoolers’ baseline heart rate and RSA (Van Dijk et al., 
2012). Thus, although the evidence is only preliminary, they do not seem suggestive of 
an altered functioning of the ANS in children of prenatally depressed women.  
Only a small number of studies to date has investigated the impact of maternal 
depression during pregnancy on the immune system functioning in offspring. Two 
studies reported an association between antenatal depression and altered immune 
parameters in newborns soon after birth (Kianbakht et al., 2013; Mattes et al., 2009). 
In particular, Kianbakht and colleagues (2013) reported an increased lymphocyte 
count and a decreased ratio of cord blood levels of immunoglobulins to maternal blood 
levels of immunoglobulins in newborns of prenatally depressed as compared to 
controls. Mattes and colleagues (2009) showed an association between maternal 
depressive symptoms at 20 gestational weeks and heightened immune 
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responsiveness in neonates, as indicated by higher cytokine production both 
spontaneously and stimulated by bacterial antigens and allergens. Furthermore, Plant 
and colleagues (Plant et al., 2016) found that antenatal exposure to maternal 
depression predicted increased offspring inflammation, as indexed by higher levels of 
C-Reactive Protein (CRP), at 25 years and that the effect was independent of later 
adverse experiences such as child maltreatment and adult diagnosis of mood disorder.  
In summary, while a dysregulation of the stress and inflammatory response 
systems in the offspring might be a mechanism underlying the impact of antenatal 
maternal stress on later mental and health outcomes, evidence for an association 
between prenatal maternal depression and neuroendocrine alterations in the offspring 
is complex and inconsistent. Although there is little research on immune functioning in 
offspring prenatally exposed to maternal depression, preliminary evidence suggest 
that this might represent a promising route to be explored.  
 
1.2.2.6 Functional and structural brain alterations   
A number of studies have evaluated whether antenatal exposure to maternal 
depression is associated with functional and structural alterations of the brain in 
offspring that, in turn, might explain the greater risk for behavioral and mental health 
problems.  
Early studies showed an association between antenatal maternal depression 
and an altered pattern of resting brain electrical activity as measured through 
electroencephalography (EEG) in infants soon after birth until 6 months of age (Field 
et al. 1995; Jones et al. 1997; Diego et al., 2004). In particular, greater activation in 
right-frontal cortex relative to the left, which is considered an early marker of 
behavioural inhibition and negative affectivity (Fox & Davidson, 1986), was observed 
in infants of prenatally depressed mother as compared to infants of healthy women. In 
addition, greater right frontal EEG asymmetry was particularly evident in newborns of 
depressed mothers showing concomitant severe anxious symptoms (Field et al., 
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2003). A recent study showed that not only a clinical diagnosed depressive disorder 
but also depressive symptoms in late pregnancy are associated with greater relative 
right frontal asymmetry in 2-day-old infants (Gustafsson et al., 2018). In contrast, 
prenatal depressive symptoms were not found to predict frontal EEG activity and 
functional connectivity in 6 and 18-month-olds, although an increase in maternal 
symptoms from pregnancy to 3 months after delivery was related to greater right 
frontal activity and relative right frontal asymmetry amongst 6-month-old infants (Soe 
et al., 2016). 
More recently, magnetic resonance imaging studies have begun to shed light 
on the neurobiological correlates of prenatal exposure to maternal depression. In 
particular, after controlling for postnatal maternal mood, women’s self-reported 
depressive symptoms during pregnancy have been associated with cortical thinning, 
particularly over the frontal lobe, in 2-5 year olds (Lebel et al., 2016) and in 6-9 year 
olds children (Sandman et al., 2015). Furthermore, maternal depressive symptoms 
during pregnancy were related to alterations of the microstructure of the amygdala 
(Rifkin-Graboi et al., 2013) and of amygdala functional connectivity with dorsal 
prefrontal cortex, bilaterally, in neonates at birth (Posner et al., 2016) and with cortico-
limbic circuits in 6-month-olds (Qiu et al., 2015) and 4.5 year-old girls (Soe et al., 
2018), as well as with greater right amygdala volume in preschool girls but not in boys 
(Wen et al., 2017). In contrast, a recent study did not show any gender differences in 
the association between prenatal depression exposure and larger right amygdala 
volume, but found that infant genotype moderated the association (Qiu et al., 2017). 
In summary, converging evidence demonstrates that in utero exposure to 
maternal depression (both alone and in interaction with infant gender and genes) is 
associated with different aspects of offspring brain development. In particular, 
antenatal maternal depression seems to be associated with differences in the 
development of frontal and limbic circuits, with possible implications for later emotion 
regulation and the development of psychopathology. In addition, initial data suggest 
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that gender and timing effects deserve further exploration, with preliminary evidence of 
stronger associations in girls (Soe et al., 2018, Wen et al., 2017), and in mid 
pregnancy (i.e. in gestational week 17 but not 11 or 32, Lebel et al., 2006). 
 
1.2.3 The differential effects of antenatal maternal anxiety on child outcomes 
One issue that research has only begun to address is whether different types 
of antenatal maternal stress have greater effect than others on fetal development. 
More specifically, the unique and specific effect of maternal antenatal 
psychopathology, such as depression, as compared to anxiety, is still unknown. Few 
studies examined both antenatal maternal anxiety and depression in the same sample. 
As anxiety and depression are quite strongly co-morbid or correlated, marked 
differences between anxiety and depression predictions might be unlikely, and indeed, 
comparable associations between anxiety or depression and child outcomes have 
been reported (e.g. Davis et al., 2011; Werner et al., 2013; O’Donnell et al., 2013).  
However, there are also studies reporting conflicting results. For example, 
Barker and colleagues (2011) reported a broader effect of prenatal maternal 
depression on child functioning, as compared to maternal anxiety. Specifically, 
prenatal depressive symptoms predicted both a small increase in children’s 
externalizing problems and decrease in verbal intelligence quotient (IQ), whereas 
maternal anxiety predicted only an increased risk for child internalizing difficulties. 
Similarly, Lin and colleagues (2017) reported significant prospective associations 
between maternal antenatal depression, but not anxiety, and toddler’s cognitive 
development. In contrast, Ibanez and colleagues (2015), found a significant inverse 
association among maternal antenatal anxiety, but not depression, and children’s 
cognitive performances at 2 and 3 years of age. Likewise, data from the ALSPAC 
study suggested a stronger effect of maternal anxiety than depression on children’s 
behavioral problems (O’Connor, Heron, & Glover, 2002; O’Connor et al., 2003). 
Recently, a meta-analysis by Madigan and colleagues (2018) obtained a stronger 
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effect for maternal antenatal depression versus anxiety on infants’ socio-emotional 
development. O’ Connor and colleagues (2005) found that prenatal anxiety symptoms, 
but not depressive, predicted children’s cortisol diurnal pattern at 10 years of age. 
Similarly, Grant and colleagues (2009) reported maternal prenatal anxiety, rather than 
depression, predicting 7-month-olds cortisol reactivity. 
Methodological issues might account for these conflicting findings. For 
example, while self-report measures of depressive symptoms during pregnancy often 
inquire about the past week, anxiety is sometimes evaluated using “trait” measures 
that assess general functioning. However, there are also possible theoretical 
explanations for the differential association between prenatal depression versus 
anxiety and child outcomes. Indeed, while maternal anxiety and depression are often 
assumed to be part of the same underlying construct of antenatal stress, it is largely 
unknown the extent to which they are related to different alterations of relevant intra-
uterine biological systems during pregnancy, thus possibly affecting fetal development 
in different ways. Future studies should clarify the prenatal risk phenotype that might 
be more implicated in fetal/child development, as well as elucidating the specific 
underlying mechanisms.  
 
1.3 Critical issues  
1.3.1 Threats to causality 
Many independent prospective studies from different countries around the 
world have now demonstrated a significant link between antenatal maternal 
depression and child developmental outcomes in humans, suggesting that this should 
be a major area for future research. The diversity of outcomes linked to antenatal 
depression exposure is impressive and, although few studies included long follow-up 
periods, there is evidence to suggest that antenatal maternal depression exerts 
persisting effects on offspring’s behaviour and physiology (e.g. O’Donnell et al., 2013), 
thus pointing to antenatal maternal depression as a broad risk factor for child 
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development. Notwithstanding the substantial evidence base linking antenatal 
maternal depression to child outcomes, proving that this association is truly causal and 
that fetal programming is actually occurring is challenging. This is mainly because 
while the observational designs used in human studies to a certain extent informed us 
on the temporal order of risk factors (i.e. antenatal maternal depression) and child 
outcomes, it does not allow us to draw causal conclusions. Inevitably, there are a large 
variety of confounds, ranging from maternal diet during pregnancy to postnatal 
environmental factors to shared genetics, that could be linked to both maternal 
depression and offspring outcomes and cause spurious associations (Rothman, 
Greenland, & Lash, 2008). Furthermore, as depression during pregnancy is a strong 
predictor of postnatal depression, continuity of exposure over time might make it 
difficult to disentangle the risk effect of exposure in utero from later postnatal 
exposures.  
An increasingly adopted approach is to include the assessment of as many 
potential confounders as possible. However, even then it is not possible to test for all 
possible confounders, thus unmeasured confounding factors and measurement error 
in the evaluation of confounding factors may lead to residual confounding that can 
never be completely ruled out in observational studies (Rice et al., in press; Gage et 
al., 2016). These kinds of studies have shown that the association between antenatal 
maternal depression and child outcomes remains consistent even after controlling for 
many confounding factors, such as prenatal smoking and alcohol consumption, 
socioeconomic status or postnatal maternal symptomatology (e.g. O’Donnell et al., 
2013; O’Connor et al., 2013). Moreover, studies showing a link between antenatal 
depression and neonatal outcomes evaluated soon after birth (e.g. Davis et al., 2011) 
or adoption-after-birth studies (e.g. Laurent et al., 2013), although limited, have shown 
the true effects of antenatal maternal depression, independent from postnatal effects 
(but not from genetic confounds).  
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A number of studies have attempted to control for shared genetic background 
between mother and child that could underlie both maternal symptoms and child 
behaviour, by using different approaches, including genetically informed designs. 
These studies have begun to provide initial evidence suggesting that the link between 
prenatal maternal depression and child development is at least partially independent 
from genetics. For example, Rice and colleagues employed an in vitro fertilization 
prenatal cross fostering design, comparing mother-child dyads who were genetically 
related to those who were not, in order to control for maternal heritable factors (Rice et 
al., 2010). They found a significant association between maternal stress and child 
conduct problems, but not on child ADHD or anxiety, in unrelated dyads after 
controlling for postnatal symptoms, consistent with it being a true prenatal effect. Other 
studies compare maternal prenatal exposure with paternal prenatal exposures (Smith, 
2008), so that if a true intrauterine effect underlies the link between exposure and child 
outcomes, a stronger association with maternal exposure, rather than paternal 
exposure, would be expected. Conversely, similar associations among child outcomes 
and either maternal or paternal exposures, would indicate that alternative factors, 
including genetic and environmental factors are likely to underlie the observed 
associations. Using this approach, a stronger association between maternal 
depression, as compared to paternal depression, was found for child attention 
problems in the ALSPAC cohort, providing some support for a direct intrauterine 
mechanism underlying the association; however, such an effect was not observed in 
the Generation R cohort (Van Batenburgh-Eddes et al., 2013). Alternative designs, 
such as sibling comparison designs or twin designs, where unexposed siblings or 
twins are used as “control” matched to exposed individuals, have not yet been widely 
employed in this field (e.g. Knopik et al., 2016). 
Studies on the effects of prenatal exposure to natural disasters, which are 
presumably randomly distributed with respect to genetics (e.g. King et al., 2012; 
Yehuda et al., 2005; Huiznik et al., 2007), provide further evidence that the effects of 
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prenatal stress are not just due to genetic vulnerabilities. Moreover, studies examining 
biological mechanisms possibly underlying the association between maternal 
antenatal depression and child outcomes (e.g. Oberlander et al., 2008; Stroud et al., 
2016) are starting to uncover intra-uterine mechanisms involved in fetal programming, 
which lends further credibility to the hypothesis that the association represents a true 
exposure effect. 
Lastly, research on the effectiveness of interventions specifically designed to 
reduce maternal antenatal depression on child outcomes could help to establish 
whether the link between prenatal depression and offspring outcomes is truly causal. 
As limited knowledge exists to date concerning the potential effects of antidepressants 
on the developing fetus (reviewed in El Marroun et al., 2014) and there is limited 
acceptance of pharmacological treatments during pregnancy  (Freeman, 2007), it is 
important to elucidate the effects of psychological treatment of antenatal depression 
on child development. However, to date, there are surprisingly few randomized 
controlled trials (RCTs) on the effectiveness of psychological therapy for maternal 
prenatal depression on infant outcomes. Rahman and colleagues (2008) examined the 
impact of cognitive-behavioral therapy aimed at reducing maternal depression both 
prenatally and postnatally on child development. While a significant impact of 
intervention on parenting practices was found, the focus on both the ante- and 
postnatal periods does not allow to disentangle the specific effects of prenatal 
treatment of depression. Two different studies examined the impact of cognitive-
behavioral therapy for antenatal depression on infant outcomes, respectively, at 2 
months (Netsi et al., 2015) and 9 months (Milgrom et al., 2015) after delivery in two 
independent pilot RCTs. Although differences between treatments groups on infant 
outcomes did not reach the statistical significance in the study by Netsi and colleagues 
(2015), an improvement in depression scores during pregnancy was related to “easier” 
infant temperament and shorter sleep duration in the cognitive-behavioral therapy 
group but not in the control group. Similarly, Milgrom and colleagues (2015) reported 
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better infant outcomes in the intervention group, as compared to controls, concerning 
infant self-regulation, problem solving and negative affectivity.  
Beside the scientific significance of testing whether the observed associations 
between maternal antenatal depression and offspring outcomes are causal, these 
studies have important clinical implications for early intervention with at risk mother-
child dyads. Interventions aimed at reducing prenatal risk factors, such as depressive 
symptoms, will be effective in promoting child development only if there is a true 
causal link between prenatal exposure and child outcomes. Thus, more research is 
needed to inform treatment development regarding the timing and target of 
interventions so that pregnant women and health practitioners can be provided with 
accurate and clear guidance and effective support.  
 
1.3.2 Gestational windows of vulnerability 
While timing of exposure appears to be important in fetal programming, little is 
known about the most sensitive time in gestation for all the effects previously 
described. Effects of antenatal maternal stress on child outcomes have been reported 
throughout gestation and different studies have shown different periods of vulnerability 
to the influence of prenatal depression, or more general stress. For example, studies 
on the risk for schizophrenia indicated that the most sensitive period for prenatal stress 
exposure was the first trimester (e.g. Khashan et al., 2008). Maternal stress both 
during the first and second trimesters of pregnancy have been found to affect cognitive 
development (e.g. Laplante et al., 2004; Velders et al., 2011). Strongest effect of 
antenatal maternal stress on birth outcomes (e.g. Cherak et al., 2018), HPA axis 
reactivity (e.g. Davis et al., 2011; Vedhara et al., 2012; Yehuda et al., 2005) and 
offspring’s emotional problems (reviewed in Rice, Jones, & Thapar, 2007) have tended 
to be reported in late pregnancy as compared to earlier exposure.  
These differences in timing, if they are reliable, are likely to depend on the 
outcome examined and the stage of development of the relevant brain circuit or 
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function. It is well-established that different organ systems develop along different time 
courses. Periods of greater development and rapid growth are considered windows of 
increased sensitivity to environmental stimuli and insults (Drake & Walker, 2004; Seckl 
& Meaney, 2004). Thus, it is possible that environmental signals, such as changes in 
nutrition, hormonal balance etc., at a particular developmental stage may interfere with 
the development of some organs but not others (Grossman et al., 2003).  
Fetal magnetic resonance imaging has now shown that the fetal brain 
undergoes rapid growth and development across pregnancy, changing approximately 
17-fold its relative size from mid to late gestation (Huang et al., 2006; 2010), making 
the fetal brain particularly vulnerable to environmental insults. Brain regions develop at 
different times and the processes involved followed a well-defined discrete time course 
which include neurogenesis, neuronal migration and differentiation, synaptogenesis, 
the development of non-neuronal components (glia, myelination, cerebrovasculature) 
and apoptosis (Grossman et al., 2003). Despite the fact that these processes are 
largely driven by genetic influences, especially early in development, there are critical 
periods of vulnerability for each process during which they are more sensitive to 
environmental perturbation, so that even a minor environmental deviation could disrupt 
these developmental processes and have substantial effects on the outcome 
(reviewed by Rice & Barone, 2000). Thus, for example, severe stress exposure early 
in gestation might increase the risk for schizophrenia (Kashan et al., 2008) because it 
alters the processes of neuronal migration, which is also hypothesized to be 
compromised in schizophrenia. In contrast, late pregnancy is characterized by rapid 
growth and development, including synaptic migration and the beginning of synaptic 
differentiation. Alterations in these processes may impact upon the risk for later 
psychopathology (Rice et al., 2007).  
However, the major issue for research into the timing effects of prenatal 
exposure on child outcomes is that it is obviously not ethically possible to 
experimentally introduce a stressor at a specific gestational point and the usual study 
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designs do not us allow to determine the onset and offset of the prenatal stress 
experience. Thus, there is limited leverage for testing a timing effect and it is hard to 
disentangle whether the observed associations are specific for the selected gestational 
windows or might be the result of a continuous prenatal exposure combined with 
measurement error. For example, maternal reports of anxiety and depression are 
characterized by their chronicity and by high levels of within-individual stability 
throughout pregnancy (Dipietro, Costigan, & Sipsma, 2008). Thus, the prenatal stress 
exposure it is likely to be relatively continuous over gestation rather than discrete. A 
special case concerns studies that capitalized on acute stress events, such as natural 
disaster, in order to study timing effects (e.g. King et al., 2012; Yehuda et al., 2005). 
However, duration and timing of prenatal stress exposure is still likely to be 
confounded in these studies with women experiencing the event earlier in pregnancy 
being affected for a greater percentage of gestation than those exposed later.  
Additionally, while findings suggest that both males and females are 
susceptible to the organizational influences of antenatal stress, it has been shown that 
the patterns of effects may differ depending on the gestational time windows and type 
of outcomes examined (e.g. De Brujin et al., 2009), thus suggesting that sex 
differences in the processes underpinning the effects of antenatal stress on child 
development might exist (Glover & Hill, 2012). 
 
1.3.3 Postnatal environmental moderation  
It is widely recognized that postnatal experiences, and particularly those 
involving mother-child interaction, play a crucial role in shaping child developmental 
trajectories (Grossman et al., 2003; Tottenham, 2017), inducing neurobiological, 
epigenetic, and behavioral adaptations (Monk, Spicer, & Champagne, 2012; Maccari 
et al., 2014). In particular, maternal sensitivity, defined as the caregiver’s ability to 
detect and respond in a timely and accurate manner to infants’ cues (Ainsworth et al., 
1978), is considered one of the most powerful forces on early child development 
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(Tottenham 2017), exerting widespread and long-lasting effects on several domains, 
such as attachment (e.g. Verhage et al., 2016), physiological regulation (e.g. Conradt 
et al., 2016), social and emotional development (Kok et al., 2013; Leerkes, Blankson, 
& O’Brien, 2009; Raby et al., 2015), academic achievement (e.g. Raby et al., 2015), 
and physical health (e.g. Anderson et al., 2011). Thus, research into fetal 
programming of later outcomes needs to account not only for prenatal effects but also 
for postnatal factors, related for example to postnatal symptomatology and postnatal 
maternal care.  
As previously mentioned, antenatal depression is one of the strongest 
predictors of postnatal depression (e.g. Heron et al., 2004) and exposure to maternal 
depression during the first years of life has been shown to be related to lower maternal 
sensitivity (Bernard et al., 2018) and to adversely impact child behaviour (e.g. 
Ashman, Dawson, & Panagiotides, 2008; Bureau, Easterbrooks, & Lyons-Ruth, 2009), 
stress-related physiology (e.g. Murray et al., 2010) and brain development (e.g. Lupien 
et al., 2011). A recent study reported substantial continuity in maternal anxiety and 
depressive symptoms, as well as in family disharmony, from pregnancy to 18 months 
after delivery (Bekkhus et al., 2011) suggesting that prenatal influences are strongly 
associated with similar postnatal experiences. To the extent that exposure to 
environmental adversity continues from prenatal to postnatal life, it might confound 
fetal programming effects. Thus, on the one hand, continued exposure to adversity 
might occur, with antenatal depressive symptoms persisting or recurring after birth and 
influencing the quality of maternal care and in turn, infant’s development. On the other 
hand, it is also possible that the early postnatal environment, such as the quality of 
maternal care, moderates the link between in utero exposure to maternal depression 
and child outcomes.  
Despite several studies having accounted for the effects of postnatal 
symptomatology (e.g. O’ Donnell et al., 2013), other postnatal environmental factors 
such as the quality of maternal caregiving has been largely neglected. First of all, 
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whether poor maternal parenting in the early postnatal period completely or partially 
mediates the link between prenatal depression and child outcomes has only been 
rarely addressed (Monk et al., 2012). Endendijk and colleagues (2005) found no 
association between prenatal maternal distress and maternal sensitivity, thus 
precluding testing mediation by maternal care in the link between antenatal distress 
and child behavioral problems. Similarly, maternal antenatal depressive symptoms 
were not found to be associated with maternal parenting quality (Hayes, Goodman, & 
Carlson, 2013) and mother-infant attachment (Tharner et al., 2012) in two studies. 
Thus, to date, no empirical support for a mediation role of maternal parenting in the 
link between antenatal depression and child outcomes has been found, although more 
research is needed to explicitly test this hypothesis.  
In addition, little is known about the moderating role of early postnatal care in 
the link between maternal prenatal stress or depression and child outcomes. 
Considerable evidence from animal models provides evidence that the effects of 
prenatal stress may be moderated and even reversed by positive postnatal rearing 
(e.g. Maccari et al., 1995). Meaney and his group have clearly demonstrated how 
variations in maternal care can have long lasting influences on offspring behaviour and 
physiology. For example, rodent models showed that even brief periods of postnatal 
handling or mother licking and grooming cause long-lasting decreases in offspring’s 
anxious behaviors and stress reactivity (reviewed in Meaney, 2001). It has been 
shown that postnatal handling or increased maternal care can reverse prenatal stress-
induced alterations in spatial memory performance and stress reactivity (Brabham et 
al., 2000) or hippocampal neurogenesis (Lemaire et al., 2006). In addition, adoption 
after birth was found to completely reverse the effects of prenatal stress on HPA axis 
function (Maccari et al., 1995), while prolonged maternal separation was associated 
with a significant increase in HPA axis reactivity to acute stress in prenatally-stressed 
rats (Plotsky & Meaney, 1993). Although many of these mechanisms are likely to 
occur in humans too, several differences between humans and animal models make 
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difficult to generalize findings. What animal research highlights is that the period of 
sensitivity or programming extends well beyond the prenatal period, thus suggesting 
that the interaction between prenatal and postnatal environmental factors in 
influencing developmental trajectories should be a major area of inquiry in humans 
too.  
Initial findings in humans have suggested an interplay between prenatal and 
postnatal environment. For example, socio-economic status was found to moderate 
the effects of low birth weight on behavioral problems in childhood and adolescence 
(Kelly et al., 2001; Bohnert & Breslau, 2008). Similarly, positive maternal care 
eliminated the association between low birth weight and both child ADHD symptoms 
(Tully et al., 2004) and hippocampal volume in adulthood (Buss et al., 2007). While 
these preliminary findings are interesting, it is noteworthy that birth weight is only a 
proxy of intrauterine conditions. 
Similarly, a small set of studies has evaluated the impact of tactile stimulation, 
such as maternal stroking, over the first weeks of life in the association between 
prenatal anxiety or depression and infant outcomes. It was shown that maternal 
stroking moderated the effects of prenatal stress on children’s physiological and 
behavioural reactivity at 7 months (Sharp et al., 2012), internalizing symptoms at 2.5 
years (Sharp et al., 2015) and internalizing and externalizing behaviors at 3.5 years 
(Pickles et al., 2017), suggesting an effect of early maternal behaviors strikingly similar 
to that reported in animal models.   
A limited number of studies examined the influence of maternal care in 
moderating the effects of prenatal maternal stress on child development. The quality of 
maternal care has been found to moderate the effects of prenatal maternal anxiety 
(Grant et al., 2010) and cortisol (Bergman et al., 2010) on infant cognitive 
development. In the Queensland Flood Study, maternal structuring, defined as the 
caregiver’s ability to scaffold the child’s activity, but not sensitivity, interacted with 
antenatal exposure to the natural disaster to predict language development at 30 
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months of age (Austin et al., 2017). Furthermore, the quality of early maternal 
caregiving moderated the influence of self-reported stressful life events during 
pregnancy on child fearfulness (Bergman et al., 2008), the influence of prenatal 
psychiatric diagnosis on 4-month-olds’ baseline cortisol levels (Kaplan et al., 2009) 
and the effects of prenatal anxiety on 7-month-old behavioural reactivity to the still-
face procedure (Grant et al., 2010b). Lastly, in one study maternal sensitivity appeared 
to influence the link between maternal depression/anxiety during pregnancy and 
internalizing problems in 2-5 year olds girls, but not boys (Endendijk et al., 2005). 
Nevertheless, no effects of maternal care in the link between prenatal stress and child 
outcomes, such as cortisol reactivity (e.g. Grant et al., 2009), heart rate variability 
(Kaplan et al., 2009) and impulse control (Graham et al., 2017), have also been 
reported.  
The limited number of studies and considerable methodological variations 
among them, concerning the assessment of prenatal stress (i.e. self-reported stress 
symptoms, psychiatric diagnosis, natural disaster or stress hormones levels), maternal 
care (i.e. maternal sensitivity, structuring or mother-infant attachment) and age of the 
child does not allow us to draw clear conclusions. However, taken together, data 
suggest that the consequences of prenatal stress exposure on child development may 
be at least partially dependent on the quality of the postnatal environment, in line with 
the PAR model. 
Recently, it has been proposed that prenatal experiences might actually affect 
infant susceptibility to the influences of their postnatal environment in a process that 
has been described as “prenatal programming of postnatal plasticity” (Pluess & 
Belsky, 2011) or “meta-plasticity” (O’Donnell & Meaney, 2017). In this sense, antenatal 
adversity would not influence any specific outcome, but rather the degree of 
developmental plasticity or susceptibility to subsequent positive or negative 
environmental influences. However, this hypothesis is only beginning to be addressed. 
In the study noted above by Grant and colleagues (2010a), a positive association 
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between maternal sensitivity and cognitive development was found among infants 
prenatally exposed to maternal anxiety but not among controls. In a subsequent study 
the authors (Grant et al., 2015) found that the effects of socioeconomic status on long-
term memory were greater among children prenatally treated with synthetic 
glucocorticoid treatment. In particular, memory impairments were reported only in 
those children who experienced both fetal glucocorticoid exposure and postnatal 
sociodemographic adversity (Grant et al., 2015). However, antenatal glucocorticoid 
exposure was not associated with enhanced memory performance in the context of 
low sociodemographic risk, as a developmental plasticity effect would predict (Belsky 
& Pluess, 2009). 
 
1.3.4 Genetic moderation  
As noted already, beside postnatal environmental factors, genetic factors 
potentially confound the association between prenatal maternal stress and offspring 
behaviour. However, as previously mentioned, studies using genetically informative 
designs or other controls (e.g. paternal versus maternal stress measures) provide 
some evidence to suggest that effects of prenatal maternal stress on child outcomes 
exist independently of genetic factors.  Another important role for genetics, however, 
might be in making some individuals particularly vulnerable to the influence of prenatal 
environment (Pluess & Belsky, 2011). There is now increasing evidence pointing to an 
interplay between genes and intrauterine exposure to maternal stress in influencing 
offspring’s neurodevelopment. For example, it has been found that the polymorphism 
in the serotonin transporter promoter gene (5-HTTLPR), which has been found to 
moderate the effect of adverse early environment on a range of outcomes (e.g. Barry, 
Kochanska, & Philibert, 2008), also moderates the effects of prenatal anxiety on 6-
month-olds negative emotionality (Pluess et al., 2011). In particular, infants carrying 
the short allele, which has been regarded as the “plasticity gene” (Jay Belsky & 
Pluess, 2009), were more affected by maternal anxiety during pregnancy, showing 
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more negative emotionality. Similarly, the monoamine oxidase functional A (MAOA) 
functional polymorphism moderated the impact of maternal stressful life events during 
pregnancy on negative emotionality in response to the NBAS when measured a few 
weeks after birth (Hill et al., 2013). Other studies reported that dopamine gene 
variants, such as the polymorphism for receptor D4 (DRD4) gene, interacted with 
maternal prenatal stress to predict offspring aggressive and antisocial behaviour in 
childhood (Zohsel et al., 2014) and adulthood (Buchmann et al., 2014) and with 
maternal smoking during pregnancy in influencing boys’ externalizing behaviors 
(O’Brien et al., 2013).  
 In summary, while there is evidence that the associations between prenatal 
adversity and offspring neurodevelopment is at least partially independent from 
genetics (e.g. Rice et al., 2010) or postnatal (e.g. Davis et al., 2011) influences, initial 
evidence suggests that gene x prenatal environment interactions might affect 
physiological and behavioural outcomes in later life. In light of the significant influences 
of genetic and postnatal environmental factors in determining individual developmental 
trajectories, there is a need for prenatal programming models to account for this 
complexity by including genetic and postnatal environmental pathways, as well as their 
interactions. 
 
1.4  Biological mechanisms underlying fetal programming  
The data reviewed above shows that there is consistent evidence for an 
association between maternal antenatal stress, and more specifically depressive 
symptoms, and a wide range of physiological and behavioral alterations in offspring. In 
addition, increasing evidence suggest that the impact of maternal antenatal stress on 
child development depends on timing of exposure and gender, and might be 






Figure 1.1 - A schematic representation of the principal proposed pathways linking 
maternal antenatal stress with offspring’s neurodevelopmental outcomes.The wider line 
depict the association between antenatal maternal symptoms of depression, anxiety or 
stress and child outcomes for which there is strong evidence. Thin boxes indicate 
possible pathways underlying the well-established association. While for schematic 
purposes pathways are depicted in separate boxes, they are likely to interact at different 
stages. Genetic and epigenetic mechanisms will not be the focus of the current 
dissertation, however, they represent an important potential pathway linking antenatal 
maternal stress with offspring’s neurodevelopmental outcomes. The model also 
highlights factors that can moderate the impact of antenatal maternal stress on child 
outcomes at different stages (in the dashed thin box). In the current dissertation the 
moderating role of postnatal maternal care will be investigated, although all these 
factors merit greater emphasis in future research. 
 
Studies using genetically informed designs or assessing infants soon after birth 
indicate that some of these associations may be independent from genetic or postnatal 
environmental influences, suggesting that intrauterine mechanisms of fetal 
programming are at work. Despite great effort directed toward elucidating these 
mechanisms, it is still largely unknown how maternal antenatal distress is actually 
“transferred” to the fetus to influence fetal development. Stress-induced increases in 
maternal cortisol levels have traditionally been considered the candidate mediator of 
maternal stress transfer to the fetus (e.g. Cottrell & Seckl, 2009). However, other 
potential mediators have been proposed, including catecholamines, cytokines, 
serotonin and tryptophan, maternal microbiota, as well as placental and epigenetic 
mechanisms (Rakers et al., 2017).  
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The current dissertation focuses on the examination of three intrauterine 
mechanisms possibly underlying the link between antenatal maternal depression and 
altered outcomes in offspring, involving the major stress responsive systems, namely 
the HPA axis, the SNS and the IRS, as depicted in Figure 1.1. While these 
mechanisms will be reviewed separately, they are not likely to be alternative to each 
other; rather, it can be hypothesized that maternal-stress transfer arises from the 
combined effect of several different mechanisms acting together in a synergistic way. 
In particular, under stress conditions, a coordinated physiological response is 
activated, involving several levels of the central nervous system, including the 
autonomic, neuroendocrine, and immune system components (Lupien et al., 2009). All 
these systems are affected by stress and, in turn, affect each other within an efficient 
and evolutionarily-conserved stress response system. In addition, they are also 
implicated in the pathophysiological changes that occur in response to chronic stress 
(Lupien et al., 2009).  
The functioning of all these systems is substantially altered during pregnancy 
(e.g. Sherer, Posillico, & Schwarz, 2017; Christian, 2012). These adaptations are 
thought to support fetal growth and development, while preventing both the mother 
and fetus from excessive exposure to stress hormones and stress-related 
physiological alterations (Christian, 2012a). Thus, individual differences in 
physiological adaptations during pregnancy may have important consequences for 
both maternal health and fetal development.  
Before discussing in details the possible mechanisms of fetal programming and 
the available evidence, a brief overview of the functioning of the stress and 
inflammatory response systems and of the changes undergoing during the perinatal 






1.4.1 The HPA axis  
The hypothalamus–pituitary-adrenal (HPA) axis is an integrated neural and 
endocrine system that is involved in several physiological processes (Michael & 
Papageorghiou, 2008) and, along with the sympathetic adrenomedullary (SAM) 
system, is a key component of the stress response systems in mammals.  
Under stress conditions, whether psychological or physical, several brain areas 
are activated to recruit the hypothalamus and more specifically, the paraventricular 
nucleus (PVN) which, in turn, activates the hormonal cascade of the HPA axis 
(McGowan & Matthews, 2018), as shown in Figure 1.2. In particular, the PVN releases 
corticotrophin-releasing hormone (CRH), arginine-vasopressin (AVP) and oxytocin 
(Sawchenko et al., 1996). CRH and AVP stimulates the secretion of 
adrenocorticotrophic hormone (ACTH) from the anterior pituitary and the subsequent 
release of glucocorticoids from the adrenal cortex into the bloodstream (Godoy et al., 
2018).  
The main glucocorticoid in humans is cortisol (corticosterone in rodents). Once 
released, cortisol acts in the brain by binding to glucocorticoid (GR) and 
mineralocorticoid (MR) receptors, and exerts negative-feedback control over the 
activity of the HPA axis, in order to prevent detrimental consequences related to a 
prolonged and excessive stress response (de Kloet, 1991; Joëls & Baram, 2009). 
Glucocorticoids exert their effects on neurons expressing GRs and MRs 
through genomic and non-genomic mechanisms (de Kloet & Sarabdjitsingh, 2008; 
Groeneweg et al., 2012; Joëls, Sarabdjitsingh, & Karst, 2012). As compared to GRs, 
MRs show higher affinity for glucocorticoids but are expressed in fewer areas of the 
brain, while GRs are abundant and widely expressed throughout the brain (De Kloet et 
al., 2005). As a result, under basal conditions, high affinity MRs are occupied, while 
GRs are largely free. Under stress conditions or during the peak phase of the diurnal 
cycle, GRs also are partially occupied (Kitchener et al., 2004). Notably, it has been 
shown that GR gene expression, and consequently HPA axis function, can be 
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modulated by environmental experiences through epigenetic mechanisms (Buschdorf 
& Meaney, 2011) both in animals (Weaver et al., 2004) and in humans (Palma-Gudiel 
et al., 2015). In addition, GRs and MRs have been found to be implicated in regulation 
of cortisol levels throughout the day, as shown in clinical pharmacological studies (e.g. 
Otte et al., 2010).  
 
Figure 1.2 -Schematic representation of the Hypothalamic-Pituitary-Adrenal (HPA) axis 
functioning (from Lupien et al., 2009) 
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1.4.1.1 Cortisol  
Cortisol is a steroid hormone which constitutes the end product of the HPA axis 
in humans. Cortisol plays an essential function in maintaining health and well-being 
and supporting several physiological processes, including immunity, growth, 
reproductive function as well as cognitive and affective processes (de Kloet, Oitzl, & 
Joëls, 1999). In addition, cortisol exerts a central role in preparing the organism to 
successfully respond to stress by mobilising energetic resources, shutting down 
nonessential physiological systems, and coordinating behavioural responses (Johnson 
et al., 1992). The acute cortisol stress response is characterized by peak levels 10-20 
minutes after the stressor, followed by a recovery to baseline levels (Figure 1.3B). 
Although cortisol stress response is adaptive in the short term, prolonged or extreme 
HPA axis activation can have detrimental effects on the organism.  
 
Figure 1.3 - A) Salivary cortisol and alpha amylase diurnal concentrations; B) Salivary 
cortisol acute stress response (adapted from O' Donnell et al., 2009) 
 
Cortisol follows a distinctive circadian rhythm; as shown in Figure 1.3A, the 
lowest levels in late evening are followed by an increase towards the end of the sleep-
cycle which peaks approximately 30 minutes after awakening and then gradually 
declines throughout the day. The naturally occurring increase of about 50–75% in 
cortisol levels as a response to awakening (Pruessner et al., 1997) has been termed 
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Cortisol Awakening Response (CAR). The CAR is a distinct component of cortisol 
diurnal rhythm which has been increasingly studied as it is thought to represent a 
useful marker of HPA axis function (Clow et al., 2010).  
 
1.4.1.2 The HPA axis during the perinatal period  
Regulation of the maternal HPA axis changes dramatically during pregnancy 
and the early postpartum period. In particular, plasma concentrations of CRH, ACTH 
and cortisol increase progressively across gestation, resulting in gradual hypertrophy 
of the pituitary and adrenal glands (Mastorakos & Ilias, 2003). Levels of salivary 
cortisol (reflecting the unbound fraction of the hormone, Obel et al., 2005) begin to rise 
steadily from the 25th week of gestation and reach around three-fold the non-pregnant 
levels in the third trimester (Jung et al., 2011; Allolio et al., 1990). As shown in Figure 
1.4, the substantial changes in the HPA axis during pregnancy are mainly driven by 
the growth and development of a new organ, the placenta. During the second and third 
trimester of pregnancy, large quantities of CRH are also produced by the placenta 
(Petraglia et al., 1993), with circulating levels of CRH, as detected in plasma, reaching 
up to 1000-fold increase by the end of gestation (Lindsay & Nieman, 2005). Plasma 
CRH is considered a marker of the ‘placental clock’ which sets the timing of parturition 
(McLean & Smith, 2001). Notably, placental CRH (pCRH) and hypothalamic CRH 
(hCRH) are structurally and biochemically similar (Petraglia et al., 1996) and pCRH 
stimulates the secretion of ACTH from maternal anterior pituitary and, in consequence, 
production of cortisol from the adrenal glands. However, differently from the negative 
feedback effect at the hypothalamic level, maternal cortisol exerts a positive effect on 
pCRH synthesis creating a positive “HPA-axis-placental feed-forward drive”, leading to 
dramatic elevations in ACTH, pCRH and cortisol across gestation (Mastorakos & Ilias, 






Figure 1.4 - Changes in the maternal HPA axis during pregnancy and possible effects of 
fetal cortisol overexposure. Placental CRH (pCRH) stimulates both the maternal pituitary 
and adrenal, leading to increased cortisol production. Increased cortisol levels, in turn, 
further stimulate pCRH production. Placental enzyme 11β-HSD2 partially inhibit cortisol 
passage through the placental barrier (from Duthie & Reynolds, 2013) 
 
Despite all these functional changes, the diurnal cortisol secretion pattern, 
including the CAR, is largely maintained across gestation, with a steep increase after 
awakening, peaking approximately 30 minutes after awakening, and gradually 
decreasing throughout the day (Allolio et al., 1990; De Weerth & Buitelaar, 2005; 
Kivlighan et al., 2008; Hellgren et al., 2013).However, as pregnancy progresses, 
increased circulating levels of cortisol downregulate the secretion of hCRH, thus 
leading to a dampened responsiveness of the HPA axis to both psychological and 
physical stressors (Kammerer et al., 2002; De Weerth & Buitelaar, 2005). This 
physiological change is considered to be adaptive in that it prevents potential 
detrimental consequences of foetal exposure to heightened levels of maternal 
glucocorticoids and promotes maternal anabolic adaptations that are necessary for a 
successful pregnancy (Brunton, 2010). 
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The process of parturition is associated with a substantial increase in maternal 
cortisol. Soon after delivery, the sharp drop in pCRH levels following the expulsion of 
the placenta exposes the maternal HPA axis to severe perturbations. While plasma 
CRH, cortisol and ACTH levels decline after birth, returning to pre-pregnancy values 
within 1-4 days postpartum (Allollio et al., 1990), the HPA axis stress responsiveness 
is still relatively suppressed during the early postpartum period and it takes 
approximately 12 weeks for the HPA axis to return to the pre-pregnancy level of 
function (Magiakou et al., 1996). 
Recently, it has been suggested that some of the pregnancy-related 
adaptations in the HPA axis depend on fetal sex. Higher cortisol levels in women 
carrying female foetuses in the third trimester have been reported (DiPietro et al., 
2011; Bleker et al., 2017), while the opposite pattern was found in the second trimester 
(DiPietro et al., 2011). In addition, Giesbrecht and colleagues (2015) reported a flatter 
cortisol diurnal patter in women carrying a female fetus, as compared to a male fetus. 
Despite being preliminary, these findings highlight the complex bi-directional 
communication between mother and fetus, suggesting a reciprocal regulation of stress 
physiology, which deserves further investigation. In addition, cortisol during pregnancy 
can be affected by several biological and lifestyle factors so that higher cortisol levels 
have been associated with being primiparous, (e.g. Bleker et al., 2016), non-smoking 
(Dušková et al., 2014), lower maternal age (Bleker et al., 2016), lower pre-pregnancy 
maternal body mass index (BMI) (e.g. Stirrat et al., 2016), higher C-Reactive Protein 
(CRP) levels (Bleker et al., 2016) and self-reported sleep (e.g. Crowley et al., 2016), 
thus highlighting the multi-faceted nature of cortisol regulation. 
Lastly, findings of an association between cortisol levels and several measures 
of psychosocial stress during pregnancy are inconsistent. While some studies found 
modest associations (e.g. Evans, Myers, & Monk, 2008; Giesbrecht et al., 2012; 
Simon et al., 2016; Heuvel et al., 2018; Kivlighan et al., 2008; O’Connor et al., 2014; 
Obel et al., 2005), many others reported non-significant findings (e.g. Harville et al., 
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2009; Baibazarova et al., 2013; Salacz et al., 2012; Shea et al., 2007; Voegtline et al., 
2013; Bleker et al., 2017; Himes & Simhan, 2011), thus leading to hypothesize that 
biological and environmental factors during pregnancy might be more closely related 
to maternal cortisol secretion, as compared to psychological factors (Bleker et al., 
2017), and suggesting a potential discrepancy between self-reported and endocrine 
stress measures.   
These findings call into question the traditional view of cortisol as the primary 
candidate mediating the effects of antenatal stress on foetal development, which are 
based on observations of subjective stress. However, the discrepancies in the 
literature might be related to several methodological variations in cortisol assessments 
(e.g., single assessments, CAR, morning and evening cortisol, as well as home versus 
laboratory/clinic collection), assay methods (e.g., saliva, plasma, urine) and gestational 
timing. Concerning this latter point, it is noteworthy that most studies are limited to the 
third trimester of gestation (e.g. Davis et al., 2007; Hellgren et al., 2013; Kivlighan et 
al., 2008; Simon et al., 2016). As cortisol significantly increase over the course of 
pregnancy, it is unclear whether the potential association between maternal stress and 
cortisol levels might still be detected with advancing gestation. For example, Obel et 
al. (2005) found paradoxical associations between psychological distress and cortisol 
levels in early pregnancy as compared to late pregnancy, thus suggesting that the 
stage of pregnancy can play a role in the link. 
Lastly, the available literature suffers from considerable heterogeneity in the 
assessment of maternal “stress” experience. While assessments are mainly based on 
self-report questionnaires, a wide range of constructs have been examined in different 
studies including perceived stress, state-trait anxiety, pregnancy-specific anxiety and 
hassles, depressive symptoms, coping style, life events and social support. In the 
following section, the available evidence for a specific association between maternal 
depressive symptoms and HPA axis functioning during the perinatal period is 
reviewed, which leads to the suggestion that indices of cortisol diurnal secretion, rather 
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than absolute values, might provide a more reliable measure during pregnancy. Next, 
we will examine potential mechanisms involving prenatal programming by the HPA 
axis. 
 
1.4.1.3 The HPA axis and perinatal depressive symptoms  
A dysregulation of the HPA axis in major depressive disorders (MDD) is a well-
established finding in psychiatry (Ising et al., 2007; Holsboer, 2000). According to 
meta-analytical evidence, both morning and evening salivary cortisol levels are 
increased in patients with MDD as compared to controls (Knorr et al., 2010). In 
addition, a recent meta-analysis showed blunted cortisol stress responsiveness in 
women with MDD, while an increased cortisol reactivity in depressed men (Zorn et al., 
2017). A flatter diurnal cortisol rhythm has also been reported in women with MDD as 
well reduced suppression of the cortisol response by dexamethasone (Jarcho et al., 
2013), indicating reduced glucocorticoid receptor sensitivity in the HPA axis negative 
feedback, commonly referred to as “glucocorticoid resistance”. These findings suggest 
a dysregulation of the HPA axis at multiple levels. In addition, it has been proposed 
that distinct clinical depressive syndromes, namely melancholic and atypical 
depression, might relate to different profiles of HPA axis functioning (Gold & Chrousos, 
2002). Specifically, atypical depression, characterized by mood reactivity, weight gain, 
hypersomnia etc., have been linked to HPA axis hypo-responsiveness (Levitan et al., 
2002), with lower cortisol levels at awakening and flattened diurnal cortisol patterns 
(Lamers et al., 2013). In contrast, melancholic depression, characterized by depressed 
mood, loss of pleasure, insomnia, reduced appetite and/or weight loss, has been 
consistently associated with HPA axis hyperactivation (Lamers et al., 2013). 
Given that dysfunction of the HPA axis play a central role in the 
pathophysiology of MDD, it has been proposed that the profound alterations of the 
HPA axis during pregnancy and in the early postpartum might contribute in influencing 
the risk for mood disorders over the perinatal period (e.g. Glynn, Davis, & Sandman, 
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2013; Kammerer, Taylor, & Glover, 2006; Mastorakos & Illias, 2000). For example, the 
abrupt cortisol withdrawal occurring soon after delivery may trigger postnatal 
depressive symptoms (Bloch, Daly, & Rubinow, 2003). However, this hypothesis has 
not yet received strong empirical support.  
Few studies have examined the association between cortisol levels and 
depression during the first trimester of pregnancy and those generally report no 
association (Glynn & Sandman, 2014; Goedhart et al., 2010; Luiza, Gallaher, & 
Powers, 2015; Pluess et al., 2010; Heuvel et al., 2018). Evidence for an association 
between cortisol levels and depressive symptoms across the second trimester is 
mixed. Higher urinary cortisol levels have been reported in women with elevated 
depressive symptoms (Diego et al., 2009). In addition, O’ Keane and colleagues 
(2011) reported higher evening, but not morning, cortisol concentrations in women with 
depression, while O’ Connor and colleagues (O’Connor et al., 2014) reported lower 
cortisol levels at awakening and a flatter diurnal pattern (but no differences in CAR), 
resulting in overall higher cortisol levels across the day, in clinically depressed women, 
with a stronger effect for diagnostic data than self-reported symptoms. Furthermore, a 
number of studies failed to detect any significant association between second-
trimester cortisol and depression (Braithwaite, Murphy, & Ramchandani, 2016; Field et 
al., 2009; Davis et al., 2007; Glynn and Sandman, 2014; Shea et al., 2007, Heuvel et 
al., 2018). A greater number of studies explored the association between third-
trimester cortisol and depressive symptomatology. Higher urinary and serum cortisol 
levels (Diego et al., 2009; Lommatzsch et al., 2006), as well as higher morning and 
afternoon salivary cortisol concentrations (Bjelanovic et al., 2015) have been reported 
in women with antenatal depression in this stage of pregnancy. O’Connor and 
colleagues (2014) reported a pattern of association (i.e. lower morning levels and 
flatter diurnal decline in depressed women) similar to the one detected in the second 
trimester. Lastly, two studies found significantly higher morning cortisol levels in 
women with a comorbid diagnosis of depression and anxiety, as compared to controls, 
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but not in women with only one diagnosis (Monk et al., 2011; Evans et al., 2008) and a 
considerable number of reports failed to detect any significant association (Braithwaite 
et al. 2016; Cheng & Pickler, 2010; Davis et al. 2011; Deligiannidis et al., 2016; Field 
et al. 2009; Glynn and Sandman 2014; Hellgren et al. 2013; Iliadis et al., 2015; 
Pedersen et al., 1993; Peer et al., 2013; Pluess et al. 2010; Salacz et al. 2012, Heuvel 
et al., 2018). Substantial methodological variations limit possible comparisons across 
studies. However, a recent systematic review selected “higher quality” studies based 
on the “Systematic Assessment of Quality in Observational Research” (Ross et al., 
2011) and concluded that no significant evidence exists for an association between 
antenatal maternal cortisol levels and depression (Seth, Lewis, & Galbally, 2016). 
These findings are striking as compared to well-established meta-analytical evidence 
regarding the association between MDD and HPA axis dysregulation in non-pregnant 
populations (e.g. Knorr et al., 2010, Helhammer et al., 2009) and might suggest that 
the dramatic HPA-axis resetting occurring during pregnancy might overcome our 
ability to detect significant hormone-behaviour associations. 
Likewise, evidence for an association between maternal depressive symptoms 
and cortisol levels in the early postpartum period is inconsistent (Seth et al., 2016). 
Early studies reported higher cortisol levels in women displaying higher depressive 
symptoms in the first week postpartum (Handley, 1980; Ehlert et al., 1990; Okano & 
Nomura, 1992; Taylor, Littlewood, & Adams, 1994), although Harris and colleagues 
(1996) reported lower cortisol concentrations in depressed women following delivery. 
More recent studies, reported lower cortisol levels in women at risk for depression 
respectively at 4-6 weeks postpartum (Groer & Morgan, 2007) and within 12 months 
postpartum (Parry et al., 2003). In addition, some studies provided evidence for an 
altered cortisol diurnal pattern in postnatally depressed women. Specifically, Taylor 
and colleagues (2009) showed a dampened CAR in depressed women 4-6 weeks 
postpartum and De Rezende and colleagues (2016) reported a suppression of the 
CAR jointly with higher cortisol concentrations 12 hours after waking, suggesting a 
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reduction in cortisol diurnal variation, in the group of depressed women compared to 
controls 6 months postpartum. Lastly, Corwin and colleagues (2015) reported higher 
diurnal cortisol, as indexed by Area Under the Curve with respect to the ground 
(AUCg, Pruessner et al., 2003), in women with depressive symptoms in the early 
postpartum (14 days after delivery), but not in the following 6 months or in the first 
week after delivery. In contrast, numerous studies failed to detect any significant 
association between cortisol levels and postnatal depression (e.g. Groer, Jevitt, & Ji, 
2015; Shimizu et al., 2015; Diego et al., 2009; Harris et al., 1994; Figueiredo & Costa, 
2009; Tsubouchi et al., 2011; Feksi et al., 1984; Abou-Saleh et al., 1998; Susman et 
al., 1999; Davis et al., 2007; O’Keane et al., 2011; Cheng & Pickler, 2010; Kuevi et al., 
1983, Brimsmead et al., 1985). 
There are several possible methodological reasons for inconsistencies in the 
direction and effect of the association between depression and cortisol during the 
perinatal period. First of all, there is the issue of the comparatively low statistical power 
of the studies, due to limited samples size and the inclusion of small number of 
depressed participants. Secondly, many studies have used relatively poor quality 
cortisol measurements, and in particular, limited sampling occasions which do not 
allow the capture of relevant information about the cortisol diurnal pattern. In addition, 
studies vary widely in the substrates and methods for cortisol assay which limits 
possible comparisons across studies. Third, extant studies inconsistently include 
control variables known to affect cortisol, such as sleep, food intake, physical activity, 
medication (Hellhammer, Wüst, & Kudielka, 2009), together with pregnancy-related 
factors (i.e., gestational age, parity, pre-pregnancy BMI or foetal sex, e.g. DiPietro et 
al., 2011; Kivighlan et al., 2008), which may further confound results. Indeed, recent 
results from Bleker and colleagues (2017) on a very large sample of pregnant women 
(N=3039) suggested that maternal psychosocial factors were not associated with 
maternal cortisol levels during pregnancy, once the effects of biological and lifestyle 
factors were taken into account. Fourth, differences in the assessment of maternal 
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depression (i.e. self-reported measures or diagnostic interview) might influence the 
results.  
However, it is also possible that due to the substantial physiological alterations 
occurring during pregnancy, involving in particular the HPA axis, but not limited to it, 
well-established research findings indicating elevated cortisol as a biomarker of 
depression (e.g. Knorr et al., 2010), may not extend to the perinatal period. For 
example, it may be argued that observed cortisol values during pregnancy primarily 
reflect maternal and fetal development (Davis et al., 2011). In addition, as maternal 
HPA axis stress reactivity is gradually attenuated as pregnancy progresses 
(Kammerer et al., 2002), it has been suggested that the link between cortisol and 
measures of depression might become weaker as pregnancy advances (O’Connor et 
al., 2014). However, as previously described, generally no significant associations 
have been reported in the first trimester of pregnancy, thus, the proposed mechanism 
of shift toward a weaker association between distress and cortisol in late gestation 
seems to be insufficient to fully explain the picture.  
As most studies have been conducted on low risk samples, it might be 
hypothesized that “mild” conditions of distress do not significantly affect the regulation 
of the HPA axis, while above a threshold of significant psychological distress, 
biological and psychological stress measures might become coupled, so that a 
significant change in one may be related to changes in the other. For example, 
salivary cortisol levels at 36 weeks gestation were not found to be elevated in a 
sample of clinically depressed or anxious women compared to controls, while women 
with a comorbid diagnosis of depression and anxiety displayed higher levels than 
controls or either group with a single diagnosis (Evans et al. 2008). Nevertheless, non-
significant associations between antenatal cortisol and depression have been reported 
also in several clinical samples (e.g. Shea et al., 2007; Hellgren et al., 2013; Hellgren 
et al., 2016; Rouse & Goodman, 2014; Katz et al., 2012).  
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Lastly, it might be simply that cortisol is not the most accurate marker of 
subjective stress experiences, particularly during pregnancy. Indeed, it is affected by 
many other factors other than stress (Kudielka, Hellhammer, & Wüst, 2009) and a poor 
or null covariance of perceived stress and cortisol has often been reported even 
outside the perinatal period (Helhammer et al., 2009), possibly because of the 
complex interplay of neurobiological events that link psychological stress to HPA axis 
activation, but also because of methodological difficulties in the assessment of 
perceived stress through self-report questionnaires (Helhammer et al., 2009, Harville 
et al., 2009).  
These findings are striking bearing in mind that cortisol has been traditionally 
considered the primary mediator of the effects of antenatal stress on foetal 
development. Nonetheless, it might be hypothesized that the programming influences 
of prenatal stress, such as maternal depression, on offspring development outcomes 
is directly mediated by cortisol levels only in cases of very severe stress  or that 
alternative mechanisms involving for example placental permeability to cortisol might 
be involved in fetal programming (e.g. O’Donnell 2011; Glover, O’Connor, & 
O’Donnell, 2010). In what follows, the possible mechanisms of fetal programming by 
maternal cortisol are discussed and the available evidence for the effects of maternal 
cortisol during pregnancy on child outcomes is reviewed.  
Lastly, it is possible that maternal depression might be related to a 
dysregulation of other biological systems, such as the SNS or immune system, 
independent of, though related to, the HPA axis, and that these alterations might result 
in fetal programming effects. These latter possibilities will be examined in section 1.4.2 
and 1.4.3.  
 
1.4.1.4 Prenatal programming by HPA axis  
Glucocorticoids, such as cortisol, play an essential role in supporting fetal 
growth, organ maturation and brain development during pregnancy (Lupien et al., 
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2009; Waffarn & Davis, 2012). However, it has been shown that prenatal exposure to 
excessive glucocorticoids levels, both synthetic and endogenous, during sensitive 
developmental periods can have detrimental effects on fetal growth and brain 
development, especially in regions rich in cortisol receptors (e.g. Coe & Lubach, 2005; 
Khalife et al., 2013; Davis et al., 2009; Davis et al.,, 2013; Giesbrecht et al., 2016; 
Lewinn et al., 2009). In particular, glucocorticoid overexposure can interfere with 
synaptogenesis processes and neurotransmitter function in the developing fetal brain, 
as well as adversely affect glucocorticoid receptor expression and the development of 
the stress response systems (Seckl & Meaney, 2004; McGowan & Matthews, 2018). A 
study by Salaria and colleagues (2006) employing a microarray analyses, showed that 
chronic cortisol exposure is able to regulate a huge number of genes involved in cell 
growth and intracellular signaling within fetal brain tissue, highlighting the widespread 
effect of cortisol exposure on the fetal brain. 
A body of studies has investigated the effects of prenatal exposure to synthetic 
glucocorticoids, which are often administered to accelerate fetal lung development in 
woman at risk for premature delivery and, differently from endogenous glucocorticoids 
are not metabolized by the placenta. These studies document a range of associated 
adverse child outcomes, including lower birth weight and smaller head circumference 
at birth (Davis et al., 2009; Piazze et al., 2005), altered stress reactivity (Davis et al., 
2004; 2006; 2011), inattention and poor cognitive performance (Khalife et al., 2013). 
Thus, these data provide further evidence for the role of early exposure to 
glucocorticoids in shaping brain development. 
Under normal conditions, the fetus is largely protected from exposure to 
elevated maternal cortisol levels through the activity of the placental enzyme 11b-
hydroxysteroid-dehydrogenase type 2 (11β-HSD2), which converts cortisol to the 
inactive cortisone (Figure 1.4, Benediktsson et al., 1997). However, it has been shown 
that a proportion of maternal cortisol is still able to cross the placenta (Gitau et al., 
1998; 2001), reaching fetal blood at approximately 10-20% of maternal levels (Murphy 
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& Clifton, 2003) and directly influencing fetal brain development (Seckl & Meaney 
2004). Additionally, gene expression of the placental enzyme 11βHSD2 has been 
shown to increase over pregnancy, in parallel with increased cortisol levels, to protect 
the foetus from excessive cortisol exposure (Schoof et al., 2001; Seth et al., 2015). 
At least four mechanisms through which maternal cortisol levels could 
influence fetal development have been proposed and will be described separately, 
although it is likely that a combination of these mechanisms might underline the effect 
of prenatal stress on fetal development. First, the traditional model of fetal 
programming by exposure to excessive maternal glucocorticoids posits that mood-
related increases in maternal cortisol levels might lead to cortisol crossing the 
placental barrier and directly affecting fetal development (Seckl & Holmes, 2007). 
However, while this model has proved to be generally consistent in animal models 
(Seckl & Meaney, 2004), evidence both for an association between maternal antenatal 
cortisol levels and offspring outcomes (Zijlmans et al., 2015) and for an association 
between maternal antenatal depression and cortisol levels (Seth et al., 2016) in 
humans is weak. Secondly, individual variability in cortisol placental permeability has 
been shown. In particular, in animals it has been reported that maternal diet (Langley-
Evans et al., 1996), and stress (Welberg, 2005; Mairesse et al., 2007; Lucassen et al., 
2009) might affect the placental barrier. In humans, preliminary evidence indicates that 
maternal medical conditions, such as pre-eclampsia (McCalla et al., 1998) or asthma 
(Murphy et al., 2003), infection (Johnstone et al., 2005), inflammation (Kossintseva et 
al., 2006), norepinephrine levels (Sarkar et al., 2001), licorice consumption (Räikkönen 
et al., 2010), maternal anxiety (O’Donnell et al., 2012) and depression (Seth et al., 
2015), might be related to a reduced expression and activity of the placental 11β-
HSD2, allowing more cortisol to transfer through the placenta). This latter mechanism 
would explain how overexposure to glucocorticoids might occur even in absence of 
distress-linked higher than typical maternal cortisol levels. Third, maternal cortisol 
might affect fetal development by placental secretion of CRH (Petraglia et al., 1987). 
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PCRH enters the fetal circulation through the umbilical vein and stimulates the fetal 
HPA axis to produce ACTH and cortisol, which, in turn, further stimulates pCRH 
secretion in a fetal positive feedback loop (Majzoub & Karalis, 1999). At the same 
time, maternal cortisol stimulates the secretion of pCRH (Cheng et al., 2000), resulting 
in increasing concentrations of maternal cortisol and pCRH within the maternal 
positive feedback loop. Lastly, elevated cortisol may affect utero-placental blood flow 
with indirect negative effects on offspring growth and brain development (Mina et al., 
2015).  
 
1.4.1.5 Maternal cortisol and child outcomes 
Despite the relative lack of association between maternal psychological stress 
and cortisol levels in pregnancy, several studies have investigated the relationship 
between maternal HPA axis functioning during pregnancy and offspring’s outcomes 
and these have yielded mixed findings (reviewed in Zijlmans, Riksen-Walraven, & de 
Weerth, 2015). Most of these studies collected maternal salivary samples to assess 
free cortisol levels during pregnancy and the most robust protocol included multiple 
samples collected over two days in order to calculate the average total cortisol output 
across the day as well as the diurnal rhythm of cortisol secretion (Harville et al., 2009). 
A small number of studies measured amniotic fluid cortisol, which is thought to 
represent a marker of fetal cortisol exposure (Sarkar et al., 2007), and only a handful 
of reports assessed maternal urine or serum cortisol levels.  
Generally, higher maternal cortisol levels, in particular a higher CAR (Bolten et 
al., 2011), higher morning cortisol values (Goedhart et al., 2010) and a flatter diurnal 
cortisol slope (D’Anna-Hernandez et al., 2012) have been related to lower birth weight. 
Significant associations between maternal cortisol and body length at birth were found 
only in late pregnancy (Bolten et al., 2011), while no associations were found with 
head circumference at birth (Bolten et al., 2011), as well as BMI at 5 years of age (Van 
Dijk et al., 2012). In contrast, a recent study reported maternal cortisol in late gestation 
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to predict infant body fat increase over the first 6 months of life (Entringer et al., 2017), 
suggesting a potential role of antenatal cortisol in programming later obesity risk. 
Findings of an association between prenatal maternal cortisol and gestational 
age at birth are mixed, as either negative (e.g. Diego et al., 2009; Erickson et al., 
2001; Mercer et al., 2010) or no associations (D’Anna-Hernandez et al., 2012; Ruiz et 
al., 2001) have been reported. Baibarazova and colleagues (2013) reported higher 
amniotic fluid cortisol, but not maternal cortisol, to be associated with shorter 
gestational age and lower birth weight. 
Evidence for a link between maternal cortisol concentrations during pregnancy 
and infants’ mental and motor development are inconclusive. Higher maternal cortisol 
in late, but not early, pregnancy predicted lower infant mental development in four 
studies at 3 months of age (Buitelaar et al., 2003; Huizink et al., 2003), 17 months 
(Bergman, Sarkar, et al., 2010) and 7 year olds respectively (LeWinn et al., 2009), but 
not in two studies at 8 months (Buitelaar et al., 2003; Huizink et al., 2003). Similarly, 
higher maternal basal cortisol and reduced cortisol response during mid- and late 
pregnancy predicted learning and memory performance in 5-month-old infants but not 
at 3 months of age (Thompson et al., 2017). In contrast, Davis and Sandman (2010) 
reported higher levels of cortisol, both in early and late pregnancy, to predict 
accelerated mental development during the first year of life, resulting in better 
cognitive outcomes at 12 months of age. Furthermore, in a recent study, the authors 
showed that higher maternal cortisol during the third trimester predicted better child 
cognitive functioning between 6 and 9 years of age (Davis et al., 2017). In addition, 
maternal cortisol in late pregnancy, but not in early gestation, was negatively related to 
infants’ motor development in a few studies (Buitelaar et al., 2003; Huizink et al., 
2003), though not all (Davis and Sandman, 2010).  
Similarly, little evidence exists for a link between maternal cortisol in early and 
mid-gestation and children’s temperament (Davis et al., 2007; Gutteling et al., 2005; 
Buitelaar et al., 2003), while mixed findings have been reported concerning an 
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association between maternal cortisol measured during late gestation and offspring’s 
temperament. One study reported a link between higher maternal cortisol in late 
gestation and greater child negative reactivity at 8 weeks of age (Davis et al., 2007) 
and another report showed high maternal cortisol levels at waking to relate to infants’ 
higher ‘emotion’ and ‘activity’ scores at week 7, but not in week 18 (De Weerth, Van 
Hees, & Buitelaar, 2003). However, a number of studies failed to detect any significant 
associations (Buitelaar et al., 2003; Gutteling et al., 2005; Rothenberg et al., 2011; 
Braithwaite et al., 2017). 
A few papers examined the association between prenatal cortisol and 
children’s behavioral problems. Higher cortisol levels during early and mid-pregnancy 
were related to higher levels of child anxiety, according to maternal reports in one 
study (Davis & Sandman, 2012), and more affective problems in 7-year-old girls but 
not boys in another (Buss et al., 2012). In contrast, no significant association was 
found between maternal prenatal cortisol in late gestation and children behavioral 
problems in two studies (Gutteling et al., 2005; Buss et al., 2012). 
Some evidence exists for an association between antenatal maternal cortisol 
levels and children’s stress reactivity. Higher levels of maternal cortisol during 
pregnancy have been related to children’s greater cortisol response to the heel stick at 
birth (Davis et al., 2011), to the inoculation at four years of age (Gutteling, De Weerth, 
& Buitelaar, 2004) and to the first day of school at five years of age (Gutteling et al., 
2005). In contrast, a few studies failed to detect any significant associations between 
prenatal maternal cortisol and infant cortisol responses during the first year of life 
(Tollenaar et al., 2011; Braithwaite et al., 2017). A recent study by Giesbrecht and 
colleagues (2017) revealed sex differences in the interactive effects of maternal 
prenatal cortisol and distress on 3-month-olds cortisol reactivity to a blood draw. 
Specifically, a dampened infant cortisol reactivity was associated with exposure to high 
maternal distress and flattened patterns of diurnal maternal cortisol in females, and 
with prenatal exposure to a steeper maternal CAR and daytime slope in males. In 
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addition, higher maternal cortisol concentrations were found to predict infant’s slower 
behavioral recovery after the heel-stick soon after birth (Davis et al., 2011) and more 
negative behavioral response at bathing sessions during the first 20 weeks of life (De 
Weerth et al., 2003).  
Lastly, preliminary evidence exists for a role of antenatal cortisol levels in 
influencing fetal brain development. Specifically, maternal prenatal cortisol was 
significantly negatively associated with ultrasound parameters of fetal brain growth (Li 
et al., 2012). Buss and colleagues (2012) reported that higher maternal cortisol levels 
in early, but not late, gestation, predicted larger right amygdala volume in 7-year-old 
girls, but not in boys, and this, in turn was associated with more affective problems. 
Lastly, Davis and colleagues (2017) showed that higher maternal cortisol 
concentrations in late pregnancy were associated with greater child cortical thickness 
in frontal regions at 6-9 years of age, suggesting that elevations in maternal cortisol in 
a normative sample might promote fetal brain development.  
To summarize, despite maternal cortisol has been the most studied mediator of 
the effects of maternal antenatal distress on infant outcomes, empirical evidence of a 
link between maternal cortisol concentrations and a wide range of child outcomes is 
not straightforward and, according to a recent review, approximately 76% of studies 
failed to detect a significant association (Zijlmans et al., 2015). Thus, it is increasingly 
clear that cortisol alone cannot fully explain all the programming effects of maternal 
antenatal stress, especially during early gestation, and that alternative mechanisms, 
involving, for example, other stress-related alterations or inflammatory processes 
might play a role.  
 
1.4.2 The Sympathetic-Nervous-System (SNS) 
The Autonomic Nervous System (ANS) is a very complex, multifaceted neural 
network that is involved in regulating a wide range of physiological processes, 
including the response to stress. In particular, the Sympathetic Nervous System 
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(SNS), one branch of the ANS, and the adrenal medulla together constitute the 
sympathetic adrenomedullary (SAM) system which, besides the HPA-axis, is the 
second key component of the Stress Response System1. The SAM is activated within 
seconds by stress and triggers a rapid physiological adaptation in order to prepare the 
organism to face the initial phase of a stressful event (De Kloet et al., 2005). As 
compared to the hormonal HPA axis response which takes approximately ten minutes 
to release cortisol and reach its peak concentration in serum, the SAM response 
represents the first response to stress which is rapid but short-lasting.  
As shown in Figure 1.5, the chromaffin cells of the adrenal medulla are 
innervated by sympathetic preganglionic neurons located in the intermediolateral gray 
matter of the spinal cord. Activation of the SAM triggers the release of 
chatecholamines, and in particular epinephrine (E, 80%) and norepinephrine (NE, 
20%) from the chromaffin cells of the adrenal medulla into circulation and NE from 
sympathetic neurons that innervate almost all organs, which mediate a number of 
behavioral and physiological changes that are part of the short-term “fight or flight” 
response (Wetherell et al., 2006). Specifically, chatecholamines bind to β-adrenergic 
receptors on a vast array of target tissues and induces changes in blood vessels, 
glands, visceral organs and smooth muscles, in order to promote blood supply to the 
brain and muscles (Tank & Lee Wong, 2015). For example, catecholamines increase 
heart rate and stroke volume, cause vasodilatation in muscles and constriction of 
blood vessels in the skin and gut. Although neither E nor NE cross the blood-brain 
barrier, their peripheral actions are paralleled in the brain by NE produced by the locus 
coeruleus (Morilak et al., 2005) which serve the function of maintaining alertness and 
participate in processes that activate the HPA axis. 
 
                                                          
1 Although it is acknowledged that the parasympathethic branch of the ANS is involved in stress 




      
Figure 1.5 - Representation of the anatomy of the SAM system, a component of the SNS. 
Its cell bodies (preganglionic neurons) are located in the interomediolateral (IML) cell 
column and exit the spinal cord via the ventral root to form cholinergic direct synapses 
on the chromaffin cells of the medulla of the adrenal glands. When stimulated, the 
chromaffin cells (equivalent to postgangiolinc sympathetic neurons) release 
catecholamines (epinephrine and norepinephrine) in the general circulation that act like 
hormones affecting organs and tissues via adrenergic receptors and enhance SNS 
activity (from Gunnar & Quevedo, 2002) 
 
1.4.2.1 Salivary Alpha Amylase (sAA) 
The assessment of chatecholamine levels in humans is not straightforward. 
Repeated blood draws from venous blood are needed to obtain a reliable assessment 
of chatecholamine levels and SNS activity (Goldstein, Eisenhofer, & Kopin, 2003) This 
is often perceived as stressful and might be biased by local sympathethic activity 
(Veith, Best & Halter, 1984). In addition, salivary catecholamine concentrations are 
consistently lower than blood levels, thus being inadequate to reflect the acute 
changes in SNS activity (Kennedy et al., 2001). 
In the last decade, increasing attention has been directed to salivary enzyme 
alpha-amylase (sAA) which is thought to be a non-invasive stress marker of SNS 
activation (reviewed in Nater & Rohleder, 2009). sAA is an enzyme mainly involved in 
the digestion of starch in the oral cavity and also has bacterial interactive functions 
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(Scannapieco, Torres, & Levine, 1993). Since sAA secretion is regulated by the ANS, 
and particularly the SNS which controls salivary glands via beta-adrenergic receptors 
(Baum, 1987), sAA levels have been proposed to reflect stress-related changes in 
SAM activity (Chatterton et al., 1996; van Stegeren et al., 2006) and in a series of 
studies have been shown to be highly sensitive to stress (reviewed in Nater & 
Roheleder, 2009).  
Early human studies showed that immersing participants in cold water (Speirs 
et al., 1974) or intense physical exercise (Gilman et al., 1979) activates an SNS 
response and associated sAA increase. In addition, beta-adrenergic blockers were 
found to decrease sAA concentrations (e.g. Nederfors & Dahlöf, 1996). More recently, 
several studies have shown increased levels of sAA in response to physical and 
psychological stress conditions (e.g. academic examinations, the trier social stress 
test, the cold pressor task; reviewed in Nater and Rohleder, 2009). However, mixed 
findings have been reported concerning an association between sAA concentrations 
and plasma catecholamines (e.g. Ehlert et al., 2006; Rohleder et al., 2004; Thoma et 
al., 2012). In particular, while in all these studies a stress-induced increase in both sAA 
and catecholamines levels paralleling each other was found, significant correlations 
between individual time points of sAA and catecholamines or averaged total measures 
(such as the AUC) have not always been found (Rohlder et al., 2004; Wetherell et al., 
2006). Thus, it has been questioned whether a strong association between plasma 
catecholamines and sAA in response to stress exists. Nevertheless, sAA levels in 
response to stress were found to be associated with some indices of SNS activity such 
as left ventricular ejection time (Bosch et al., 2003), ratio between low frequency 
power and high frequency power of heart rate variability, thought to reflect sympathetic 
tone, (Nater et al., 2006) and skin conductance (El-Sheikh et al., 2008). In addition, a 
recent study using multilevel models showed strong increases in sAA in response to 
stress that were mediated via NE and E (Ditzen, Ehlert, & Nater, 2014).  
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SAA levels in response to acute stress peak between 5 and 10 min after the 
onset of a stressor and return to baseline approximately 10 minutes after the stressor, 
consistent with it being a marker of the rapid SNS response (Granger et al., 2007; 
Nater et al., 2006). In addition, sAA stress responses have been reported to be either 
largely uncorrelated (Granger et al., 2007) or associated at different time lags with 
cortisol responses (Engert et al., 2011). This has led to regard sAA as a non-
redundant stress marker that allows to complement a more comprehensive 
assessment of the stress response.  
As shown in Figure 1.3A, sAA is characterized by a marked diurnal profile. In 
particular, sAA levels show a significant decrease in the first 30 minutes after 
awakening and a steady increase towards the afternoon and evening (Marchand et al., 
2016; Nater et al., 2007). While sAA daily pattern is independent of the cortisol diurnal 
rhythm (Nater et al., 2007), the opposite diurnal pattern between the two markers has 
been suggest reflecting “a circadian compensatory drive related to allostatic 
mechanisms” (Marchand et al., 2016). The sAA diurnal pattern has been shown to be 
influenced by age (Nater et al., 2007) and sex (Marchand et al., 2016), but not by 
factors such as physical activity, smoking, eating or drinking and BMI (Nater et al., 
2007). Thus it is considered a “relatively robust” stress marker (Wingenfeld et al., 
2010). In addition, preliminary evidence suggests that psychosocial factors might 
influence sAA levels. For example, strong correlations between sAA concentrations 
and state anxiety measures during stress task have been reported (Noto et al., 2005; 
Takai et al., 2004).  
 
1.4.2.2 The SNS system during the perinatal period 
As previously mentioned, pregnancy is accompanied by substantial changes in 
maternal stress response systems that serve the function of sustaining pregnancy and 
supporting both maternal and fetal energetic requests. In particular, during this phase 
the ANS shows a shift toward greater sympathetic and reduced parasympathetic 
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modulation (DiPietro, Costigan, & Gurewitsch, 2005), paralleled by significant 
increases in blood volume and heart rate and a reduction in vascular resistance in 
order to support the increased cardiac output (Silversides & Colman, 2007). Changes 
in ANS parameters have been shown to begin early in gestation and increase linearly 
as pregnancy progresses (Di Pietro et al., 2005). In addition, there is a progressive 
decrease in blood pressure which reaches the lowest values at mid-gestation, followed 
by an increase to pre-pregnancy levels near delivery. These substantial changes are 
crucial to support fetal development and a lack of such adaptation has been 
associated with adverse outcomes. For example, higher blood pressure in early 
pregnancy predicts greater risk of preeclampsia later in pregnancy, as well as lower 
birth weight (reviewed in Christian et al., 2012).  
Evidence concerning pregnancy-related changes in plasma NE and E are 
mixed. Either no changes (Barron et al., 1986; Lederman et al.,1989), as well as 
increasing levels (Elenkov et al., 2001) or decreasing levels (Nisell, Hjemdahl, & Linde, 
1985) as gestation advances have been reported. Nonetheless, higher levels of 
plasma catecholamines have been consistently reported among pregnant women with 
preeclampsia or gestational hypertension (Kaaja et al., 1999; Manyonda et al., 1998). 
In addition, preliminary evidence suggests that diurnal variations in plasma E and NE 
are maintained in normal pregnancy (De Weerth & Buitelaar, 2005). 
Similarly to the HPA axis, maternal SNS stress reactivity to psychological or 
physiological stressors is significantly dampened during pregnancy (e.g. de Weerth 
and Buitelaar, 2005; Entringer et al., 2010; Klinkenberg et al., 2009; Nierop et al., 
2006).  
To date, little is known about pregnancy-related changes in sAA levels. A 
number of early small studies suggested that salivary flow rate and sAA levels are not 
affected by advancing gestation (D’Alessandro et al., 1989; Salvolini et al., 1998). One 
study examined antenatal sAA response to stress and reported significantly lower sAA 
levels following a psychosocial stressor in pregnant women, as compared to non-
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pregnant women (Nierop et al., 2006). In addition, Giesbrecht and colleagues (2013) 
reported that sAA diurnal rhythm is preserved during pregnancy and is not influenced 
by factors such as fetal sex, gestational age, maternal age and BMI. In contrast, 
previous history of miscarriage was related to an altered sAA pattern, as indicated by a 
flatter sAA diurnal profile. More recently, in a larger study, Giesbrecht and colleagues 
(2015) reported fetal sex differences in sAA diurnal pattern, with women carrying a 
female fetus showing elevated daytime sAA slopes as compared to women with a 
male fetus.  
Despite sAA response appearing to be dampened during pregnancy, 
preliminary evidence indicates that sAA remains sensitive to the influences of 
psychosocial stress. In particular, Giesbrecht et al., (2013), reported that higher trait 
anxiety was associated with increased sAA levels over the day in mid-pregnancy, 
while chronic fatigue was related to decreased sAA levels. In addition, momentary 
depression and positive mood were associated with momentary increases in sAA 
concentrations, providing evidence for the responsivity of this biomarker to emotional 
arousal even during pregnancy.  
 
1.4.2.3 SNS and perinatal depressive symptoms 
An imbalance of the ANS is frequently observed in patients suffering from 
major depression and is thought to play a role in the pathophysiology of this condition 
(Moret & Briley, 2011; Schumann, Andrack, & Bär, 2017). Several methods of 
measuring ANS have been used and generally an increased sympathetic activation 
has been reported in depressed patients as compared to controls. In particular, 
increased heart rate (Agelink et al., 2002; Berger et al., 2012), skin conductance (e.g. 
Schuman et al., 2017), pupil diameters (e.g. Bär et al., 2004), as well as lower heart 
rate variability (HRV; Licht et al., 2008) has often been found among depressed 
individuals. In addition, higher levels of catecholamines have been reported in 
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depressed patients (e.g. Veith et al., 1994) and a number of antidepressants act by 
inhibiting noradrenaline reuptake (Moret and Briley, 2011). 
The role of sAA as a biomarker of SNS activation in major depression has 
received limited attention. A number of studies reported higher sAA levels measured at 
different times during the day in adults with unremitted MDD, as compared to healthy 
controls (Booij et al., 2015; Cubała et al., 2014; Ishitobi et al., 2010; Tanaka et al., 
2012). In addition, a large cohort study showed a trend toward an increase in evening 
sAA concentrations according to psychiatric conditions (Veen et al., 2013) with current 
MDD patients showing the highest sAA levels, followed by remitted MDD patients and, 
lastly, healthy adults. In contrast, no differences in sAA levels in response to stress 
have been reported among women with remitted MDD and never depressed controls 
in another study (Bagley, Weaver, & Buchanan, 2011).  
Despite evidence of a dysregulation of the ANS among depressed non-
pregnant individuals, only a limited number of studies have examined the association 
between depressive symptoms and ANS functioning during the perinatal period. 
Higher norepinephrine and lower dopamine levels in depressed pregnant women have 
been found in some studies (Lundy et al., 1999; Field et al., 2004; Diego et al., 2006), 
while others failed to find any association between catecholamines levels and 
depression (Field et al., 2006; Shimizu et al., 2015). In addition, increased 
noradrenergic activity has been reported in women with postpartum blues 6 weeks 
after delivery (Doornbos et al., 2008).  
Moreover, a lack of dampening of ANS stress reactivity, evaluated through 
HRV, was shown in more anxious women (Braeken et al., 2015), although depressive 
symptoms were not assessed in this study.  
To our knowledge, only two studies evaluated the association between 
prenatal sAA diurnal levels and depression. Specifically, Braithwaite and colleagues 
(2015) found higher sAA levels at wakening in women with depressive symptoms from 
a low risk sample compared with controls without depressive symptoms in late 
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pregnancy, while Giesbrecht and colleagues (2013) found no association between the 
average sAA trajectory throughout the day and depressive symptoms in a non-clinical 
sample. In contrast, chronic anxiety, momentary depressed and positive mood were all 
positively associated with sAA diurnal levels during pregnancy. 
 
1.4.2.4 Prenatal programming by maternal SNS 
Despite the fact that alterations of maternal SNS functioning and, more 
specifically, increased maternal chatecholamines levels, have been suggested as a 
possible mechanism underlying the impact of prenatal mood on foetal development 
(Braithwaite, Murphy, & Ramchandani, 2014; Rakers et al., 2017), to date it has 
received limited empirical attention. This is possibly related to the evidence that 
catecholamines are hydrophilic and do not directly cross the placental barrier in 
physiologically relevant concentrations (Giannakoulopoulos et al., 1999). While a 
number of early studies in animals and human placental tissues showed a minor 
placental passage of NE (around 5-10%) from mother to fetus (e.g. Morgan, Sandler, 
& Panigel, 1972), others do not (e.g. Jones & Robinson, 1975). In addition, it was 
shown that fetal and maternal NE levels in response to invasive procedures were not 
correlated, suggesting that no transfer from mother to fetus occurs 
(Giannakoulopoulos et al., 1999).  
While uncertainty exists concerning a potential direct effect of maternal 
catecholamines levels on fetal development, stress-induced release of catecholamines 
might affect fetal development indirectly, by affecting placental metabolism (Merlot, 
Couret, & Otten, 2008). Indeed, it has been shown that increased maternal 
catecholamines could cause constriction of placental blood vessels and reduce 
placental blood supply, thus leading to restricted oxygen and nutrients to the foetus 
(Rakers et al., 2015) and, possibly, contributing to adverse birth outcomes, such as 
lower birth weight and premature delivery.  
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While the impact of maternal stress and catecholamine levels during 
pregnancy on uterine blood flow has been clearly demonstrated in animals (e.g. 
Rakers et al., 2015), to date, no study has examined the association between maternal 
antenatal catecholamine levels and fetal or placental hemodynamics in humans. In 
addition, evidence of an association between maternal psychological distress during 
pregnancy and altered uterine blood flow, assessed through Doppler ultrasound 
techniques, is inconclusive (reviewed in Rakers et al., 2017). For example, Helbig and 
colleagues (2013) found that maternal distress was associated with a decrease in 
umbilical blood flow in late pregnancy. In contrast, Monk and colleagues (2012) failed 
to detect a significant association between maternal depression or anxiety and uterine 
or umbilical blood flow during pregnancy. However, differently from animal studies, all 
these reports are based on at-rest assessment and none examined uterine blood flow 
in response to stressful situations.  Additionally, foetal oxygen and nutrient restriction 
have been found to activate the foetal HPA axis (Edwards & McMillen, 2002) and fetal 
catecholamine release (Gu & Jones, 1986), thus constituting a possible pathway 
through which maternal distress might affect the development of fetal stress response 
systems. A preliminary study showed that maternal antenatal depression was 
associated with a decreased placental expression of monoamine oxidase A (MAO A) 
(Blakeley et al., 2013), an enzyme that metabolizes a range of monoamines and that is 
considered responsible of placental catecholamine clearance, thus suggesting an 
additional pathway for the effects of maternal antenatal mood on fetal development, 
possibly mediated by catecholamine-related mechanisms. Lastly, catecholamines 
have been found to down-regulate 11β-HSD2 gene expression in human placental 
trophoblast (Sarkar et al., 2001). Impairment of the placental glucocorticoid barrier via 
activation of the SNS could be another possible mechanism increasing fetal exposure 
to maternal glucocorticoids.  
The above mentioned evidence converges to suggest that increases in 
maternal catecholamine levels, as a result of stress-induced activation of the SNS, 
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could be an alternative mechanisms by which antenatal depression might impact 
offspring’s outcomes. However, SNS-mediated mechanisms of fetal programming 
have been very poorly explored in humans. In the following section, we will review 
existing evidence regarding the link between maternal SNS functioning and offspring 
outcomes. 
 
1.4.2.5 Maternal SNS functioning and child outcomes 
Very few studies have explored the link between variations in maternal SNS 
activity and changes in fetal physiology and behaviour in humans (Braeken et al., 
2013; Monk et al., 2011). Specifically, Braeken and colleagues (2013) showed 
reduced maternal HRV during the first trimester of pregnancy in women with a history 
of anxiety disorder and in offspring of these women at 2-4 months of age, which, in 
turn, was related to greater fearfulness at 9-10 months. In addition, in the anxious 
group of women, maternal HRV and infant HRV were correlated, unlike the control 
group. However, it is not possible to establish whether this was a causal association or 
simply the effect of other underlying processes. In contrast, Monk and colleagues 
(2011) reported no association between changes in fetal heart rate and women’s 
concurrent cardiorespiratory activity.  
Furthermore, in animal studies, it has been consistently demonstrated that 
excessive levels of catecholamines can impair fetal development, leading to fetal 
growth retardation or fetal hypoxia (e.g. Bassett & Hanson, 1998; Macko et al., 2016). 
However, in humans, only one study evaluated the impact of maternal antenatal 
catecholamines levels on fetal/child outcomes (Holzman et al., 2009), showing that 
high levels of maternal urinary NE, E and dopamine during mid-gestation predicted a 
greater risk of preterm birth.  
To our knowledge, only two studies explored the association between maternal 
prenatal sAA levels and pregnancy outcomes. An altered diurnal sAA pattern in 
women with history of miscarriage compared to women with no such history has been 
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reported (Giesbrecht et al., 2013). In contrast, Garcia-Blanco and colleagues (2017) 
reported that, differently from cortisol, maternal sAA levels at the timed of threatened 
preterm labor did not significantly predict time until delivery.  
Similarly, evidence for a link between maternal sAA levels and child outcomes 
are still scarce. Giesbrecht and colleagues (2015) showed an association between 
maternal prenatal diurnal levels of sAA and newborns’ weight at birth, with women 
showing a blunted sAA awakening response having lower birth weight infants. Rash 
and colleagues (2016) employed discriminant function analyses and showed that 
maternal diurnal sAA levels together with other stress biomarkers and self-report 
stress measures during pregnancy distinguished among 6-month-olds HPA axis and 
ANS reactivity profiles. Furthermore, recently, Braithwaithe and colleagues (2017) 
found that maternal sAA levels in the second or third trimester of gestation predicted 2-
month-olds negative emotionality in a sex dependent manner, with higher maternal 
antenatal diurnal sAA levels being related to lower levels of distress to limits in males 
but not in females.  
 
1.4.3 Inflammatory response system (IRS)  
Infections, injuries and stress conditions activate an inflammatory response of 
the immune system. Importantly, inflammation, which plays a key role in many human 
diseases, has been shown to be activated not only by immune-challenges such as 
infections or injuries, but also by non-immunological environmental and psychological 
stimuli, such as stress conditions (e.g. Miller et al., 2006). Thus, it is increasingly 
regarded as a potential pathway linking stress experiences with health and disease.  
A full description of the immune system is beyond the scope of the current 
thesis. In what follows a brief overview of the immune system functioning is provided 
with the purpose of elucidating the link between antenatal depression and 




In order to elucidate the relationship between psychological stressors and the 
immune system, as well as changes occurring in the immune system during the 
perinatal period, it is useful to distinguish between natural or innate immunity and 
specific or adaptive immunity. Natural immunity is a non-specific immune response 
which is carried out by all-purpose cells that are able to attack several different 
pathogens quickly (minutes to hours from the challenge). Granulocytes are the main 
group of these cells and include neutrophils and macrophages, which are responsible 
for the generalized inflammatory response. Neutrophils and macrophages converge at 
the site of infection or injury where they release toxic substances and phagocytose 
both pathogens and damaged tissues. In addition, macrophages release cytokines, 
communication molecules that have a wide range of effects on the organism, including 
fever and inflammation, and promote healing. Pro-inflammatory cytokines include 
Interleukine-1 (IL-1), Interleukine-6 (IL-6), and tumor necrosis factor alpha (TNFα). 
Other cells involved in natural immunity include the natural killer cells, that are thought 
to play an important role in the early phases of infections before specific immunity is 
fully activated, and complement, proteins that up-regulate inflammation and also aid in 
antibody-mediated immunity. 
Specific immunity involves a more specific, although slower, immune response 
which is mainly mediated by lymphocytes. Lymphocytes are characterized by antigen-
specific receptors that respond to only one kind of pathogen. When activated, they 
give rise to a proliferative response known as clonal proliferation, where they divide to 
produce a population of antigen-specific cells in a process that can take up to several 
days before a full defence is mounted. Three types of lymphocytes are involved in 
specific immunity, namely, T-helper cells, T- cytotoxic cells, and B cells. T-helper cells 
primarily produce cytokines that amplify the inflammatory response. They can be 
distinguished into Th1 and Th2 cells. Th1 cells activate a cellular immune response to 
intracellular pathogens such as viruses, by producing cytokines, including IL-2 and 
interferon gamma (IFNγ), that selectively activate T-cytotoxic cells and natural killer 
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cells. Th2 cells are responsible of humoral immune response against extracellular 
pathogens, like parasites and bacteria, and produce different cytokines, such as IL-4 
and IL-10, which selectively activate B cells and mast cells to attack extracellular 
pathogens. T-cytotoxic cells recognize cells that are infected by viruses or are 
damaged and destroy them. B cells produce antibodies (i.e. Immunoglobulin (Ig) A, 
IgE, IgM, IgG and IgD), proteins that serve several functions such as neutralizing 
toxins or binding to free viruses to prevent their entry into cells.  
 
1.4.3.1 Stress and inflammation  
Although initial views posited that the immune system was autonomous, 
important pathways linking it with many other biological systems, in particular the 
nervous system and the endocrine system, are now well-established. This means that 
stressful events that activate a response from the ANS or HPA axis can also elicit 
responses from the immune system, as shown in Figure 1.6; the coordination of the 
SNS, HPA-axis and IRS response, in particular to acute stress, is essential to health 
and well-being (Gunnar & Quevedo, 2007; Kuhlman et al., 2017).  
It is now well-established that stress is associated with changes in immune 
system functioning, as indicated by elevated pro-inflammatory cytokines levels, greater 
inflammatory response to psychological stressors and to in vitro and in vivo immune 
challenges (e.g. Dunn & Swiergiel, 2005; Dunn, Swiergiel, & de Beaurepaire, 2005; 
Yang & Glaser, 2002; Johnson et al., 2002; Pace et al., 2006; Kiecolt-Glaser et al., 
2003; Lutgendorf et al., 1999). 
There are different stress-induced neuroendocrine pathways through which 
stress can activate the immune system and alter its functioning. First of all, 
sympathetic fibres from the brain descend into lymphoid tissues and release several 
substances that bind to receptors on white blood cells and influence the inflammatory 
response (Felten & Felten, 1994).  
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Figure 1.6 - Coordinated HPA axis, SAM system and IRS response to acute stress (from 
Kuhlman et al., 2017) 
 
All lymphocytes have adrenergic receptors, although density and sensitivity 
vary among cell types and influence cells responsiveness to stress. For example, 
natural killer cells have a large number of high-affinity β2-adrenergic receptors, while B 
cells have high density but lower affinity receptors, and T cells have the lowest density 
(Kuhlman et al., 2017). Secondly, NE, E and cortisol, secreted respectively by the 
SAM and HPA axis under stress conditions, bind to specific receptors on white blood 
cells and have different regulatory influences on their distribution and function (Felten 
& Felten, 1994). Cortisol has mainly anti-inflammatory effects, although this has been 
shown to depend also on circumstances and concentrations (Dhabhar, 2002). 
Glucocorticoids receptors can be found in immune cells and binding of 
glucocorticoids to these receptors downregulates cytokine production, thus preventing 
excessive cytokines elevations (Silverman & Sternberg, 2012). It has been found that 
prolonged or chronic stress in humans can lead to insensitivity of the glucocorticoids 
receptors in immunes cells that become unresponsive to the inhibitory signals of 
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glucocorticoids (Cohen et al., 2012). Less is known about the role of the SNS, and 
catecholamines in particular, in modulating the immune response. However, the SNS 
appear to exert both anti-inflammatory and pro-inflammatory influences, by 
suppressing inflammation in already activated cells, while activating inflammatory 
responses in non-activated immune cells (Rohleder, 2012). Third, it has been 
proposed that changes in lifestyle due to stressful experiences (such as alcohol use or 
sleep changes) can also alter immune system functioning (Segerstrom & Miller, 2004). 
Lastly, beside these neuroendocrine pathways, recent interest has been directed 
toward inflammasome, a multiprotein complex that is produced in response to 
pathogens or stressors, and could represent a key immunological interface between 
stress and inflammation (for an exhaustive discussion see Iwata, Ota, & Duman, 
2013). 
While initial models posited that stress generally suppresses the immune 
response, thus leading to greater incidence of infectious or neoplastic diseases among 
chronically stressed individuals (Andersen, Kiecolt-Glaser, & Glaser, 1994), it was later 
proposed that chronic stress might shift the Th1-Th2 balance of the immune response, 
without necessarily altering the overall system functioning (Cohen et al., 2012). 
Specifically, it was suggested that chronic stress alters patterns of cytokine secretion, 
possibly mediated by stress hormones such as cortisol, thus simultaneously 
suppressing Th1 (cellular) activity and increasing production of Th2 (humoral) 
cytokines (Chiappelli et al., 1994). This Th1-to-Th2 shift could increase vulnerability to 
infectious and neoplastic disease, because Th1 is suppressed, as well as vulnerability 
to autoimmune and allergic diseases, because Th2 is enhanced. This model is able to 
reconcile stress-related immune changes with stress-related disease outcomes 
(Cohen et al., 2012).  
Segerstrom and Miller (2004) performed a meta-analyses of 293 independent 
studies for a total of 18,941 participants in order to examine the association between 
different psychosocial stressors and immune parameters. Results indicate that 
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stressful events are consistently associated with changes in the immune system and 
that characteristics of those events influence the kind of changes. In particular, acute 
stressors were related to an upregulation of natural immunity and downregulation of 
specific immunity, brief naturalistic stressors (such as exams) elicited a cytokines shift 
with a suppression of cellular, but not humoral, immunity, while chronic stressors 
trigger a global immunosuppression.  
 
1.4.3.2 C-Reactive Protein (CRP) and Interleukin-6 (IL-6) 
Measurement of concentrations of serum inflammatory markers by 
immunoassay is increasingly performed to evaluate the IRS functioning. Psychiatry 
research has focused on the assessment of a number of cytokines, such as IL-6, IL-
1β, TNF-α, or Interferon-gamma (IFN-gamma), or ratios of some of these, as well as 
acute-phase proteins, a class of proteins which is produced by the liver in response to 
inflammation, such as C-Reactive Protein (CRP). In the current thesis, we will focus on 
IL-6 and CRP that are consider the most important biomarkers of chronic or systemic 
low-grade inflammation (Rohleder et al., 2012). Chronic low-grade systemic 
inflammation has been identified as one of the major pathophysiological mechanisms, 
being predictive of later morbidity and mortality (Ershler & Keller, 2000). It has been 
associated with several disease and disorders and, as will be discussed in what 
follows, IL-6 and CRP circulating levels have been found to be consistently increased 
in patients with depression (Valkanova, Ebmeier, & Allan, 2013), thus representing a 
promising avenue for research into inflammatory pathways involved in perinatal 
depression and prenatal programming.  
Interleukine-6 (IL-6) is produced by both Th1 and Th2 cells (Szelényi, 2001). It 
is primarily regarded as a pro-inflammatory cytokine because it is mainly involved in 
triggering inflammation (Rohleder et al., 2012); however, it has been shown that, 
depending on biological conditions, IL-6 can have also anti-inflammatory or 
immunosuppressive influences (Ohno et al., 2016). It has been shown that infections 
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or tissue damage trigger an immediate expression of IL-6 which sends out an alarm 
signal to the entire body and induces synthesis of acute phase proteins such as CRP. 
In addition, IL-6 is involved in the acquired immune response by stimulating antibody 
production and effector T-cell development. Furthermore, like other pro-inflammatory 
cytokines, IL-6 is known to trigger an HPA axis response and contribute to increase 
cortisol secretion (Steensberg et al., 2003). IL-6 expression is terminated once the 
source of stress is removed. However, it has been shown that dysregulated persistent 
IL-6 production might lead to the onset or development of several diseases (Tanaka, 
Narazaki, & Kishimoto, 2014). Recently, a number of lines of evidence point to IL-6 as 
a key pro-inflammatory factor involved in the pathogenesis of depression (Walsh et al., 
2016; van Dooren et al., 2016; Sjögren et al., 2006). In addition, it has been proposed 
that elevated IL-6 serum levels might serve as a future diagnostic biomarker (e.g. 
(Chase et al., 2016), as well as a marker of response to treatment (Manoharan et al., 
2016) that deserves further investigation.  
C-Reactive Protein (CRP) has attracted increasing interest in recent years. It is 
an acute phase serum protein that is primarily synthesized in the liver as a part of the 
acute-phase response of the IRS. CRP is synthesized very rapidly and reaches very 
high levels during the height of the inflammatory response. Its synthesis is mainly 
induced by IL-6 and IL-1, although it has been shown that different agents can 
influence its production, including corticosteroids (Du Clos & Mold, 2004). 
Accumulating evidence suggests that CRP is a marker of “low-grade” systemic 
inflammation which strongly predict several health outcomes, including cardiovascular 
diseases (e.g. Genest, 2010), cancer (e.g. Nakamura et al., 2012), cirrhosis (e.g. 
Cervoni et al., 2012), and adverse pregnancy outcomes, such as premature ruptures 
of membranes and preterm birth (e.g. Moghaddam Banaem et al., 2012). Thus, 
interest in CRP as an easily measurable prognostic biomarker for early detection of 
risk of morbidity has consistently increased during the last decade. Recently, higher 
CRP levels have been reported in an increasing number of psychopathological 
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conditions, such as depression (e.g. Howren, Lamkin, & Suls, 2009), anxiety (e.g. 
Liukkonen et al., 2011) and psychological distress (e.g. Goldman-Mellor, Brydon, & 
Steptoe, 2010) across a continuum of severity. Thus, it has been suggested that 
heightened levels of CRP, in the absence of acute medical conditions, reflect an 
increased rate of synthesis of CRP induced by low-grade inflammatory processes 
during periods of chronic stress (Carpenter et al., 2012), that might be measurable well 
before the clear onset of significant clinical syndromes.  
Levels of circulating inflammatory markers have been shown to be impacted by 
sample collection protocols, including handling, processing and storage procedures, 
and time of the day of collection (e.g. Skogstrand et al., 2008), as well as by some 
demographic and health-related factors, such as age, ethnicity (Christian et al., 2013; 
Gillespie, Porter, & Christian, 2016), body mass index and medications (Christian & 
Porter, 2014). In contrast, no effects of fetal sex on serum concentrations of maternal 
cytokines during pregnancy have been reported (Mitchell, Palettas, & Christian, 2017).  
Notably, both IL-6 and CRP serum levels have been found to be affected 
consistently by both acute and chronic stress (Marsland et al., 2017; Segerstrom & 
Miller, 2004; Steptoe, Hamer, & Chida, 2007). Cross-sectional studies have shown 
association between psychosocial factors and both increased IL-6 (e.g. Kiecolt-Glaser 
et al., 2003) and CRP concentrations (e.g. Rohleder et al., 2009) in non-pregnant 
adults and preliminary evidence suggests that associations also exist during 
pregnancy (Christian, 2012b; Coussons-read et al., 2012; Coussons-Read et al., 
2005).  
 
1.4.3.3 Immune system functioning during the perinatal period  
Similarly to the HPA axis and SNS, maternal immune system functioning is 
substantially altered during normal pregnancy to protect women from pathogens and, 
at the same time, avoid fetal rejection (La Rocca et al., 2014). While it was initially 
believed that pregnancy was a state of general immunosuppression, it has been later 
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proposed that pregnancy is a period of immunomodulation with early and late 
pregnancy being characterized by greater inflammation or pro-inflammatory to anti-
inflammatory activity (Th1>Th2 activity), while mid-pregnancy is characterized by 
lower inflammation (Th2>Th1 activity) (e.g. La Rocca et al., 2014; Sykes et al.,, 2012). 
Pregnancy hormones, including progesterone and estradiol, are known to promote 
Th2 cells activity and are held responsible for the predominance of Th2 activity 
associated with advancing pregnancy (Sykes et al., 2012). In particular, immune 
system regulation across gestation is now believed to follow three phases. During the 
first phase, characterized by a pro-inflammatory state, inflammatory factors, such as 
cytokines, are produced in the endometrium and released to support implantation and 
placentation processes (Mor et al., 2011). The second phase corresponds to a period 
of rapid fetal growth and is characterized by an anti-inflammatory state, often 
associated with greater maternal well-being (Mor et al., 2011). During this period, the 
placenta is thought to play an important role by supporting the shift from Th1 (cell-
mediated) to Th2 (humoral-mediated) immune responses (Kumpel & Manoussaka, 
2012). Paralleling these changes, pregnancy-related improvement or remission of Th1 
autoimmune diseases (e.g. rheumatoid arthritis) and worsening of diseases 
characterized by Th2 dominance, such as lupus, are often reported (e.g. Straub, 
Buttgereit, & Cutolo, 2005; Langer-Gould et al., 2002). In addition, the reduced cell-
mediated immunity associated with the Th2 bias might, at least partially, explain the 
increased susceptibility during pregnancy to conditions with an intra-cellular 
pathogenesis, such as influenza and Listeria monocytogenes (Poole & Claman, 2004). 
Lastly, the third phase begins before labor, when immune cells migrate into the 
myometrium and create a pro-inflammatory state (Brewster et al., 2008). The 
inflammatory response is heightened during labor and continues into the early 
postpartum period to support healing and involution (Sennstrom et al., 2000). A shift to 
a predominant Th1 activity has been reported in the postpartum period and has been 
associated with increased susceptibility to infections during that period (Elenkov et al., 
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2001). The Th2 cytokine predominance which exists during pregnancy has been 
shown to return to non-pregnant Th1:Th2 cell ratio by 4 weeks postpartum (Saito et 
al., 1999). 
Concerning circulating levels of cytokines, both pro-inflammatory and anti-
inflammatory cytokines have been shown to be mildly increased during pregnancy 
(e.g. (Curry et al., 2008; Christian & Porter, 2014). In particular, IL-6 is known to serve 
multiple functions in pregnancy maintenance (Markert, Morales-Prieto, & Fitzgerald, 
2011) and higher than typical elevations in IL-6 concentrations during pregnancy have 
been associated with many adverse pregnancy outcomes, such as miscarriage 
(Galazios et al., 2011), preeclampsia (Guven et al., 2009), gestational diabetes 
(Kuzmicki et al., 2009) and preterm delivery (Coussons-Read et al., 2012). 
In addition, attenuated pro-inflammatory cytokine production in response to in 
vitro and in vivo immune challenges has also been reported in healthy pregnancy, 
particularly in the third trimester, and it is thought to prevent fetal rejection and protect 
the fetus from excessive maternal inflammation (Christian, 2012b; Gillespie et al., 
2016). 
 
1.4.3.4 IRS functioning and perinatal depression 
A role for inflammation and related cytokines in MDD was first suggested in the 
1980’s and since then has been well-documented (reviewed in Miller & Raison, 2016). 
Depressed non-pregnant adults show the key features of an inflammatory response, 
including an increased expression of pro-inflammatory cytokines and their receptors 
and elevations in acute-phase reactants both in blood and cerebrospinal fluid (Miller, 
Maletic, & Raison, 2009). In addition, the expression of a wide range of immune genes 
and proteins was found to be upregulated in post-mortem brains of depressed 
individuals who committed suicide (Bufalino et al., 2013). Several meta-analyses 
demonstrated significant association between depression and elevations in circulating 
levels of pro-inflammatory cytokines, namely IL-1 β, IL-6 and tumour necrosis factor-
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alpha (TNF-α), and acute phase proteins, such as C-reactive protein (CRP), 
suggesting that these might represent the most reliable biomarkers of inflammation in 
patients with depression (e.g. Dowlati et al., 2010; Howren et al., 2009; Liu, Ho, & 
Mak, 2012; Valkanova et al., 2013). Although the association is likely to be 
bidirectional, findings support causality as well. It has been demonstrated that 
therapeutic administration of pro-inflammatory cytokines causes non-depressed 
individuals to experience depressive symptoms (Bonaccorso et al., 2002; Capuron et 
al., 2002). Similarly, blockade of cytokines reduces depressive symptoms in patients 
with MDD or patients with medical diseases (Abbott et al., 2015; Köhler et al., 2014; 
Miller & Raison, 2015; Raison et al., 2013). Lastly, polymorphisms in inflammatory 
cytokine genes have been implicated in depression and its response to treatment 
(Bufalino et al., 2013). Consistent with this body of literature, large community studies 
showed that increased inflammation, as indicated by heightened CRP or IL-6 levels, 
predict the later development of depression (Au et al., 2015; Gimeno et al., 2009).  
Based on this evidence, it has been hypothesized that dramatic changes in 
both the stress and immune system during the perinatal period might play a role in the 
development of depression during the perinatal period (e.g. Corwin & Pajer, 2008). 
However, this is still a relatively new and unexplored area of inquiry. A number of 
studies over the last two decades have attempted to clarify the relationships among 
IRS functioning and perinatal depressive symptoms. Nevertheless, heterogeneity in 
both mood and inflammation assessment do not yet allow any firm conclusions to be 
drawn (see Osborne & Monk, 2013 for a review). Several studies reported higher 
levels of pro-inflammatory cytokines, such as IL-1β, IL-6, TNF-α, or CRP, IFN-gamma, 
in depressed pregnant women regardless of gestational timing (Azar & Mercer, 2013; 
Cassidy-Bushrow et al., 2012; Christian et al., 2009; Coussons-Read, Okun, & Nettles, 
2007; Haeri, Baker, & Ruano, 2013; Roomruangwong, Kanchanatawan, & 
Sirivichayakul, 2017; Scrandis et al., 2008). Furthermore, Christian and colleagues 
(2010) showed that depressive symptoms predict exaggerated inflammatory 
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responses to influenza virus vaccination during pregnancy, suggesting a sensitization 
of the inflammatory response related to depression during the antenatal period. 
However, negative associations between depressive symptoms and a number of 
inflammatory markers levels have also been reported both in early (Latendresse, Ruiz, 
& Wong, 2013), mid- (Shelton, Schminkey, & Groer, 2015) and late (Edvinsson et al., 
2017) pregnancy, suggesting that depression during pregnancy might be different from 
depression outside the perinatal period. In addition, a handful of studies did not find 
any evidence of significant association between depressive symptoms and a number 
of inflammatory markers during pregnancy (e.g. Blackmore et al., 2014; 2011, 
Karlsson et al., 2016; Simpson et al., 2016; Walsh et al., 2016). 
Inflammation is also thought to play a role in the development of postpartum 
depression. In particular, an excessive inflammatory response to labor and delivery, 
both alone or in interaction with a dysregulation of the HPA axis, has been proposed to 
predispose some women to experience depressive symptoms in the postnatal period 
(e.g. Corwin & Pajer, 2008). For example, Kendall-Tackett (2007) suggests that many 
previously identified risk factors for postpartum depression, such as stress, sleep 
disturbances, pain, history of depression or trauma, are all characterized by having 
inflammation as the underlying mechanism. Increased serum concentrations of 
inflammatory markers in women experiencing postpartum depression have been 
reported in a number of studies (e.g. Boufidou et al., 2009; Liu et al., 2016; Maes et 
al., 2000b), beginning soon after delivery throughout the first 6 months postpartum. 
Nevertheless, contradictory findings have also been reported. Few studies showed 
negative associations between postnatal depression and levels of inflammatory 
markers associations (e.g. Scrandis et al., 2008; Corwin et al., 2015), while a 
consistent number of reports did not detect any significant associations (Groer & 
Davis, 2006; Blackmore et al., 2014; Corwin et al., 2015; Skalkidou et al., 2009; Groer 
et al., 2015; Cheng & Pickler, 2014). Corwin and colleagues (2008) reported increased 
IL-1β levels 2 weeks after delivery in women with symptoms of depression, but not 1 
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or 4 weeks postpartum. Groer and Morgan (2007) reported a lower Th1/Th2 ratio in 
postnatally depressed women, suggesting some impairment in cellular immunity. In 
addition, they showed that this was not true for women who were breastfeeding, as 
compare to formula-feeding mothers, suggesting that breastfeeding, and related 
physiological changes, may exert something of a protective role (Groer & Davis, 
2006).  
 
1.4.3.5 Prenatal programming by maternal inflammation  
Animal studies have documented that cytokines are present in the fetal brain 
from early gestation (e.g. Meyer et al., 2006) and that increases in specific cytokines 
levels, such as TNF-α and IL-1β, are related to important developmental events in fetal 
brain (Dziegielewska et al., 2000). An early study in humans suggested a role of 
cytokines in fetal brain development due to cytokine and chemokine expression in 
forebrain cells of human fetuses from 5 weeks of gestation (Mousa et al., 1999). In 
addition, in vitro studies shown that cytokines and chemokines can be produced by 
human fetal microglia and astrocytes (Lee, Nagai, & Kim, 2002; Rezaie et al., 2004), 
with an increased production in response to infections (Cheeran et al., 2001; 
Lokensgard et al., 2001), and that glial cells in fetal brain receive and respond to 
signals from inflammatory cytokines (Hanisch, 2002). Thus, it has been hypothesized 
that cytokines could play a critical role in fetal neural, synaptic and glia cell 
development (Deverman & Patterson, 2009), although further research is needed in 
humans.  
While an increase in pro-inflammatory cytokines as gestation advances is 
normal and, to a certain extent might promote fetal brain development, it has also 
been shown that excessive inflammation and a shift toward a Th1 predominance can 
represent a threat to successful pregnancy. Heightened levels of pro-inflammatory 
cytokines in maternal serum or amniotic fluid have been causally linked with greater 
risk of preterm delivery (e.g. Hagberg, Mallard, & Jacobsson, 2005) or pre-eclampsia 
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(e.g. Kurki et al., 2000). In addition, a lack of attenuation of inflammatory responses to 
in vitro challenges has been found among women who later miscarried or gave birth to 
small for gestational-age babies (Marzi et al., 1996) or women with a history of 
recurrent spontaneous abortions (Makhseed et al., 2000). 
Recently, it has been proposed that maternal inflammation, through release of 
cytokines, might play a significant role in “transferring” maternal distress to the fetus 
(Entringer et al., 2010; Ratnayake et al., 2013). However, the actual mechanisms by 
which this might occur are still mostly unknown. Both direct mechanisms via placental 
transfer into the fetal compartment or indirect effects mediated by placental 
inflammation have been hypothesized and require further exploration (reviewed in 
Rakers et al., 2017). Recently, Ross and colleagues (2016) reported significant 
associations between maternal pro-inflammatory markers during pregnancy and cord 
blood inflammation at birth, suggesting that maternal inflammation can be translated to 
fetal circulation, although the mediating mechanisms are still to be elucidated. Studies 
have shown that heightened levels of circulating maternal cytokines can cross the 
placenta to reach the fetus and influence its development. For example, rodent models 
revealed that the administration of cytokines, such as IL6, leads to significant levels of 
those markers in the amniotic fluid and fetal tissue (Dahlgren et al., 2006; Ponzio et 
al., 2007). Similarly, it has been shown that placental bidirectional transfer of IL-6 
occurs in human healthy pregnancy (Zaretsky et al., 2004), indicating that some 
specific cytokines, at least, can directly cross the placenta and get into fetal circulation. 
Nonetheless, different ex vivo perfusion studies in human placentas did not find 
evidence of placental transfer of cytokines (e.g. Aaltonen et al., 2005). 
Another possible mechanism for the adverse effect of maternal inflammation 
on fetal development involves the production of cytokines from the placenta itself, 
which would explain why these substances are found in the amniotic fluid and fetal 
circulation (Ratnayake et al., 2013). Interestingly, maternal IRS activation and related 
cytokine secretion has been found to induce placental production of pro-inflammatory 
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cytokines (Hsiao & Patterson, 2012), although it is still unclear whether maternal 
antenatal distress can trigger placental cytokine production. It has also been proposed 
that an altered balance between pro- and anti-inflammatory cytokines, rather that 
excessive production and release of specific cytokines into the fetal compartment, 
might adversely impact normal brain development (Meyer et al., 2006; Deverman & 
Patterson, 2009), although this hypothesis requires exploration in humans. 
The effects of maternal cytokines on fetal development is thought to be 
mediated by an effect on fetal development of glial cells or stress response systems 
(Ratnayake et al., 2013). Animal studies have shown that prenatal infection or 
inflammation can alter the function of glial cells with a permanent adverse impact on 
the fetal brain (Perry, Nicoll, & Holmes, 2010). Furthermore, once increased levels of 
maternal cytokines have entered into the fetal circulation, they can activate the fetal 
HPA axis to elicit a stress response, which can subsequently influence HPA axis 
function in later life (Chrousos & Kino, 2005). For example, Samuelsson and 
colleagues (2004) showed that peripheral injection of IL-6 in pregnant rats affects 
offspring cardiovascular and HPA regulation, increasing basal activity and reactivity to 
acute stress. Consistent with animal data, preliminary studies on very preterm babies 
have suggested a link between prenatal exposure to inflammation and altered infants 
HPA activity (e.g. Gover et al., 2013), indicating that exposure to inflammatory signals 
in the intrauterine environment could influence the development of the HPA axis, 
leading to long-term functional changes. Lastly, it has been shown that maternal pro-
inflammatory cytokines, specifically IL-1β, IL-6 and TNF-α, can reduce the activity of 
the placental 11-βHSD2, leading to more than 75% of the enzyme activity being 
suppressed (Kossintseva et al., 2006). Thus, fetal glucocorticoid overexposure due to 






1.4.3.6 Maternal inflammation and child outcomes.  
The effects of maternal inflammation during pregnancy on offspring 
neurodevelopment remains relatively unknown. Strong evidence indicates that 
prenatal exposure to IRS-activating infections influences several outcomes in later life, 
including stress reactivity and susceptibility to metabolic, immunological and 
neuropsychiatric diseases such as Alzheimer’s, Parkinson’s, schizophrenia, and 
autism (Nelson & Willoughby, 2000, 2002; Rantakallio et al., 1997; Shi et al., 2003). 
Nonetheless, the non-experimental nature of this body of findings does not allow us to 
disentangle whether the observed effects on the developing fetal brain are due to 
infection-induced maternal IRS activation or to infection itself. Evidence for a specific 
causal role of maternal cytokines in fetal programming is mainly based on animal 
studies (Mandal et al., 2013; Meyer et al., 2008; Straley et al., 2017). In a study using 
mouse models, maternal stress triggered placental inflammation, as indicated by 
upregulation of pro-inflammatory placental genes, and this, in turn, resulted in an 
offspring hyperactive phenotype. In addition, administration of anti-inflammatory drugs 
prevented gene upregulation and altered the phenotype in the offspring (Bronson & 
Bale, 2014). Furthermore, several studies on pregnant rats showed that peripheral 
injection of IL-6 produced a number of negative outcomes in the offspring, including 
structural changes in the hippocampus and reduced learning abilities, increased body 
weight and decreased insulin sensitivity and hypertension and hyperactivity of the HPA 
axis (e.g. Dahlgren et al., 2006; Samuelsson et al., 2004). Notably, maternal IRS 
activation induced by viral mimic during pregnancy resulted in a schizophrenia-like 
phenotype in the offspring, unless they were IL-6-knockout mice or an IL-6 antibody 
was added to the viral mimic (Smith et al., 2007), suggesting an important role of 
maternal IL- 6 in programming risk for later disease.  
Only a few studies in humans have attempted to explore the association 
between antenatal maternal cytokine levels and offspring risk for schizophrenic 
spectrum disorders (Allswede et al., 2016; Brown et al., 2004; Buka et al., 2001), 
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generally, reporting no associations. In addition, when positive associations between 
specific markers and risk for psychosis in the offspring were found, these were not 
replicated in the other reports. In addition, to our knowledge, only one report related 
levels of maternal specific inflammatory markers during pregnancy to later risk of MDD 
in the offspring (Gillespie et al., 2016). The authors showed that maternal inflammation 
during pregnancy increased the risk for major depression in adulthood in offspring in a 
sex-dependent manner. Specifically, prenatal exposure to a higher concentration of 
maternal TNF-α and IL-10 were associated with a lower risk of depression among 
female offspring, and with a higher risk of depression among males.  
As previously mentioned, maternal inflammation has been consistently linked 
to adverse pregnancy outcomes, such as preeclampsia, miscarriage and gestational 
diabetes (reviewed in Christian et al., 2012). In addition, a number of studies showed 
that increased levels of circulating inflammatory markers predict adverse birth 
outcomes, such as shorter gestational length, lower birth weight and shorter body 
length (e.g. Kuzawa et al., 2017; Pringle et al., 2015), while some others have 
suggested that an altered maternal Th1-Th2 balance during pregnancy favouring a 
Th1 response, rather than Th2, might be implicated in risk for preterm delivery 
(Ekelund et al., 2008; Sykes et al., 2012a). 
Moreover, some preliminary studies have investigated the mediating role of 
maternal inflammation in the link between antenatal maternal stress and birth 
outcomes, and these have yielded inconsistent findings. Okun and colleagues (2013) 
reported an association between maternal increased IL-6 levels and smaller birth 
weights in depressed women, although the effect became non-significant in an 
adjusted model. Coussons-Read and colleagues (2012) reported an association 
between higher CRP, IL-6 and TNF-α levels and shorter gestation. In addition, they 
showed that maternal levels of IL-6 and TNF-α during pregnancy partially mediated 
the effects of antenatal maternal pregnancy-specific distress on gestational length, 
although the direction of findings was unexpected, with greater maternal distress being 
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associated with lower, rather than higher, inflammation and, in turn, less impact on 
gestational age. Lastly, Miller and colleagues (Miller et al., 2017) found that high 
maternal IL-6 levels during pregnancy mediated the association between maternal 
disadvantaged childhood and negative birth outcomes such as lower birth weight and 
preterm delivery. 
A very limited number of studies have directly investigated the impact of 
prenatal levels of maternal inflammatory markers on child developmental outcomes, 
beyond birth outcomes. Graham and colleagues (2017) were the first to show that 
maternal averaged IL-6 levels across pregnancy was associated with newborn brain 
development. Specifically, higher IL-6 concentrations were associated with larger right 
amygdala volume and stronger bilateral amygdala connectivity to brain regions 
involved in sensory processing and integration, learning and memory. The alterations 
in newborns’ amygdala, in turn, predicted lower impulse control at 24 months of age, 
after controlling for variations in mother-child relationship. Furthermore, very recent 
work from the same group of researchers additionally showed that maternal averaged 
IL-6 concentrations during pregnancy was associated with reduced functional 
anisotropy in the central portion of the uncinate fasciculus of newborns’ brains, 
suggesting that maternal antenatal inflammation predicts reduced integrity of the main 
frontolimbic fibre tract (Rasmussen et al., 2018). Moreover, they showed a positive 
association between maternal IL-6 levels and rate of increase in functional anisotropy 
of the uncinate fasciculus across the first year of life, suggesting a compensatory 
postnatal growth, so that no association between maternal antenatal IL-6 and 
functional anisotropy was detected at 12 months of age. Maternal antenatal IL-6 levels 
also predict poorer cognitive development at 12 months of age and, importantly, this 
was mediated by the postnatal catch-up growth in functional anisotropy. 
Another recent study by Osborne and colleagues (2018) showed that higher 
levels of maternal TNFα, vascular endothelial growth factor, and IL-10 in the third 
trimester of pregnancy were associated with infant outcomes, specifically, less optimal 
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neurobehavioral function, as assessed at the NBAS 6 days after childbirth, and higher 
cortisol levels in response to the immunization at 12 months of age, but not at 2 
months of age. Lastly, Gustaffson and colleagues (2018) reported that maternal pro-
inflammatory cytokines (indexed though a latent variable including IL-6, TNF-α, and 
monocyte chemoattractant protein-1) in late pregnancy mediate the link between 
prenatal depressive symptoms and 6-month-olds negative affect   
Despite this evidence being only preliminary, findings are suggestive of a role 
of maternal inflammation during pregnancy in influencing fetal brain development, 
indicating that an inflammation-mediated pathway from antenatal depression to child 
altered outcomes deserves further investigation.  
 
1.2 The current thesis 
 
The studies described above provide an overview of accumulating evidence 
linking maternal antenatal stress to bio-behavioural outcomes in the child, suggesting 
that understanding pathways influencing fetal development should be a global health 
challenge. Nonetheless, the science of fetal origins of psychopathology poses several 
key questions. 
First of all, there is a need for a clear characterization of maternal antenatal 
stress experience both from a psychological and biological perspectives. Studies 
relating specific maternal antenatal influences to specific neurodevelopmental 
outcomes hold greater promise in revealing underlying mechanisms.  
Secondly, while biological and psychological stress measures are often 
assumed to be markers of the same underlying construct, evidence suggests that 
maternal psychological distress is not necessarily related to increased stress 
biomarkers and, similarly, higher levels of stress hormones do not seem to 
automatically reflect maternal experience (Harville et al., 2009; Sandman et al., 2012). 
Rather, as biological and psychological stress measures have both been found to be 
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related to child outcomes, it has been proposed that the effects of these factors on 
offspring development might occur through different pathways, although these still 
need to be elucidated (O’Donnell & Meaney, 2017). 
Third, while it is known that under stress conditions both the stress and 
immune systems are activated and extensively interact with each other (e.g. Chrousos 
& Kino, 2005), the majority of studies in the field focus exclusively on neuroendocrine 
mediators of maternal stress experience. Studies evaluating multiple biological stress 
measures are scarce and, to our knowledge, no published study has measured 
concurrently the activity across the HPA axis, SNS and IRS.  
Fourth, mounting evidence suggest that genetic and postnatal environmental 
factors play a role in programming later developmental trajectories. In particular, 
animal models suggest that early rearing conditions can moderate the impact of 
prenatal stress exposure on offspring development, however the generalizability of 
these findings to humans is still unknown. As a greater understanding of whether 
postnatal caregiving experiences might moderate the effects of antenatal stress 
exposure has considerable theoretical and practical significance, more research into 
the interplay between prenatal and postnatal environmental influences in humans is 
needed.  
Building on existing knowledge, the current dissertation attempts to address 
these key issues by adopting a multi-systems approach in order to examine 
prospective associations among naturally occurring variations in maternal antenatal 
depressive symptoms, stress and inflammatory biomarkers concentrations and 
offspring’s bio-behavioral outcomes from birth to three months of age, taking into 
account the role of postnatal maternal care.  
A community sample of healthy pregnant women, together with their offspring, 
was studied from late pregnancy to three months after delivery as described in 
Chapter 2. In Chapter 3, cross-sectional associations between maternal depressive 
symptoms and levels of stress and inflammatory markers in late pregnancy and soon 
115 
 
after delivery were examined. Chapters 4 and 5 aimed at investigating the prospective 
associations between variations in maternal depressive symptoms, stress and 
inflammatory markers during pregnancy and infant behavioral and biological outcomes 
at birth (Chapter 4) and 3 months after delivery (Chapter 5). Lastly, Chapter 6 was 
designed to explore the role of postnatal maternal care in the association between 
prenatal maternal influences and 3-month-olds’ bio-behavioral outcomes. To our 
knowledge, the present study is unique in the assessment of multiple biological 
markers of maternal stress and immune systems in association with infant outcomes. 
The neonatal assessment soon after birth provided a unique opportunity to examine 
the effects of antenatal maternal stress, largely independent from postnatal 
environmental factors. Furthermore, the evaluation of the quality of early maternal 
postnatal care, jointly with maternal postnatal symptoms, is rarely included in research 
within the DOHaD field and allowed to preliminarily examined the complex interplay 
between prenatal and postnatal environemental factors in influencing infants’ 
development. Lastly, despite the most sensitive time in gestation for the adverse 
effects of antenatal maternal stress has not yet been established, the current 
dissertation focuses on examining effects of exposure in late pregnancy as this is a 
period of rapid infant growth and brain development (Grossman et al., 2003) in which 
exposure to maternal stress signals is thought to influence the developing fetal stress 
response system (Davis et al., 2011) and is associated with later risk for emotional 
problems (Rice et al., 2007).  
Based on available literature, we tested the following hypothesis:  
1) Women with higher depressive symptoms would showed heightened inflammation 
and an altered cortisol diurnal pattern during pregnancy and after delivery (Chapter 
3). 
2) Higher maternal antenatal depressive symptoms would be associated with more 
negative birth outcomes and greater stress reactivity in offspring at birth (Chapter 
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4) as well as with 3-month-olds’ greater stress reactivity, negative emotionality and 
poorer cognitive/motor development (Chapter 5). 
3) Variations in maternal diurnal cortisol in late pregnancy would predict newborns’ 
birth outcomes and stress reactivity at birth (Chapter 4), as well as infants’ stress 
regulation, temperament and cognitive/motor development at 3 months of age 
(Chapter 5).  
4) We tested two main hypotheses concerning the role of maternal caregiving in the 
observed associations between prenatal maternal influences and infants’ 
development: a) Higher maternal prenatal depressive symptoms would be 
associated with lower maternal sensitive caregiving, as measured through the 
Emotional Availability (EA) Scales (4th edition, Biringen et al., 2008), possibly 
mediating the influence of antenatal depression on infant’s outcomes. b) Maternal 
sensitive caregiving would moderate the association between prenatal maternal 
influences and infant’s outcomes at 3 months of age (Chapter 6). Due to limited 
available literature, we made a broad hypothesis that high maternal EA 3 months 
after childbirth would be able to buffer the negative effect of prenatal stress 
exposure (as indexed either by psychological or biological measures) on infants’ 
development.  
Furthermore, in Chapter 3, we conducted exploratory analyses to test whether 
maternal antenatal depressive symptoms would be associated with an altered diurnal 
sAA pattern as well as the association between stress and inflammatory markers 
between women with higher versus lower depressive symptoms. In particular, after 
Corwin and colleagues (2015), we hypothesized that women with higher depressive 
symptoms would show a positive association between stress and inflammatory 
markers during the perinatal period. 
In Chapter 4 and 5, we investigated possible novel mediators of the effects of 
maternal antenatal stress on child outcomes involving the IRS and the SNS 
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functioning which have received very limited empirical support to date. In particular, 
exploratory analyses examined possible associations between either maternal 
antenatal inflammation or diurnal sAA levels and a wide range of outcomes in offspring 
including birth outcomes, stress reactivity, temperament, motor and cognitive 
development. Due to the lack of available literature, we made no a priori hypothesis 
concerning these associations.  
Lastly, as perinatal depression and anxiety are strongly correlated (Falah-
Hassani et al., 2017), in each chapter, we investigated whether the observed 
associations were specific to depression or can be replicated for anxiety. These 
exploratory analyses were expected to provide some preliminary insight into the 





Chapter 2: Materials and methods  
 
2.1 The Effects of Depression on Infants (EDI) Study 
The findings discussed in this dissertation come from a community sample of 
mother infant-dyads recruited as part of the Effects of Depression on Infants (EDI) 
Study, an ongoing longitudinal research, based at the Scientific Institute Eugenio 
Medea in Italy, investigating the effects of antenatal maternal depression on children 
bio-behavioral development. The EDI Study started in 2014 and it is still ongoing. It 
consisted of a screening phase at 30-33 weeks of gestation and of five assessment 
phases, respectively, at 34-36 weeks of gestation (phase 1), at delivery (phase 2), 12 
weeks after delivery (phase 3), 13 months after delivery (phase 4) and 36 months after 
delivery (phase 5). As data coding and analyses for phases 4 and 5 is still ongoing and 
data collection for phase 5 is underway, only data from the first three phases (i.e. 
pregnancy, birth, 12 weeks) will be included in the current dissertation. Specifically, 
maternal data from phase 1 and 2 will be part of Chapter 3, maternal data from phase 
1 and infants’ data from phase 2 will be included in Chapter 4, while data collected in 
phase 1 and phase 3 will be object of Chapters 5 and 6. Only sample characteristics 
and methods pertinent to the aims of the current dissertation are described below.  
 
2.2 Participants recruitment 
Women in the early third trimester of gestation were consecutively recruited at 
the beginning of childbirth classes or through ads placed in the clinic waiting rooms of 
3 hospitals located nearby the Medea Institute in Italy. A researcher from the team 
presented the EDI study at the first lesson of childbirth classes and women who were 
interested to participate were given an information pack and some screening 
questionnaires and forms to be filled out between 30 and 33 weeks of gestation.  
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Approximately 20% (N=237) of women informed about the study at 111 
childbirth classes were willing to participate and return the questionnaires. In addition, 
15 women contacted the team after seeing the ads in the hospitals to take part in the 
study. Thus, 252 women in the early third trimester of gestation (weeks of gestation: 
M=31.41, SD=1.61) took part in the screening phase of the study.  
 
2.3 Inclusion/exclusion criteria 
The following prenatal inclusion criteria were established: being between 18-45 
years of age, less than 36-weeks pregnant, in good health, normotensive, with 
singleton uncomplicated pregnancy naturally conceived, anticipating a vaginal birth in 
one of the hospitals involved in the study, non-smoker, not afflicted by any disease 
that might affect the immune or endocrine systems and not taking any chronic 
medications, including anti-inflammatory, anti-depressant or steroid medications, not 
having done or anticipating intravenous anti-D immunoglobulin, and with no known 
substance/alcohol abuse problems or chronic psychiatric disorders (with the exception 
of depression and anxiety disorders). All inclusion criteria were adopted in order to 
limit possible conditions that might themselves be associated with an altered 
functioning of the biological systems examined. Furthermore, the upper limit of the age 
range was set to be 45 years old, as pregnancy in women aged over 45 years is 
uncommon and pregnancy complications (such as high blood pressure, diabetes 
during pregnancy, placental problems and birth complications) are more likely to 
occur. The lower limit was set to 18 years as the Italian legislation required to obtain 
consent from both parents before involving participants under 18 years within a 
research project, therefore mothers aged less than 18 years would have not been able 




Postnatal criteria for inclusion were: infants born at term (>37 weeks of 
gestation) or late preterm (>35 weeks of gestation) and in good health. These criteria 
were adopted to ensure that effects of prematurity or health problems did not confound 
the results of the current studies. In addition, there were a number of study-specific 
postnatal inclusion criteria for studies included in Chapter 3, 4 and 6. Postnatal criteria 
for continued inclusion in the study presented in Chapter 3 were: having a vaginal 
delivery of a live infant, without experiencing hemorrhage or transfusion. Postnatal 
criteria for continued inclusion in the study presented in Chapter 4 were: delivering in 
one of the three hospitals involved and available videotaped data of the heel-stick 
procedure. Postnatal criteria for continued inclusion in the study presented in Chapter 
6 were: available data on maternal sensitivity.  
 
2.4 Sample 
Sample for Chapter 3: From the screened sample, 2 women were excluded for 
smoking during pregnancy, 3 for taking chronic medications, 2 for having a chronic 
disease, 10 for gestational diabetes, 13 for hypothyroidism, 14 for antenatal 
intravenous anti-D immunoglobulin, 7 for antenatal progesterone treatment, 1 for 
antenatal betamethasone administration, 1 for twin pregnancy, 4 for artificial 
conception, 5 for delivering before phase 1 was done, 2 for being more than 36-weeks 
pregnant and 11 for, anticipating delivery in a hospitals not involved in the study. In 
addition, 65 women did not agree to participate to the subsequent study phases. Thus, 
110 women (mean age= 33.00; SD= 3.85) were included in the study. The final 
sample consisted of middle-high class (90%), mostly Italian (96.4%), married (62.7%) 
or cohabiting (35.5%), with at least high school diploma (89.4%) and primiparous 
(90%) women. The sociodemographic characteristics of the sample reflect the low-risk 
nature of the sample. Sociodemographic characteristics as well as depression and 
anxiety scores for the three groups (i.e. participants, excluded women and women who 
withdrew their participation) are reported in Table 2.1.  
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Table 2.1 - Sociodemographic and clinical characteristics of women included in the 
study, excluded or who withdrew their participation after the screening phase. 
 
* Percentages for Education, Family SES and Marital Status do not add to100% due to missing values. 
EPDS, score at the Edinburgh Postnatal Depression Scale (Cox et al., 2010); STAI-T, score at the State-
Trait Anxiety Inventory trait scale (Spielberger et al., 1970)  
 
Excluded women as well as women who withdrew their participation did not 
differ significantly from participants on depression and anxiety scores and on any 
demographic variables with the exception of socioeconomic status, as assessed with 
the 9-point Hollingshead (1957) scale for parental occupation. Specifically, women 
who did not consent to participate to the follow-up assessment phases were more 
likely to be from a low socio-economic class than participants or women who were 
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death at 38 weeks due to umbilical cord accident were excluded from the postnatal 
phase of Chapter 3, while 1 woman withdrew her participation due to her newborn’s 
health problems, leaving 89 women with available postnatal data for Chapter 3. 
Sample for Chapter 4: From the initial sample of 110 women included in the 
prenatal phase, 1 intrauterine death at 38 weeks, 1 delivery in a different hospital and 
3 women with no behavioral data (due to delay in giving notice of the delivery) were 
excluded from the study presented in Chapter 4. Additionally, 1 woman withdrew her 
participation after delivery due to her newborn’s health problems. Thus, the sample for 
Chapter 4 consisted of 104 infants (mean postnatal age=1.96 days, SD=0.68; 51.9% 
males) and their mothers (mean age=33.04, SD=3.83). Eighty-six babies (82.7%) were 
born by vaginal delivery and eighteen (17.3%) by caesarean section. Two newborns 
were born respectively at 35 and at 36 gestational weeks but as they were in good 
health and did not require any intervention, they were included in the sample. 
Sample for Chapter 5: From the initial sample of 110 women, one intrauterine 
death and 1 infant with serious health problems at the 12-weeks assessment were 
excluded from the initial sample. Additionally, 1 woman withdrew her participation after 
delivery due to her newborn’s health problems. Thus, 107 infants (mean postnatal 
age=12 weeks, SD=1.84; 52.3% males) and their mothers were included in the study 
presented in Chapter 5. 
Sample for Chapter 6: From the sample of 107 infants participating in Study 3, 
3 women did not have data on maternal sensitivity because they did not attend the 
postnatal assessment session at the Medea Institute due to logistic reasons (i.e. living 
too far from the Medea Institute). Thus, the final sample for Study 4 consisted of 104 
infants (mean postnatal age=12 weeks, SD=1.84; 51% males) and their mothers.  
 
2.5 Assessment protocol  
The assessment protocol of the phases of the EDI study included in the current 




Figure 2.1 - Schematic representation of the longitudinal assessment protocol of the 
current dissertation. In light blue are reported maternal assessment, while in dark blue 
infant assessment 
 
Screening phase: between 30-33 weeks of gestation, pregnant women filled 
out questionnaires on depression and anxiety and a demographic and pregnancy-
related information form. Women who gave written informed consent to participation to 
the follow-up phases and fulfil the inclusion criteria were included in the study.  
Phase 1: between 34-36 weeks of gestation women were invited to attend a 
morning session at the Medea Institute or at the hospitals involved. During this 
session, the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I; First 
et al., 2002) was administered, together with the Raven Standard Progressive 
Matrices (RSPM, Raven & Court, 1998). In addition, women were asked to donate a 
blood sample and to return their saliva samples collected during the previous days. In 
that occasion, women were reminded to inform the research team once their babies 
were born through a text message and to perform once again the saliva collection from 
the morning after delivery. Additionally, one week before the due date and, eventually, 
on due date, women were contacted once again to remind to give notice of delivery.  
Phase 2: between 48-72 hours after delivery (mean hours after delivery=52.36; 
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SD=19.70), women were asked to fill in once again the questionnaires on depression 
and anxiety, to provide once again a blood sample and to collect their saliva samples 
beginning from the morning after delivery (mean hours after delivery=17.64; 
SD=10.16) according to the same procedures adopted during pregnancy. Women 
were also asked to fill out a form on health and delivery, while data on birth outcomes 
were extracted from medical records. Lastly, infants’ behavioral and cortisol response 
to the heel-stick was assessed.  
Phase 3: at 12 weeks of age, infants’ behavioral and cortisol response to the 
inoculation was evaluated during the routine first inoculation visit at the infant’s 
pediatric health center. Infant cognitive and motor development, as well as maternal 
sensitivity were assessed in a subsequent session at the Medea Institute. Additionally, 
women were asked to complete a form on infants’ health and two questionnaires on 
infants’ temperament, daily sleep and crying behaviour, as well as to fill out once again 
questionnaires on depression and anxiety.  
Women’s written informed consent was required at each phase of the study. In 
addition, written informed consent was required from both parents for the participation 
of their baby in each postnatal phase. The Ethics Committee of University College 
London, of Scientific Institute Eugenio Medea and of the hospitals and pediatric health 
centers involved approved the study protocol.  
 
2.6 Maternal measures  
Maternal depression was assessed through the Edinburgh Postnatal 
Depression Scale (EPDS; Cox, Holden, & Sagovsky, 2010) during pregnancy, after 
delivery and 12 weeks after delivery. The EPDS is the most widely used self-report 
questionnaire to screen for perinatal depression (Underwood et al., 2016). Although 
originally developed to screen for postnatal depression, it has been validated also for 
pregnancy, demonstrating excellent reliability and validity (Murray & Cox, 1990). As 
compared to other similar screening instruments, the EPDS is more specific to the 
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perinatal period and less reliant on somatic symptoms (such as sleep and appetite 
dysregulation) which are normative in pregnancy. It consists of 10 items each scored 
on a 4-points Likert scale ranging from 0 to 3, giving scores ranging from 0 (not 
depressed) to 30 (very depressed). Currently, there is no clear consensus about the 
most optimal cut-off to significantly screen for a risk of antenatal depression and a 
range of cut-offs have been employed (from 9/10 to 12/13). A continuous total sum 
score was employed in the main analyses because the study sample was a 
community sample drawn from the general population and the frequency of women 
scoring above the cut-off was expectedly low.  
Maternal anxiety was evaluated in parallel with assessments of maternal 
depression through the State-Trait Anxiety Inventory (STAI; Spielberger et al., 1970) a 
well-validated self-report measure of anxiety. The STAI consists of a state (STAI-S) 
and a trait (STAI-T) subscale, each constituting of 20 items to be rated on a 4-points 
scale ranging from 1 ‘not at all’ to 4 ‘very much’. The maximum score for each 
questionnaire is 80, with higher scores indicating higher anxiety. Trait anxiety or 
anxiety as a general trait reflects a dispositional anxiety proneness, while state anxiety 
measures anxiety at the moment of the rating and is supposed to reflect a transient 
anxiety condition. The STAI has been widely employed during pregnancy (e.g. Pluess 
et al., 2010; Davis et al., 2011), and has been translated and validated also in Italian 
(Pedrabissi & Santinello, 1989), showing good internal consistency with coefficients 
ranging from 0.89 to 0.91 and both construct and concurrent validity (Barnes, Harp, & 
Jung, 2002). In the current sample, trait anxiety as measured through the STAI, was 
strongly correlated with state anxiety on the STAI at all time points (pregnancy r=.78, 
delivery r=.64 and 12-weeks after delivery r=.73 p<.001), in line with previous reports 
(e.g. Huizink et al., 2017). The trait anxiety total sum score was employed in all main 
analyses because there is some evidence suggesting that it might account also for a 
proportion of pregnancy-related anxiety which is often found to be highly predictive of 
offspring outcomes in low risk samples (e.g. Tollenaar et al., 2011). Supplementary 
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analyses including measures of state anxiety rather than trait anxiety lead to 
substantially similar results as those using trait anxiety as a predictor. 
Maternal diagnostic status was assessed during pregnancy through the 
Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-
Patient Edition (SCID-I RV-NP; First et al., 2002). The SCID–I is a semi-structured 
diagnostic interview, widely used in psychiatric research studies. It consists of 
standardised diagnostic questions arranged in modules corresponding to each DSM–
IV-TR Axis-I disorder (American Psychiatric Association, 2000). The test–retest 
reliability of SCID–I falls between reported values for similar instruments (First et al., 
1995) . All women were interviewed by two trained clinical psychologists in order to 
ascertain the presence of a current depressive/anxiety disorder and exclude other 
diagnoses. Five women (4.5%) fulfilled the criteria for a diagnosis of Major Depressive 
Episode, while 4 women (3.6%) fulfilled the criteria for a diagnosis of Anxiety Disorder 
during pregnancy. Considering the low rate of clinically depressed or anxious women 
in the current study sample, which is in line with reported antenatal prevalence for 
these disorders in low-risk samples (Bennett et al., 2004), the diagnostic status was 
not employed in the analyses presented in the current dissertation and the SCID-I was 
employed exclusively to ascertain that women did not have any substance/alcohol 
abuse problems or chronic psychiatric disorders with the exception of depression and 
anxiety disorders.  
Maternal cognitive function was assessed during pregnancy through the Raven 
Standard Progressive Matrices (RSPM, Raven & Court, 1998), a widely employed test 
that evaluate non-verbal general cognitive ability. It consists of 60 multiple choice 
items divided in five set of 12 items each administered in ascending order of difficulty. 
Each item requires participants to identify the missing element that completes a 
pattern from a number of options. The RSPM was administered individually by a 
clinical psychologist and administration time was limited to 30 minutes. The RSPM has 
shown good validity and acceptable test-retest reliability coefficients ranging from 0.76 
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to 0.91 in various cross-cultural studies of intelligence (Raven et al., 1998). In addition, 
although the RSPM offers substantially shorter administration, good correlations with 
other measures of intelligence and with educational level have been reported (e.g. 
Nikolaos et al., 2016; O’Leary, Rusch, & Guastello, 1991). The RSPM raw scores, as a 
measure of individual general cognitive ability, were employed in the analyses. 
Maternal sociodemographic characteristics were evaluated at the screening 
phase through an ad-hoc form. Women were asked to report for themselves and for 
the father of their baby the following sociodemographic information: birthdate, 
nationality, education, actual employment, income, marital status, parity and, 
eventually, birthdate and sex of other children. Actual employment were used to 
calculate maternal, paternal and family socio-economic status (SES) according to the 
9-point Hollingshead (1957) scale for parental occupation.  
Health and pregnancy-related information were collected at the screening 
phase through an ad-hoc form. Specifically, participants were asked to provide data 
concerning: due date, date of last menstruation, fetal sex, natural conception, fertility 
treatment, any complication or risk or medical disorder related to pregnancy, any 
disease or dysfunction not related to pregnancy, parity, actual and pre-pregnancy 
weight and height, any medication during pregnancy (including over-the-counter drugs 
and vitamins, immunization shots -e.g. measles shot, a flu shot, a shot for Rh 
incompatibility-, antibiotics, antivirals or antifungals), use of cigarettes, alcohol or other 
substances during pregnancy, ever seek professional help for psychological problems. 
Self-reported height and weight were used to estimate pre-pregnancy BMI.  
Health and delivery-related information were collected after delivery through an 
ad-hoc form. Participants were asked to report on: date and time of delivery, length of 
labor, induction of labor, type of delivery, assisted vaginal delivery, episiotomy, 
perineal tear, any stitches, any complications at site of episiotomy/stitches, 
anaethesia, rupture of membranes before delivery and eventual time, fever during 
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labor, any complication/abnormal sign/blood transfusion, any medication, expected 
time of discharge.   
Maternal Emotional Availability was evaluated at the 12-weeks assessment 
during a 15-minutes videotaped free-play session. Mothers were left with their 3-
month-olds in a room equipped with a standard set of age-appropriate toys and were 
told to interact with their child as they normally would do at home. The quality of 
maternal caregiving was evaluated through the Emotional Availability (EA) Scales, 
Infancy/Early Childhood Version (4th edition, Biringen, 2008), as described in section 
3.5.3. The EA scales integrate attachment (Ainsworth et al., 1978) and emotional 
perspectives (Emde & Easterbrooks, 1985), emphasizing the emotional quality of the 
interaction. An increasing number of studies have employed this instrument to 
investigate caregiving behaviors and mother-child relationship both in typical and 
atypical populations (e.g. Lock & MacMahon, 2006, Trapolini et al., 2008, Austin et al., 
2017). The EA scales have been validated also for very young children (Carter et al., 
1998) and have been shown to consistently predict infants’ attachment classifications 
(e.g. Easterbrooks, Biesecker, & Lyons-Ruth, 2000). The validity and stability of the 
EA construct over time have been well demonstrated (Biringen et al., 2014). The EA 
scales included four global ratings of caregiver behaviors, specifically: 1) Sensitivity, 
which refers to the caregiver’s ability to be warm and emotionally connected with the 
child, show appropriate and authentic affect and be responsive to the child’s signals; 
2) Structuring, which refers to the caregiver’s ability to appropriate scaffold and 
structure the child’s play in a way that is well received by the child; 3) Non-
intrusiveness, which refers to the caregiver’s ability to be available to the child without 
interfering with the child’s age-appropriate autonomy; 4) Non-hostility, which refers to a 
style of interaction with the child that is not negative, abrasive, impatient or 
antagonistic. Each scale is rated with a direct score ranging from 1 (non-optimal) to 7 
(optimal), as well as along 7 sub-scales generating a total score ranging from 7 to 29. 
In order to maximize variability in the EA scores, total scores, rather than the direct 
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scores, were employed in data analyses as previously done (Austin et al., 2017). 
Additionally, as the four maternal EA scales were moderately inter-correlated (rs= 
0.73–0.50) in order to reduce the number of variables for analyses, they were 
standardized and summed to create an overall index of maternal EA (Cronbach’s α = 
.85), as done in prior work (Taylor-Colls & Fearon, 2015). Two clinical psychologists, 
both trained by Biringen and reliable in the use of the EA scale, 4th Edition, both with 
the author, Zeynep Biringen, and with each other, coded independently the videotaped 
interactions after the end of data collection. Both raters were blind to all prenatal and 
postnatal data. A subsample of 20 randomly chosen dyads (around 19.5% of the 
sample) were coded by both raters. Intra-class correlation (ICC) coefficients ranged 
from .75 to .91 with a mean ICC of .84. 
  
2.7 Child measures 
Birth outcomes were extracted from medical records after delivery. The 
following information concerning newborns’ health were collected: sex, gestational 
age, weight, body length and head circumference at birth, Apgar scores, any evidence 
of fetal distress during labor, any fever, any evidence of infection or congenital 
anomaly, any medication, any treatment/intervention, breast or formula feeding, 
expected time of discharge were collected.  
Health-related information were collected at 12 weeks through an ad hoc form 
that a researcher filled out with the mother. More specifically, the following information 
concerning physical health, feeding and sleep were collected: actual weight, body 
length, day spent in hospital after birth, any disease/disorder after birth, any 
medication or treatment from birth to date, any hospitalization/outpatient 
procedures/surgery from birth to date, actual health and health in the past 2 weeks, 
breastfeeding or formula feeding or mixed, daily feeding schedule, anyone smoking in 
family, any day-care.  
Temperament was assessed at 12 weeks of age through the Very Short Form 
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of the Infant Behavior Questionnaire (IBQ-R-VSF; Putnam et al., 2014). The IBQ is a 
well-established standardized measure designed to evaluate individual differences in 
temperament in infants aged from 3 to 12 months by caregiver report. The IBQ-R-VSF 
consists of 37 items describing specific infants’ behaviors in common situations. 
Parents are asked to report on a 7-point scale, which ranges from “never” to “always”, 
the frequency of each behavior during the past 2 weeks. A “not applicable” response is 
also possible when the infant has never experienced the situation described. The 
items measured three broad, empirically derived, temperamental dimensions, namely 
negative affectivity, positive affectivity/surgency, and orienting/regulatory capacity, that 
are proposed to be comparable to three of the Big Five personality traits found in 
adults, Neuroticism, Extraversion, and Conscientiousness, respectively. The negative 
affectivity dimension measures sadness, distress to limitation and fear. The positive 
affectivity/surgency dimension included measures of approach, vocal reactivity, high-
intensity pleasure, smiling and laughing, activity level and perceptual sensitivity. The 
orienting/regulatory capacity dimension evaluates duration of orienting, low-intensity 
pleasure, cuddliness and soothability. Levels of reliability and stability of the IBQ-R-
VSF are similar to those obtained with the longer versions of the scale and other 
temperament measures (Putnam et al., 2014). 
Crying was assessed at 12 weeks of age through the Baby’s Day Diary (R. 
Barr, 1985), a 24-hour record of infant behaviors to be completed at home by the 
caregiver. The Baby’s Day Diary has been previously employed with infants as young 
as 4 days (Fujiwara et al., 2011), as well as in the first months after delivery (Radesky 
et al., 2013). Mothers were instructed to record over a 24-hour period the durations of 
6 infant behavioral states (i.e. awake and alert, awake and fussing, awake and crying, 
awake and inconsolable crying, feeding, sleeping). Inconsolable crying was defined as 
“infant crying that cannot be soothed.” Total minutes of infant distress (fussing, crying, 
and inconsolable crying) per day and minutes of inconsolable crying per day were 
abstracted from the diary. The assessment of frequency and duration of crying, as 
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evaluated through the Baby’s Day Diary, has been shown to strongly correlate with 
audiotape recordings (Barr et al., 1988; St James-Roberts, Hurry, & Bowyer, 1993). 
Additionally, the evaluation of infant’s behavior through the Baby’s Day Diary has been 
demonstrated to be independent from postnatal maternal depressive symptoms (A. R. 
Miller, Barr, & Eaton, 1993). 
Mental and motor development was evaluated at 12 weeks of age through the 
Bayley Scales of Infant and Toddler Development – Third Edition (Bayley III, Bayley, 
2006). The Bayley III are a well-standardized and widely employed developmental 
assessment. The examination was performed by two trained clinical psychologists 
blind to prenatal data, according to the standardized protocol. The Bayley III provides 
four types of norm-referenced scores: scaled scores for the 5 subtests (Cognitive, 
Expressive Communication, Receptive Communication, Fine Motor, Gross Motor), 
composite scores for cognitive, language, and motor domains, percentile ranks and 
growth scores. In the current study we focused on age-standardized composite scores 
for the Cognitive and Motor domain calculated by using test norms (mean= 100; SD= 
15). The Bayley III have been widely employed in research and are generally 
recognized as the ‘gold standard’ tool to evaluate development of very young children 
(Bedford, Walton, & Ahn, 2013).  
Stress regulation was assessed both at birth and at 12 weeks of age. On both 
occasions, infants’ cortisol and behavioral responses to a painful stressor (i.e. heel-
stick at birth and inoculation at 12 weeks of age) were evaluated, although the 
procedures were slightly different. Both the heel-stick and the inoculation have been 
previously extensively employed to evaluate infants stress reactivity (heel-stick e.g. 
Davis et al., 2011; Giesbrecht et al., 2017; inoculation e.g. Braithwaithe et al., 2016) 
and demonstrated to activate significantly the HPA axis soon after birth up through 6 
months of age (for a review see Gunnar, Talge, & Herrera, 2009; Jansen et al., 2010). 
On both occasions, the entire procedure was videotaped to be later coded and efforts 
were made to keep infant’s body, and specifically face, in full view. At birth, the 
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procedure included 10-minute baseline period, followed by the heel-stick and by 5-
minutes recovery. The heel-stick was performed by a neonatal nurse: the baby’s heel 
was disinfected with an alcohol swab, lanced with an automatic device and repeatedly 
squeezed to collect the blood sample. Average length of the heel stick was 3.99 
minutes (SD=2.32). At 12 weeks of age, the procedure began with undressing of the 
baby until 2 minutes after the last needle was retracted. Specifically, the infant was 
undressed and laid down and either a doctor or a nurse administered two injections, 
respectively, for the hexavalent vaccine (tetani, diphtheria, pertussis, hepatitis B virus, 
polio virus, haemophilus influenza type B) and pneumococcal vaccine in the infants’ 
thigh. Then the infant was given to the mother, who was free to soothe the baby. Mean 
duration of the shot administration was 1.06 minutes (SD=00.30). Videotaped infants 
behaviors were coded as described below.  
 
2.8 Behavioral reactivity coding  
Behavioral stress reactivity at birth. Newborns’ behaviour in response to the 
heel-stick procedure was evaluated using a modified version of a coding system 
employed by Davis et al. (2011). Specifically, infants’ videotaped behaviour during the 
heel-stick procedure was coded every 20-seconds on a 5-point scale (i.e. sleep, 
drowsy, awake and alert, awake and fussy, and crying). Despite the original system 
employed by Davis (2011) included two different levels of sleep, specifically, quiet and 
active sleep, after consulting with the author, the two categories were combined in a 
single category named sleep, as it was often hard to distinguish between the two types 
of sleep from video-recorded observation. The highest state observed during each 
epoch was coded. As the length of the heel-stick was variable, the first 2 minutes from 
the beginning of the blood draw were coded for all infants to ensure complete data for 
the whole sample. The average state score for each of the three phases (10-minutes 
baseline, 2-minutes response, 5-minutes recovery) was calculated. For approximately 
10% of cases (N=10), two observers, blinded to all prenatal and postnatal information, 
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independently coded behaviour. Intra-class correlations were, respectively, equal to 
1.0 for baseline, 0.99 for response and 0.99 for recovery, ps<.001. 
Behavioral stress reactivity at 12 weeks of age. Infants’ behaviour in response 
to the inoculation was evaluated continuously once the last needle was retracted for 
the subsequent 2 minutes at 5-seconds intervals according to Jahromi and colleagues 
coding system (2004). Specifically, infants’ distress was coded on a 4-point scale 
indicating an increasing in the intensity of the negative affect: 0 (no vocalization), 1 
(fussing, whining or whimpering), 2 (low-intensity crying), 3 (very intense loud crying 
with a out-of-control quality and typically accompanied by red face, squinted eyes and 
open mouth). The predominant (>2.5 seconds) level of intensity during each 5-
seconds interval was scored. A measure of overall crying intensity was obtained by 
averaging scores across the intervals, while a measure of overall cry duration was 
calculated by adding the number of intervals during which the infant was distressed 
(i.e. received a rating >0) and multiplying by 5. The videotapes were coded by a 
trained graduate student with a MSc in Developmental Psychology, blinded to all 
prenatal and postnatal data. Twenty-one percent of the observations were coded by 
an independent trained coder. Intra-class correlations were 0.998, p<.001.  
 
2.9 Biological measures  
2.9.1 Samples collection 
Infants’ saliva collection. On both occasions, infants’ saliva was collected by 
introducing a specifically designed swab (Salimetrics Infant Swab) in the infant’s 
mouth until it was saturated. The saturated portion of the swab was then placed in a 
5mL syringe to extract saliva by compression and immediately checked for saliva 
volume. This method of collection is safe and non-invasive, and has been shown not 
to be disturbing for the infants (e.g., Davis et al., 2004). Baseline salivary cortisol 
samples were collected before the beginning of the heel-stick after the baseline period 
at birth and right before entering in the doctor room for the inoculation procedure at 12 
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weeks of age. Additionally, saliva samples were collected after 20 and 40 minutes 
from the end of the procedures in order to capture the peak cortisol response to the 
painful stressor (Gunnar et al., 2009). Infants were not fed in the 30 minutes before the 
heel-stick (mean time from last feeding=68.50 minutes, SD=50.05) and before the 
inoculation (mean time from last feeding=102.99 minutes, SD=54.60), with the 
exception of 1 infant who was fed 11 minutes before the baseline saliva collection at 
the 12-weeks assessment. On both occasions, all infants were not handled during the 
study protocol besides that which was strictly required for the examination. Previous 
studies suggested that there is no diurnal rhythm of salivary cortisol shortly after 
birth, while an adult-type circadian rhythm appear to emerge around 2–3 months 
after birth (Spangler, 1991). Thus, concerted efforts with the paediatric health 
centres were made to arrange all inoculations in the morning between 09.00 and 
12.00, with the exception of 4 infants who were examined at 2 pm. Time of the day 
was examined as a covariate in all cortisol models both at birth and at 12 weeks of 
age. In addition, information on additional variables potentially affecting cortisol 
concentrations, such as time of last feeding, time of last sleeping etc., were recorded 
on both occasions.  
Maternal saliva collection. Women were asked to collect saliva samples on two 
consecutive days immediately upon awakening, 30 minutes after awakening and 
before going to bed between the 34th and 36th gestational weeks and the morning after 
delivery. The times of saliva collection throughout the day were chosen as they are 
thought to provide an index of cortisol and sAA diurnal pattern (O’Donnell et al., 2013), 
while minimising inconvenience for participants. During pregnancy samples were 
collected at home, while after delivery they were collected in the hospital, according to 
the same protocol. Participants were carefully instructed to collect saliva and were 
given a saliva sampling pack which included six 2.0 mL colour-coded polypropylene 
cryovials, six shorten plastic straws, instructions and a diary. Whole unstimulated 
saliva samples were collected by passive drool as generally recommended (Granger 
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et al., 2007). Specifically, women were instructed to: rinse out their mouth with water 
before saliva collection, allow saliva to pool in the mouth and gently drool through the 
straw into the tube, place it in their home refrigerator (or in the fridge of the maternity 
ward when the sampling occurs in hospitals) and fill in the diary. Additionally, 
participants were asked to avoid: eating, tooth-brushing and exercising in the 30 
minutes before collection and eating a major meal in the hour before the evening 
sample. On the diary, participants were asked to report: date, time of collection, hours 
of sleep, nocturnal awakening, occurrence of eating/toot-brushing/exercising, 
medication, presence/absence of blood in the oral cavity or unhealed dental caries. 
Women were reminded of the collection through pre-scheduled phone callings and 
were instructed to employ a cooler for returning samples at the pregnancy 
assessment. All samples were kept on ice until reaching the laboratory. Times 
recorded on the diary were used as an index of compliance with sampling procedure 
and were check for correspondence to planned sampling time. During pregnancy the 
mean time from the awakening collection and the 30-minutes post-waking collection 
was 30.82 minutes on day 1 (SD=3.64, range: 20.00-60.00) and 31.44 minutes on day 
2 (SD=6.81, range: 20.00-90.00). After delivery, the mean time from the awakening 
collection and the 30-minutes post-waking collection was 32.05 minutes on day 1 
(SD=6.53, range: 20.00-65.00) and 35.89 minutes on day 2 (SD=18.53, range: 29.00-
140.00). As 1 pregnant woman and 4 women after delivery, according to diaries, 
collected the second sample more than one hour from awakening, and the decline in 
cortisol usually occurs one hour after wake up, these samples were excluded from 
analyses (O’Donnell et al., 2013; O’Connor et al., 2014). In addition, in order to 
guarantee the data quality of salivary samples, all individual samples were visually 
inspected for contamination and checked for reporting of potentially interfering 
behaviors on the diary. All saliva samples were stored frozen at -80° until assayed. On 
day of assay, the saliva samples were thawed, vortexed and centrifuged at 1500 x g 
for 15 minutes in order to remove mucins. 
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Maternal blood collection. Blood samples were drawn by venipuncture by 
qualified nurse at the hospital or at the Medea Institute using specific polypropylene 
test tubes.  Sample were kept refrigerated at +4°, following well-established practices 
(e.g. Skogstrand et al., 2008), until they reach the Biological Lab of Medea Institute 
were serum was centrifuged, aliquoted, and stored at −80 °C until analyzed. Diurnal 
variations in inflammatory markers have been reported, although phase estimates are 
conflicting (reviewed in Nilsonne et al., 2016). In order to attempts to account for 
diurnal variations, all blood sampling was conducted in the morning, with the exception 
of 8 postpartum samples collected between 14:00 and 16:00 due to organizational 
reasons. Time of the day was examined as a potential factor affecting inflammatory 
markers concentrations both during pregnancy and after delivery.  
 
 
2.9.2 Biochemical assay  
Salivary Cortisol Assay. Salivary cortisol assay was performed at the Biological 
Lab of Medea Institute using a high sensitivity enzyme immunoassay kit (Expanded 
Range High Sensitivity Cortisol EIA Kit, Salimetrics), specifically designed and 
validated for the quantitative measurement of salivary cortisol, following the protocol 
suggested by the manufecturer. This specific kit is a competitive immunoassay where 
cortisol in saliva samples and standards, competes with horseradish peroxidise-linked 
cortisol for antibody binding sites on a microtitre plate. After one-hour incubation, 
unbound components are washed away. Bound cortisol is measured by the reaction of 
the horseradish peroxidase enzyme to a second incubation (25 min) in the dark with 
tetramethylbenzidene that results in a blue color. This reaction is stopped by adding an 
acidic solution that produce a change in color from blue to yellow. The optical density 
is then spectrophotometrically measured in a standard laboratory plate reader at 450 
nm. The amount of bound cortisol detected is inversely proportional to the amount of 
cortisol in the sample. The average optical density for all duplicate readings is then 
computed and the percent bound for each standard, control, and sample is computed 
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by dividing the optical density of each well by the average optical density for the zero. 
Then a standard curve is generated using a data reduction software and the 
concentrations of the controls and saliva samples is determined with reference to the 
optical density of the standards of known concentration. Results are computed in 
µg/dl. This assay has shown good sensitivity, with lowest limit of detection equal to 
0.007 μg/dL. In addition, salivary cortisol assayed through this method has been 
shown to highly correlate with serum cortisol (r(47)= 0.91, p<0.0001). All samples from 
any individual participant were run on the same assay to minimize method variability. 
The assay requires 25μl of saliva; salivary cortisol assays were run in duplicate, 
except for 2 maternal samples, 10 infants’ samples collected at birth and 8 infants 
samples collected at 12 weeks of age with minimal volume. Average intra- and inter-
assay coefficients for maternal samples were <6% and <8%, respectively, and <7% 
and <10% for infants’ samples. 
Salivary AA Assay. Assay of sAA was performed at the Salimetrics Centre of 
Excellence testing lab at Anglia Ruskin University where maternal salivary samples 
were shipped in dry ice at the end of the data collection. Due to budget restrictions and 
limited saliva volume at delivery sAA was examined only in pregnancy. Samples were 
assayed for sAA using a kinetic enzyme assay kit (Salimetrics α-Amylase Kinetic 
Enzyme Assay Kit) specifically designed and validated for the kinetic measurement of 
sAA activity. This method requires 10 µL of saliva and employs a chromagenic 
substrate, specifically 2-chloro-p-nitrophenol linked with maltotriose. Before the 
beginning of the assay, saliva samples are diluted (with a final dilution of 1:200) using 
an automated liquid handler (Tecan Evo). Then the diluted saliva samples and controls 
are plated out by the liquid handler and the heated substrate is added to all wells using 
a Biohit 1200µl multichannel pipette. The enzymatic action of sAA on this substrate 
yields 2-chloro-p-nitrophenol, which is spectrophotometrically measured at 405 nm 
one minute and three minutes after the substrate is added in a 96-well microtiter plate 
with controls provided. The amount of sAA in the sample is directly proportional to the 
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increase in absorbance at 405 nm from one-minute reading to three minutes reading. 
Results are computed in U/mL. A random 10% of the sAA assays were run in 
duplicate to confirm reliability. The intra-assay coefficient of variation was < 3%.  
Serum CRP and IL-6 assay.  Serum CRP and IL-6 concentrations were 
assayed at LaboSpace in Milan where maternal samples were shipped in dry ice. 
Samples were assayed using Quantikine High Sensitivity ELISA kits (R&D Systems 
Europe, LTD), specifically designed for the quantitative measurement of IL-6 and CRP 
and widely employed in research (e.g. Blackmore et al., 2011, Coussons-Read et al., 
2012). This method employs the quantitative sandwich enzyme immunoassay 
technique and requires 100 μL of serum for IL-6 assay and 50 μL of diluted (100-fold 
dilution) serum for CRP assay. On the day of assay, serum samples were thawed and 
bring to room temperature. Standards and serum samples are then pipetted into the 
wells of a microplate pre-coated with a monoclonal antibody specific for IL-6 or CRP 
and incubated for 2 hours at room temperature. Any IL-6 or CRP present in the 
samples is bound by the immobilized antibody. After washing away any unbound 
substances, an enzyme-linked polyclonal antibody specific for IL-6 or CRP is added to 
the wells and incubated for other 2 hours. Following a wash to remove any unbound 
antibody-enzyme reagent, a substrate solution is added to the wells. After one-hour 
incubation period, an amplifier solution is added and, during 30 minutes incubation, 
color develops in proportion to the amount of IL-6 or CRP bound in the initial step, until 
color development is stopped by a specific solution. The optical density is then 
measured using a microplate reader set to 490 nm for IL-6 and 450 nm for CRP. The 
duplicate readings for each standard, control and samples are then averaged and the 
average zero standard optical density is subtracted. Then a standard curve is 
generated through computer software to determine the CRP and IL-6 concentrations 
of the samples. The CRP concentrations read from the standard curve are then 
multiplied by the dilution factor. Results were computed in pg/mL for IL-6 and ng/mL 
for CRP. Both CRP and IL-6 assays have shown good sensitivity, with lowest limit of 
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detection equal to 0.039 pg/mL for IL-6 and 0.010 ng/mL for CRP. All samples from 
one participant were run in duplicate and on the same assay to minimize method 
variability. Intra-assay coefficient of variation (CV) was <6% for IL-6 and <3% for CRP, 
inter-assay CV was <10% for both markers.  
 
2.10 Missing data  
Attrition. The drop-out rate from the prenatal phase to the postnatal ones was 
very low. Specifically, less than 1% from phase 1 to phase 2, with only one woman 
withdrawing her participation at the postnatal phases. Additionally, there were no 
withdrawn from phase 2 to phase 3, although less than 3% of women from the initial 
sample attended only one of the two sessions included in phase 3. Women who were 
excluded or withdrew from each postnatal phase did not differ from participants on any 
demographic variables, depression or anxiety scores, thus suggesting no selective 
attrition within this sample.    
Behavioral missing data. Data concerning infants’ motor and cognitive 
development and maternal EA were available for 104 dyads out of 107, as the 
remaining dyads did not attend the second postnatal session at the Medea, scheduled 
12 weeks after delivery, due to logistic reasons (i.e. living too far from the institute). In 
addition, both behavioral and biological data concerning the inoculation at 12 weeks of 
age were available for 94 infants out of 107, as for 2 infants’ parents did not consent to 
the inoculation, while 11 infants were vaccinated in a district outside the province of 
Lecco and Como that were involved in the project and for which we gained the 
approval of their ethics committees’.  
Biological missing data. All women provided completed salivary samples during 
pregnancy, while after delivery 68 women out of 89 women, included in the postnatal 
phase of Study 1 provided completed salivary data. Twelve women have uncompleted 
postnatal salivary data (specifically, 5 women had no data at bedtime on day 2 
because of being discharged, 4 women were missing the 30 minutes post awakening 
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collection either on day 1 or 2, 2 women were missing data from 2 sampling occasions 
on day 1 and 1 woman provided no salivary data on day 2), while 9 women were not 
able to perform the saliva collection after delivery due to postpartum pain. In addition, 
97 women out of 110 agreed to blood sampling in pregnancy and 66 out of 89 after 
delivery.  
Concerning infants’ cortisol data, at birth complete salivary data were available 
for 49 infants, while one or two sample were missing for 30 infants and 25 infants had 
no data due to insufficient saliva volumes. At the 12 weeks-assessment, complete 
cortisol data were available for 78 infants out of 94 undergoing the inoculation, while 
one or two sample were missing for 16 infants. Despite the amount of missing data for 
infants’ salivary cortisol, particularly at birth, is considerable, it is not unusual in early 
infancy (e.g. Azak et al., 2013; Thayer & Kuzawa, 2014; Thayer & Kuzawa 2014) and 
is typically found in infants who are not familiar with pacifiers such as 48-72 hours-old 
newborns (Harmon et al., 2007; Goldberg et al., 2003; Granger et al., 2007). Although 
specific swabs designed for the collection of saliva in newborns (Salimetrics Infants 
Swabs) were employed in the current study, the nature of this problem involves that 
saliva is very scarce in newborns soon after birth (Gunnar, 1992) and volumes 
become even less after stress. While saliva stimulants might be an option, they have 
been shown to compromise sample integrity and interfere with analytical methods 
(Schwartz et al., 1998). It is generally acknowledged that saliva collection through a 
stress-free non-invasive method in very young research participants is challenging 
(e.g. Granger et al., 2007) and, indeed, there is a paucity of work assessing salivary 
cortisol in newborns soon after birth although it represents a unique opportunity to 
investigate fetal programming processes independently of postnatal influences 
(Egliston, McMahon, & Austin, 2007). As will be discussed later, multilevel models 
were chosen as they also allow to better handle missing data by maximizing all valid 
data points.  
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Non-compliance analyses. In order to control for the missing data issue post-
hoc, non-compliance analyses were run to check for differences between children with 
complete, partial or missing behavioral/biological data on any sociodemographic, 
maternal, infants’ or situational (e.g time of the day, length of the inoculation etc.) 
variables. No significant differences were found, suggesting that there was no 
systematic pattern of missing data. Women who did not agree to blood sampling did 
not differ from women who provided blood samples on demographic and pregnancy or 
delivery-related variables, depression or anxiety scores, with the exception of maternal 
age, with younger women being more likely to refuse antenatal blood sampling as 
compared to older women (F=4.08(1, 108), p=.05). No differences between women 
with complete, partial or missing salivary data after delivery on any sociodemographic 
or delivery-related variables was found, suggesting that there was no systematic 
pattern of missing data.  
 
2.11 Statistical analyses 
 
2.11.1 Data transformation.  
In all studies, numeric variables were first examined for outliers and skewness. 
Specifically, samples greater than 3 SD from the mean were removed and variables 
were tested for normality through the Kolmogorov-Smirnov Test. Skewed data were 
natural log transformed prior to analysis to approximate normal distributions. Model 
parameters for ln-transformed values are presented in tables, while non-transformed 
values are employed in the descriptive statistics table and figures to facilitate 
interpretation.  
Given the low rate of women scoring above the EPDS cut-off and the focus of 
the current dissertations on naturally occurring variations in maternal symptoms across 
the whole normative range, the total score of the EPDS or STAI was employed as a 
continuous variable in the analyses. 
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Four summary parameters were calculated to index different aspects of 
maternal cortisol and sAA diurnal activity, namely, waking levels, response to 
awakening, diurnal slope and total diurnal output. Specifically, as cortisol and sAA 
values at each time points across the two days were highly correlated (rs between .51 
and .59 for cortisol and .55 to .78 for sAA), they were averaged over days for each 
time points (i.e. wake, 30 min post wake and bedtime) and mean values were used as 
done in prior works (e.g. Pluess et al., 2010; De Weerth and Buitelaar, 2005, 
Braithwaithe et al., 2015). Response to awakening was calculated by subtracting 
waking values from the 30min post-waking levels, while diurnal slope was calculated 
by subtracting the bedtime values from the waking values, as done in several prior 
studies (e.g. de Weerth et al., 2013). Additionally, daily average cortisol and sAA were 
calculated as the area under the curve (AUCg) using the trapezoid method with 
respect to the ground (Pruessner et al., 2003) for each day separately and, as the two 
values were highly correlated (r=.58, p<.001, for cortisol, r=.74, p<.001 for sAA), the 
mean of the two days was used (e.g. Shea et al., 2007). These composite measures 
are widely employed (e.g. De Weerth et al., 2013; Giesbrecht et al., 2017) and are 
thought to reflect different aspects of cortisol and sAA physiology. In particular, the 
response to awakening and diurnal slope reflect diurnal changes related to the HPA 
axis or SNS daily functioning, while the AUCg provide unique information about the 
overall secretion over the day (Adam & Kumari, 2009). As reported in previous studies 
(e.g. De Weerth et al., 2013), the awakening response and diurnal decline were 
moderately interrelated suggesting that a greater response to awakening was related 
to a flatter diurnal slope both for cortisol and sAA (respectively, r=-.47 and r=-.55, 
p<.001).  
 
2.11.2 Preliminary analyses.  
Unadjusted associations between maternal antenatal variables and infant 
outcomes, as well as among maternal biological markers and self-reported depressive 
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symptoms were explored using Pearson product-moment correlation coefficient. 
Additionally, in all studies, preliminary analyses were performed to identify potential 
confounders of the associations under investigation. Specifically, in Chapter 3, the 
potential effects of variables known to potentially affect maternal stress and 
inflammatory markers concentrations were examined. These included demographic 
and pregnancy-related variables such as age, marital status, employment, income, 
education, SES, weeks of gestation, foetal sex, parity, body mass index (BMI) actual 
and prior to pregnancy, medications and use of prenatal vitamins, sampling time. Pre-
pregnancy BMI was highly correlated with current BMI (r=.95 p<.001). Because current 
BMI was influenced by pregnancy-related weight gain, pre-pregnancy BMI was 
employed in all subsequent statistical analyses. Additionally, recent food or drink 
intake, brushing teeth, physical activity, dental work, presence of blood in the oral 
cavity, smoking, disrupted sleep, hours of sleep, spontaneous awakening, working 
versus weekday of collection, wake time, sampling time and time between collections 
were all examined as potential confounds for the salivary cortisol and sAA assay. The 
occurrence of eating and brushing teeth shortly before sampling were rare both during 
pregnancy and after delivery (respectively, 0.9-3.6% during pregnancy and 2.6-7.8% 
after delivery for eating, while 0.9-9.1% and 6.6-7.9% for brushing teeth). Drinking 
water within 30 minutes of sample collection was more common, 5.5-15.5% during 
pregnancy and 7.6-23.7% after delivery. Lastly, a series of variables related to labor 
and delivery were examined as potential confounds on biological assay performed 
postpartum. Specifically, length of pregnancy, length of labor, induction of labor, 
amniotomy, episiotomy, perineal injury, vacuum-assisted delivery, epidural anhestesia, 
fever during labor, any complication, blood transfusion, medication, time from delivery 
and breastfeeding were included 
In Chapter 4, 5 and 6 the effects of sociodemographic factors (e.g. maternal 
age, marital status, education and SES), pregnancy- and delivery-related factors (e.g. 
parity, mode of delivery, assisted delivery, length of labor), infant factors (e.g. 
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gestational age, birth weight, gender, Apgar scores, postnatal age), situational factors 
(e.g. length of the heel-stick procedure, time of the day and time from last feeding) on 
child outcomes were examined. In additions, in Chapter 5 and 6 the potential effect of 
maternal postnatal symptomatology was also investigated. The associations between 
continuous confounders (e.g. maternal age) and outcomes were measured using 
Pearson product-moment correlation coefficient, while the effects of categorical 
confounders (e.g. fetal sex) on the outcomes investigated were examined through 
univariate analysis of variance (ANOVA). All variables found to be significantly 
associated with levels of biological markers were included in the following models as 
covariates.  
 
2.11.3 Hierarchical Regression Analyses 
In Chapter 4, 5 and 6 separate hierarchical regression analyses were 
performed in order to evaluate the effects of maternal variables (i.e. antenatal 
depressive symptoms, antenatal stress and inflammatory markers, postnatal EA) on all 
infants’ outcomes investigated, with the exception of stress reactivity, while adjusting 
for covariates. In chapter 4 and 5, covariates were entered in the first step. The EPDS 
scores was entered in a second step to assess the independent effect of prenatal 
maternal depressive symptoms on birth outcomes, while the biological markers 
concentrations were included in a third step to evaluate the unique contribution of 
maternal antenatal physiology to child outcomes. In Chapter 6, prenatal maternal 
variables were entered in a second step, following covariates, jointly with maternal EA 
scores, while the interacting effect of maternal prenatal and postnatal variables in 
predicting child outcomes was evaluated in the last step.  
Preliminary analyses and Hierarchical Regression Analyses were performed 





2.11.4 Hierarchical Linear Models (HLMs)  
Hierarchical Linear Models (HLMs) were employed in all studies in order to 
model diurnal or stress reactivity data. While study-specific aims and model fitting are 
described in each study, the general principles and advantages of HLMs are briefly 
discussed in what follows. 
HLMs (Raudenbush & Bryk, 2002), also often referred as Multilevel Models (H. 
Goldstein, 2011) or Mixed Models (Little et al., 1996), are increasingly employed in 
data analysis because they provide a powerful tool to model data simultaneously at 
different levels (i.e. between occasions and between individuals), to estimate how 
much variance can be attributed to each of these levels, and to investigate whether 
and how predictors of interest can predict variations at these different levels 
(Goldstein, 2011; Singer et al., 2003; Steenbergen & Jones, 2002). As compared to 
conventional techniques, such as repeated measures ANOVA, they present several 
advantages, including that they do not require each individual to have the same 
number or complete observations or observations regularly spaced in time (Goldstein, 
2011). Furthermore, HLMs allow to accurately model nested data (Goldstein et al., 
2011). Typically, neuroendocrine data, such as cortisol or sAA diurnal data, are 
characterized by a hierarchical structure. For example, samples from one individual 
are collected on a number of occasions during the day (e.g. wake up, 30 minutes after 
waking, bedtime) over repeated days (e.g. day 1 and 2). Thus, as shown in Figure 2.2, 
sampling occasions (level 1, within-day variance) are nested within two time-points 
(level 2, between days variance) and time-points are nested within individuals (level 3, 
between-individuals variance). HLMs assume that the total variance in data can be 
partitioned at different levels and allow to compute the variance at each level relative 
to the total variance (Hruschka, Kohrt, & Worthman, 2005). A clear partition of the 
sources of variance is fundamental to avoid incorrectly interpreting within-individual 
variations as an indication of between individual differences (Hruschka et al., 2005). 
HLMs allow to attribute the total variance in cortisol or sAA diurnal data to one of three 
146 
 
levels (i.e. within-day, between days and between individuals) and estimated the 
relative contribution of each level to the total variance in cortisol or sAA data can be 
obtained. Similarly, data on acute stress reactivity, whether behavioral or 
physiological, are characterized by a nested structure in their design. There are 
typically repeated sampling occasions (e.g. baseline, response and a recovery, level 
1) nested within individuals (level 2). HLMs can be a useful tool to model the individual 
pattern of response to stress, while accounting for the nested structure of the design.    
 
Figure 2.2- Illustrative hierarchical model for salivary cortisol or AA diurnal data 
 
Moreover, HLMs allow to compare the individual diurnal profiles or trajectories 
of response, rather than just probing association with mean levels at a given time 
point, while controlling for the effects of initial values. In particular, with HLMs the 
influences of predictor variables on parameters that are relevant to cortisol or sAA 
diurnal or reactivity profile can be examined. In Study 1, three cortisol or sAA 
parameters were tested for association with the predictors investigated: 1) intercept, 
representing waking level; 2) morning slope representing the change from waking to 
30 minutes after; 3) afternoon slope representing the slope to bedtime. In Study 2, 3 
and 4, the following parameters of infants’ cortisol/behavioral reactivity were 
examined: 1) intercept, representing baseline level; 2) linear slope, representing the 
linear increase/decrease in response to stress; 3) quadratic slope, representing the 
curvature of the trajectory of stress response.    
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An additional strength of HLMs is the ability to explore both fixed and random 
effects. Similarly to conventional analyses, such as linear regression, HLMs allow to 
determine the relationship between a predictor variable and an outcome of interest 
(fixed effect). Additionally, it allows to determine if this effect varies from participant to 
participant (random effect). For example, when examining cortisol diurnal pattern, as 
shown in Figure 2.3, the inclusion of a random intercept allows for between-person 
variability in cortisol waking values, while the inclusion of a random linear slope allows 
for between-person variability in the diurnal cortisol slope. 
 
 
Figure 2.3 - Increasing model complexity for diurnal cortisol data. Model A: population 
average diurnal slope (typically negative). Model B: individual means over the day 
(random intercept). Model C: individual means and diurnal slopes (random intercept and 
random linear slope). (From Hruschka et al., 2005) 
 
An additional advantage of HLMs is its robustness for handling missing data 
(Tabachnick & Fidell, 2007) by maximizing all valid data points. Indeed, HLMs do not 
rely on means values and do not exclude a case if there are any missing data for that 
case, rather all model parameters are modelled using all available data.  
Study-specific model fitting is described in each study methods section, 
however, in all studies model fitting proceeded in three stages. First, unconditional 
means models were computed to evaluate the relative contributions of each level (e.g. 
within-day, between days and between individuals) to the total variance. Secondly, 
baseline models including all the parameters of interest that describe individual 
trajectories were fitted. Third, explanatory models including level-2 predictors 
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(beginning with covariates and then adding predictors of interest) were fitted. 
Explanatory variables were centered around the grand mean and entered in the model 
one-by-one. Lastly, cross-level interactions between level-2 predictors of interest and 
level-1 parameters are included to evaluate the extent to which intercepts and slopes 
vary accordingly to level-2 predictor. Model fit was tested with likelihood deviance 
difference test for nested models. Specifically, variables were kept in the model when 
their presence resulted in a significant (p<.05) reduction of the likelihood ratio statistic. 
To test the statistical significance of the regression coefficients, the Wald’s chi-square 
test was performed. All HLM analyses were carried out using MLWiN 2.29. All 
statistical tests were two-sided and a p<.05 was considered statistically significant. 
 
2.11.5 Supplementary analyses  
Given the high correlation between antenatal depression and anxiety scores, 
comparable analyses with anxiety scores as individual-level predictor, rather than 
depression were performed in all studies. In order to avoid multicollinearity issues and 
as maternal anxiety and depression are expected to differ in their underlying biology 
(O’Donnell & Meaney, 2017), they were entered separately in all models. Analyses 
including maternal anxiety rather than depression are reported in Supplementary 
Sections.  
In addition, in Chapter 3, graphical analyses were used to explore the 
relationship between stress and inflammatory markers among women with higher 







Chapter 3: Exploring the biological underpinnings of 




Pregnancy and the postpartum period are considered times of heightened risk 
for women to develop depression (Kessler, 2003), with 8-17% of women in high-
income countries experiencing depressive symptoms antenatally, and around 9-13% 
in the twelve months following delivery (for a review Woody et al., 2017). There is now 
considerable evidence of an association between depressive symptoms during the 
perinatal period and a wide range of adverse physical and psychological outcomes for 
both women and their offspring (reviewed in Gentile, 2017). Thus, in the light of the 
substantial personal, social and economic burden of perinatal depression, 
understanding possible risk factors, mechanisms and treatment is a key priority for 
maternal-child health worldwide. 
The major physiological changes and hormonal fluctuations occurring during 
pregnancy and after delivery have been argued to play a role in increasing women’s 
vulnerability to developing depression during the perinatal period (Kammerer, Taylor, 
& Glover, 2006; Corwin & Pajer, 2008). For this reason, in the last decades, the 
attention of scholars has been focused on identifying the biological factors that might 
be involved in risk for perinatal mood disorder and potentially relate to poor obstetric 
outcomes and alterations in offspring development. To date, the most studied 
candidate has been the Hypothalamic-Pituitary-Adrenal (HPA) axis, followed by the 
Inflammatory Response System (IRS). In contrast, the Sympathetic Nervous System 
(SNS), which is thought to play a crucial role in the stress response jointly with the 
HPA axis, has been much less investigated. As described in Chapter 1, the regulation 
of all these systems changes dramatically during pregnancy and after delivery in order 
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to support fetal development and prepare for childbirth and nursing. In light of the 
major neuroendocrine and immune alterations occurring during the perinatal period, it 
has been questioned whether well-established research findings of an association 
between depressive symptoms and an anomalous functioning of the stress and 
inflammatory response systems in non-pregnant adults (e.g. Dowlati et al., 2010; Knorr 
et al., 2010), might extend to pregnant women. That is, the association between 
depressive symptoms and levels of stress or inflammatory markers may be different in 
pregnancy or may be confounded by the substantial neuroendocrine resetting 
associated with pregnancy, thus making research into psychobiological factors 
associated with perinatal depression a complex as much as intriguing challenge. In the 
next sections, we will examine available evidence on the relationship between 
perinatal depression and the functioning of the stress response system (SRS) and 
IRS.   
 
3.1.1 HPA axis and perinatal depression 
Dysregulation of the HPA axis, as indexed by altered cortisol levels in most 
studies, in depressed non-pregnant adults is among the most consistent and robust 
findings in psychiatry and it has been proposed as a possible biomarker for depression 
(Holsboer, 2000; Ising et al., 2007). A meta-analysis by Knorr and colleagues (2010) 
including 20 case-control studies, found a small but significant increase in both 
morning and evening salivary cortisol levels in depressed patients as compared to 
controls. However, the picture is far less coherent in pregnancy where either no 
significant associations between basal levels of maternal cortisol and depressive 
symptoms (e.g. Hellgren et al., 2013; Katz et al., 2012; Bleker et al., 2017; Iliadis et al., 
2015) or slight positive associations during specific gestational time windows have 
been reported (e.g. Voegtline et al., 2013; Field et al., 2006; Lommatzsch et al., 2006). 
Furthermore, a small number of studies on low risk samples found lower levels of 
cortisol in pregnant women with depressive symptoms (e.g. Harris et al., 1996; 
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Tsubouchi et al., 2011). In a recent systematic literature review, Seth and colleagues 
(2016) selected “higher quality” studies, based on the quality of samples and 
assessments as well as greater statistical power, and concluded that there is no 
evidence of an association between antenatal depression and cortisol levels during 
pregnancy. The association between cortisol and postnatal depressive symptoms is 
even more uncertain. The majority of studies have focused on non-clinical samples; 
among these, a number of studies reported higher cortisol levels in women with 
depressive symptoms from 1 to 8 weeks postpartum (e.g. Taylor et al., 2009; Iliadis et 
al., 2015; Nierop et al., 2006), while others found either lower cortisol levels (e.g. 
Groer & Morgan, 2007) or no association at all (e.g. Shimizu et al., 2015; Davis et al., 
2007; O’Keane et al., 2011). 
Despite extensive research investigating the associations between perinatal 
depression and cortisol (reviewed in Orta et al., 2018; Seth et al., 2016), mood-related 
alterations in the diurnal cortisol pattern have been poorly investigated. A lower waking 
cortisol level (O’Connor et al., 2014), a blunted cortisol awakening response (CAR; 
Osborne et al., 2018), a flatter diurnal decline (O’Connor et al., 2014), increased 
evening (O’Keane et al., 2011; Osborne et al., 2018) and averaged daily cortisol 
(O’Connor et al., 2014; Osborne et al., 2018) in clinically depressed pregnant women 
have been found in some studies, though not all (Shea et al., 2007; Hellgren et al., 
2013). Likewise, a blunted CAR have been reported in depressed women at 6-8 
weeks (Taylor et al., 2009) and 6 months (De Rezende et al., 2016) postpartum, 
whereas Corwin and colleagues (2015) reported higher daily cortisol in depressed 
women 14 days, but not 7 days or 6 months after delivery. Conversely, studies on non-
clinical samples have failed to detect any associations between depressive symptoms 
and diurnal cortisol measures both antenatally (Rash et al., 2015; Heuvel et al., 2018) 
and postnatally (Cheng & Pickler, 2010, Scheyer & Urizar, 2016). Lastly, few studies 
have investigated the associations between cortisol levels and depressive symptoms 
at both points -  antenatally and postnatally (O’Keane et al., 2011; Iliadis et al., 2015; 
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Scheyer & Urizar 2016), and they have all adopted a cross-sectional design, thus it is 
still unknown whether antenatal depressive symptoms are associated with changes in 
diurnal cortisol from pre- to post-pregnancy. 
 
3.1.2 SNS and perinatal depression 
Despite existing evidence for a dysregulation of the SNS, as indexed by higher 
levels of catecholamines (e.g. Veith et al., 1994), in depressed adults, few studies 
have evaluated the association between SNS activity and perinatal depression, and 
these have yielded mixed results. Higher norepinephrine and lower dopamine levels 
have been found in depressed pregnant women in some studies (Lundy et al., 1999; 
Field et al., 2004; Diego et al., 2006), while others failed to find any association (Field 
et al., 2006; Shimizu et al., 2015). Recently, salivary α-amylase (sAA), an enzyme 
produced by the salivary glands, has been proposed as a non-invasive and reliable 
marker of SNS activity (Nater & Rohleder, 2009). A small number of studies have 
evaluated sAA levels in depression and reported generally higher sAA levels in 
patients with major depression compared to controls (Tanaka et al., 2012; Veen et al., 
2013; Ishitobi et al., 2010; Booij et al., 2015) and remitted patients (Bagley et al., 2011; 
Veen et al., 2013; Ishitobi et al., 2010). Although sAA has been shown to provide a 
convenient index of SNS even in pregnancy (Nierop et al., 2006), to our knowledge, 
only two studies have evaluated the association between prenatal sAA diurnal levels 
and depression. Specifically, Braithwaite and colleagues (2015) found higher sAA 
levels at awakening in a very small sample of women reporting higher depressive 
symptoms (N=9), as compared to non-depressed controls (n=26), in the third trimester 
of pregnancy but not in the second. However, the small sample size, particularly of the 
at risk for depression group, the very large variability in sAA concentrations reported in 
the study and the use of composite measures to index sAA diurnal pattern constitute 
limitations of the study and limit the impact and generalizability of the 
findings.Giesbrecht and colleagues (2013) examined the association between 
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maternal mood and diurnal sAA in a community sample of 83 pregnant women using 
multilevel models. The authors found no association between the average sAA 
trajectory throughout the day and depression, although momentary depression, 
positive mood and trait anxiety were all positively associated with increases in sAA 
over the day during pregnancy. 
  
3.1.3 IRS and perinatal depression 
Immune dysregulation is increasingly regarded as a central mechanism in the 
pathophysiology of major depression (Miller et al., 2009). Recent meta-analytical 
findings have pointed out significant associations between depression and increased 
levels of a number of inflammatory markers, including pro-inflammatory cytokines, 
such as interleukine-6 (IL-6), or acute phase proteins, such as C-reactive protein 
(CRP), in depressed non pregnant adults (e.g. Valkanova et al., 2013; Dowlati et al., 
2010; Liu et al., 2012). On the basis of this evidence, several studies over the last two 
decades have sought to elucidate the link between inflammation and perinatal 
depression, although findings do not yet allow firm conclusions to be drawn (see 
Osborne & Monk, 2013 for a review). IL-6 and CRP, which have been found 
consistently increased in patients with depression (Valkanova et al., 2013), are among 
the most studied markers. Either positive (e.g. Scrandis et al., 2008; Christian et al., 
2009;  Liu et al., 2016) or null associations (e.g. Blackmore et al., 2011; Buglione-
Corbett et al., 2018; Skalkidou et al., 2009) between depressive symptoms and IL-6 
and/or CRP levels have been reported during pregnancy, as well as following birth-to-
6 months postpartum. Few studies have investigated the cross-sectional relationship 
between depression and inflammation both antenatally and postnatally (Accortt et al., 
2016; Bränn et al., 2017; Corwin et al., 2015; Maes et al., 2000; Scrandis et al., 2008) 
and, to our knowledge, only Osborne and colleagues (2019) have examined how 
changes in cytokines levels across the perinatal period relates to depressive 
symptoms. Those authors reported a greater increase in pro-inflammatory cytokines 
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levels, including IL-6, from the second to the third trimester of gestation, followed by a 
greater decrease at 6 weeks postpartum in a small group of women (N=12) with higher 
antenatal depressive symptoms, as compared to non-depressed women (N=37). 
 
3.1.4 Coordination between SRS and IRS    
Besides their individual effects, the stress and inflammatory response systems 
exhibit significant bidirectional interactions (Kuhlman et al., 2017). The principal stress 
hormones, glucocorticoids and catecholamines, exert regulatory influences on the 
functioning of the immune system (Elenkov & Chrousos, 2006). In particular, 
glucocorticoids have been shown to down-regulate inflammation within a well-
documented cytokine-glucocorticoid feedback circuit (Elenkov, 2008). Failure of 
glucocorticoids to limit inflammation (e.g. Miller, Cohen, & Ritchey, 2002), leads to 
dysregulation of both cytokines production and cortisol secretion (Corwin et al., 2013) 
and is hypothesized to play a role in the development of several disorders (Raison & 
Miller, 2003), including depression (Pace, Hu, & Miller, 2007; Pariante, 2017). More 
than two decades ago, Chrousos and Tsigos proposed that a disruption of the 
bidirectional relationship between inflammation and the HPA axis might increase 
vulnerability to developing postpartum depression (Chrousos, 1995; Tsigos & 
Chrousos, 2002). However, to date, a limited number of studies investigated 
concurrently the functioning of the SRS and IRS during the perinatal period as well as 
possible associations with symptoms of depression. Walsh and colleagues (2016) 
found a positive association between cortisol and IL-6 levels in a high-risk sample of 
pregnant teenagers, while Shelton and colleagues (2015) reported an inverse 
association among cortisol and pro-inflammatory cytokines concentrations in a low risk 
sample of pregnant women. However, none of these studies investigated possible link 
with depressive symptoms. To our knowledge, only Corwin and colleagues (2015) has 
investigated the interplay between cytokines and cortisol in influencing mood. They 
found a positive association between pro-inflammatory cytokines and cortisol two 
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weeks after delivery in women who were experiencing significant postnatal depressive 
symptoms, while no association in euthymic women, suggesting that variability in the 
bi-directional interactions between the HPA-axis and IRS soon after delivery might 
influence the risk for postpartum depression.  
 
3.2 Summary and study hypotheses 
Headway has been made towards a better understanding of the link between 
depressive symptoms and an altered functioning of the neuroendocrine and immune 
systems during the perinatal period, however many questions remain unanswered. 
Despite mounting evidence for a role of a dysregulation of the stress and inflammatory 
response system in the pathophysiology of depression outside the perinatal period 
(e.g. Juruena et al., 2018; Khulman et al., 2017; Pariante et al., 2017), evidence of an 
association between perinatal depressive symptoms and an alteration of these 
systems during pregnancy and after delivery is mixed. Heterogeneity in the 
assessment of mood, as well as in timing of assessment (from early pregnancy up to 
months after delivery) makes comparisons across studies within the existing literature 
difficult. Similarly, large variability in cortisol and sAA diurnal measures may play a role 
in findings inconsistencies with studies differing in the selection of composite scores 
(e.g. CAR, decline, etc.) and in the way they are calculated. More advanced statistical 
techniques, such as multilevel models, have been recommended for analysing 
repeated measures of stress markers (Hruschka et al., 2005; Zijlmans et al., 2015) 
and might help to detect alterations in cortisol or sAA diurnal pattern related to 
perinatal depressive symptoms, yet they are scarcely applied. Additionally, while it is 
now increasingly acknowledged that the stress and immune systems extensively 
interact with each other to prepare the organism to adapt in the face of challenge (e.g. 
Chrousos & Kino, 2005), the majority of studies focused on a single biological system, 
under the assumption that a dysfunction of this system might be a central mechanism 
involved in perinatal depression. However, inconsistent findings in the literature might 
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suggest that a better understanding of the link between perinatal depressive 
symptoms and altered psychophysiology may be obtained by measuring concurrent 
activity across multiple systems. To date, several studies have investigated 
associations between perinatal depressive symptoms and either HPA axis or IRS 
functioning; however, few studies have investigated the concurrent activity of these 
two systems (Corwin et al., 2013; 2015; Shelton et al., 2015; Walsh et al., 2016) and, 
to our knowledge, none have included SNS markers. Lastly, studies have largely been 
cross-sectional, thus the relationship between mood and change in biomarker levels 
over the perinatal period is mostly unknown.   
The current study begins to fill these gaps by investigating the cross-sectional 
and prospective associations among depressive symptoms and variations in multiple 
stress (i.e. diurnal cortisol and sAA) and inflammatory (i.e. IL-6 and CRP) markers in 
late pregnancy and after delivery. Based on existing evidence, we hypothesized that 
higher depressive symptoms would be associated with heightened inflammation and 
an altered cortisol diurnal pattern, as detected through multilevel models. Conversely, 
no formal hypothesis was made regarding the association between depressive 
symptoms and diurnal sAA due to limited available literature. Additionally, 
supplementary analyses investigated an exploratory hypothesis and examined the 
robustness of the associations found for depression. Specifically, we sought to extend 
findings from Corwin and colleagues (2015) by exploring the association among stress 
and inflammatory markers in women with higher versus lower depressive symptoms 
pre- and post-partum. Based on findings from Corwin and colleagues (2015), a 
positive association between inflammatory markers and stress hormones in women 
with higher depressive symptoms would be expected. Furthermore, as perinatal 
depression and anxiety are strongly correlated (Falah-Hassani et al., 2017), we 
explored whether the observed biological alterations were specific to depression or 




3.3 Material and methods 
 
3.3.1 Participants 
Women in the early third trimester of gestation were consecutively recruited at 
the beginning of child birth classes or through ads placed in clinic waiting rooms of 3 
hospitals located nearby the Medea Institute in Italy, as part the Effects of Depression 
on Infants (EDI) Study, a wider longitudinal project investigating the effects of maternal 
antenatal depressive symptoms on newborn’s bio-behavioral development.  
Two hundred and fifty-two women participated in the screening phase (weeks 
of gestation: M=31.41, SD=1.61). Prenatal inclusion criteria were: aged 18-45 years, 
normotensive, with singleton uncomplicated pregnancy, non-smoker, not afflicted by 
any disease, not taking any chronic medications, and with no known substance/alcohol 
abuse problems or chronic psychiatric disorders (except for depression and anxiety). 
From the initial sample of 252 women, 77 women were excluded because they did not 
meet the inclusion criteria and 65 women did not agree to participate in the 
subsequent study phases. Thus, the final sample consisted of 110 women (mean 
age= 33.00; SD= 3.85). Excluded women as well as women who withdrew their 
participation did not differ significantly from the remaining participants on depression 
and anxiety scores or on any demographic variables with the exception of 
socioeconomic status, as assessed with the 9-point Hollingshead (1957) scale for 
parental occupation. Specifically, women who did not consent to participate in the 
follow-up assessment phases were more likely to be from a low socio-economic class 
than participants or women who were excluded (χ2(4, N=229)=11.93, p=.02). The 
majority of participants were Italian (96.4%), middle-upper class (90%), as assessed 
by the 9-point Hollingshead (1957) scale, and at their first pregnancy (90%). The 
average score on the EPDS was 5.37 (SD= 4.41) during pregnancy and 5.53 (SD= 
4.77) after delivery; 19 women (17.3%) scored at or above a clinical cut-off of 10 
during pregnancy and 18 (16.8%) after delivery.  
158 
 
Nineteen caesarean sections and 1 intrauterine death at 38 weeks due to 
umbilical cord accident were excluded from the postnatal phase while 1 woman 
withdrew her participation due to her newborn’s health problems. Thus, data from 89 
women were available at the postnatal phase. Women who were excluded from the 
postnatal phase did not differ from participants on any demographic variables, 
depression or anxiety scores.  
 
3.3.2 Procedure  
Pregnant women, between 30-33 weeks of gestation, filled out the Edinburgh 
Postnatal Depression Scale (EPDS), the State-Trait Anxiety Inventory (STAI) and a 
demographic and pregnancy information form. Women who gave written informed 
consent to participation in the follow-up phases and fulfilled the inclusion criteria were 
invited to attend a morning session between 34-36 weeks of gestation. During this 
session, the Structured Clinical Interview for DSM-IV-TR Axis I Disorders (SCID-I) was 
administered and women were asked to donate a blood sample and to return their 
saliva samples collected during the previous days. Beginning from the morning after 
delivery (mean hours after delivery=17.64; SD=10.16) women were asked to once 
again collect their saliva samples. In addition, between 48-72 hours after delivery 
(mean hours after delivery=52.36; SD=19.70), they were asked to provide another 
blood sample and to once again fill in the EPDS and STAI as well as a form on health 
and delivery.  
The Ethics Committee of University College London, of Scientific Institute 
Eugenio Medea and of the hospitals involved approved the study protocol.  
 
3.3.3 Instruments 
Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden & Sagovsky, 
1987). The EPDS is a 10-items self-report questionnaire widely used to screen for 
perinatal depressive symptoms on a 4-point Likert scale. A cut-off of 10 has been 
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shown to indicate a significant risk for depression (e.g. Bergink et al. 2011) and is the 
recommended cut-off for the validated Italian version (Benvenuti et al., 1999).  
State-Trait Anxiety Inventory (STAI) (Spielberger, Gorsuch & Lushene, 1970). 
The STAI-T is a well-validated 20 item self-report measure of anxiety that measures 
the “trait anxiety” or anxiety as a general trait. It is widely employed during pregnancy 
(e.g. Pluess et al., 2010), and has been translated and validated also in Italian 
(Pedrabissi & Santinello, 1989).  
Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, 
Non-Patient Edition (SCID-I RV-NP; First et al., 2002). The SCID–I is a semi-
structured diagnostic interview, widely used in psychiatric research to assess DSM–IV-
TR Axis-I disorder (American Psychiatric Association, 2000). Due to the low number of 
women fulfilling the criteria for a diagnosis of Major Depressive Episode and Anxiety 
Disorder (respectively 4,5% and 3,6%) in the current sample, the diagnostic status 
was not employed in the analyses and the SCID-I was employed exclusively to 
exclude any substance/alcohol abuse problems or other chronic psychiatric disorders.  
Pregnancy- and delivery-related forms. An ad-hoc prenatal form was used to 
collect pregnancy and health-related data (e.g. due date, any complication/medical 
disorder, pre-pregnancy weight and height, medication). Self-reported height and 
weight were used to estimate pre-pregnancy BMI. After delivery, an ad-hoc postnatal 
form was employed to collect health and delivery-related data (e.g. length of labor, 
type of delivery, any episiotomy, epidural anaesthesia, medication). 
   
3.3.4 Biological collection and assay 
Venous blood samples and analyses of cytokine concentrations. Blood 
samples were drawn by venipuncture by a qualified nurse and kept refrigerated at +4° 
until they reached the Biological Lab of Medea Institute where serum was centrifuged, 
aliquoted, and stored at −80 °C until analyzed. All blood samples were collected in the 
morning, with the exception of 8 postnatal sampling that were performed between 
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14:00 and 16:00 due to organizational reasons. 97 women out of 110 agreed to blood 
sampling in pregnancy and 66 out of 89 after delivery. Serum CRP and IL-6 
concentrations were assayed in duplicate by using Quantikine High Sensitivity ELISA 
kits (R&D Systems Europe, LTD) at LaboSpace in Milan according to the instructions 
of the manufacturer. Intra-assay coefficient of variation (CV) was <6% for IL-6 and 
<3% for CRP, inter-assay CV was <10% for both markers.  
Saliva collection and analyses of salivary cortisol and alpha amylase 
concentrations. Participants collected whole unstimulated saliva samples on two 
consecutive days immediately upon awakening, 30 minutes post-wakening and before 
going to bed, in order to capture cortisol and sAA diurnal pattern. Participants were 
asked to refrain from eating, tooth-brushing and exercising 30 minutes prior to 
collection and eating a major meal 60 minutes prior to the evening sample. In addition, 
women were asked to report time of collection on a diary and were reminded of the 
collection through pre-scheduled phone callings. All samples were kept on ice until 
reaching the laboratory where they were stored frozen at -80° until assayed. One 
hundred and ten women provided completed saliva samples during pregnancy. After 
delivery, 68 women provided completed salivary data, 12 women had incomplete 
salivary data while 9 women were not able to perform the saliva collection after 
delivery due to postpartum pain. During pregnancy, the mean time from the awakening 
collection and the 30-minutes post-waking collection was 30.82 minutes on day 1 
(SD=3.64, range: 20.00-60.00) and 31.44 minutes on day 2 (SD=6.81, range: 20.00-
90.00). After delivery, the mean time from the awakening collection and the 30-
minutes post-waking collection was 32.05 minutes on day 1 (SD=6.53, range: 20.00-
65.00) and 35.89 minutes on day 2 (SD=18.53, range: 29.00-140.00). As 1 pregnant 
woman and 4 women after delivery, according to diaries, collected the second sample 
more than one hour from awakening, and the decline in cortisol usually occurs one 
hour after waking up, these samples were excluded from analyses (O’Donnell, 2013; 
O’Connor, 2014).  
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Salivary cortisol assay was performed at the Biological Lab of Medea Institute 
whereas sAA samples were shipped in dry ice to the Salimetrics Centre of Excellence 
testing lab at Anglia Ruskin University. All samples from one woman were run in the 
same assay to minimize method variability. Due to budget restrictions and limited 
saliva volume at delivery sAA was examined only in pregnancy. A competitive high 
sensitivity enzyme immunoassay kit (Expanded Range High Sensitivity Cortisol EIA 
Kit, Salimetrics), specifically designed and validated for the quantitative measurement 
of salivary cortisol, was used for the assessment of cortisol following the 
manufacturer’s procedures. Salivary cortisol assays were run in duplicate, except for 2 
samples with minimal volume. Average intra- and inter-assay coefficients were <6% 
and <8%, respectively. Results were computed in µg/dl. Samples were assayed for 
sAA using a kinetic enzyme assay kit (Salimetrics α-Amylase Kinetic Enzyme Assay 
Kit) specifically designed and validated for the kinetic measurement of sAA activity. A 
random 10% of the sAA assays were run in duplicate to confirm reliability. The intra-
assay coefficient of variation was < 3%. Results were computed in U/mL. 
 
3.3.5 Statistical analyses 
Given the low rate of depression in the sample according to the EPDS cut-off of 
10 (17.3%), the total score of the EPDS was employed as a continuous variable in the 
main analyses. As typically done in literature (e.g. Christian et al., 2009), each 
biomarker was entered in the statistical models as the outcome variable in order to 
model the trajectory over time and control for possible confounders when investigating 
the association between depressive symptoms and physiological levels.  
Variables were first examined for outliers and skewness. Distributions of 
biological markers were positively skewed even after removing samples greater than 3 
SD from the mean (n=7 for prenatal cortisol, n=8 for postnatal cortisol, n=4 for sAA, 
n=3 for prenatal IL-6), thus measures were natural log transformed prior to analysis to 
approximate normal distributions. Daily average salivary cortisol and sAA were 
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computed for each day as the area under the curve according to the trapezoid method 
with respect to the ground (AUCg, Pruessner et al., 2003). As the correlations between 
AUCg values across the 2 days (r(104)=.57, p<.001 for cortisol and r(98)=.22, p<.05 
for sAA) were comparable to those found in previous studies (Wust et al., 2000; Shea 
et al., 2007), the mean of the 2 days was used. Preliminary Pearson bivariate 
correlations and univariate analysis of variance (ANOVA) were undertaken to evaluate 
the potential effect of variables known to affect stress and immune physiology. 
Hierarchical Linear Models (HLMs) were estimated to investigate the influence 
of maternal depressive symptoms on diurnal levels of biological markers during 
pregnancy and after delivery as well as on the markers’ longitudinal trajectory from 
pregnancy to delivery, while accounting for the hierarchical structure of the data 
(individual samples nested within two time-points and time-points nested within 
individuals). HLMs for salivary cortisol and sAA were specified at three levels where 
individuals were level 3, days of collection level 2 and mean cortisol/sAA values across 
the day were level 1. Time was centered at waking so that the model intercept 
represented the mean cortisol/sAA levels at waking, the morning slope represents the 
mean change from waking to 30 minutes after and the afternoon slope represents the 
mean decline to bedtime. HLMs models for inflammatory markers were specified at 
two levels with individuals at level 2 and occasions at level 1. Time was centered at 
pregnancy so that the model intercept reflected the mean prenatal CRP/IL-6 level and 
the slope represents the mean change from pregnancy to delivery. In the first stage of 
the analysis, for all markers, unconditional mean models were computed to evaluate 
how much variance in biological levels can be attributed to between-subject, between-
days (only for sAA and cortisol) and between-occasions variations. Then, the effect of 
time on each biomarker value was tested. Models initially included random intercepts 
to allow between-person variability at the intercept. Subsequently, the effect of 
including random slopes (both for morning and afternoon decline for sAA and cortisol) 
for time was evaluated. The error term was allowed to vary randomly in each model. 
163 
 
The explanatory variables were centered around the grand mean and entered in the 
model one-by-one. Confounding variables that were found to be significantly related to 
biological levels in preliminary analyses were examined as potential predictors. The 
fixed effect of maternal depressive symptoms on the intercept and time slopes was 
tested sequentially. Model fit was tested with likelihood deviance difference test for 
nested models. Specifically, variables were kept in the model when their presence 
resulted in a significant (p<.05) reduction of the likelihood ratio statistic. To test the 
statistical significance of the regression coefficients, the Wald’s chi-square test was 
performed. To aid interpretation, ln transformed model estimates were interpreted as 
the percent change in the biological marker level per unit change in the independent 
variable through the following transformation: β%change=100 x [exp(βln)]-1. 
Given the high correlation between depression and anxiety, comparable 
analyses with anxiety scores as individual-level predictor were run and are reported in 
the supplementary results section. 
Graphical analyses were used to explore different patterns of correlations 
between sAA or cortisol AUCg and inflammatory markers between women scoring 
above versus under the median of the EPDS. The relationship trends were further 
investigated through multiple linear regressions. In these models, levels of 
inflammation were the outcomes variables and the difference in the relationship 
patterns between stress and inflammatory markers were evaluated by testing the 
significance of the interaction term between EPDS and cortisol or sAA AUCg on levels 
of inflammation, while controlling for covariates.  
Statistical analyses were performed using SPSS 24 and MLWiN. All statistical 







3.4.1 Preliminary analyses 
Descriptive statistics for all biological markers examined are presented in Table 
3.1 using raw values, while ln transformed values are employed in all analyses.  
Several potential confounding factors that could impact the assay of biological 
markers, such as demographic, pregnancy and delivery-related variables as well as 
situational factors (e.g. sampling time, hours of sleep, spontaneous awakening etc.), 
were examined. Univariate ANOVA indicated a significant effect of foetal sex on 
waking cortisol levels (F(105,1)=5.45, p=.021). Specifically, relative to males, women 
carrying female foetuses had lower cortisol levels at awakening. Thus, foetal sex was 
included as a covariate in subsequent cortisol analyses. In addition, time from delivery 
to saliva collection was significantly related with postnatal cortisol levels at awakening 
(r=-.32, p<.05), 30 minutes after (r=-.26, p<.05) and with cortisol AUCg (r=-.31, p<.05) 
on postnatal day 1 of collection, thus was included as control in subsequent analyses. 
No significant associations were found among demographic and pregnancy-related 
variables and sAA levels (all ps>.05). 
Age was significantly related to levels of CRP during pregnancy (r=-.29 
p=.004), while pre-pregnancy BMI was significantly associated with both CRP (r=.43, 
p<.001) and IL-6 (r=.24, p=.02) levels during pregnancy. Based on these analyses, 
pre-pregnancy BMI and age were included as covariates in subsequent analyses of 
psychosocial correlates of inflammation. Furthermore, length of gestation was 
significantly related to IL-6 levels after delivery (r=.25, p<.05) and was included as 





Table 3.1 - Descriptive statistics for maternal biological levels during pregnancy and 
after delivery 
 Pregnancy Delivery 
 Mean SD Mean SD 
Cortisol (µg/dl)     
Waking 0.381 0.129 0.435 0.182 
Waking +30’  0.504 0.151 0.575 0.255 
Bedtime 0.177 0.063 0.200 0.089 
sAA (U/ml)     
Waking 68.683 63.748 -- -- 
Waking +30’  47.605 37.974 -- -- 
Bedtime 97.171 79.583 -- -- 
CRP (ng/ml) 3786.741 2772.981 11660.282 3541.091 
IL-6 (pg/ml) 1.674 1.019 7.025 2.856 
 
 
3.4.2 Diurnal cortisol  
Diurnal variation in cortisol during pregnancy  
The unconditional means model for prenatal cortisol showed significant within-
person variability in cortisol levels over occasions (level-1; σ2e0=0.018, p<.001), while 
variability at the individual level (level-3, σ2v0=0.001, p=0.62) and between-days (level-
2, σ2u0=0.000, p=0.99) were not significant. Before fitting explanatory models including 
level-3 predictors, a baseline model of diurnal cortisol was fit to obtain estimates of 
cortisol levels at awakening (intercept) and the slopes for both the cortisol response to 
awakening (i.e. morning slope) and diurnal decline (i.e. afternoon slope). Model 
parameters for ln-transformed cortisol values are presented in Table 3.2 while results 





Table 3.2 - Preliminary and full prediction models for prenatal diurnal cortisol 
Prenatal Cortisol Model 1 Model 2 
 Estimate SE p Estimate  SE p 
Fixed effects       
Intercept 0.329 0.008 <.001 0.327 0.008 <.001 
Morning 0.086 0.010 <.001 0.092 0.024 <.001 
Afternoon -0.152 0.007 <.001 -0.188 0.017 <.001 
Fetal sex -0.029 0.010 0.005 -0.026 0.010 0.009 
EPDS    -0.026 0.008 0.002 
EPDS X Morning    -0.004 0.014 0.778 
EPDS X Afternoon    0.022 0.009 0.019 
Random effects       
Level 3 (individual)       
Intercept variance 0.002 0.001 <.001 0.002 0.001 <.001 
Morning slope variance 0.005 0.001 <.001 0.005 0.001 <.001 
Intercept/morning slope    
covariance 
0.000 0.001 0.668 0.000 0.001 0.871 
Level 2 (day)       
Intercept variance 0.005 0.000 <.001 0.005 0.000 <.001 
Level 1 (times)       
Intercept variance 0.000 0.000 0.998 0.000 0.000 0.998 
 
The estimated grand mean level of cortisol at awakening was 0.37 ug/dl and 
there was significant between-person variability in this value (p<.001). In line with 
previous studies, cortisol diurnal pattern was preserved during pregnancy, with a 
significant increase 30 minutes after awakening, as indexed by the morning slope 
(p<.001), and a significant decrease over the rest of the day, as indicated by the 
afternoon slope (p<.001). This model resulted in a significant improvement of the fit 
over the unconditional means model (deviance difference (2)=542.13, p<.001). The 
inclusion of a random morning slope term (as well as the random intercept and 
morning slope covariance terms) additionally significantly improved the model fit 
(deviance difference (2)=47.56, p<.001), suggesting significant variability between-
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person in the cortisol response to awakening. There was no significant effect of day of 
collection on mean cortisol values or on cortisol daytime trajectory (all ps>.05), 
suggesting no systematic differences between measurement on day 1 and day 2. As 
previously shown, fetal sex was significantly associated with cortisol mean waking 
level (p=.005), with 2.9% lower values in women carrying a female fetus as compared 
to male, but not with the overall daytime trajectory (all ps>.05). Thus, the effect of fetal 
sex was included as a control in all subsequent explanatory models. No other 
significant associations between cortisol diurnal levels and demographic, pregnancy-
related variables, wake time and hours of sleep were found (all ps>.05).  
Prenatal depressive symptoms were associated with lower cortisol levels at 
waking (2.6% lower with every 1-point increase on the EPDS, p=.002) and 30 minutes 
after waking (3% lower with every 1-point increase on the EPDS, p=.002), after 
adjusting for covariates. Additionally, prenatal depressive symptoms were related to a 
flatter afternoon cortisol decline (2.2% smaller slope with every 1-point increase on the 
EPDS, p=.019). This effect is illustrated in Figure 3.1. Inclusion of depressive 
symptoms resulted in a significantly improvement of model fit over the baseline model 
(deviance difference (3)=12.44, p=.006). Additionally, analyses (not reported in table) 
indicated that the effect of prenatal depression on cortisol diurnal pattern was not 





Figure 3.1 - Diurnal cortisol values for women with higher (+1 SD) and lower (-1SD) 
depressive symptoms during pregnancy, after adjusting for covariates. 
 
Diurnal variation in cortisol after delivery 
The base model for postnatal cortisol (Table 3.3) indicated significant between-
day (level-2, σ2u0=0.017, p<.001) and between-person (level-3, σ
2
v0=0.004, p<.001) 
variation in mean waking cortisol levels and suggested that the cortisol daytime 
trajectory is substantially maintained soon after delivery (p<.001). The inclusion of a 
random morning slope term (as well as the random intercept and morning slope 
covariance terms) significantly improved the model fit (deviance difference (2)=16.17, 
p<.001). The significant positive association between the random effects of intercept at 
level 3 and morning slope indicates a greater cortisol increase 30 minutes after waking 
in individuals with higher cortisol levels at waking. There was no significant effect of 
day of collection on cortisol values (all ps>.05). However, there was a marginally 
significant effect of time from delivery (p=.072). Specifically, cortisol levels at waking 
were around 0.2% lower for every additional hour between delivery and sample 
collection. Thus, time from delivery was included as a covariate in subsequent models. 
All other demographic, pregnancy- and delivery-related variables were not significantly 
169 
 
associated with cortisol values (all ps>.05). No significant effects of postnatal 
depressive symptoms, as measured by the EPDS, on mean cortisol waking levels as 
well as on the diurnal trajectory were found.  
 
Table 3.3 - Preliminary and full prediction models for postnatal diurnal cortisol 
Postnatal Cortisol Model 1 Model 2 
 Estimate SE p Estimate  SE p 
Fixed effects       
Intercept 0.353 0.012 <.001 0.350 0.012 <.001 
Morning 0.088 0.017 <.001 0.084 0.016 <.001 
Afternoon -0.170 0.016 <.001 -0.166 0.016 <.001 
Time from delivery -0.002 0.001 0.072 -0.002 0.001 0.078 
EPDS    -0.020 0.014 0.155 
EPDS X Morning    -0.024 0.019 0.215 
EPDS X Afternoon    0.025 0.019 0.176 
Random effects       
Level 3 (individual)       
Intercept variance 0.001 0.001 0.297 0.001 0.001 0.191 
Morning slope variance 0.002 0.003 0.459 0.001 0.003 0.674 
Intercept/morning slope    
covariance 
0.004 0.001 <.001 0.004 0.001 <.001 
Level 2 (day)       
Intercept variance 0.017 0.001 <.001 0.017 0.001 <.001 
Level 1 (times)       
Intercept variance 0.000 0.000 0.999 0.000 0.000 0.999 
 
 
Diurnal variation in cortisol from pregnancy to delivery 
The unconditional means model for cortisol revealed significant variability 
between occasions (i.e. pregnancy versus delivery; level-3; σ2v0=0.024, p<.001). As 
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expected, there was a significant effect of occasion on mean cortisol waking values 
(p<.001), with 3.25% higher cortisol values at delivery as compared to prenatal levels, 
while no effect of occasion on cortisol morning or afternoon slope (p>.05). Both foetal 
sex and time from delivery were retained in the model as covariates as they were 
previously found to be related to cortisol levels. Prenatal depressive symptoms were 
associated with lower cortisol levels at waking during pregnancy (p=.012), but not after 
delivery (p=.315). Additionally, prenatal depressive symptoms were related to a 
greater increase in cortisol waking levels from pregnancy to delivery (estimate=0.046, 
SE=0.017; p=.006). However, the inclusion of prenatal depressive symptoms and of 
the interactions with time and occasions did not yield to a significant improvement of 
the fit over the baseline model (deviance difference (6) =9.16, p=0.165).  
 
3.4.3 Diurnal sAA 
The unconditional means model for sAA levels during pregnancy showed 
significant variability in sAA values between person (level-3, σ2v0=0.412, p<.001) and 
between days (level-2; σ2u0=0.446, p<.001). The estimated grand mean level of sAA at 
awakening was 43.70 U/ml and there was significant variability in this value between 
persons and days (p<.001). Pregnant women showed the expected sAA diurnal 
trajectory with a significant decrease from awakening to 30 minutes after (p<.001) and 
a significant increase over the rest of the day (p<.001) (Table 3.4). This model resulted 
in a significant improvement of the fit over the unconditional model (deviance 
difference (2)= 94.25, p<.001). In addition, a random afternoon slope term significantly 
improve the fit of the model (deviance difference (2)=20.34, p<.001). The negative 
association between the random effects of intercept at level 3 and afternoon slope 
indicates that a higher sAA increased from 30 minutes after awakening to bedtime was 
seen in individuals with lower sAA levels at awakening. There was a significant effect 
of day of collection on mean sAA waking values (p=.002), with higher levels on day 2 
as compared to day 1, while no effect on sAA diurnal trajectory. Thus, day of collection 
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was retained as a covariate in the following analyses. Demographic, pregnancy-
related variables, wake time and hours of sleep were not significantly associated with 
diurnal sAA levels (all ps>.05).  
There was no effect of depressive symptoms on mean sAA waking levels, 
while there was a marginally significant effect of depression on sAA morning slope 
(p=.06), with depressive symptoms being related to a flatter morning sAA decline. 
However, inclusion of depressive symptoms did not yield a significant improvement of 
model fit over the baseline model (deviance difference (3)=3.78, p=.286). 
Table 3.4 – Preliminary and full prediction models for prenatal diurnal sAA 
Prenatal sAA Model 1 Model 2 
 Estimate SE p Estimate  SE p 
Fixed effects       
Intercept 3.731 0.079 <.001 3.731 0.079 <.001 
Morning -0.242 0.052 <.001 -0.241 0.051 <.001 
Afternoon 0.460 0.066 <.001 0.461 0.066 <.001 
Sampling day 0.140 0.042 0.002 0.140 0.042 0.002 
EPDS    -0.126 0.104 0.223 
EPDS X Morning    0.128 0.069 0.065 
EPDS X Afternoon    0.083 0.090 0.354 
Random effects       
Level 3 (individual)       
Intercept variance 0.498 0.077 <.001 0.497 0.077 <.001 
Afternoon slope variance 0.193 0.058 <.001 0.194 0.057 <.001 
Intercept/afternoon slope    
covariance 
-0.127 0.050 0.011 -0.127 0.050 0.011 
Level 2 (day)       
Intercept variance 0.287 0.020 <.001 0.285 0.019 <.001 
Level 1 (times)       
Intercept variance 0.000 0.000 0.999 0.000 0.000 0.999 
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3.4.4 Inflammatory markers 
CRP and IL-6 levels during pregnancy 
The estimated grand mean level of inflammatory markers during pregnancy 
was 2880.30 for CRP and 1.54 for IL-6 with significant between-persons variability 
around these values (p<.001). Age and maternal pre-pregnancy BMI were significantly 
related to prenatal CRP levels with 6% lower CRP levels per year older (estimate=-
0.056, SE=0.018; p=.002) and 9.2% higher CRP with each point on the BMI 
(estimate=0.086, SE=0.018; p<.001). Only maternal pre-pregnancy BMI was found to 
significantly predict IL-6 levels during pregnancy (estimate=0.018, SE=0.008; p=.018), 
with 1.8% higher IL-6 concentrations with each BMI point. All other demographic and 
pregnancy-related variables were not significantly associated with CRP and IL-6 
values (all ps>.05).  
There was a significant effect of depressive symptoms on IL-6 levels during 
pregnancy with around 8.1% higher IL-6 concentrations with every point increase on 
the EPDS (estimate=0.078, SE=0.039; p=.044). The inclusion of depressive symptoms 
significantly improved the model fit over the baseline model (deviance difference (1) = 
3.95, p=0.044). In contrast, prenatal depressive symptoms were not significantly 
related to mean CRP levels (estimate=0.075, SE=0.094; p=.429).  
 
CRP and IL-6 levels after delivery  
The estimated grand mean level of CRP and IL-6 after delivery were, 
respectively, 11202 and 6.50 with a significant between person variation around these 
values (p<.001). Neither CRP nor IL-6 levels after delivery were significantly related to 
any demographic or pregnancy-related variables (all ps>.05). Duration of pregnancy 
was significantly associated with IL-6 levels after delivery (estimate=0.084, SE=0.040; 
p=0.037), with 8.7% higher IL-6 levels per additional gestational week, and was thus 
included as a covariate in subsequent analyses. No effects of postnatal depressive 
symptoms on mean CRP or IL-6 levels after delivery were found (all ps>.05).  
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CRP and IL-6 trajectory from pregnancy to delivery 
The unconditional means models for CRP and IL-6 showed significant 
between-occasion variability (level-1, respectively σ2e0=0.866 and σ
2
e0=0.393, p<.001), 
while variability at the individual level was not significant (both ps>.05). As expected, 
both CRP and IL-6 levels were significantly higher soon after delivery as compared to 
late pregnancy (both ps<.001, Table 3.5).  
 
Table 3.5 – Full prediction models for inflammatory markers trajectory from pregnancy 
to delivery 
 IL-6 CRP 
 Estimate SE p Estimate  SE P 
Fixed effects       
Intercept 0.935 0.029 <.001 7.968 0.070 <.001 
Time 1.089 0.050 <.001 1.355 0.074 <.001 
Age    -0.054 0.018 0.003 
BMI 1.699 0.709 0.016 0.086 0.018 <.001 
EPDS 0.077 0.039 0.045 0.074 0.094 0.436 
Age x Time    0.039 0.019 0.046 
BMI x Time    -0.081 0.019 <.001 
EPDS X Time -0.023 0.064 0.724 -0.155 0.098 0.114 
Random effects       
Level 2 (individual)       
Intercept variance 0.081 0.012 <.001 0.473 0.068 <.001 
Time variance 0.166 0.030 .001 0.485 0.075 <.001 
Intercept/time    
covariance 
-0.051 0.015 <.001 -0.445 0.068 <.001 
Level 1 (times)       




Additionally, there was significant between-person variability in both CRP and 
IL-6 trajectory from late pregnancy to delivery, as indicated by the significant random 
slope for time (both ps<.001). The negative associations between the random effects 
of intercept at level 2 and time slope, both for CRP and IL-6, indicate that a greater 
increase from pregnancy to delivery was seen in individuals with lower inflammatory 
markers levels in pregnancy. All demographic, pregnancy- and delivery related 
variables examined were not significantly related to IL-6 change from pregnancy to 
delivery. However, there was a significant effect of maternal pre-pregnancy BMI 
(p<.001) and age (p=0.003) on CRP slope of time, with a higher BMI and a younger 
age being related to a flatter increase of CRP levels from pregnancy to delivery (in 
addition to the main effect on mean CRP prenatal levels previously shown; deviance 
difference (4)=30.3, p<.001). Thus, both maternal age and BMI were included in the 
subsequent analyses. 
No significant effects of prenatal depressive symptoms on CRP and IL-6 slope 
from pregnancy to delivery were found (all ps>.05). 
 
3.4.5 Correlations between systems  
Table 3.6 shows bivariate correlations between depressive symptoms and 
levels of biological markers in the whole sample. Graphical analyses were employed in 
order to explore relationship patterns between cortisol/sAA AUCg and IRS markers 
among women who scored above or below the median at the EPDS both during 
pregnancy and after delivery. As shown in Figure 3.2, these patterns were quite 
different for cortisol and IL-6 and for sAA and IL-6 during pregnancy. Specifically, in 
women scoring above the median at the EPDS, cortisol AUCg and sAA AUCg 
increased with increasing levels of IL-6 (respectively, p=.03 and p=.002), while this 
was not true in women scoring below the median (both ps>.05). No differences in 




Table 3.6 - Bivariate correlations for primary study variables 
 
* p<.05; **p<.01 
 
To further explore these relationship patterns during pregnancy, separate 
models were fitted to evaluate whether average levels of stress hormones predict the 
average levels of inflammatory markers, and whether depressive symptoms influence 
these associations, while adjusting for covariates. There was no main effect of cortisol 
or sAA AUCg on mean IL-6 or CRP levels during pregnancy (all ps>.05). However, 
there was a significant interaction between prenatal depressive symptoms and sAA 
(p>.01) and a marginally significant interaction between prenatal depressive symptoms 
and cortisol (p=.06) on IL-6 levels during pregnancy. Specifically, higher sAA or 
cortisol AUCg were associated with higher IL-6 levels only in women with higher EPDS 
scores (+1SD; p<.05), while the association was non-significant in women with lower 
EPDS scores (p>.05). Both sAA and cortisol models yielded a significant improvement 
 1 2 3 4 5 6 7 8 
1. Prenatal EPDS 
        
2. Prenatal 
Cortisol AUCg  -.15        
3. Prenatal sAA 
AUCg  .05 .25**       
4. Prenatal IL-6 
.19* .10 .17      
5. Prenatal CRP 
.11 .08 -.01 .31**     
6. Postnatal 
EPDS  .44** -.13 .07 .14 .19    
7. Postnatal 
Cortisol AUCg  -.13 .09 -.16 -.09 -.03 -.20   
8. Postnatal IL-6  .12 .01 .06 .27* .08 .005 .09  
9. Postnatal CRP 
-.19 .001 -.15 -.33** .22 -.02 -.09 -.18 
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in the model fit as compared to the IL-6 baseline model (deviance difference for sAA 
(2)=12.97, p<.01; deviance difference for cortisol (2)=12.03, p<.01).  
 
         
Figure 3.2 - Relationship between antenatal diurnal cortisol or sAA AUCg and 
inflammatory markers in women scoring above (red) or under (blue) the median at the 
EPDS during pregnancy. 
 
 
3.4.6 Supplementary analyses 
Given the considerable overlap between depression and anxiety (r=.65 
antenatally and r=.46 postnatally, p<.001), we performed an additional set of analyses 
examining maternal anxiety rather than depression as an individual-level predictor in 
the explanatory models in order to test the robustness of the effects found for maternal 
depression. There were no significant effects of anxiety on cortisol diurnal levels, IL-6 
and CRP both prenatally and postnatally (all ps>.05). However, the model indicated a 
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significant main effect of anxiety on mean waking sAA levels (estimate=-0.663, 
SE=0.312; p=.033) as well as on the sAA morning slope (estimate=0.594, SE=0.209; 
p=.004) during pregnancy. Specifically, higher levels of anxiety were related to lower 
sAA concentrations at waking and to a flatter decline from waking to 30 minutes after. 
This model significantly improved the model fit over the baseline model (deviance 
difference (3)=19.71, p<.001). Thus, in contrast with findings for depression, antenatal 
anxiety symptoms were not significantly associated with diurnal cortisol or IL-6 levels, 




The present results confirm and extend major findings regarding the 
relationship between depressive symptoms and dysregulation of the stress and 
immune response systems during pregnancy studied individually, while providing a 
more comprehensive picture of these relationships by assessing multiple biological 
markers simultaneously and examining their change from pre- to post-pregnancy.  
 
3.5.1 Depressive symptoms and SRS and IRS functioning during pregnancy 
As hypothesized, results indicated an association between depressive 
symptoms and both diurnal cortisol variations, as detected through multilevel models, 
and heightened inflammation in a community sample of pregnant women. Specifically, 
higher depressive symptoms in late gestation were associated with lower levels of 
cortisol at waking and 30 minutes after, as well as a flatter diurnal decline, after 
controlling for covariates. These findings are in line with previous studies on high 
psychosocial risk samples providing evidence of a flattened diurnal pattern in 
depressed women (e.g. O’Connor et al., 2014; Suglia et al., 2010). However, when the 
overall diurnal cortisol output, as indexed by the AUCg, was examined, we were not 
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able to detect any significant association with depressive symptoms. This result is 
consistent with previous evidence (e.g. Hellgren et al., 2013; Cheng & Pickler, 2010) 
and underlines the need for a thorough characterization of cortisol diurnal pattern in 
order to identify associations between HPA axis functioning and depressive symptoms 
during pregnancy, especially in low-risk samples.  
While cortisol awakening response (CAR) has attracted considerable attention 
as a promising biomarker of HPA axis function, being associated with several health 
outcomes (Clow, et al., 2010), including depression in non-pregnant individuals (Huber 
et al.,  2006; Vreeburg, Sophie; Hoogendijk, 2009), we found no evidence of an 
association between maternal depressive symptoms and CAR in late pregnancy. 
Although our assessment does not allow us to properly evaluate the CAR (Stalder et 
al., 2016), as samples were collected only at waking and 30 minutes after, our results 
converge with previous reports using either composite scores (C.-Y. Cheng & Pickler, 
2010; Shea et al., 2007) or mixed models (Hellgren et al., 2013; O’Connor, Tang, et 
al., 2014). Despite the fact that further investigations are required, it can be 
hypothesized that while the CAR is still present in late pregnancy, due to the 
pregnancy-related HPA axis physiological resetting, including elevations in absolute 
cortisol levels and dampened reactivity, it may dissociate to a certain extent from 
environmental factors. Alternatively, the current findings converge with a few prior 
studies to suggest that evening cortisol measures or measures of diurnal decline might 
be more sensitive to the effect of stress during pregnancy (Harville et al., 2009; 
O’Connor et al., 2014; Obel et al., 2005).  
Furthermore, consistently with previous reports (Cassidy-Bushrow et al., 2012; 
Christian et al., 2009; Coussons-Read, Okun, & Nettles, 2007), higher depressive 
symptoms were associated with increased IL-6 levels during pregnancy, after 
adjusting for relevant covariates. This result is in line with accumulating evidence of a 
role for inflammation in vulnerability to depression in non-pregnant samples. In 
addition, it is noteworthy that inflammatory processes are particularly relevant during 
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pregnancy. Indeed, although circulating levels of pro-inflammatory cytokines have 
been found to be increased at the end of healthy gestation (Fransson et al., 2012), 
higher than typical elevations have been associated with adverse obstetric and birth 
outcomes such as preeclampsia and preterm birth (e.g. Vannuccini et al., 2016; 
Rusterholz et al., 2007). Accumulating evidence indicates an association between 
pregnancy morbidities such as preeclampsia and preterm labour and depressive 
symptoms (reviewed in Alder et al., 2007). Thus, our findings of a link between 
depressive symptomatology and increased inflammation in a low risk sample of 
healthy pregnant women, might speak in favour of a possible inflammatory pathway 
from depression to adverse pregnancy outcomes that would deserve further 
consideration in future studies.    
Importantly, despite the strong association between prenatal depression and 
anxiety, our exploratory analyses indicated that findings of an altered HPA axis and 
IRS functioning were specific to depression, as weak and non-significant effects were 
found for anxiety symptoms. This is particularly relevant as the lack of consistency in 
the literature emphasizes the need for a clear characterization of the risk phenotypes 
that may ultimately impact fetal development, both in terms of psychiatric construct 
and biological processes.  
Beside the above mentioned findings, some non-significant findings from our 
study might be relevant in the context of existing literature. First of all, in contrast to 
our expectations and to results from previous studies (e.g. Azar & Mercer, 2013; 
Scrandis et al., 2008), CRP levels were not related to depressive symptomatology. 
However, a lack of an association between antenatal CRP levels and depressive 
symptoms has been already reported in some studies (e.g. Cassidy-Bushrow et al., 
2012; Catov et al., 2014). It is important to note that CRP is generally considered a 
non-specific marker of systemic inflammation, being primarily synthesized in the liver 
in response to pro-inflammatory cytokines, and reflecting levels of circulating 
interleukins, such as IL-6 (Dantzer & Kelley, 2007). Hence, as expected, prenatal IL-6 
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and CRP levels were highly correlated in the current sample. However, different 
trajectories of change over time for IL-6 and CRP have been observed during 
pregnancy (Christian et al., 2014) and it has been shown that an increase in IL-6 is not 
always paralleled by CRP production (Czarkowska-Paczek et al., 2005). In addition, 
CRP levels increase and fall more rapidly and markedly than other acute-phase 
proteins. Thus, evaluating “basal” levels of CRP might be challenging and it is not 
possible to rule out a wide range of factors influencing circulating levels of CRP, such 
as pro-inflammatory cytokines, corticosteroids etc. (Du Clos & Mold, 2004). Therefore, 
the lack of an association between CRP and depression may be due to 
methodological issues, especially since CRP, as compared to IL-6, has been found to 
be particularly sensitive to processing and storage conditions (Skogstrand et al., 
2008). On the other hand, it still remains plausible that IL-6, rather than CRP, is a 
more adequate biomarker for depression, driving the association between 
inflammation and depressive symptoms.  
Secondly, we did not find any substantial evidence of altered SNS functioning, 
as indexed by sAA diurnal levels, in women at risk for depression during pregnancy. 
Specifically, only a marginally significant effect of depressive symptoms in flattening 
the sAA morning decline during pregnancy was detected, but depression was not 
retained as a significant predictor in the final model. To date, only two studies have 
examined the link between sAA and depression during pregnancy and these have 
yielded mixed results. Giesbrecht and colleagues (2013) failed to detect any significant 
association between depression and sAA daytime trajectory, whereas, more recently, 
Braithwaite and colleagues (2015) reported higher sAA levels at waking in women with 
depressive symptoms compared with non-depressed controls. However, in this latter 
study, sAA levels were averaged across two days of collection and compared between 
two small groups scoring above and under the cut-off of the EPDS. It is possible that 
the significant variability between days in sAA mean waking values, as well as the use 
of the EPDS score as a continuous variable in our analyses, might have limited our 
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ability to detect a significant effect. Additionally, as sAA levels have been observed to 
decrease as gestation advances (Giesbrecht et al., 2013; Nierop et al., 2006), 
pregnancy-related adjustments might further impair the possibility to identify a 
significant effect. Alternatively, it can be hypothesized that a dysregulation of the SNS 
might be more closely involved in the occurrence of anxiety rather than depressive 
symptoms. Indeed, we provided evidence of a significant association between higher 
levels of prenatal anxiety and lower sAA waking levels as well as a flatter decline from 
waking to 30 minutes after. This result is in line with previous evidence of an 
association between sAA or catecholamines concentrations and anxiety during 
pregnancy (e.g. Giesbrecht et al., 2013; Field et al., 2004; Field et al., 2006).  
 
3.5.2 Depressive symptoms and SRS and IRS functioning after delivery 
While we reported a moderate correlation between prenatal and postnatal 
depressive symptoms, contrary to what we expected, no cross-sectional associations 
between postnatal depressive symptoms and either diurnal cortisol or inflammatory 
markers levels were found. This finding is in line with a number of studies which failed 
to detect any significant association between serum levels of IL-6 evaluated early in 
labor or soon after delivery and postpartum depression at 1-5 days, 6 weeks and 6 
months after delivery (e.g. (Corwin et al., 2015; Fransson et al., 2012; Groer et al., 
2015; Skalkidou et al., 2009). However, it is important to note that a small number of 
studies have found evidence of altered IRS functioning in the early puerperium period 
and depressive symptoms (e.g. Maes et al., 2000). Interestingly, Boufidou and 
colleagues (2009) found higher cerebrospinal fluid IL-6 levels, but not serum levels, at 
delivery to be related to risk for postnatal depression. As far as we know, only Corwin 
and colleagues (2015) investigated the association between depressive symptoms 
and HPA axis functioning, as indexed by cortisol diurnal pattern, in the early 
puerperium (i.e. seven days after delivery); consistent with our results, the authors 
found no significant association between cortisol diurnal AUCg one week after delivery 
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and depressive symptoms.  
There are a number of possible explanations for these null findings. First of all, 
despite the strong continuity between prenatal and postnatal depression, it has been 
argued that antenatal and postpartum depression represent two separate disorders 
(Kammerer et al., 2006), thus possibly reflecting distinct endocrine and inflammatory 
states. Additionally, it is also possible that the association between depressive 
symptoms and biomarkers during the first few weeks after childbirth might be masked 
by the strong hormonal and inflammatory response to parturition. Indeed, in line with 
previous reports (e.g. Corwin et al., 2015), we observed a significant activation of both 
the stress and the immune response systems in the first days after childbirth, as 
suggested by the general increase over the prenatal levels in all markers. It is possible 
that, as the biological response to delivery normalizes, significant associations 
between depression and cortisol or cytokines might emerge. Indeed, in the study by 
Corwin and colleagues (2015) no significant differences were observed between 
postnatally depressed women and controls in cortisol AUCg one week after delivery, 
but significant differences were highlighted two weeks after delivery. Consistently, a 
small number of studies have examined the cortisol diurnal pattern postnatally and 
found evidence of a link between depressive symptoms and suppression of the CAR 
(De Rezende et al., 2016; Taylor et al., 2009) as well as a flatter diurnal pattern (De 
Rezende et al., 2016) from 6 weeks to 6 months postpartum. Additionally, it can be 
hypothesized that a follow up evaluation of depressive symptoms could have revealed 
significant differences in the HPA axis and IRS functioning after delivery in women 
who later developed postpartum depression. Consistently with this, Liu and colleagues 
(2016) recently reported higher CRP and IL-6 levels after delivery in women with 




3.5.3 Prenatal depressive symptoms and change in SRS and IRS functioning from 
pregnancy to delivery 
The current study was also designed to explore whether prenatal depressive 
symptoms were associated with a different trajectory of change in cortisol and 
inflammatory markers concentrations from pregnancy to the early puerperium.  
Cortisol is known to increase through gestation and advancing labor and to 
peak during delivery. The physiological changes in the HPA axis functioning, mainly 
driven by the secretion of corticotropin-releasing hormone (CRH) from the placenta 
(Mastorakos & Ilias, 2003), are thought to play a role in maternal and fetal wellbeing 
and to promote normal labor progression (Allolio et al., 1990; Paula J. Brunton & 
Russell, 2008; Brian Harris et al., 1994). Although we provided marginal evidence of a 
greater increase in cortisol waking levels from pregnancy to the first days after 
childbirth in women with higher antenatal depressive symptoms, the final model did not 
yield to a significant improvement of the model fit over the baseline model. This null 
finding might be an issue of statistical power. Alternatively, it can be hypothesized that 
due to the substantial elevations in cortisol levels in response to labor and delivery, 
significant associations with mild variations in antenatal depressive symptoms might 
be difficult to detect. To our knowledge, no previous study has evaluated the 
association between prenatal depressive symptoms and changes in cortisol from 
pregnancy to the early puerperium. Yim and colleagues (2009) evaluated the 
longitudinal trajectory of pCRH across gestation and found a significant increase in 
pCRH levels until delivery in women who later developed postpartum depressive 
symptoms. Additionally, O’Keane and colleagues (2011) reported a smaller drop in 
CRH levels from pregnancy to 1-6 days after delivery in women showing higher 
symptoms of postpartum blues. While cortisol and CRH at 37 weeks of gestation have 
been shown to be significantly associated (Sandman et al., 2006), considerable 
methodological differences between the current findings and the above mentioned 
studies limit possible comparisons. Future studies in larger and different samples, 
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particularly those containing more clinical depressed women, could be able to better 
address the role of antenatal depressive symptoms in influencing cortisol trajectory 
from pregnancy to the early puerperium.   
While we observed a marked increase in concentrations of inflammatory 
markers from pregnancy to the early puerperium, prenatal depressive symptoms were 
not found to significantly affect the longitudinal trajectory of the markers we examined. 
Our findings are in contrast with results from Maes and colleagues (2000) reporting 
higher IL-6 levels soon after delivery in women whose depression scores significantly 
increased from pregnancy to delivery. However, the unusual way of combining 
prenatal and postnatal mood symptoms in this study makes it hard to compare results. 
To date, only a handful of studies have evaluated the relationship between mood and 
IRS functioning antenatally and postnatally (e.g. Corwin et al., 2015; Scrandis et al., 
2008; Maes et al., 2000) and these have mainly focused on postpartum depression. 
However, as prenatal depression is considered one of the strongest predictors of 
postnatal depression (Robertson et al., 2004) and a dysregulation of stress hormones 
and cytokines is thought to be involved in the development of postnatal depression, 
the role of prenatal depressive symptoms in influencing the longitudinal trajectory of 
endocrine and immune biomarkers from pregnancy to the early postpartum warrants 
further consideration in future studies.  
 
3.5.4 Correlations between SRS and IRS  
Our findings of differences in both the IRS and HPA axis in association with 
depression during pregnancy fit well within the existing literature. However, it has been 
suggested that alterations in any one system, studied individually, may offer only a 
partial picture of the processes involved in vulnerability for psychopathology. 
Nonetheless, the bidirectional interactions between the stress and the immune 
systems in the perinatal period and whether they differ according to symptomatology 
remain largely unclear and unexplored. 
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Our exploratory analyses indicate that prenatal depressive symptoms 
moderated the association between IL-6 and sAA and, marginally, between IL-6 and 
cortisol. In particular, as hypothesized, higher diurnal levels of sAA or cortisol were 
associated with higher inflammation only in women with higher depressive symptoms 
during pregnancy. In healthy non-pregnant adults, a rise in pro-inflammatory cytokines, 
as a consequence of an infection or stressor, activates the central components of the 
SRS, increasing cortisol and catecholamines secretion (Elenkov, 2008). 
Glucocorticoids and catecholamines, in turn, are thought to act as anti-inflammatory 
agents, systemically mediating a suppression of the inflammatory response and up-
regulating the production of anti-inflammatory cytokines (Elenkov & Chrousos, 2006), 
in order to protect organism from the detrimental effects of a prolonged inflammatory 
response. In the last decade, significant advances have been made in understanding 
the neuroendocrine-immune interface and there is now reasonable evidence to 
suggest that the hormonal control of the pro- versus anti-inflammatory cytokine 
balance may represent a key mechanism by which stress gets ‘under the skin’ 
(Elenkov & Chrousos 2006). However, to date, only a limited number of studies have 
explored the HPA axis-immune interface during pregnancy (e.g. Corwin et al., 2013; 
Walsh et al., 2016; Shelton et al., 2015) and, to our knowledge, no studies investigated 
the role of the SNS in these mechanisms.  
Increasing evidence, particularly from the observation of the course of 
autoimmune disease during pregnancy, suggests that increased levels of cortisol and 
norepinephrine in the third trimester of gestation might inhibit pro-inflammatory 
cytokine production and potentiate anti-inflammatory cytokine production (Elenkov et 
al., 2001; Elenkov & Chrousos, 2002; Mizokami et al., 2004). Tentatively, our findings, 
among the first evaluating this mechanism, could be interpreted to indicate that the 
ability of stress hormones to limit inflammation may be impaired in pregnant women 
with higher depressive symptoms, as suggested by the positive association between 
sAA or cortisol diurnal levels and IL-6 concentrations. As tight regulation of 
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inflammatory responses during pregnancy is crucial for a successful gestation and 
delivery (Mor et al., 2011), a disruption of the regulatory stress hormones-inflammatory 
circuit might lead to an over-activation of the IRS, with potential adverse consequence 
for mother and baby. Reduced regulation of the inflammatory response in non-
pregnant adults has been related to chronic stress and has been associated to 
glucocorticoid resistance (Cohen et al., 2012; Miller et al., 2009; Rohleder, 2012). 
Despite the preliminary nature of our findings, they are in line with few existing 
evidence of a disruption of the negative feedback relationship between cortisol and 
pro-inflammatory cytokines during pregnancy, considered suggestive of glucocorticoid 
resistance, in high risk samples (Corwin et al., 2013; Walsh et al., 2016). 
Nevertheless, it is important to emphasize that the current findings are small-scale and 
exploratory and need replication in larger longitudinal studies. Although antenatal 
depressive symptoms were not associated with averaged diurnal cortisol or sAA 
levels, as indexed by the AUCg, in the whole sample, they were significantly 
associated with an altered diurnal cortisol profile and, marginally, with sAA pattern, 
possibly reflecting subtle disturbances in the HPA axis and SNS functioning. We might 
speculate that a dysfunctional SRS might be less capable of inhibiting the 
inflammatory response, as it normally does, thus leading to increased inflammation. 
Additionally, it has been recently proposed that the well-documented anti-inflammatory 
effects of glucocorticoids might occur at high dosages, while at low or intermediate 
concentrations, glucocorticoids might lose their immunosuppressive properties and 
even stimulate the inflammatory response (Horowitz et al., 2013; Sorrells, JR, Munhoz, 
& Sapolsky, 2016). 
Contrary to our predictions and to results obtained by Corwin and colleagues 
(2013), we found no significant association between stress hormones and 
inflammatory markers in women with lower depressive symptoms. Although this result 
could be due to limited statistical power to detect a small effect, it could also suggest 
that the anti-inflammatory response to the physiological pregnancy-related increase in 
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cortisol is dampened or lacking in the third trimester of healthy pregnancy. This is in 
line with findings from Corwin and colleagues (2015) reporting a significant positive 
association between postnatal diurnal cortisol and pro-inflammatory cytokines in 
postnatally depressed women, while no association in euthymic women. However, we 
are at the very beginning of our understanding of these mechanisms during the 
perinatal period. In order to better capture and understand deviations from typical 
functioning, the well-documented bidirectional stress-immune interactions occurring 
outside the perinatal period needs to be fully investigated during pregnancy and in the 
early puerperium.  
 
3.5.5 Limitations 
Some limitations of the present study are noteworthy. First, it is important to 
note that the current findings come from a sample of healthy women from a middle-
high socioeconomic background and that, as expected in a community sample, levels 
of depressive symptoms were relatively low, thus limiting generalizability to 
populations at high psychosocial risk or clinical psychiatric populations. It is possible 
that evaluating women with clinically significant depression could reveal more 
profound alterations of the SRS and IRS, although this hypothesis needs to be directly 
tested. Second, a larger sample size would have allowed more power to detect small 
effects, although the longitudinal design, the exclusion of complicated pregnancies or 
women taking any chronic medication and a multidimensional approach strengthens 
our results. Third, despite the current findings are in line with evidence of a role of 
dysregulation in the HPA axis and IRS functioning in increasing vulnerability for 
depression (Horowitz et al., 2013), it is important to underline that, due to the 
correlational nature of this study, it is not possible to establish whether the observed 
associations reflect causal processes. In addition, we cannot rule out unmeasured 
confounds or third variables that might explain the associations we reported, including 
genetic variants that might account for both inflammation or cortisol dysregulation and 
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occurrence of depressive symptoms (reviewed in Barnes, Mondelli, & Pariante, 2017; 
Spijker & van Rossum, 2009). Fourth, we collected data at one time only during 
pregnancy and after delivery, thus limiting the generalizability of our results at other 
gestational and postpartum time-windows. It is our aim to follow-up this cohort to 
determine if the observed alterations could be predictive of later postpartum symptoms 
as well as their impact on infant development. Fifth, our assessment of the HPA axis 
and SNS activity was quite thorough, measuring cortisol and sAA three times a day 
over two days as recommended in the existing literature (Harville et al., 2009) and 
including diaries. However, salivary samples were collected at home and despite 
considerable effort to ensure compliance with the protocol and fidelity of the diurnal 
collection, these were not objectively measured. Lastly, although it is acknowledged 
that the parasympathetic branch of the autonomic nervous system (PNS) is involved in 
stress regulation, we did not include any measure of PNS functioning and we did not 
evaluate SNS functioning soon after delivery. However, we believe that our study 
could lead the way to future research adopting a multidimensional approach to the 
investigation of perinatal depression.  
 
3.6 Conclusions 
To conclude, the current study adds to the growing literature suggesting a 
dysregulation of the HPA axis and IRS in perinatal depression and is among the first to 
report initial evidence suggestive of a disruption in the feedback relationship between 
pro-inflammatory cytokines and stress hormones during the perinatal period in women 
with higher depressive symptoms, emphasizing the need for an integrated multisystem 
approach to the understanding of the biological underpinnings of perinatal depression. 
Confirming our findings in larger samples may help to identify early biomarkers 
associated with perinatal depression as well as new treatment targets, improving the 
quality of life in women and their children. 
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Chapter 4: Beyond the HPA-axis: exploring maternal 





Mounting evidence indicates that maternal depression during pregnancy is 
associated with an increased risk of altered physiological, behavioral, emotional and 
cognitive outcomes in offspring (reviewed in Gentile, 2017). Additionally, antenatal 
depression has been linked with a modest but statistically significant increase risk for 
shortened gestation and smaller size at birth (for a meta-analyses see Grote et al., 
2010), which in turn, are known to constitute risk factors for the subsequent cognitive 
and socio-emotional development (Wadhwa, 2005). These early perturbations to child 
development might confer heightened vulnerability for the development of later 
psychopathology (Schlotz & Phillips, 2009). Notably, associations between prenatal 
stress and some indices of child development were found when using an in vitro 
fertilization prenatal cross fostering design which controls for maternal heritable factors 
(Rice et al., 2010). Effects have also been found to remain strong and significant when 
controlling for measured confounding factors, such as smoking or socioeconomic 
status (e.g. O’Connor et al., 2013), or postnatal effects, such as postnatal 
symptomatology (e.g. O’Donnell et al., 2013, though not in all studies (e.g. Rice et al., 
2010). Thus, it has been proposed that biological mechanisms occurring in the 
intrauterine environment might mediate, at least in part, the link between antenatal 
maternal depression and adverse developmental outcomes, in a process often 
described as “fetal programming” (e.g. Barker, 2004). In particular, several effects of 
the in utero exposure to maternal depression are thought to arise from an alteration of 
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the foetal stress response systems, such as the Hypothalamic-Pituitary-Adrenal (HPA) 
axis (see Glover, O’Connor, & O’Donnell, 2010), carrying possibly long-lasting effects 
on how the brain will respond physiologically and behaviourally to stress and 
enhancing the risk of adverse behavioral and physiological outcomes (Megan R. 
Gunnar & Vazquez, 2001; Tarullo & Gunnar, 2006). In the last decades, an increasing 
number of reports have sought to elucidate the biological mechanisms underlying fetal 
programming of offspring’s stress reactivity. Based on animal studies, scholars have 
focused primarily on the mediating role of the maternal HPA axis. However, the weight 
of supporting evidence in humans is not yet convincing (Rakers et al., 2017) and it is 
now clear that complementary or alternative mechanisms of stress involving, for 
example, the maternal sympathetic nervous system (SNS) or the inflammatory 
response systems (IRS) warrant further consideration. In the following sections, we will 
examine available evidence on a possible role of the HPA axis, SNS and IRS in fetal 
programming.   
 
4.1.1 Prenatal HPA axis functioning and offspring’s stress reactivity 
Glucocorticoids such as cortisol, play a crucial role in promoting fetal brain 
development and organ maturation (McGowan & Matthews, 2018; Reynolds, 2013b) 
during pregnancy. However, excessive fetal exposure to glucocorticoids, both 
synthetic and endogenous, can have detrimental effects in later life (Seckl & Holmes, 
2007; Waffarn & Davis, 2012). Indeed, while the fetus is largely protected from cortisol 
exposure through the activity of the placental enzyme 11β-hydroxysteroid 
dehydrogenase type 2 (11β-HSD2), a proportion of maternal cortisol crosses the 
placenta and influences fetal development (Gitau et al., 1998). Thus, it has been 
hypothesized that distress-linked elevations in maternal cortisol or a distress-linked 
impairment of the activity of placental 11β-HSD2, might lead to more cortisol passing 
through the placenta and directly affecting fetal development and stress physiology, 
with potentially long-lasting consequences (O’Donnell et al., 2009). Additionally, a 
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dysregulation of maternal HPA axis has been proposed as a potential pathway through 
which antenatal depression might lead to adverse birth outcomes. In particular, it has 
been suggested that stress-related increases in maternal cortisol might alter the blood 
flow to placenta, resulting in restriction of oxygen and nutrients to the fetus, which in 
turn might lead to fetal growth restriction and/or to premature delivery.  
In humans, only partial support for a link between antenatal maternal cortisol 
and offspring development has been found (reviewed in Zijlmans et al., 2015). 
Preliminary findings relate higher maternal cortisol during pregnancy with lower 
offspring birthweight and/or shorter gestational age (reviewed in Reynolds, 2013), 
although results are dependent on the gestational timing and method of cortisol 
assessment. Notably, a large prospective study by Goedhart and colleagues (2010) 
showed that the negative association between maternal cortisol levels in early 
pregnancy and birth outcomes became statistically insignificant when potential 
confounders where controlled for in the analyses. 
A handful of prospective studies have investigated the association between 
antenatal maternal cortisol and offspring stress reactivity, and these have provided 
mixed results. High quality and methodologically rigorous research from Davis and 
colleagues (2011) showed higher maternal afternoon cortisol in late pregnancy to 
predict greater newborns’ cortisol reactivity to the heel-stick at birth. Additionally, 
increased levels of maternal cortisol in early gestation were associated with newborns’ 
slower behavioral recovery to the painful stressor. In line with these findings, higher 
maternal cortisol have been associated with greater cortisol reactivity to the inoculation 
at 4 years old (Gutteling et al., 2004) and to the first day of school at 5 years (Gutteling 
et al., 2005) in two small samples. However, an association between higher amniotic 
fluid cortisol, which is though to provide a more direct index of fetal cortisol exposure, 
and 17-month-olds’ lower cortisol response to maternal separation in a sample of 125 
infants (O’Connor et al., 2013) has also been reported. Additionally, a number of 
studies failed to find any significant association between maternal cortisol levels during 
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pregnancy and infant’s cortisol reactivity to either painful (e.g. Braithwaite, Murphy, & 
Ramchandani, 2016) or social (e.g.  Tollenaar et al., 2011) stressors over the first year 
of age. Interestingly, a recent study by Giesbrecth and colleagues (2017) on a large 
sample of 236 mother-infant dyads highlighted sex differences in the effects of 
prenatal maternal cortisol and distress on 3-month-olds’ cortisol response to the heel-
stick, with a blunted cortisol response being associated with exposure to high maternal 
distress and flattened diurnal cortisol trajectory in females, whereas with a steeper 
maternal diurnal cortisol profile in males.   
  
4.1.2 Prenatal SNS functioning and offspring stress reactivity 
During pregnancy, the SNS is increasingly involved to support maternal and 
fetal energetic requests, with a rise in blood volume and heart rate as well as a 
reduction in vascular resistance (Silversides & Colman, 2007). Although 
catecholamines, produced by the SNS under stress conditions, do not cross the 
placental barrier in biologically relevant concentrations (Giannakoulopoulos et al., 
1999), stress-related activation of the SNS might affect utero-placental perfusion, 
indirectly influencing fetal growth and, in turn, activating the fetal HPA axis (Rakers et 
al., 2017). Furthermore, catecholamines might down-regulate 11β-HSD2 gene 
expression (Sarkar et al., 2001), thus possibly increasing fetal glucocorticoid exposure. 
Despite evidence suggests that elevations in maternal catecholamines, as a result of 
stress-induced activation of the SNS, could be an alternative mechanism by which 
antenatal depression might impact offspring’s outcomes, a SNS-mediated mechanism 
of fetal programming have been very poorly explored in humans. Recently, the 
opportunity to evaluate maternal SNS functioning through the non-invasive 
assessment of levels of salivary alpha amylase (sAA), an enzyme produced by 
salivary glands (Nater & Rohleder, 2009), leads the way for more research into the 
role of maternal SNS in fetal programming. However, to our knowledge, only a very 
small number of studies explored the association between sAA levels during 
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pregnancy and child outcomes. Specifically, Giesbrecht and colleagues (2015) found 
evidence of an association between maternal prenatal levels of sAA and newborns’ 
birth weight in a large sample of dyads (N=291), with women showing a blunted sAA 
awakening response having lower birth weight infants. Additionally, an altered diurnal 
sAA pattern was found to relate to previous history of miscarriage in a smaller sample 
of women (N=93; Giesbrecht et al., 2013). Furthermore, Rash and colleagues (2016) 
found that maternal prenatal sAA awakening response distinguished among 6-month-
olds stress reactivity profiles using discriminant function analyses on a large sample of 
mothers and infants (N=254). Lastly, Braithwaithe and colleagues (2017) found a 
significant interaction between maternal prenatal sAA diurnal levels and infants’ sex in 
predicting 2-month-olds’ distress to limit in a sample of 88 infants. However, the study 
was underpowered and the separate effect in males and females, although in the 
opposite direction (with higher maternal prenatal sAA diurnal levels being associated 
with lower levels of distress to limits in boys, while higher in females), were not 
significant. To our knowledge, no previous study has directly examined how maternal 
antenatal SNS functioning, as indexed by sAA diurnal levels, relate to early cortisol 
and behavioral reactivity to stress in offspring.   
 
4.1.3 Prenatal IRS functioning and offsprings’ stress reactivity 
Emerging data support a role of inflammatory pathways in the pathophysiology 
of depression (Miller & Raison, 2016) and, consistently with this hypothesis, 
inflammatory markers, such as Interleukine-6 (IL-6) and C-reactive protein (CRP) have 
been generally found to be increased in depressed pregnant women (Osborne & 
Monk, 2013). However, knowledge about fetal programming by maternal inflammation 
is limited. During healthy pregnancy cytokines, produced by cells of the immune 
system in response to stress and infections, play a crucial role in maintaining a fine 
balance between pro-inflammatory and anti-inflammatory influences. While circulating 
levels of pro-inflammatory cytokines, such as Interleukine-6 (IL-6), are increased at the 
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end of healthy pregnancy (Curry et al., 2008), higher than typical elevations have been 
linked with adverse pregnancy and birth outcomes such as rejection of the fetus, 
preeclampsia, spontaneous preterm delivery and lower birth weight (e.g. Vannuccini et 
al., 2016; Rusterholz et al., 2007; Gillespie, Porter, & Christian, 2016; Sykes et al., 
2012). In addition, preliminary evidence exists for a link between maternal antenatal 
distress, maternal inflammation and adverse birth outcomes. Specifically, Okun and 
colleagues (2013) reported an association between maternal increased IL-6 levels and 
smaller birth weights in a small sample of depressed women (N=32), although the 
effect became non-significant once the model was adjusted for several covariates (i.e. 
race, parity, education, BMI and medications). Furthermore, Coussons-Read and 
colleagues (2012) found increased psychological distress and higher levels of 
inflammatory markers, such as IL-6 or TNF-α, in women who delivered prematurely 
(N=17) as compared to women who delivered at term (N=156). Furthermore, antenatal 
levels of  IL-6 partially mediate the effects of maternal distress on gestational length. 
However, the direction of the effect was unexpected (i.e. with higher levels of distress 
being associated with lower IL-6 and, in turn, less impact on gestational length) and it 
was no longer significant after correction for multiple comparisons.  
Besides affecting maternal health and birth outcomes, animal models suggest 
that maternal antenatal inflammation could influence fetal development and stress-
related physiology with long-lasting effects (e.g. Rounioja et al., 2005; Samuelsson et 
al., 2004). Consistently with animal data, preliminary studies on very preterm babies 
showed a link between prenatal exposure to inflammation and altered infants’ HPA 
activity (e.g. Gover et al., 2013; Soliman et al., 2004). In addition, maternal IRS 
activation during pregnancy have been consistently associated with a range of 
neuronal dysfunctions and related behavioral phenotypes, such as autism and 
schizophrenia (for a review see Knuesel et al., 2014) and initial neuroimaging 
evidence in human suggests that maternal IL-6 levels during pregnancy can affect 
fetal brain development, leading to altered newborns’ amygdala volume and 
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connectivity (Graham et al., 2017) and reduced functional anisotropy in the central 
portion of the uncinate fasciculus of newborns’ brains (Rasmussen et al., 2018). 
Nevertheless, the actual mechanisms of fetal programming by maternal inflammation 
are still mostly unknown. Interestingly, it has been shown that placental transfer of IL-6 
occurs in human healthy pregnancy (Zarestky et al., 2004). In addition, indirect effects 
mediated by placental inflammation have been hypothesized and require further 
exploration (reviewed in Rakers et al., 2017). 
To the best of our knowledge, only two studies in human have investigated the 
association between maternal antenatal cytokines levels and child behavioral and 
stress-related outcomes. Specifically, Osborne and colleagues (2018) showed that 
higher levels of maternal pro-inflammatory cytokines in late pregnancy were 
associated with less optimal neurobehavioral function soon after birth and greater 
cortisol reactivity to the immunization at 12 months of age in a sample of 49 depressed 
women and 57 healthy controls. However, results are limited to unadjusted 
correlations and require replication while accounting for potential confounders of the 
association. Furthermore, a pilot study by Gustaffson and colleagues (2018)showed 
that maternal antenatal inflammation, indexed using a latent variable that included il-6, 
TNF-α and monocyte chemoattractant protein-1 concentrations, mediate the link 
between prenatal depressive symptoms and 6-month-olds negative affect. However, 
the sample was relatively small (N=68) and consisted of women at risk for attention-
deficit/hyperactivity disorder, thus findings might not generalize to larger and different 
populations. 
 
4.2 Summary and study hypotheses  
There is mounting evidence suggesting that in utero exposure to maternal 
depression is a risk factor for subsequent child development. One mechanism through 
which maternal antenatal depression is thought to affect offspring development is by 
altering the fetal development of the stress response systems with long term effects. 
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However, the biological “mediators” involved in the embedding of such adverse 
experience into the individual stress physiology remains unknown. The most studied 
candidate has been cortisol, the end product of the HPA axis, however, the evidence 
in humans for an association between maternal antenatal cortisol levels and offspring 
outcomes, such as birth outcomes and stress reactivity, is inconsistent (reviewed in 
Zjlmans et al., 2015). This is mainly because results are beset by large variability in 
cortisol measures (i.e. sampling times, gestational weeks and biological material from 
which cortisol is measured), infant’s age and inconsistent inclusion of possible 
confounders in the analyses as well as inconsistent reporting and inappropriate 
handling of missing data, thus making hard to disentangle the effects of maternal 
cortisol from the consequences of variability in study design and methodology. 
Salivary cortisol is considered a reliable measure of total free plasma cortisol and, 
compared to blood cortisol measures, allow to obtain ‘stress-free’ repeated samples 
over the day to picture the circadian rhythmicity of cortisol secretion. Furthermore 
multiple diurnal cortisol measures are thought to better capture individual variability in 
the HPA-axis functioning and to obtain more reliable estimates of global cortisol 
production (Adam & Kumari, 2009); however, only few studies have studied the role of 
variations in maternal diurnal cortisol pattern in fetal programming and none have 
examined possible associations with newborns’ stress reactivity soon after birth. 
Alternatives to an HPA-axis pathway in the link between antenatal maternal 
depression and offspring outcomes have not yet received considerable empirical 
support. While initial evidence exists for an association between an altered maternal 
SNS or IRS functioning during pregnancy and birth outcomes, very little is known 
about the potential role of maternal inflammation or diurnal variation in sAA levels in 
shaping infants stress reactivity.  
The current study sought to investigate the influence of naturally occurring 
variations in maternal depressive symptoms, stress hormones and inflammatory 
markers in late pregnancy on birth outcomes and early stress regulation in a sample of 
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healthy women and infants. To our knowledge, the present study is unique in the 
assessment of multiple biological markers of maternal stress and immune systems in 
association with infant outcomes. We evaluated newborns soon after birth in order to 
limit postnatal influences and we focused on late pregnancy, as exposure to maternal 
stress signals in late gestation is thought to influence the developing fetal stress 
response systems (Davis et al., 2011) and is associated with later risk for emotional 
problems (Rice et al., 2007). Furthermore, we tested the robustness of the effects of 
antenatal maternal depression on infant early outcomes, by investigating associations 
with possible overlapping predictors, such as maternal anxiety. Based on available 
literature, we hypothesized that higher maternal depressive symptoms during 
pregnancy would be associated with more negative birth outcomes and with greater 
stress reactivity in offspring. Furthermore, we predicted that variations in maternal 
diurnal cortisol pattern would be associated with newborns’ birth outcomes and stress 
resactivity. Conversely, analyses on possible associations between maternal antenatal 
inflammation or sAA levels and newborns’ birth outcomes and stress reactivity were 
exploratory and we made no a priori hypothesis due to limited available literature.  
 
4.3 Material and methods 
 
4.3.1 Participants  
Study participants included mother-infant dyads from the Effects of Depression 
on Infants (EDI) Study, an ongoing longitudinal investigation into the effects of 
maternal depression on infants’ bio-behavioral development. Women at 30-33 
gestational weeks were consecutively recruited in 3 Italian hospitals and followed 
longitudinally. Prenatal inclusion criteria were: aged 18-45 years, normotensive, with 
singleton uncomplicated pregnancy, non-smoker, not afflicted by any disease, not 
taking any chronic medications, and with no known substance/alcohol abuse problems 
or chronic psychiatric disorders (except for depression and anxiety). From the initial 
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sample of 110 women, 6 were excluded for reasons related to intrauterine death and 
newborn health problems (N= 2), delivery in a different hospital (N= 1) and lack of 
behavioral data (N= 3). Most women (mean age=33.04, SD=3.83) were Italian 
(97.1%), middle-high class (94.8%) and primiparous (89.4%). Infants (51.9% males) 
were mostly born by vaginal delivery (82.7%) and were full term, except for two born, 
respectively, at 35 and 36 gestational weeks in good health. Women who were 
excluded did not differ from participants on any demographic variables, depression or 
anxiety scores.  
 
4.3.2 Procedure 
All pregnant women filled in two questionnaires on anxiety and depression and 
a demographic and pregnancy information form between 30-33 gestational weeks 
(mean gestational age=31.45; SD=1.40) and provided biological samples between 34-
36 gestational weeks (mean gestational age=34.76; SD=1.12). Between 48-72 hours 
after delivery, infants’ behavioral and cortisol response to the heel-stick was assessed 
and women filled in a form on delivery and new-born’s health. The Ethics Committee 
of the Scientific Institute Eugenio Medea, of University College London, and of the 
hospitals involved approved the study protocol.  
 
4.3.3 Maternal assessment 
Psychological assessment. Maternal antenatal depressive symptoms were 
evaluated through the Italian version (Benvenuti et al., 1999) of the 10-item Edinburgh 
Postnatal Depression Scale (EPDS; Cox et al.,1987), a self-report questionnaires 
widely used to screen for perinatal depression. Maternal anxiety symptoms were 
assessed through the Italian version (Pedrabissi & Santinello, 1989) of the 20-item trait 
anxiety subscale of the State-Trait Anxiety Inventory (STAI-T; Spielberger et al., 1970), 
a well-validated self-report measure of trait anxiety, widely employed during pregnancy 
(e.g. Goedhart et al., 2010).  
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Health status. Both during pregnancy and after delivery, participants were 
asked to fill in an ad-hoc form to collect data on health, pregnancy (e.g. any 
complication/risk/medical disorder etc.) and delivery (e.g. length of labor, analgesia 
etc.). 
Biological assessment. Ninety-seven women out of 104 consented to blood 
draw. Blood was drawn by venipuncture in the morning and kept refrigerated at +4° 
until it reached the Biological Lab of Medea Institute where serum was centrifuged, 
aliquoted, and stored at −80°. Biological assays for IL-6 and CRP levels were run in 
duplicate by using Quantikine High Sensitivity ELISA kits (R&D Systems Europe, LTD) 
at LaboSpace in Milan according to the manufacturer’s instructions. Intra-assay 
coefficient of variation (CV) was <6% for IL-6 and <3% for CRP, inter-assay CV was 
<10% for both markers.  
Saliva was collected at home on two consecutive days immediately upon 
awakening, 30 minutes post-awakening and before going to bed to provide a general 
index of the diurnal pattern (O’Donnell et al., 2013). Participants were instructed to 
collect whole unstimulated saliva samples by passive drool, to record time of collection 
on a diary and to avoid eating, tooth-brushing and exercising 30 minutes before 
collection and eating a meal in the hour before the evening sample. The mean time 
from the awakening collection and the 30-minutes post-waking collection was 30.82 
minutes on day 1 (SD=3.64, range: 20.00-60.00) and 31.44 minutes on day 2 
(SD=6.81, range: 20.00-90.00). As 1 pregnant woman collected the second sample 
more than one hour from awakening, this sample was excluded from analyses (e.g. 
O’Donnell, 2013). All saliva samples were stored frozen at -80° until assayed for 
salivary cortisol at the Biological Lab of Medea Institute, using a competitive high 
sensitivity enzyme immunoassay kit (Expanded Range High Sensitivity Cortisol EIA 
Kit, Salimetrics), and for sAA at the Salimetrics Centre of Excellence testing lab at 
Anglia Ruskin University, using a kinetic enzyme assay kit (Salimetrics α-Amylase 
Kinetic Enzyme Assay Kit). All samples for each woman were run in the same assay to 
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minimize method variability. Salivary cortisol assays were run in duplicate, except for 2 
samples with minimal volume. Average intra- and inter-assay coefficients were <6% 
and <8%, respectively. A random 10% of the sAA assays were run in duplicate to 
confirm reliability. The intra-assay coefficient of variation was < 3%.  
 
4.3.4 Neonatal assessment 
Health and birth outcomes. Information on newborns’ health (i.e. gestational 
age, weight, body length and head circumference at birth, Apgar scores, any 
complication/abnormal sign, any medication/treatment, breast or formula feeding, time 
of discharge) was extracted from medical records.   
Behavioral assessment. Newborns’ behaviour was videotaped during 10-
minute baseline period, followed by the heel-stick and by 5-minutes recovery between 
48 and 72 hours after birth (mean=57.06; SD=12.15). The average length of the heel 
stick was 3.99 minutes (SD=2.32). Newborns’ videotaped behavior was evaluated 
every 20-seconds on a 5-point scale (i.e. sleep, drowsy, awake and alert, awake and 
fussy, and crying), according to a modified version of a coding system employed by 
Davis et al. (2011). The highest state observed during each epoch was coded. As the 
length of the heel-stick was variable, the first 2 minutes from the beginning of the blood 
draw were coded for all infants to ensure complete data for the whole sample. The 
average state score for each of the three phases (10-minutes baseline, 2-minutes 
response, 5-minutes recovery) was calculated. For approximately 10% of cases 
(N=10), two observers, independently coded newborn’s behaviour. Intra-class 
correlation was, respectively, equal to 1.0 for baseline, 0.99 for response and 0.99 for 
recovery. Coders were blinded to all prenatal or postnatal data. 
Cortisol collection and assay. Salivary cortisol samples were collected after the 
baseline period before the beginning of the heel-stick, and after 20 and 40 minutes 
through specifically designed swab (SalivaBio Infant’s Swab, Salimetrics). Infants were 
not fed in the 30 minutes before the heel-stick (mean time from last feeding=68.50 
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minutes, SD=50.05) and were not handled during the study protocol besides that 
which was strictly required for the examination. Complete cortisol data were available 
for 49 infants while one or two sample were missing for 30 infants and 25 infants had 
no data due to insufficient saliva volumes. Infants with complete, partial or missing 
data did not differ on any sociodemographic/maternal variables, infants-related 
variables or situational factors. Saliva samples were stored at -80º until assayed for 
cortisol according to the same procedure described for maternal cortisol. All samples 
from any individual infant were run on the same assay and in duplicate, excepted for 
10 samples with minimal volume. The average intra- and inter-assay coefficients of 
variance were below 7% and 10%, respectively.  
 
4.3.5 Statistical analyses 
Variables were first examined for outliers and skewness. Distributions of both 
maternal and infants’ biological markers were positively skewed even after removing 
samples greater than 3 SD from the mean (N=7 for maternal cortisol, N=4 for sAA, 
N=3 for IL-6, n=4 for infants’ cortisol), thus variables were natural log transformed to 
approximate normal distributions. Four summary parameters were calculated to index 
different aspects of maternal HPA and SNS diurnal functioning. Specifically, cortisol 
and sAA values were averaged across the 2 days for each time point and mean values 
were used to compute: awakening values, response to awakening (calculated by 
subtracting waking values from the 30min post-waking levels) and diurnal slope 
(calculated by subtracting the bedtime values from the waking values), as done in prior 
work (e.g. de Weerth et al., 2013). Additionally, daily average cortisol and sAA were 
calculated as the area under the curve (AUCg) using the trapezoid method with 
respect to the ground (Pruessner et al., 2003) for each day separately and, as the two 
values were highly correlated (r=.58, p<.001, for cortisol, r=.74, p<.001 for sAA), the 
mean of the 2 days was used. To evaluate the potential effect of variables known to 
affect stress and immune physiology, preliminary Pearson correlations and univariate 
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analysis of variance (ANOVA) were employed. All variables found to be significantly 
associated with the outcomes examined where included as covariates in all 
subsequent analyses.  
Separate hierarchical regression analyses were performed to evaluate the 
effects of maternal prenatal depression and biological markers on infant birth 
outcomes (i.e. birth weight, body length, and head circumference), while adjusting for 
covariates. Hierarchical Linear Models (HLMs) were estimated to investigate the 
influence of maternal depression and biological functioning during pregnancy on the 
trajectories of infants’ cortisol and behavioral reactivity, while accounting for the 
hierarchical structure of the data (three time-points nested within individuals). HLMs 
were specified at two levels where individuals were level 2 and time was level 1. Time 
was centered at baseline so that the model intercept represents the mean 
cortisol/behavioral state at baseline. Before fitting explanatory models including level-2 
predictors, a baseline model of cortisol and behavioral response was fitted to describe 
the trajectory of infants’ response, including a linear and quadratic slope for time. A 
random intercept and a random linear slope were included to allow between-person 
variability. The explanatory variables were centered around the grand mean and 
entered in the model one-by-one. Gender was centered at males. Model fit was tested 
with likelihood deviance difference tests for nested models.   
Given the high correlation between maternal depression and anxiety (r=.60, 
p<.001), an additional set of analyses were performed to evaluate the effects of 
maternal anxiety, rather than depression and are reported in Supplementary Section.   







4.4 Results  
 
4.4.1 Descriptive analyses and confounders 
Descriptive characteristics for all study variables are presented in Table 4.1, 
whereas correlations between prenatal variables, birth outcomes and stress reactivity 
are shown in Table 4.2.  
In a series of univariate correlation analyses we evaluated the associations 
between sociodemographic factors (maternal age, marital status, education and SES), 
pregnancy- and delivery-related factors (parity, mode of delivery, assisted delivery, 
length of labor), infant factors (gestational age, birth weight, gender, Apgar scores and 
postnatal age), situational factors (length of the heel-stick procedure, time of the day 
and time from last feeding) and newborn outcomes. Gestational age was associated 
with 20-min post-stressor cortisol levels (r=-.31, p=.02) and length of the heel-stick 
was positively related to both 20-min post-stressor cortisol levels (r=.30, p=.02) and 
averaged behavioral state during the response period (r=.20, p=.04). Thus, they were 
included as covariates in HLMs.  
Additionally, while infant’s sex was not related to cortisol or behavior, there was 
a significant association between fetal sex and maternal waking cortisol levels 
(F(101,1)=5.02, p=.03). As sex-differences in the association between prenatal 
distress and infant cortisol have also been reported (e.g. Giesbrecth et al., 2017), 
infant’s gender was included as a covariate in subsequent analyses. Furthermore, 
gestational age, sex and maternal pre-pregnancy BMI were associated with birth 
outcomes, with infants with higher gestational ages, males and born from mothers with 
higher BMI, having greater anthropometric measures (all ps<.05), and were included 






Table 4.1 - Descriptive statistics for study variables at the prenatal and postnatal 
assessment 
Study Variable Mean SD Range 
Prenatal    
Maternal cortisol (µg/dl)    
Waking 0.38 0.13 0.13-0.83 
Waking +30’  0.50 0.15 0.10-0.91 
Bedtime 0.18 0.06 0.01-0.41 
Response to waking 0.12 0.16 -0.52-0.52 
Diurnal slope 0.20 0.13 -0.12-.70 
AUCg 262.63 58.59 83.76-442.71 
Maternal sAA (U/ml)    
Waking 69.84 64.75 3.00-463.84 
Waking +30’  47.74 37.90 2.80-190.10 
Bedtime 99.14 80.95 3.28-562.71 
Response to waking -21.07 52.65 -350.94-119.97 
Diurnal slope -28.48 85.67 -405.11-298.32 
AUCg 3601.07 690.76 1777.74-5394.20 
Maternal CRP (ng/ml) 3730.16 2766.02 480.04-11244.10 
Maternal IL-6 (pg/ml) 1.68 1.04 0.48-6.47 
Maternal depression (EPDS) 5.41 4.44 0-19 
Maternal anxiety (STAI-T) 36.52 9.64 21-71 
Postnatal    
Gestational age (weeks) 39.48 1.25 35-42 
Birth weight (grams) 3296.83 443.27 2170-4440 
Body Length (cm) 50.08 1.88 45-54 
Head Circumference (cm) 34.48 1.30 31.50-39.50 
Newborns’ cortisol (µg/dl)    
Baseline  0.66 0.45 0.06-2.27 
20-min post-stressor  0.83 0.63 0.15-3.00 
40-min post-stressor 0.82 0.73 0.17-3.04 
Newborns’ behavior    
Baseline  2.15 1.16 1.00-4.63 
Response   3.69 1.10 1.00-5.00 
Recovery  2.47 1.17 1.00-4.80 
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Table 4.2 – Bivariate correlations among prenatal variables, birth outcomes and infant stress reactivity 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase; CRP, C-Reactive Protein; IL-6, Interleukine-6. 
* p<.05; **p<.01, 
t
 p=.06, p>.05 was considered non-significant. 
 1 2 3 4 5 6 7 8 9 10 11 12 13 
1. Prenatal EPDS              
2. Prenatal Cortisol 
AUCg  
-.17             
3. Prenatal sAA AUCg  .07 .24*            
4. Prenatal IL-6 .20* .13 .19           
5. Prenatal CRP .13 .11 -.01 .31**          
6. Birth weight  .11 -.03 .18
t
 .03 .24*         
7. Body length .06 -.05 .08 -.03 .14 .90**        
8. Head Circumference .16 .02 .06 -.18 .09 .63** .59**       
9. Cortisol baseline -.22
t
 .01 -.00 -.10 .06 .14 .11 .05      
10. Cortisol post 20’ -.08 -.03 .04 -.14 -.14 -.02 -.06 .03 .27     
11. Cortisol post 40’ -.08 .04 -.02 -.07 .04 -.06 -.08 .00 .01 .80**    
12. Behavioral baseline -.00 .09 .01 -.01 .02 -.01 .00 -.13 .31** .21 .17   
13. Behavioral response -.10 -.05 .11 -.06 -.09 .13 .07 .08 .00 .21 .03 .01  
14. Behavioral recovery -.16 .12 .10 .02 -.07 .11 .13 .08 .12 .30* .11 .14 .51** 
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4.4.2 Association between maternal prenatal variables and birth outcomes 
As shown in Table 4.3, multiple hierarchical regression analyses revealed 
significant associations between both higher maternal sAA waking and AUCg levels 
and higher infant weight at birth, as well as between higher IL-6 levels and smaller 
head circumference at birth, after controlling for pre-pregnancy BMI, infant’s sex, and 
gestational age. No significant associations between maternal cortisol or maternal 
depression and any birth outcomes were found. 
 
4.4.3 Association between maternal prenatal variables and newborns’ cortisol 
reactivity 
The unconditional means model for newborns cortisol showed significant 
variability at the individual level (level-2; σ2u0=0.042, p<.001) and between-occasions 
(level-1; σ2e0=0.057 p<.001). Infants displayed the expected cortisol response 
characterized by a significant linear slope of time (p=.03), and a marginally significant 
quadratic slope (p=.07). Also the random linear slope term was statistically significant 
(p<.001), suggesting significant between-person variability in the cortisol linear 
increase. Overall, this model resulted in a significant improvement in fit over the 
unconditional means model (deviance difference (4)=37.50, p<.001).   
Fixed independent effects of prenatal variables (i.e. depression, cortisol, sAA, 
CRP and IL-6) on mean cortisol baseline levels and on the linear and quadratic slopes 
of time were tested separately, while controlling for gestational age, infant’s sex and 
length of the heel-stick.  
As shown in Table 4.4, maternal cortisol response to awakening (CAR) was 
significantly associated with both the linear (p=0.012) and quadratic (p=.013) slopes of 
newborn’s cortisol response. Specifically, as shown in Figure 4.1a, higher maternal 
CAR during pregnancy was related to a flatter cortisol response to the heel-stick, while 




Table 4.3 – Hierarchical linear regression analyses predicting weight and head circumference at birth 
Note: AUCg, area under the curve with respect to the ground; sAA, salivary alpha amylase; BMI, Body Mass Index;  
 
 
 Birth Weight Head Circumference 
 Cortisol AUCg sAA AUCg sAA waking IL-6 CRP 
Cortisol 
AUCg 
sAA AUCg IL-6 CRP 
 β p β p β p β p β p β p β p β p β p 
Step 1:                    
Gender -.19 .03 -.18 .04 -.18 .04 -.13 .17 -.14 .14 -.17 .08 -.17 .08 -.10 .34 -.14 .19 
Pre-pregnancy 
BMI 
.23 .01 .22 .01 .22 .01 .16 .09 .19 .05 .20 .04 .19 .06 .11 .30 .12 .27 
Gestational Age .41 .00 .40 .00 .40 000 .43 .00 .42 .00 .24 .01 .23 .02 .27 .01 .25 .02 
ΔR
2
 for step 1 .28 .00 .26 .00 .26 .00 .25 .00 .24 .00 .15 .00 .14 .00 .11 .03 .10 .03 
Fmodel 13.14 .00 12.50 .00 12.50 .00 9.70 .00 9.64 .00 5.28 .00 5.03 .00 3.26 .03 3.25 .03 
Step 2:                    
EPDS .12 .14 .14 .10 .14 .10 .13 .16 .15 .11 .12 .20 .15 .12 .15 .16 .16 .12 
ΔR
2
 for step 2 .01 .14 .02 .10 .02 .10 .02 .16 .02 .11 .01 .20 .02 .12 .02 .16 .02 .12 
Fmodel 10.51 .00 10.21 .00 10.21 .00 7.85 .00 8.01 .00 4.41 .00 4.44 .00 2.97 .02 3.08 .02 
Step 3:                    
Biological 
predictors 
-.06 .46 .18 .03 .17 .05 -.06 .52 .09 .36 -.09 .35 .02 .82 -.33 .00 -.01 .96 
ΔR
2
 for step 3 .00 .46 .03 .03 .03 .05 .00 .52 .01 .36 .01 .35 .00 .82 .10 .00 .00 .96 
Fmodel 8.48 .00 9.36 .00 9.18 .00 6.32 .00 6.56 .00 3.70 .00 3.53 .01 4.62 .00 2.43 .04 
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 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 0.508 (0.039) <.001 0.508 (0.038) <.001 0.504 (0.038) <.001 0.505 (0.046) <.001 
Gender -0.053 (0.052) 0.31 -0.050 (0.051) 0.32 -0.046 (0.050) 0.36 -0.051 (0.051) 0.32 
Gestational Age -0.022 (0.019) 0.25 -0.025 (0.020) 0.21 -0.027 (0.019) 0.16 -0.021 (0.020) 0.29 
Heel-stick length 0.001 (0.011) 0.98 0.001 (0.010) 0.93 0.004 (0.011) 0.69 0.001 (0.011) 0.91 
EPDS  -0.075 (0.040) 0.06 -0.068 (0.038) 0.08 -0.063 (0.039) 0.11 -0.071 (0.040) 0.08 
Cortisol -0.135 (0.315) 0.66 0.245 (0.253) 0.33 0.337 (0.286) 0.24 0.000 (0.001) 0.94 
Linear -0.005 (0.008) 0.54 0.008 (0.003) <.001 0.013 (0.005) 0.01 0.003 (0.003) 0.27 
EPDS  0.002 (0.003) 0.47 0.001 (0.003) 0.59 0.001 (0.003) 0.77 0.001 (0.003) 0.73 
Cortisol 0.029 (0.023) 0.20 -0.042 (0.017) 0.01 0.035 (0.020) 0.08 -0.000 (0.000) 0.48 
Quadratic 0.000 (0.000) 0.41 -0.000 (0.000) <.001 -0.000 (0.000) 0.02 -0.000 (0.000) 0.51 
EPDS  -0.000 (0.000) 0.65 -0.000 (0.000) 0.79 -0.000 (0.000) 0.94 -0.000 (0.000) 0.95 
Cortisol -0.001 (0.000) 0.17 0.001 (0.000) 0.01 0.001 (0.000) 0.09 0.000 (0.000) 0.32 
Random effects         
Level 2 (individual)         
Intercept variance 0.034(0.010) <.001 0.036(0.010) <.001 0.034(0.010) <.001 0.034(0.010) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.000(0.000) 0.09 -0.001(0.000) 0.07 -0.000(0.000) 0.07 -0.000(0.000) 0.09 
Level 1 (occasions)         
Intercept variance 0.022(0.005) <.001 0.020(0.004) <.001 0.022(0.005) <.001 0.022(0.005) <.001 
Note: Cortisol diurnal indices are examined separately in Model 1-4. CAR, cortisol awakening response, AUCg, area under the curve with respect to the ground; 
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The inclusion of maternal CAR resulted in a significant improvement in the 
model fit (deviance difference (3)=9.173, p=.02). In contrast, there was no significant 
association between newborns’ cortisol response and maternal sAA, IL-6 or CRP 
levels.  
 
4.4.4 Association between maternal prenatal variables and newborns’ behavioral 
reactivity 
The unconditional means model for newborns behavioral regulation showed 
significant variability between-occasions (level-1; σ2e0=0.136, p<.001), while variability 
at the individual level was not significant (level-2; σ2u0=0.006, p=.47). There was a 
significant behavioral change in response to the heel-stick, as indexed by the 
significant linear and quadratic slopes of time (both ps<.001). The random linear slope 
term was statistically significant (p<.001), suggesting significant between-person 
variability in the behavioral linear increase. Additionally, the significant positive 
association (p=.013) between the random effects of intercept at level-2 and the linear 
slope indicates that there was a greater increased in the behavioral state in response 
to the heel-stick in individuals with higher behavioral states at baseline. Overall, this 
model results in a significant improve of the fit over the unconditional means model 
(deviance difference (4)=106.46, p<.001).   
Fixed independent effects of prenatal variables on mean behavioral state at 
baseline and change over time were tested separately, while controlling for covariates. 
Maternal diurnal slope was significantly associated with both the linear (p=.02) and 
quadratic (p=.05) slopes of newborns’ behavioral response (Table 4.5). Specifically, as 
shown in Figure 4.1b, a lower maternal cortisol diurnal slope was associated with 
greater behavioral reactivity in the infant, while a higher maternal diurnal slope was 
related to a less marked behavioral reactivity. The inclusion of maternal diurnal slope 














 Estimate (SE) p Estimate (SE) p Estimate (SE) p Estimate (SE) p 
Fixed effects         
Intercept 1.086 (0.040) <.001 1.090 (0.040) <.001 1.086 (0.040) <.001 1.086 (0.040) <.001 
Gender 0.001 (0.046) 0.99 0.001 (0.046) 0.99 0.004 (0.046) 0.98 0.008 (0.046) 0.86 
Gestational Age 0.020 (0.018) 0.28 0.014 (0.019) 0.46 0.020 (0.018) 0.23 0.022 (0.019) 0.22 
Heel-stick length 0.009 (0.010) 0.39 0.011 (0.010) 0.24 0.009 (0.010) 0.36 0.012 (0.010) 0.21 
EPDS  0.002 (0.046) 0.96 0.003 (0.046) 0.95 0.003 (0.046) 0.95 0.008 (0.047) 0.86 
Cortisol 0.180 (0.380) 0.63 0.264 (0.322) 0.41 0.274 (0.353) 0.44 0.001 (0.001) 0.35 
Linear 0.047 (0.008) <.001 0.029 (0.003) <.001 0.038 (0.004) <.001 0.048 (0.011) <.001 
EPDS  -0.002 (0.003) 0.50 -0.001 (0.003) 0.79 -0.002 (0.003) 0.56 -0.002 (0.003) 0.56 
Cortisol -0.055 (0.025) 0.03 -0.003 (0.022) 0.88 -0.056 (0.024) 0.02 -0.000 (0.000) 0.08 
Quadratic -0.000 (0.000) <.001 -0.000 (0.000) <.001 -0.001 (0.000) <.001 -0.001 (0.000) <.001 
EPDS  0.000 (0.000) 0.83 -0.000 (0.000) 0.92 0.000 (0.000) 0.90 0.000 (0.000) 0.86 
Cortisol 0.001 (0.000) 0.07 0.000 (0.000) 0.92 0.001 (0.000) 0.05 0.000 (0.000) 0.07 
Random effects         
Level 2 (individual)         
Intercept variance 0.058(0.017) <.001 0.056(0.017) <.001 0.058(0.017) <.001 0.058(0.017) <.001 
Linear slope variance 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 0.000(0.000) <.001 
Intercept/Linear slope    
covariance 
-0.001(0.000) .01 -0.001(0.000) .01 -0.001(0.000) .01 -0.001(0.000) .01 
Level 1 (occasions)         
Intercept variance 0.055(0.008) <.001 0.057(0.008) <.001 0.055(0.008) <.001 0.056(0.008) <.001 






Figure 4.1 – a) Cortisol values before and after the heel-stick for newborns whose mothers had higher (+1 SD) and lower (-1SD) cortisol 
awakening response (CAR), after adjusting for covariates; b) Averaged behavioural state before, during and after the heel-stick for newborns 






Additionally, maternal cortisol at awakening was significantly associated with 
the linear slope of newborns’ response (p=.03), with lower levels of cortisol being 
associated with a steeper increase in behavioral response to the heel-stick, while 
higher levels of cortisol were related to a flatter increase. However, the inclusion of 
maternal cortisol at awakening did not significantly improve the model fit (deviance 
difference (3)=6.34, p=.10). Maternal depressive symptoms, diurnal sAA or 
inflammatory markers were not significantly associated with infants’ behavioral 
regulation.  
 
4.4.5 Supplementary analyses  
The set of analyses run to test the effects of maternal anxiety on newborns’ 
cortisol and behavioral reactivity yielded comparable results to those found for 
maternal depression. Specifically, no significant main effect for maternal anxiety on 
newborns’ cortisol and behavioral response was found (all ps>.05). In addition, 
including maternal anxiety, rather than depression, did not change the direction and 
significance of the effects of maternal diurnal cortisol measures on newborns’ cortisol 





Findings from the present study extend available literature by showing that 
variations in maternal diurnal cortisol in the last trimester of pregnancy are related to 
specific newborns’ behavioural and physiological patterns of stress reactivity soon 
after birth, in line with our hypothesis. Furthermore, the current results add to the 
limited literature on alternative biological mechanisms involved in fetal programming, 
by highlighting significant associations between variations in markers of maternal SNS 
and IRS functioning and birth outcomes in a low risk sample of mother-infant dyads. In 
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contrast with our predictions, maternal self-reported depressive or anxiety symptoms 
during pregnancy were not related with newborn’s birth outcomes or stress reactivity.  
 
4.5.1 Prenatal maternal factors and birth outcomes 
Markers of maternal IRS and SNS functioning during pregnancy were 
significantly associated with newborns’ anthropometric measures, such as head 
circumference and birth weight. Unexpectedly, however,maternal diurnal cortisol levels 
and self-reported distress symptoms were not related to any birth outcomes.      
The significant association between higher prenatal maternal IL-6 levels and 
smaller head circumference at birth is a novel finding. While observational 
epidemiological studies report that maternal infections during pregnancy – which 
activate IRS - are associated with increased risk of neuropsychiatric disorders, such as 
schizophrenia, in the resulting offspring (Estes & Mcallister, 2016), the extent to which 
there is a programming effect of maternal cytokines is unknown. Head circumference 
is considered a marker for intrauterine brain development and is associated with later 
cognitive function (Broekman et al., 2009a). Thus, our findings are consistent with 
results from animal studies (e.g. Meyer et al., 2006) and preliminary brain imaging 
studies in human infants (Grahman et al., 2017; Rasmussen et al., 2018) suggesting 
that maternal inflammation can affect fetal growth and neural development. Whether 
directly transferred through the placenta or indirectly affecting the fetal development 
through placental inflammation, elevated cytokines are hypothesized to act at multiple 
levels of the fetal brain, affecting neurogenesis, gliogenesis and the neurotransmitter 
systems (reviewed in Rakers et al., 2017). An alternative mechanism is that epigenetic 
mechanisms could mediate the impact of prenatal maternal inflammation on fetal brain 
development with potentially long-lasting effects as suggested by results of animal 
studies (Kundakovic & Jaric, 2017). Future efforts are needed to elucidate the role of 




Interestingly, consistently with previous findings (reviewed in Osborne & Monk, 
2013), we reported a positive association between IL-6 levels and depressive 
symptoms in a low risk sample of pregnant women free from any medication or 
medical conditions. This result is in line with accumulating evidence for a role of 
inflammation in the vulnerability for depression in non-pregnant samples (Miller & 
Raison, 2016) and encourages further research into a possible inflammatory pathway 
from depression to altered offspring outcomes. However, it is important to note that, 
contrary to our initial hypothesis, depressive symptoms were not associated with 
newborns’ birth outcomes. This is consistent with  studies on low risk samples showing 
null or weak associations between prenatal continuous depression measures and 
adverse birth outcomes (reviewed in Grote et al., 2010). Furthermore, a systematic 
review showed that antenatal depression is rarely associated with newborn’s 
gestational age and birth weight in larger studies and in studies where potential 
confounders of the association, such as sociodemographic variables, timing of delivery 
and pre-pregnancy maternal BMI, are taken into account (Accort et al., 2015). Thus, 
we might speculate that the association between antenatal depression and birth 
outcomes is spurious and might arise from the combination of multiple risk factors. 
Research on high-risk samples are needed to further elucidate the link between 
prenatal depression, IRS functioning and birth outcomes.   
Exploratory analyses showed that higher maternal prenatal sAA levels at 
awakening and throughout the day were associated with higher infant birth weight. Our 
findings are partially in line with the only published study on the link between maternal 
sAA and birth outcomes (Giesbrecht et al., 2015), which showed an association 
between greater birth weight and higher maternal sAA waking levels and decrease 
after waking. Replication in larger cohorts is needed before the significance of these 
preliminary findings can be discussed. We might speculate that mild elevations in 
maternal sAA indicate an increased involvement of the SNS to ensure maternal and 
fetal energetic resources for growth during late normative pregnancy. This hypothesis 
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is in line with evidence (e.g. DiPietro et al., 2011), suggesting that adjustments in 
maternal neuroendocrine functioning over gestation are mainly generated and 
supported by the feto-placental unit, within a bi-directional communication. 
Lastly, in contrast with previous studies (e.g. Buss et al.,2009, Bolten et al., 
2011, Kivlighan et al., 2008) and with our initial hypothesis, maternal diurnal cortisol 
levels in late pregnancy were not associated with infants’ birth outcomes. Notably, in 
the majority of studies reporting a significant link between maternal cortisol and lower 
birthweight, cortisol was assessed in early-mid pregnancy (reviewed in Reynolds et al., 
2013). Thus, it is possible that a critical window of susceptibility for setting foetal 
growth trajectory, and for a role of HPA axis in influencing it, occurs early in gestation. 
Additionally, while animal studies provided strong support for a role of maternal HPA 
axis in determining fetal growth (see Cottrell & Seckl, 2009 for a review), a number of 
large studies in humans failed to detect a significant association between maternal 
cortisol and birth outcomes, once the model was adjusted for significant covariates, 
such as gestational age (e.g. Goedhart et al., 2010; Li et al., 2012; Gilles et al., 2018). 
Likewise, even among those studies detecting significant associations between 
maternal antenatal cortisol and birth weight, correlations were relatively weak, 
suggesting that maternal cortisol is only one factor contributing to infant birth weight 
among many others including gestational age, pregnancy complication and placental 
conditions. Further research is needed to disentangle the complex interplay of factors 
that contribute to low birth weight infants. 
 
4.5.2 Prenatal maternal factors and newborns’ stress reactivity 
Infants displayed the expected increase in cortisol levels and behavioural 
distress in response to the heel-stick in the neonatal period. In line with our 
hypotheses, findings support a role of variations in maternal diurnal cortisol rhythm, 
and in particular in maternal CAR and diurnal slope, during late pregnancy in 
influencing offspring’s stress reactivity soon after birth. However, maternal self-
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reported depressive symptoms, sAA diurnal levels and inflammatory markers were not 
significantly associated with newborn’s stress response at the heel-stick.  
Maternal CAR was related to newborns’ cortisol reactivity, with infants 
prenatally exposed to a higher maternal CAR showing a flatter cortisol response to 
stress. Only two studies have examined the role of maternal prenatal CAR on infant 
stress reactivity. In line with our findings, Giesbrecht et al. (2017) reported a significant 
association between a higher maternal CAR and blunted cortisol reactivity in 3-month 
old boys, whereas De Weerth et al. (2013) related a higher maternal CAR to impaired 
infants’ cortisol habituation, as shown by a stable cortisol response over repeated 
maternal separations. Despite methodological differences, these preliminary findings 
might suggest that prenatal exposure to higher maternal CAR might impair the infants’ 
capacity to flexibly react to stress. 
Maternal cortisol diurnal slope during pregnancy was significantly associated 
with newborns’ behavioral response to the heel-prick, with a smaller decline in 
maternal cortisol levels throughout the day being associated with greater infant 
behavioral reactivity. These findings are novel; while previous studies have shown 
greater behavioral stress reactivity in infants prenatally exposed to higher maternal 
cortisol (e.g. Davis et al., 2011; Werner et al., 2013), none of these studies included 
diurnal cortisol measures.  
Both the CAR and diurnal slope are key components of the diurnal cortisol 
rhythm that are relatively preserved and sensitive to psychological distress during 
pregnancy (Kivlighan et al., 2008). However, their role in fetal programming is still 
largely unknown. Thus, it is unclear why different measures of maternal diurnal cortisol 
relate to different aspects of infants stress reactivity (i.e. physiological or behavioral). 
Interestingly, in line with previous reports (e.g. De Weerth et al., 2013) maternal CAR 
and cortisol decline were moderately correlated, with higher CARs being related to 
flatter cortisol declines. Therefore, it would seem that an alteration of maternal diurnal 
cortisol pattern is, to a certain extent, associated with both a dampened cortisol 
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reactivity and an amplified behavioral response to stress in the infants soon after birth. 
As a lack of coordination between adrenocortical and behavioral responses has been 
associated with later psychopathology (e.g. Quas et al. 2000), it would be important to 
evaluate whether neonatal profiles of reactivity persist and are predictive of later 
patterns of stress reactivity and later emotional or behavioral dysregulation.  
Questions remain about the mechanisms underlying the associations between 
diurnal variation in maternal cortisol diurnal measures and patterns of infants’ stress 
reactivity. On the one hand, we might speculate that both a higher than typical CAR or 
a flatter cortisol diurnal decline might result in higher fetal cortisol exposure and 
potentially alter the set-point of fetal stress response systems. Consistently with this, 
animal studies suggest that the rise in glucocorticoids at the circadian peak saturates 
the 11β-HSD2 enzyme, leading to greater placental transfer of maternal 
glucocorticoids to the fetus (Venihaki et al., 2000). Alternatively, while the stress 
reactivity patterns observed a few hours after birth can be considered largely 
independent of postnatal influences, hereditary transmission might still explain the 
observed associations, with mother-infant shared genes accounting for variation in 
both maternal diurnal cortisol patterns and newborns’ stress response (e.g. Van Hulle 
et al., 2012).  
Some non-significant results are worth mentioning. First of all, differently from 
what we hypothesized, we did not find any effect of maternal depressive symptoms on 
infants’ stress regulation. This result, however, is in line with several studies (e.g. 
Stroud et al., 2016; Braithwaithe et al., 2016; Thomas et al., 2017) and with the results 
of a recent systematic review (Bleker et al., 2013). In particular, the majority of studies 
included in the review (N=10 among 13) failed to detect any independent association 
between maternal antenatal depression and children’s stress reactivity (Bleker et al., 
2018). In contrast, a considerable amount of studies do find an association when 
moderating or mediating factors involving especially the quality of postnatal 
environment were taken into account (e.g. Sharp et al., 2016; Laurent et al., 2011), 
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thus suggesting that the fetal stress response system are not affected by prenatal 
exposure to maternal depression per se but rather by a complex combination of 
prenatal and postnatal exposures. We might speculate that the effects of prenatal 
maternal depression on offspring’s stress reactivity might emerge later in development 
(O’Donnell et al., 2013) and these might be the result of the interplay between prenatal 
and postnatal maternal influences. However, methodological reasons might also 
explain this null finding, including the limited sample size whichmight have reduced the 
chance to detect a true effect, and the possibility that variations in depressive 
symptoms in a low-risk sample have little to no effect on the developing foetus, as 
compared to stronger exposures (e.g. Vedhara et al., 2012). Secondly, consistent with 
prior work (e.g. Davis et al., 2011; Baibazarova et al., 2013) maternal prenatal cortisol 
and depressive symptoms were not significantly associated, thus calling into question 
the role of cortisol as a mediator of maternal distress on fetal development. It is 
possible that the HPA axis-resetting occurring during pregnancy might overcome our 
ability to identify significant associations between endocrine and self-reports stress 
measures. Or, it is also plausible that relatively low levels of depression do not 
significantly affect the HPA axis regulation.  
Our exploratory analyses do not support alternatives to an HPA-axis mediated 
mechanism, involving the SNS and the IRS in influencing newborns’ stress reactivity. 
While animal studies consistently showed that prenatal exposure to maternal 
inflammation could impact the fetal stress response systems, leading to altered stress 
reactivity in adulthood (e.g. Samuelsson et al., 2004), to our knowledge, only Osborne 
and colleagues (2018) have investigated the role of maternal prenatal inflammation in 
influencing offspring’s stress reactivity. The authors reported unadjusted positive 
correlations between higher levels of maternal inflammatory markers in late pregnancy 
and infant higher cortisol levels in response to the immunization at 12 months of age. 
However, it is important to note that, although the sample size was comparable to the 
current one, findings were based on a sample of clinically depressed women. It is 
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possible that levels of maternal inflammation during healthy pregnancy in a low risk 
sample might not have been high enough to significantly influence fetal development, 
thus explaining the lack of significant findings in the current study. Alternatively, 
differences in infant’s age at the assessment might account for discrepancies in 
findings. Noteworthy, Osborne and colleagues (2018) did not find any difference in 
infant’s cortisol reactivity at 2 months of age between cases and controls, however 
they did not report data on possible associations among maternal antenatal 
inflammation and offspring’s stress reactivity at 2 months of age. Further replication of 
the current findings in different cohorts is needed.  
Similarly, the current study did not provide evidence of an association among 
prenatal maternal sAA levels and newborns’ stress reactivity. Only two published 
studies have thus far examined this association, reporting significant links between 
maternal sAA levels in early-mid gestation and, respectively, 2-month-olds’ negative 
emotionality (Braithwaite, Murphy, et al., 2017) and 6-month-olds stress-reactivity 
profiles (Rash et al., 2016), while no significant links were found in late pregnancy 
(Rash et al., 2016). Future research should investigate whether, as a consequence of 
changes in placental physiology and in plasticity of physiological systems, distinct 
biological mechanisms might become more prominent in influencing the developing 
fetus across gestation.  
 
4.5.3 Limitations 
Despite the strengths of the present study, including a prospective design, the 
assessment of multiple biological markers, the inclusion of confounders and the 
neonatal assessment soon after birth, the interpretation of findings should be cautious 
due to several limitations. First, data are based on a relatively small middle-high SES 
community sample evaluated in late pregnancy and levels of self-reported depressive 
symptoms were relatively low, thus limiting generalizability of results to high-risk 
populations and different gestational windows. Secondly, maternal salivary samples 
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were collected at home and compliance with the protocol was not objectively 
measured. Third, as previously reported (Egliston, McMahon, & Austin, 2007), 
obtaining sufficient saliva volumes from newborns was a challenge, thus leading to 
limited sample size for cortisol analyses. HLMs were employed in order to maximize 
the number of infants included in the final analyses and obtain reliable estimates of 
effects despite missing values for one or more time-points.  Additionally, it cannot be 
excluded that newborns’ cortisol reactivity might be masked by a still-unresolved 
cortisol response to delivery although duration of labor and mode of delivery were 
unrelated to infants’ cortisol levels.  
Lastly, as we did not use a relevant genetically informative design (Rice et al., 
in press) and the study is observational, we cannot rule out possible pleiotropic effects 
of shared genes which both influence maternal stress levels and infants’ outcomes, as 
well as unmeasured confounding and causal inferences cannot be drawn.   
 
4.6 Conclusions 
Taken together, the current results suggest that antenatal factors, related to 
alterations in maternal stress and immune response systems, are involved in 
supporting fetal growth and development with possible implications for later outcomes. 
However, the weak or null association between self-reported depressive symptoms 
and biological measures underlines the incomplete picture of the mechanisms through 
which prenatal depression may be transmitted to the foetus, affecting later 
developmental outcomes, and highlights the needs for further research into alternative 
stress mechanisms largely neglected until now. We believe that a better understanding 
of the complex pathways underlying fetal programming will not only improve our 
knowledge of typical and atypical fetal development but will also have important 




Chapter 5: Prenatal maternal influences on infant 
stress reactivity, temperament and psychomotor 





The potential for events experienced early in life to impact the long-term 
developmental trajectories has long been known. Evidence from animal studies 
indicate that induced stress during pregnancy can adversely affect fetal development, 
in a process often described as fetal programming (Seckl & Holmes, 2007), resulting in 
altered behavioral and physiological outcomes, including impaired stress regulation 
and delay in motor and cognitive development (reviewed in Weinstock, 2008), that 
persist into adulthood. In humans, there is also initial evidence of a link between 
antenatal exposure to maternal stress, in particular maternal depression, and 
heightened risk for a wide range of negative neurodevelopmental outcomes (for a 
review see Van den Bergh et al., 2017). More specifically, a number of reports have 
found poorer performances on the Neonatal Behavioral Assessment Scale soon after 
birth (e.g. Osborne et al., 2018), lower cognitive performance at later assessments 
(e.g. Bergman et al., 2007), increased fearfulness (e.g. Bergman et al., 2007) and 
negative affectivity (e.g. Glynn et al., 2018; Rouse & Goodman, 2014) in infants of 
prenatally depressed mothers. Additionally, some prospective studies relate prenatal 
exposure to maternal depression to an altered HPA-axis regulation in offspring (e.g. 
Laurent et al., 2013; Waters et al., 2013; Brennan et al., 2008), although a number of 
reports have failed to detect any significant association (e.g. Davis et al., 2011; 
Braithwaite et al., 2016; Tollenaar et al., 2011). The association between prenatal 
depression and a wide range of child developmental outcomes, including stress 
reactivity, temperament and cognition, appears to be independent of postnatal 
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maternal mood or relevant demographic characteristics (e.g. Davis et al., 2004; 
Connor et al., 2002; Glynn et al., 2018). In addition, although literature on possible 
genetic basis of the association among antenatal stress and child development is still 
limited, preliminary studies using genetically informed design have begun to 
disentangle environmental and genetic contributions and have provided initial 
evidence suggesting that some of the reported associations, though not all, are at 
least partially independent from genetics (e.g. Rice et al., 2010). Furthermore, 
although the correlational nature of the majority of the above mentioned findings 
preclude causal inferences, results concur with experimental animal models showing 
that prenatal stress exposure is associated with altered physiological, behavioral and 
cognitive outcomes (Frasch et al., 2018; Marta Weinstock, 2017). Given the relevance 
of these milestones for later health and development, early difficulties in stress 
regulation and neuromotor delays can lay the foundations for subsequent behavioral 
and cognitive problems (e.g. Dougherty et al., 2009; Gunnar & Vazquez, 2001; Olson 
et al., 2005).  
Despite a growing body of evidence linking antenatal depression to negative 
outcomes in offspring, little is known about the biological mechanisms that underlie 
these effects in humans. In the last decades, the attention of scholars has been mainly 
directed toward the mediating role of the hypothalamic–pituitary–adrenal (HPA) axis in 
programming fetal brain and behavior. More specifically, as extensively described in 
Chapter 1, it is hypothesized that mood-related increased levels of maternal cortisol 
might cross the placenta in a quantity sufficient to affect fetal development with long-
lasting consequences on offspring’s behavior and physiology (Seckl & Meaney, 2004). 
Well-established evidence from animal models indicates that prenatal over-exposure 
to glucocorticoids can affect most regions of the developing fetal brain, including 
regions involved in the regulation of emotion, stress and cognitive functions, resulting 
in enduring alterations in offspring stress regulation (e.g. Abe et al., 2007), increased 
fearful or inhibited behaviors in response to challenges (e.g. Dickerson et al., 2005) 
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and neuromotor deficits (e.g. Schneide et al., 1999). Consistent with the hypothesized 
role of glucocorticoids in these associations is the observation, in humans, that 
prenatal exposure to synthetic glucocorticoids is associated with impaired infant HPA 
axis regulation (e.g. Davis et al., 2011; Erni et al., 2012), temperamental difficulties, 
such as behavioral inhibition or fearful behaviors in response to novelty (Trautman, 
Meyer-Bahlburg, Postelnek, & New, 1995), and neurodevelopmental delays (Spinillo et 
al., 2004; Wapner et al., 2007). However, only a handful of studies in humans has 
explored the link between antenatal maternal endogenous cortisol and child’s 
neurodevelopmental outcomes such as temperament, stress reactivity and cognition, 
yielding to mixed findings (reviewed in Zijlmans, Riksen-Walraven, & de Weerth, 
2015).  
Specifically, evidence for an association between maternal stress hormones 
during pregnancy and infants’ temperamental traits is scarce. Two large high quality 
studies demonstrated that maternal afternoon cortisol (Davis et al., 2007) and 
corticotropin-releasing hormone (CRH; Davis et al., 2005) during late pregnancy, but 
not earlier, were associated with maternal reports of increased negative reactivity in 2-
month-olds (Davis et al., 2005). Likewise, Werner and colleagues (2013) showed that 
maternal morning cortisol in late pregnancy was positively associated with observer-
rated reactivity to novelty in 4-month-old infants. However, a fair number of studies 
have failed to find any significant association between maternal prenatal cortisol both 
in early and late pregnancy and infant temperament as assessed either through 
maternal or observer reports (Rouse & Goodman, 2014; Buitelaar et al., 2003; 
Braithwaite, Murphy, Ramchandani, & Hill, 2017; Rothenberger et al., 2011). Similarly, 
amniotic fluid cortisol was not found to be related to fear reactivity at 17 months 
(Bergman et al., 2010) or to fear and distress to limitations at 3 months (Baibazarova 
et al., 2013). However, the majority of these studies rely on single maternal cortisol 
sampling (e.g. Davis et al., 2007; Werner et al., 2013) and a few studies did not control 
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for possible confounders of the association (e.g. Rothenberger et al., 2011; Buitelaar 
et al., 2003).  
Likewise, a limited number of prospective studies have investigated the 
association between antenatal maternal cortisol and offspring’s cortisol reactivity with 
inconsistent results. Higher maternal cortisol during pregnancy has been associated 
with greater cortisol and behavioral reactivity from early after birth through the 
preschool years in a number of studies (Davis et al., 2011; Gutteling, De Weerth, & 
Buitelaar, 2005; Werner et al., 2013b), but not all (e.g. Tollenaar et al., 2011; 
Braithwaite et al., 2016). Additionally, a link between elevated cortisol levels during 
pregnancy and a blunted cortisol response to stress in the offspring has been reported 
in a few studies (O’Connor et al., 2014; Giesbrecht, et al., 2017).  
Even preliminary evidence for a link between maternal cortisol during 
pregnancy and infant motor and mental development in humans is inconclusive. 
Higher maternal cortisol in late pregnancy, but not in early or mid-gestation, has been 
found to predict lower cognitive development at 3 months (Huizink et al., 2003; 
Buitelaar et al., 2003), 17 months (Bergman et al., 2010) and 7-year-olds (Lewinn et 
al., 2009), but not at 8 months (Huiznik et al., 2003; Buitelaar et al., 2003). 
Remarkably, methodological rigorous work from Davis and Sandman (2010) on a low 
risk sample of 125 full-term infants, reported an opposite effect of prenatal maternal 
cortisol on infants’ cognitive development based upon the timing of exposure. More 
specifically, higher maternal cortisol early in gestation was related to lower mental 
development at 12 months, while elevated maternal cortisol in late pregnancy 
predicted higher mental development. In line with these findings, more recently, the 
authors found higher maternal cortisol in late pregnancy, but not earlier, to predict 
greater cortical thickness in frontal regions and better cognitive functioning in 6-9 year-
olds children (Davis, Head, Buss, & Sandman, 2017). Additionally, while Huizinik and 
colleagues (2003) reported a significant association between higher maternal cortisol 
in late pregnancy and infants’ lower motor development at 3 and 8 months, other 
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studies with similar sample sizes failed to find any significant association between 
maternal cortisol and motor outcomes (Bergman et al., 2010; Davis & Sandman, 
2010). 
Collectively, weak evidence exists for an association between maternal 
prenatal cortisol and physiological, behavioral and cognitive outcomes in the child 
(reviewed in Zijlmans et al., 2015), thus encouraging further research into 
complementary or competing stress-related mechanisms, involving for example the 
Sympathetic Nervous System (SNS) and the Inflammatory Response System (IRS). 
However, to date, such alternative pathways have been largely neglected.   
As extensively described in chapter 1, despite the fact that chatecholamines, 
produced by the SNS under stress conditions, do not cross the placental barrier in 
humans (Giannakoulopoulos et al., 1999), stress-related activation of the SNS might 
affect the utero-placental blood flow (Merlot et al., 2008), thus influencing indirectly 
foetal growth and, in turn, activating the foetal HPA axis (Roelfsema et al., 2005). 
Salivary alpha amylase (sAA) represents a non-invasive marker of SNS activity (Nater 
& Rohleder, 2009) and has only recently been employed to explore an SNS-mediating 
pathway in fetal programming. In particular, to date, maternal sAA levels during 
pregnancy have been linked to pregnancy and birth outcomes in two published studies 
(Giesbrecht et al., 2013; 2015), while only two works examined prenatal maternal sAA 
in relation to later infants’ neurodevelopmental outcomes (Braithwaite et al., 2017; 
Rash et al., 2016). Specifically, Braithwaite and colleagues (2017) found a significant 
interaction between maternal prenatal sAA levels and infant’s sex in predicting 
maternal reports of 2-month-olds’ distress to limitations in a sample of 88 mother-infant 
dyads. However, this study has limited statistical power and the effect was non-
significant once females and males were examined separately. Additionally, in a study 
by Rash and colleagues (2016) maternal sAA, together with other stress markers, 
discriminated between 6-month-olds’ stress reactivity patterns. However, to our 
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knowledge, no published studies have investigated the association between maternal 
sAA levels during pregnancy and infants’ cognitive or motor development.  
Similarly, the IRS represents another potential candidate mediator for fetal 
programming of later neurodevelopment. Nevertheless, to date, it has not yet received 
considerable empirical support in humans. Maternal inflammation during pregnancy 
has been shown to be associated with adverse pregnancy, birth and later child health 
outcomes (e.g. Vannuccini et al., 2016; Rusterholz et al., 2007). Furthermore maternal 
immune activation during pregnancy have been associated with an increased risk for 
offspring neuropsychiatric disorders (Estes & Mcallister, 2016). Additionally, animal 
models suggest that pro-inflammatory cytokines, secreted by the IRS, play a crucial 
role in influencing the developing fetal brain, including HPA axis regulation (e.g. 
Samuelsson et al., 2004). In humans, preliminary studies have highlighted a role of 
maternal inflammation during pregnancy in mediating the effects of antenatal distress 
on birth outcomes, such as birth weight and gestational length (Okun et al., 2013; 
Coussons-read et al., 2012; Miller et al., 2017). Research on the role of maternal 
inflammation  during pregnancy on later child outcomes is only at the beginning. To 
date, the group led by Claudia Buss has conducted the largest study on the influence 
of antenatal maternal inflammation on offspring longitudinal brain development. The 
authors showed that higher maternal IL-6 levels during pregnancy were associated 
with an alteration of newborns’ amygdala volume and connectivity, leading to lower 
impulse control at 2 years of age (Graham et al., 2017), and with both reduced 
functional anisotropy in the central portion of the uncinate fasciculus of newborns’ 
brains and poorer cognitive development at 12 months of age (Rasmussen et al., 
2018). Furthermore, recent work by Osborne and colleagues (2018) showed an 
association between higher levels of maternal proinflammatory cytokines in late 
pregnancy and both offspring’s poorer performance on the Neonatal Behavioral 
Assessment Scale 6 days after birth and greater cortisol reactivity at 12 months of 
age, although results were not adjusted for potential confounders. Gustaffson and 
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colleagues (2018) showed that maternal antenatal inflammation mediated the link 
between prenatal depressive symptoms and 6-month-olds negative affect (Gustafsson 
et al., 2018). However, findings were based on a relatively small sample (N=62) of 
women at risk for attention-deficit/hyperactivity disorder and may not generalize to 
different samples.  
Taken together, these very preliminary results encourage more research into 
the link between maternal depression, IRS functioning during pregnancy and later 
neurodevelopmental in humans.  
 
5.2 Summary and study hypotheses  
Despite some evidence for a role of maternal cortisol in shaping fetal brain 
development and for the long-lasting effects of such exposures, several grey areas 
remain about the direction and nature of these effects. For example, a number of 
studies did not include potential confounders such as maternal postnatal 
symptomatology, child’s gender and age (Rothenberger et al., 2011; De Weerth et al., 
2003), thus limiting possible inferences about the actual effects of fetal programming. 
Furthermore, the majority of studies rely on single maternal cortisol sampling (e.g. 
Davis et al., 2007; Werner et al., 2013) and did not take into account the possible role 
of variations in the diurnal cortisol pattern in influencing fetal development. Lastly, the 
majority of studies failed to detect an association between maternal endocrine stress 
measures and measures of psychological distress (e.g., Davis et al., 2011; Davis & 
Sandman, 2010; Bergman, et al., 2010; Davis & Sandman, 2012), thus questioning the 
role of the HPA-axis as a mediating mechanism of the effects of antenatal depression 
on child outcomes. Alternative biological mechanisms, involving maternal IRS or SNS, 
underlying fetal programming of later physiological and behavioral outcomes are just 
beginning to be empirically examined. In chapter 4, we first investigated the impact of 
naturally occurring variations in the functioning of maternal stress and immune 
response systems in late pregnancy on birth outcomes and stress reactivity soon after 
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birth. In the current work, we now turn to investigating whether the effects of maternal 
prenatal influences on infant physiological and behavioral outcomes persist in the 
postpartum period and whether effects that were not evident soon after birth might be 
revealed later in development. To this aim, we followed-up the same sample of healthy 
mother and infants 3 months after delivery and we combined self-report assessment of 
maternal depression during pregnancy with multiple biological markers of the stress 
and inflammation to explore the independent effects of prenatal maternal variables on 
3-month-olds’ development. We investigated a broad range of infant outcomes, 
including physiological stress reactivity, behavioral adaptation, temperament, and 
mental and motor development, which are considered important markers of later 
development, in an effort to better capture the effects of fetal programming as well as 
the extent to which distinct maternal biological systems might be differentially involved 
in predicting risk for adverse outcomes. Additionally, we controlled for several potential 
prenatal, perinatal and postnatal confounders and we investigated the extent to which 
the observed associations were specific for maternal antenatal depression, as 
compared to anxiety.   
Based on most of the findings in the literature, we hypothesized that infants 
born to mothers with higher depressive symptoms during pregnancy would have a 
more difficult temperament, be more reactive to stress and show poorer cognitive 
performances than infants of mothers with lower depressive symptoms. Furthermore, 
we predicted that alterations in maternal diurnal cortisol pattern during pregnancy 
would be related to infant’s temperament, stress reactivity and cognitive outcomes. In 
contrast, we made no a priori predictions for an association between markers of 
maternal SNS and IRS functioning and infants’ outcomes, due to limited available 






5.3 Material and methods 
 
5.3.1 Participants 
The study sample consists of mother-infants dyads recruited as part of a larger 
ongoing longitudinal study named the Effects of Depression on Infants (EDI) Study 
based at the Medea Scientific Institute in Italy. Women, mostly Italian (97.2%), middle-
high class (94.9%) during their first pregnancy (90.7%), were recruited serially 
between 30th and 33rd weeks of gestation and followed longitudinally. Women with 
multiple and/or complicated gestation, smoking or drug using, afflicted by any chronic 
disease or taking any chronic medications were excluded. Additionally, only healthy 
full term (or late preterm >35 weeks) infants were included in the current study. Thus, 
1 intrauterine death after the prenatal assessment and 2 newborns with serious health 
problems after birth were excluded from the initial sample of 110 women, resulting in 
107 mother-infant dyads been included in the current study. Infants (52.3% males and 
47.7% females) were mostly delivered vaginally (82.2%) at 39.47 mean gestational 
age (SD=1.25). Women who were excluded from the 12-weeks postnatal assessment 
did not differ from participants on any demographic variables, depression or anxiety 
scores.  
 
5.3.2 Procedure  
Maternal depressive and anxiety symptoms were assessed between 30th and 
33rd weeks of gestation and 12 weeks after delivery. Maternal salivary and blood 
samples were collected between 34th and 36th weeks of gestation, as described below, 
and maternal cognitive function was assessed on the same occasion. At 12 weeks of 
age, infants’ behavioral and cortisol response to the routine first inoculation visit as 
well as cognitive and motor development were assessed in two separate sessions. 
Additionally, at the prenatal assessment women were asked to fill in a form on 
pregnancy-related data, while at the postnatal assessment they were asked to 
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complete a form on infants’ health and two questionnaires on infants’ temperament, 
daily sleep and crying behaviour.  
The Ethics Committee of University College London, of Scientific Institute 
Eugenio Medea and of the hospitals and pediatric health centers involved approved 
the study protocol.  
 
5.3.3 Maternal assessment 
Psychological assessment. Prenatal and postnatal depressive symptoms were 
evaluated through the Italian version (Benvenuti et al., 1999) of the 10-item Edinburgh 
Postnatal Depression Scale (EPDS; Cox et al., 1987), the most widely used self-report 
questionnaire to assess perinatal depressive symptoms on a 4-point Likert scale. 
Prenatal and postnatal anxiety symptoms were evaluated on a 4-point Likert scale 
through the Italian version (Pedrabissi & Santinello, 1989) of the 20-item trait anxiety 
subscale of the State-Trait Anxiety Inventory (STAI) (Spielberger et al., 1970).  
Maternal cognitive function was evaluated during pregnancy through the Raven 
Standard Progressive Matrices (RSPM, Raven et al., 1998), a widely employed test 
that evaluate non-verbal general cognitive ability through 60 multiple choice items. The 
test time was limited to 30 minutes and the RSPM raw scores, as a measure of 
individual general cognitive ability, were employed in the analyses.  
Health status. During pregnancy, women were asked to fill in an ad-hoc form to 
collect data concerning prenatal and perinatal medical history (e.g. any 
complication/risk/medical disorder, parity, actual and pre-pregnancy weight and height, 
medication etc.)  
Biological assessment. Ninety-four women out of 107 consented to a blood 
draw between 34-36 gestational weeks. Blood samples were drawn in the morning by 
venipuncture and kept refrigerated at +4° until they reached the Biological Lab of 
Medea Institute were serum was centrifuged, aliquoted, and stored at −80 °C until 
analyzed for C-Reactive Protein (CRP) and IL-6 levels. Biological assay were run in 
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duplicate by using Quantikine High Sensitivity ELISA kits (R&D Systems Europe, LTD) 
at LaboSpace in Milan according to the instructions of the manufacturer. Intra-assay 
coefficient of variation (CV) was <6% for IL-6 and <3% for CRP, inter-assay CV was 
<10% for both markers.  
Saliva samples were collected at home on two consecutive days immediately 
upon awakening, 30 minutes post-awakening and before going to bed by passive drool 
(Granger et al., 2007). Participants were asked to record time of collection on a diary 
and avoid eating, tooth-brushing and exercising in the 30 minutes before collection 
and eating a major meal in the hour before the evening sample. All women provided 
completed saliva samples. The mean time from the awakening collection and the 30-
minutes post-waking collection was, respectively, 30.84 minutes on day 1 (SD=3.69, 
range: 20.00-60.00) and 31.48 minutes on day 2 (SD=6.90, range: 20.00-90.00). As 1 
woman collected the second sample on day 2 more than one hour from awakening, 
and the decline in cortisol usually occurs one hour after waking up, this sample was 
excluded from analyses as done in prior work (O’Donnell, 2013; O’Connor, 2014). All 
saliva samples were stored frozen at -80° until assayed for salivary cortisol at the 
Biological Lab of Medea Institute, using a competitive high sensitivity enzyme 
immunoassay kit (Expanded Range High Sensitivity Cortisol EIA Kit, Salimetrics), and 
for sAA at the Salimetrics Centre of Excellence testing lab at Anglia Ruskin University, 
using a kinetic enzyme assay kit (Salimetrics α-Amylase Kinetic Enzyme Assay Kit). 
All samples from one woman were run in the same assay to minimize method 
variability. Salivary cortisol assays were run in duplicate and averaged, except for 2 
samples with minimal volume. Average intra- and inter-assay coefficients were <6% 
and <8%, respectively. Results were computed in µg/dl. A random 10% of the sAA 
assays were run in duplicate to confirm reliability. The intra-assay coefficient of 





5.3.4 Infant assessment 
Temperament was assessed using the 37-items very short form of the Infant 
Behavior Questionnaire (IBQ-R-VSF), a well-established standardized measure 
designed to evaluate temperament in infancy aged from 3 to 12 months by caregiver 
report on a 7-point scale (Putnam et al., 2014). The items measured three broad, 
empirically derived, temperamental dimensions, namely negative affectivity, positive 
affectivity/surgency, and orienting/regulatory capacity, with levels of reliability and 
stability similar to those obtained with the longer versions of the scale and other 
temperament measures (Putnam et al., 2014). 
Crying at 12 weeks of age was assessed through the Baby’s Day Diary (Barr, 
1985), a 24-hour record of infant behaviors (i.e. awake and alert, awake and fussing, 
awake and crying, awake and inconsolable crying, feeding, sleeping) to be completed 
at home by the caregiver. Total minutes of infant distress (fussing, crying, and 
inconsolable crying) per day and minutes of inconsolable crying per day were 
abstracted from the diary. The assessment of frequency and duration of crying, as 
evaluated through the Baby’s Day Diary, has been shown to strongly correlate with 
audiotape recordings (Barr et al., 1988; St James Roberts et al., 1993) and be 
independent of postnatal maternal depressive symptoms (Miller et al., 1993). 
Mental and motor development at 12 weeks was assessed through the Bayley 
Scales of Infant and Toddler Development – Third Edition (Bayley III, Bayley 2006) in 
a session at the Medea Institute by a trained clinical psychologist blind to prenatal 
data. The Bayley III are a well-standardized and widely employed developmental 
assessment, providing three standardized composite scores for cognitive, language, 
and motor domains as well as 5 subtests (Cognitive, Expressive Communication, 
Receptive Communication, Fine Motor, Gross Motor). In the current study we focused 
on the Cognitive and Motor scales. Age-standardized composite scores for each scale 
were calculated by using test norms (mean=100; SD=15). Data for the Bayley III were 
available for 104 infants out of 107, as the remaining infants did not attend the session 
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at the Medea Institute due to logistic reasons (i.e. living too far from the Institute).   
Health status. Data on physical health (e.g. weight, body length, any 
medication, any disease/hospitalization from birth to date), feeding and sleep were 
collected at 12 weeks of age, jointly with situational data concerning the inoculation 
day (e.g. duration of trip to the health centres, time of last feeding, time of last sleeping 
etc.) through an ad hoc form that the researcher filled out with the mother. Additionally, 
data concerning infants’ health at birth (e.g. gestational age, weight, etc.) were 
extracted from medical records at birth.   
Cortisol collection and assay. Infants’ cortisol and behavioural responses to the 
inoculation were evaluated at approximately 12 weeks of age (SD=1.84) during the 
routine first inoculation visit. Specifically, the infant was undressed and laid down and 
two injections, respectively, for the hexavalent vaccine and pneumococcal vaccine, 
were administered in the infants’ thigh. Then the infant was given to the mother, who 
was free to soothe the baby. The whole procedure was videotaped. Mean duration of 
the shot administration was 1.06 minutes (SD=00.30). Data concerning the inoculation 
were available for 94 infants out of 107, as for 2 infants’ parents did not consent to the 
inoculation, while 11 infants were vaccinated in a district outside the province of Lecco 
and Como that were involved in the project and for which we gained the approval of 
their ethics committees’. Three infant saliva samples were collected in the waiting 
room, respectively right before entering in the medical room (baseline) and 20 and 40 
minutes after the administration of the shot, using a specifically designed swab 
(SalivaBio Infant’s Swab, Salimetrics). All the inoculations were performed in the 
morning between 09.00 and 12.00, except for 4 infants who were examined at 2 pm. 
Time of the day was examined as a covariate in the analyses. With the exception of 1 
infant who was fed 11 minutes before the first saliva collection, babies were not fed in 
the 30 minutes before the saliva collection (mean time from last feeding=102.99 
minutes, SD=54.60). Saliva samples were stored at -80º until assayed for cortisol 
according to the same procedure described for maternal cortisol assay. All samples 
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were run in duplicates, with the exception of 8 samples that were run in singlet due to 
minimal saliva volume. All samples from one infant were run on the same assay. The 
average intra- and inter-assay coefficients of variance were below 7% and 10%, 
respectively. Out of the 94 infants taking part to the inoculation, complete cortisol data 
were available for 78 infants, while one or two samples were missing for 16 infants due 
to insufficient saliva volume. Infants with complete or partial data did not differ on any 
sociodemographic/maternal or infants’ variables or situational factors (i.e. time of the 
day, length of the inoculation, behavioral score). 
Behavioral assessment. Coding of infant distress began once the last needle 
was retracted and continued for the subsequent 2 minutes at 5-seconds intervals 
according to a 4-point scale by Jahromi and colleagues (2004) indicating an increasing 
in the intensity of the negative affect (i.e. no vocalization; fussing, whining or 
whimpering; low-intensity crying; very intense loud crying). The predominant (>2.5 
seconds) level of intensity during each 5-seconds interval was scored. A measure of 
overall crying intensity was obtained by averaging scores across the intervals, while a 
measure of overall cry duration was calculated by adding the number of intervals 
during which the infant was distressed (i.e. received a rating >0) and multiplying by 5. 
The videotapes were coded by a trained graduate student with an MSc in 
Developmental Psychology, blinded to all prenatal and postnatal data. Twenty-one 
percent of the observations were coded by an independent trained coder. Intra-class 
correlation was 0.998, p<.001.  
 
5.3.5 Statistical analyses 
First, we examined variables for outliers and skewness. As distributions of 
maternal and infants’ biological concentrations were positively skewed even after 
removing samples greater than 3 SD from the mean (n=7 for prenatal cortisol, n=4 for 
sAA, n=3 for prenatal IL-6, n=4 for infants’ cortisol), variables were natural log (ln) 
transformed to approximate normal distributions. Model parameters for ln-transformed 
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values are presented in tables while non-transformed values are employed in the 
descriptive statistics table and figures to facilitate interpretation. Secondly, as 
extensively described in Chapter 2 and 4, four summaries measures were calculated 
from maternal daytime salivary samples to index different aspects of maternal HPA 
and SNS prenatal diurnal functioning, namely, awakening values, response to 
awakening, diurnal slope and total diurnal output as indexed by the area under the 
curve with respect to the ground (AUCg; Pruessner et al., 2003). As the number of 
women at risk for depression according to the EPDS cut-off of 10 was fairly low 
(17.3%), the total score of the EPDS was employed as a continuous predictor in the 
analyses. 
Preliminary analyses were run to investigate the potential effect of variables 
known to affect infant’s outcomes and included Pearson bivariate correlations and 
univariate analysis of variance (ANOVA). Only confounders which were significantly 
related to the dependent variables were included in subsequent analyses as 
covariates. 
In order to evaluate the independent effects of maternal prenatal variables on 
infants’ neurodevelopmental outcomes, hierarchical regression analyses and multilevel 
models were run as appropriate. Specifically, separate hierarchical regression 
analyses were performed to evaluate the impact of prenatal maternal variables on 
infant’s outcomes (i.e. IBQ-R-VSF scales scores, Bayley III scales scores, Baby’s Day 
Diary measures and behavioral response to stress), while adjusting for covariates. 
Hierarchical Linear Models (HLMs) were estimated to explore the influence of 
antenatal maternal variables on the trajectories of infants’ cortisol response to the 
inoculation, while accounting for the hierarchical structure of the data (three time-
points nested within individuals). Specifically, HLMs were specified at two levels where 
individuals were level 2 and time was level 1. Time was centered at baseline so that 
the model intercept represents the mean cortisol level at baseline. Unconditional 
means models were computed to evaluate how much variance in cortisol levels can be 
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explained by between-subject and between-occasions variations. Afterwards, we fitted 
a baseline model of cortisol response that describes the trajectory of infants’ response 
and includes a linear and quadratic slope for time. Additionally, models included a 
random intercept and a random linear slope to allow between-person variability, while 
the error term was allowed to vary randomly in each model. The level-2 predictors 
were centered around the grand mean and entered in the model one-by-one. Gender 
was centered at males. Model fit was tested with likelihood deviance difference test for 
nested models. Specifically, variables were kept in the model when their presence 
resulted in a significant (p<.05) reduction of the likelihood ratio statistic. To test the 
statistical significance of the regression coefficients, the Wald’s chi-square test was 
performed. Statistical analyses were performed using SPSS 24 and MLWiN. All 
statistical tests were two-sided and a p<.05 was considered statistically significant. 
Given the high correlation between maternal depression and anxiety during 
pregnancy (r=.67, p<.001), an additional set of analyses investigating the effects of 
maternal anxiety, rather than depression, as individual-level predictor in the 
exploratory models were run and are reported in the supplementary results section.  
 
5.3.6 Covariates.  
Variables examined as potential confounders of the relationship between 
prenatal maternal variables and infants’ outcomes in preliminary analyses included 
sociodemographic factors (i.e. maternal age, education, SES, parity, infants’ age and 
gender) and health-related factors (i.e. mode of delivery, length of labor, gestational 
age, birth weight, head circumference, actual weight, postnatal smoke exposure, 
breastfeeding versus formula-feeding). In addition, the effects of factors related to the 
day of inoculation on infant stress response were examined (i.e. time of the day, time 
from last feeding and last sleeping, length of the inoculation procedure, mode of 
transport, duration of the journey, being distressed or quiet before the inoculation). 
Furthermore, as general cognitive ability is a genetically based and substantially 
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heritable trait (e.g. Kirkpatrick et al., 2014) and maternal cognitive functioning is known 
to have a direct influence on children’s intellectual development, we examined the 
association between maternal IQ as assessed by the RPSM, and infant’s Bayley III 
scores. 
Maternal age was significantly associated with infants’ 20-min post-stressor 
cortisol levels (r=.24, p<.05). Additionally, females were found to show marginally 
higher levels of cortisol at the 40-min post stressor collection than males (F(1, 
83)=3.69, p=.06). Thus, maternal age and infant’s gender were included as covariate 
in subsequent analyses on stress reactivity. 
Infant’s gestational age at birth was significantly related to infants’ IBQ positive 
affectivity scores (r=.28, p=.007), while females showed more minutes of inconsolable 
cry during the day as compared to males (F(1, 102)=3.80, p=.05). Both infant’s gender 
and gestational age were included in the subsequent models of infant’s temperament 
and cry.  
Both gestational age at birth and maternal IQ were significantly associated with 
infants’ cognitive development (respectively, r=.23, p=.01 and r=.24, p=.01). In 
addition, females tended to perform higher on the Motor scale, as compared to males 
(F(1, 101)=3.53, p=.06). Thus gestational age, gender and maternal IQ were retained 
as covariate in the hierarchical linear regressions models on infants’ psychomotor 
development.  
Lastly, given that evidence exists of an association between maternal postnatal 
depression and infant’s outcomes (e.g., Pauli-Pott et al., 2004; Keenan, Grace, & 
Gunthorpe, 2003), we examined this relation in our sample. Maternal postnatal 
depressive symptoms were significantly related to infant’s IBQ negative affectivity 
scores (r=.24, p=.02) and with infants’ 20-min post-stressor cortisol levels (r=-.22, 
p=.04). Thus, maternal postnatal depression was included as possible confounder in 
all regression and multilevel models. Models were performed both with and without 
including postnatal depression. Adjusting for maternal depressive symptoms at 3 
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months did not affect the statistical significance and direction of the association 
between prenatal maternal variables and infants’ outcomes in any of the analyses 
presented below.  
 
5.4 Results  
 
5.4.1 Descriptive analyses 
Descriptive statistics for all study variables are presented in Table 5.1. 
Preliminary bivariate correlations showed a marginally significant association between 
maternal depression and IL-6 levels during pregnancy (r=.19, p=.06). Additionally, 
there was a significant association between maternal prenatal depressive symptoms 
and infants’ cortisol concentrations 40-minutes post-stressor (r=.22, p=.04). In 
contrast, intensity and duration of newborns’ behavioural distress at the inoculation 
were not correlated with any maternal variables (all ps>.05). Infant’s negative 
affectivity scores were positively related with maternal prenatal depressive symptoms 
(r=.45, p<.001), and negatively associated with maternal cortisol AUCg levels and sAA 
response to awakening during pregnancy (respectively r=-.22, p=.04; r=-.21, p=.05). 
Both positive affectivity and orienting/regulatory capacity IBQ scores were negatively 
related with maternal prenatal cortisol diurnal slope (respectively, r=-.22, p=.03 and r=-
.26, p=.01). Duration of total infant distress during the day, as assessed on the Baby’s 
Day Diary, was negatively related to maternal prenatal CAR (r=-.22, p=.02), while 
minutes of inconsolable crying were related to sAA response to awakening (r=-.29, 
p=.003). Infants’ cognitive development was negatively related to maternal cortisol 
AUCg during pregnancy (r=-.26, p=.01) and marginally related to cortisol levels at 





Table 5.1 – Descriptive statistics for study variables at the prenatal and postnatal 
assessment 
Study Variable Mean SD Range 
Prenatal    
Maternal cortisol (µg/dl)    
Waking 0.38 0.13 0.13-0.83 
Waking +30’  0.50 0.15 0.10-0.91 
Bedtime 0.18 0.06 0.01-0.41 
Maternal sAA (U/ml)    
Waking 69.78 64.27 3.00-463.84 
Waking +30’  47.90 38.30 2.80-190.10 
Bedtime 97.44 80.09 3.28-562.71 
Maternal CRP (ng/ml) 3720.98 2705.67 480.04-11179.80 
Maternal IL-6 (pg/ml) 1.68 1.03 0.48-6.47 
Maternal depression (EPDS) 5.36 4.46 0-19 
Maternal anxiety (STAI-T) 36.52 9.60 21-71 
Postnatal    
Cognitive composite score 102.36 10.81 75-125 
Motor composite score 99.73 8.14 85-121 
Negative affectivity 3.46 0.87 1.58-5.42 
Positive affectivity 3.87 0.79 2.00-5.54 
Orienting/regulatory capacity 5.62 0.57 4.30-6.75 
Daily Total Distress (min) 114.23 74.41 00-335.00 
Daily Inconsolable cry (min) 7.50 18.35 0-110 
Behavioral response to 
stress 
1.41 0.79 0.25-3.00 
Infants’ cortisol (µg/dl)    
Baseline  0.31 0.23 0.03-1.10 
20-min post-stressor  0.78 0.35 0.01-1.86 




5.4.2 Prenatal maternal variables and infant’s psychomotor development 
As shown in Table 5.2, multiple hierarchical regression analyses revealed 
significant associations between higher maternal cortisol AUCg and lower infant 
cognitive development at 3 months (β=-.37, t= -3.99, p<.001), as well as between 
higher maternal CRP and lower cognitive scores (β=-.23, t= -2.21, p=.03), after 
controlling for infant’s gender, gestational age, maternal IQ and both prenatal and 
postnatal depression (β=-.37, t= -3.99, p<.001). No significant effect of maternal 
prenatal variables on infant’s motor development was found.  
 
Table 5.2 – Hierarchical linear regression analyses predicting 3-month-olds’ cognitive 
scores 
 Cortisol AUCg sAA AUCg IL-6 CRP 
 β p β p β p β p 
Step 1:          
Gender .12 .20 .11 .25 .08 .45 .08 .44 
Gestational Age .21 .03 .22 .02 .20 .07 .20 .06 
Maternal IQ .23 .02 .22 .02 .20 .07 .18 .10 
Postnatal EPDS  .05 .58 .05 .61 .05 .62 .06 57 
ΔR
2
 for step 1 .12 .01 .12 .01 .09 .09 .09 .10 
Fmodel 3.26 .01 3.30 .01 2.07 .09 2.03 .10 
Step 2:          
Prenatal EPDS -.13 .28 -.12 .30 -.13 .33 -.13 .32 
ΔR
2
 for step 2 .13 .28 .01 .30 .01 .33 .01 .32 
Fmodel 2.85 .02 2.86 .02 1.85 .11 1.82 .12 
Step 3:          
Biological predictors -.37 <.001 -.12 .21 -.07 .50 -.23 .03 
ΔR
2
 for step 3 .26 <.001 .01 .21 .00 .50 .05 .03 





Concerning the covariates, gestational age was significantly positively 
associated with both motor and cognitive development, while maternal IQ was 
significantly related to infant’s cognitive scores. Additionally, infant’s gender was 
related to motor development, with females scoring higher than males. Results in 
Table 5.2 are reported only for cortisol AUCg, as all other diurnal indices were not 
significantly associated with infant’s psychomotor development.  
 
5.4.3 Prenatal maternal variables and infant’s temperament  
As shown in Table 5.3, multiple hierarchical regression analyses revealed a 
positive association between maternal prenatal depressive symptoms and infants’ IBQ 
negative affectivity scores (β=-.38, t= 3.08, p=.003), after controlling for infant’s 
gender, gestational age, and postnatal depression. Additionally, maternal sAA 
response to awakening was related to infants’ NA scores (β=-.28, t= -3.02, p=.003), 
after controlling for covariates. Specifically, a greater morning sAA decline after 
awakening was associated with infants’ higher negative affectivity scores. Moreover, 
there was a marginal association between higher maternal cortisol levels during 
pregnancy, as indexed by AUCg, and lower scores on infant’s negative affectivity at 3 
months, after adjusting for covariates (β=-.19, t= -1.8, p=.07). No significant effect of 
maternal prenatal variables on infant’s IBQ positive affectivity and orienting/regulatory 
capacity scores, as well as infant’s daily cry and sleep behavior, as reported at the 
Baby’s Day Diary, was found. Concerning the covariates, postnatal depressive 
symptoms were significantly positively related with infant’s negative affectivity scores 
(β=.30, t=2.95, p=.004), while gestational age was significantly related with infant’s 







Table 5.3 – Hierarchical linear regression analyses predicting 3-month-olds’ NA scores 




 β p β p β p β p 
Step 1:          
Gender .17 .10 .19 .06 .17 .13 .14 .21 
Gestational Age .07 .47 .05 .62 .10 .37 .09 .40 
Postnatal EPDS  .31 .004 .30 .004 .33 .004 .34 .003 
ΔR
2
 for step 1 .13 .01 .13 .01 .15 .01 .15 .01 
Fmodel 4.02 .01 4.14 .01 4.12 .01 4.12 .01 
Step 2:          
Prenatal EPDS .38 .004 .38 .003 .35 .01 .36 .01 
ΔR
2
 for step 2 .08 .004 .09 .003 .07 .01 .08 .01 
Fmodel 5.49 .001 5.78 >.001 4.97 .001 5.11 .001 
Step 3:          
Biological predictors -.19 .07 -.28 .003 -.17 .11 -.18 .10 
ΔR
2
 for step 3 .03 .07 .08 .003 .03 .12 .03 .10 
Fmodel 5.26 .001 6.91 >.001 4.57 .001 4.74 .001 
 
 
5.4.4 Prenatal maternal variables and infant’s behavioural response to stress 
Multiple hierarchical regression analyses revealed no significant association 
between maternal prenatal variables and either intensity or duration of infant’s 
behavioural distress at the inoculation, after adjusting for covariates (all ps>.05). 
 
5.4.5 Prenatal maternal variables and infant’s cortisol stress reactivity 
The unconditional means model for infants’ cortisol showed significant 
variability between-occasions (level-1; p<.001), but not at the individual level (level-2; 
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p=.78). Three-month-olds showed the expected cortisol response to the inoculation as 
indexed by the significant linear and quadratic slopes of time (both ps<.001). Also, the 
random linear slope term was statistically significant (p<.001), indicating significant 
between-person variability in the cortisol linear increase. Overall, this model results in 
a significant improvement of the fit over the unconditional means model (deviance 
difference (4)=131.07, p<.001). Fixed independent effects of prenatal variables (i.e. 
depressive symptoms, cortisol and sAA diurnal indices, CRP and IL-6 levels) on mean 
cortisol levels at baseline and on cortisol response over time were tested separately, 
while controlling for maternal age, infant’s sex and postnatal depression. 
Table 5.4 – Full prediction model for the independent effects of maternal depression 
(EPDS) on infants’ cortisol response 
 Infant cortisol response 
 Estimate (SE) p 
Fixed effects   
Intercept 0.260 (0.021) <.001 
Gender -0.009 (0.024) .71 
Maternal Age 0.006 (0.003) .07 
Postnatal EPDS -0.030 (0.019) .12 
Prenatal EPDS  0.026 (0.026) .32 
Linear 0.022 (0.002) <.001 
Prenatal EPDS -0.003 (0.002) .14 
Quadratic -0.000 (0.000) <.001 
Prenatal EPDS  -0.000 (0.000) .04 
Random effects   
Level 2 (individual)   
Intercept variance 0.008(0.004) .06 
Linear slope variance 0.000 (0.000) .03 
Intercept/Linear slope    
covariance 
-0.000(0.000) .24 
Level 1 (occasions)   
Intercept variance 0.017(0.003) <.001 
 
As shown in Table 5.4, there was a significant main effect of maternal prenatal 
depressive symptoms on the quadratic slope of infants’ cortisol response (p=.04). 
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Specifically, as shown in Figure 5.1, higher depressive symptoms were associated 
with a flatter quadratic slope, indicating a slower recovery to pre-stressor cortisol 
levels. However, maternal depression was not significantly associated with cortisol 
baseline levels or with the linear slope of the response (all ps>.05). The inclusion of 
maternal prenatal depression marginally improved the model fit (deviance difference 
(3)=7.80, p=.05).  
 
 
Figure 5.1 – Cortisol values before and after the inoculation for infants exposed 
prenatally to higher (+1 SD) and lower (-1SD) maternal depression, as indexed by the 
antenatal EPDS score, after adjusting for covariates 
 
Furthermore, maternal overall diurnal level of sAA, as indexed by AUCg, was 
significantly related to infant’s cortisol levels at baseline (estimate=-0.00, SE=.00, 
p=.03), but not in response to stress, with higher levels of maternal sAA being 
associated to infant’s lower cortisol baseline levels. However, the inclusion of maternal 
sAA AUCg did not significantly improve the model fit over the baseline model 
(deviance difference (3)=5.3, p=.15).  
Lastly, there were no significant association between maternal IL-6, CRP or 
cortisol levels during pregnancy and infants’ cortisol concentrations at baseline or in 
response to stress.  
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5.4.6 Supplementary analyses  
A supplementary set of analyses was run to test the independent effect of 
maternal anxiety, rather than depression, on infant outcomes. For what concerns 
temperament, maternal anxiety was not significantly associated with infants’ IBQ scale 
scores (p=.17). The association between maternal sAA response to awakening and 
negative affectivity scores remained significant (β=-.30, t=-2.89, p=.005), even after 
controlling for maternal anxiety rather than depression. With regards to psychomotor 
development, differently from depression, maternal anxiety was significantly 
associated with infants’ cognitive scores, with higher anxiety symptoms during 
pregnancy being related to lower cognitive development (β=-.31, t=-2.43, p=.016), 
after adjusting for covariates. Nevertheless, the association between maternal prenatal 
cortisol and infant’s cognitive scores remained significant (β=-.29, t=-2.99, p=.004), 
even after controlling for maternal anxiety rather than depression, while the 
association between prenatal CRP levels and cognitive scores was marginally 
significant (β=-.19, t=-1.86, p=.06) when adjusting for anxiety. Regarding infants’ 
stress response, no significant or marginally significant effect of maternal anxiety on 
newborns’ intensity or duration of behavioral distress as well as on cortisol baseline 




Findings from the present study provide further evidence of an association 
between maternal antenatal depression and infants’ cortisol stress reactivity and 
extend prior work highlighting significant associations between multiple biological 
measures of stress and inflammation during pregnancy and the trajectory of infant 
development, including cognitive, temperamental and stress-related outcomes, in a 




5.5.1 Prenatal maternal factors and infants’ psychomotor development 
The current study is among a small number of other very recent reports that 
suggest that maternal stress and immune signals in utero predict infant early cognitive 
development, independently from prenatal and postnatal maternal depressive 
symptoms. In contrast, no effect of prenatal maternal influences on motor development 
was found. Specifically, in line with our predictions, we observed lower cognitive 
scores in infants prenatally exposed to higher levels of maternal diurnal cortisol, after 
controlling for several potential confounders. Our findings converge with animal 
evidence indicating that prenatal maternal stress can lead to attentional, neuro-motor 
and learning deficits in offspring (reviewed in Owen, Andrews, & Matthews, 2005) and 
with studies linking prenatal glucocorticoids administration and reduced cognitive 
abilities (e.g. Coe & Lubach, 2005) or cortical thinning (Davis et al., 2013). While 
glucocorticoids play a critical role in promoting fetal growth and neuronal maturation, 
excessive levels are considered neurotoxic (Uno et al., 1994). Our findings, though 
essentially correlational in nature, are consistent with the hypothesis that higher than 
average elevations in maternal diurnal cortisol within normative pregnancy can impact 
fetal brain development and influence later cognitive development. These results are 
in line with the limited available literature in humans linking fetal overexposure to 
endogenous cortisol in late pregnancy with poor cognitive performances from 3 
months to 7 years of age (Huiznik et al., 2003; Buitelaar et al., 2003; Bergman et al., 
2010; LeWinn et al., 2009). However, it is important to note that Davis and Sandman 
(2010) found higher maternal cortisol early in gestation but lower cortisol in late 
pregnancy to be related to lower mental development at 12 months. Despite the 
similar populations, there are a few methodological differences between that study and 
ours, including that the former relied on cortisol assessments based on a single 
occasion and from plasma and that the evaluation of infant development was 




Although the exact mechanisms underlying the association between maternal 
cortisol and infant cognitive outcomes are still unclear, some hypotheses have been 
proposed. First of all, although the fetal brain is protected from elevations in maternal 
cortisol by the activity of placental 11-βHSD, it has been shown that the expression of 
this enzyme is reduced in the last stages of gestation, thus allowing more cortisol to 
cross the placenta and influence fetal brain development (Murphy et al., 2006). In 
particular, the hippocampus, crucially involved in cognition and behavior (Andrews & 
Matthews, 2004), is particularly sensitive to excessive levels of glucocorticoids. As it 
has been shown that glucocorticoid receptors in the fetal hippocampus are already 
expressed at 24 weeks of gestation (Noorlander et al., 2006), it can be hypothesized 
that cortisol overexposure in late pregnancy could influence hippocampal development 
and adversely impact brain and behavioral development. Secondly, maternal cortisol 
might influence fetal brain development indirectly, by affecting placental blood vessel 
tone and possibly leading to reduced utero-placental blood flow, with long-term 
consequences on neurodevelopmental outcomes.   
Furthermore, exploratory analyses provided novel evidence for an association 
between higher levels of maternal CRP during late pregnancy and poorer cognitive 
development at 3 months. Accumulating evidence from animal models suggests that 
maternal inflammation can impact the fetal developing brain. For example, in mice, 
induced maternal IRS activation has been found to affect fetal brain myelination (Cai et 
al., 2000) and alter hippocampus histology, with negative consequences for later 
learning and memory (Golan et al., 2005; Samuelsson et al., 2006). However, 
knowledge on the programming role of maternal inflammation on fetal brain 
development in normative human pregnancy is limited. The current findings are in line 
with initial evidence of an association between maternal circulating levels of 
inflammatory markers during pregnancy and both less optimal neonatal 
neurobehavioral function at 6 days of age (Osborne et al., 2018) and poorer cognitive 
development at 12 months of age (Rasmussen et al., 2018), suggesting that naturally 
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occurring variations in antenatal maternal levels of inflammation could influence fetal 
brain development, affecting neurodevelopmental and cognitive outcomes early in life. 
Interestingly, recent neuroimaging evidence showed that maternal inflammation during 
pregnancy is associated with structural and functional alterations in newborns brain 
(Graham et al., 2017; Rasmussen et al., 2018). In particular, Rasmussen and 
colleagues (2018) found that maternal IL-6 levels during pregnancy were inversely 
associated with newborns’ fractional anisotropy of the uncinated fasciculus, a region 
proximal to the amygdala and hippocampus, while predicted an accelerated postnatal 
growth of fractional anisotropy of the same region. Importantly, the accelerated 
postnatal growth in the structural connectivity of the uncinated mediated the 
association between antenatal Il-6 levels and infants’ cognitive outcomes. Despite 
these findings are only preliminary and observational, they support the notion that 
maternal antenatal inflammation could exert a programming effects on offspring’s 
cognitive development by affecting fetal structural brain development. It has been 
hypothesized that maternal inflammation during pregnancy could influence offspring 
neurogenesis through inflammatory mediators, leading to altered cognitive and 
behavioral outcomes (Golan et al., 2005). Nonetheless, the mechanisms through 
which maternal inflammation could actually operate upon the fetal brain are still 
unknown and need to be investigated in future studies.   
Despite CRP and IL-6 being correlated in the current sample, maternal IL-6 
concentrations were not found to predict 3-month-olds’ mental development. CRP is 
generally considered a non-specific marker of systemic inflammation, reflecting levels 
of circulating interleukins (Dantzer & Kelley, 2007). Although future studies are needed 
into the link between variations in maternal prenatal inflammation and offspring 
outcomes, our results might suggest that CRP could constitute a valid biomarker for 




As both maternal and infant factors are known to play a role in shaping infants’ 
mental development, it is worth mentioning that the effects we reported were 
independent of maternal postnatal symptomatology and were not fully explained by 
infant characteristics, such as gender and gestational age, or by maternal IQ. These 
results strengthen the hypothesis that prenatal factors independently predict infant 
cognitive development. These findings are important because evidence suggests that 
early performance on the Bayley cognitive scale are associated with IQ in later 
childhood (Cheng & Pickler, 2010; Laucht, Esser, & Schmidt, 1997), which, in turn, 
have been related to later academic performance and the occurrence of behavioral 
problems (Boutwell et al., 2017). Thus, an alteration of the trajectories of fetal brain 
development, resulting in poorer early mental development, could constitute one 
possible pathway through which prenatal stress exposures might hamper offspring 
development, with long-term consequences. 
In contrast with our initial hypotheses, we found no evidence of an association 
between maternal prenatal depressive symptoms and 3-month-olds’ cognitive 
development. As extensively described in Chapter 1, findings of an association 
between maternal antenatal depression and child mental development are 
controversial. Although issues related to statistical power and to relatively mildlevels of 
maternal depression in the current sample might have limited our ability to detect a 
significant association, it is worth mentioning that null findings have been previously 
reported both in clinical (e.g. Osborne et al., 2018; Santucci et al., 2014) and non-
clinical samples (Tse et al., 2010). However, it is noteworthy that we do report a 
significant inverse association among maternal antenatal anxiety symptoms and infant 
cognitive outcomes. While depression and anxiety have both been independently 
related to poor offspring’s cognitive performances (e.g. Brouwers, Van Baar, & Pop, 
2001; Evans et al., 2012), few studies have sought to compare their effects and these 
have yielded to mixed finding with stronger effect being reported either for depression 
(Barker et al., 2011; Lin et al., 2017) or for anxiety (Ibanez et al., 2015). Further 
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replication of the current findings in different samples and at different ages is needed 
before any conclusions can be drawn.  
Likewise, our exploratory analyses failed to detect any association between 
maternal antenatal sAA levels and infants’ psychomotor development. Evidence for a 
role of maternal SNS in fetal programming in humans is scarce and to our knowledge, 
no published data exists on the link between prenatal maternal sAA levels and fetal 
brain development. Given the exploratory nature of the current findings, replication is 
needed in larger and different sample. 
Lastly, in line with most studies (e.g. Bergman et al., 2010; Davis & Sandman, 
2010), we did not find any significant effects of prenatal maternal factors on infant’s 
motor development at 3 months. It is possible that the regions of the brain more 
crucially involved in cognitive functioning, such as the hippocampus and prefrontal 
cortex, are more sensitive to the alterations in the intra-uterine environment, than 
areas involved in motor development (Davis & Sandman, 2010).  
 
5.5.2 Prenatal maternal factors and infant temperament  
As hypothesized, maternal depression during pregnancy was significantly 
associated with maternal reports of infants’ negative affectivity (NA) at 3 months of 
age. Furthermore, we found preliminary evidence of an association between maternal 
antenatal sAA response to awakening and infants’ NA. These results were 
independent of infant gender and gestational age, as well as measures of concurrent 
maternal depression. Contrary to our predictions, maternal antenatal diurnal cortisol 
was not significantly associated with infants’ temperament. Furthermore, we did not 
find any associations between prenatal maternal variables and infants’ positive 
affectivity and orienting/regulatory capacity or crying and sleep behaviors as recorded 
on the Baby’s Day Diary.  
Temperament refers to early biologically-based individual differences in 
reactivity and self-regulation (Rothbart, 1991) which are thought to be embedded in 
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the infant’s neurophysiology and to be influenced by both genetic and environmental 
factors (e.g. Silberg et al., 2005). The current results indicate an association between 
intrauterine environmental factors and aspects of infant temperament, as reported by 
mothers, related to the tendency to experience negative emotions. As expected, 
maternal depressive symptoms during pregnancy were significantly associated with 3-
month-old infants’ negative affectivity; these effects were specific for maternal 
depression, rather than anxiety. This is in line with a number of studies that identify 
antenatal depression as a significant predictor of infants’ negative affectivity in human 
(e.g. Austin et al., 2005; Davis et al., 2007; Huot et al., 2004) and with animal models 
indicating an increase in fearful or reactive behavior in offspring prenatally exposed to 
maternal stress (Welberg & Seckl, 2001; Weinstock, 2005). Notably, infant NA can be 
reliably assessed as early as 3 months of age (Gartsein & Rothbarth, 2003) and is a 
relatively stable temperamental trait over time (Putnam et al., 2008) which has been 
associated with an increased later risk for emotional and behavioral problems, 
including depression (Dougherty et al., 2010). Taken together, these lines of evidence 
converge to suggest that intrauterine environmental factors might influence infant 
temperament, thus possibly, laying the foundations for later behavioral problems (e.g. 
Gartstein et al., 2012). However, the mechanisms underlying the link between 
antenatal maternal depression and infant NA are still to be understood. The current 
study offers an important extension to existing literature by examining a number of 
potential biological mediators, involving the stress and immune response systems. Our 
findings provide evidence that variations in maternal SNS diurnal functioning during 
pregnancy, as indexed by sAA levels, are associated with maternal report of infant NA 
3 months after birth. More specifically, a greater morning sAA decline after awakening 
was related to higher scores on infant NA, after adjusting for covariates. However, it is 
important to mention that the observed association was independent of maternal 
depressive symptoms, thus possibly suggesting that maternal antenatal depressive 
symptoms and stress signals operate through independent pathways in shaping infant 
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temperament. To our knowledge, only Braithwaithe and colleagues (2017) evaluated 
the influence of maternal sAA levels during pregnancy on infant temperament and 
found that maternal sAA diurnal levels predicted 2-month-olds negative emotionality in 
a sex-dependent manner. Specifically, high levels of maternal sAA were marginally 
associated with reduced negative emotionality in males, while in females there was the 
opposite association, although non-significant. Despite methodological differences 
limiting possible comparisons, taken together these preliminary findings indicate that 
maternal sAA diurnal levels during pregnancy might be a sensitive biomarker for 
understanding how prenatal factors shape temperament in infancy. In contrast to 
Braithwaithe and colleagues (2017), we did not find any significant association 
between the overall daytime level of maternal sAA, as indexed by the AUCg, and 
infants’ difficult temperament. On the contrary, our findings seem to suggest that 
subtle dynamic variations in the sAA diurnal pattern, rather than the total amount of 
sAA, are more closely implicated in programming behavioral outcomes in a healthy 
sample of pregnant women and infants. Although it is unclear why maternal sAA 
response to awakening may be particularly relevant for infant temperament, it has 
been recently proposed that fluctuations of stress hormones related to the diurnal 
pattern of the stress response systems might convey more adaptively-relevant 
information to the foetus concerning the postnatal environment than absolute levels 
(Giesbrecht et al., 2017). However, the preliminary nature of the current finding limits 
possible interpretation and requires replication in larger samples.  
Despite the focus on HPA-axis mediated mechanisms of fetal programming in 
the literature, contrary to our hypothesis, in the current study the association between 
maternal antenatal cortisol and maternal reports of infant temperamental NA did not 
reach statistical significance. We only observed a marginally significant association 
and the direction of the association, with higher levels of maternal cortisol predicting 
lower levels of infant NA was unexpected and requires further investigation in larger 
sample. It is noteworthy that results from recent studies relate higher prenatal 
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exposure to concentrations of stress markers such as cortisol and sAA to lower 
negative emotionality in males, while the opposite association in females (Braithwaite 
et al., 2017a; Braithwaite et al., 2017b). Although the current sample size does not 
allow us to investigate possible gender effects in the observed associations, this 
remains an important area for future research.  
In line with prior work (e.g. Bergman et al., 2007; Austin et al., 2005) 
concurrent maternal depressive symptoms were also significantly associated with 
infant NA, thus raising a number of issues. First of all, while maternal report, as 
compared to laboratory assessment, allows us to obtain evaluations of infants’ 
behaviors occurring in naturalistic settings at different times, we cannot rule out a self-
report bias with postnatally depressed mothers rating their infants as more difficult. 
However, parent-report and structured observation have been shown to provide 
convergent evaluation and, importantly, it has been shown that parental depression 
generally does not influence IBQ-R ratings (Garstein & Marmion, 2008). Secondly, a 
bidirectional link between postnatal maternal depression and infant NA is also likely to 
occur with either postnatal depressive symptoms negatively affecting infant 
temperament or infant difficult temperament having a negative impact on maternal 
psychological state, or both. However, it is important to note that the effect of prenatal 
depression remained strong and significant even after statistically controlling for 
postnatal mood, thus suggesting that postnatal mood cannot fully account for these 
results.  
Additionally, we cannot rule out other mediating mechanisms underlying the 
link between prenatal maternal factors and infant NA, including genetics. Indeed, it is 
possible that shared genetic susceptibility may contribute to the observed associations 
between maternal depressive symptoms and infants’ tendency to experience negative 
emotions. Future research is needed to disentangle intra-uterine environmental effects 




5.5.3 Prenatal maternal factors and infants’ stress reactivity  
In line with our initial hypothesis, maternal depressive symptoms during 
pregnancy predicted infants’ cortisol response to stress at 3 months, thus supporting 
existing evidence for a role of maternal depression in programming fetal stress 
reactivity. Differently from what we hypothesized however, maternal antenatal cortisol 
was not related to infants’ HPA axis stress response. Similarly, no associations 
between prenatal maternal factors and infants’ behavioral distress to the inoculation 
were found. 
As a whole, infants from the current sample displayed the expected cortisol 
response to the inoculation. However, maternal depression during late pregnancy was 
associated with individual differences in infants’ stress regulation, with infants 
prenatally exposed to higher depressive symptoms showing a flatter recovery of 
cortisol levels 40 minutes after the inoculation. Notably, this effect remained significant 
after controlling for maternal age, infant’s gender and concurrent depression, 
suggesting that prenatal exposure uniquely accounts for the association. Additionally, 
it appears to be specific to maternal depression rather than anxiety. The present 
findings are consistent with data from animal models that relates exposure to prenatal 
stress to changes in offspring HPA axis function, including HPA axis greater reactivity 
to stress (Huiznik, Mulder & Buitelaar, 2004). Additionally, this result is in line with the 
limited number of prospective studies in humans linking maternal prenatal depression 
to offspring slower cortisol recovery to experimental challenge at 12 months (Waters et 
al., 2013a) and to greater cortisol reactivity to stress across the first year of age 
(Leung et al., 2010; Brennan et al., 2008; Stroud et al., 2016; Fernandes et al., 2014). 
Interestingly, Davis and colleagues (2011) found that maternal depression during the 
third trimester of pregnancy was associated with slower newborn behavioral recovery 
to the heel-stick soon after birth, while no associations were found with newborn’s 
cortisol response. It is important to note that a recent systematic review found only 
little evidence for an association between prenatal exposure to maternal depression 
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and stress reactivity in offspring (Bleker et al., 2018). The authors suggested that large 
heterogeneity in whether the stressor evoke a response at all across studies might 
partially explain inconsistent results. In particular, studies that fail to detect a significant 
stress response in general, reported no associations between maternal antenatal 
depression and infant’s stress response (Azar et al., 2007; Laurent et al., 2011; Sharp 
et al., 2012). Thus, it has been suggested that maternal antenatal depression might 
affect the shape of the response trajectory rather than the magnitude (Bleker et al., 
2018). Our findings speak in favor of this hypothesis, showing a flatter recovery in 
cortisol levels after the stressor in children antenatally exposed to higher maternal 
depressive symptoms. 
In utero programming of the fetal stress response systems have been 
proposed as the core mechanism underlying the link between antenatal depression 
and later offspring outcomes (e.g. Kapoor, Petropoulos, & Matthews, 2008). Our 
findings support this hypothesis suggesting that prenatal exposure to maternal 
depression may exert programming effects on the fetus by altering the set points of the 
fetal HPA axis with later consequences for infant’s stress regulation. This result is 
particularly relevant as a dysregulation of the HPA axis has been suggested as an 
early marker of vulnerability for later behavioral and emotional problems in children 
(e.g. Turner‐Cobb, Rixon, & Jessop, 2008). Additionally, it is noteworhty that 
depressed individuals, as compared to controls, have been found to fail to adjust the 
cortisol response to stress, showing a lack of dynamic changes in cortisol levels 
following stress exposure across the age span (Lopez-Duran, Kovacs, & George, 
2009). For example, it has been reported that depressed preschoolers displayed 
persistently elevated cortisol levels in response to stressors (Luby et al., 2003; 2004). 
Although the current findings require replication in larger and different cohorts, we 
might speculate that a lack of recovery in cortisol levels after a painful stressor in 3-
month-old infants of prenatally depressed women might resemble the pattern of 
response observed in depressed individuals, suggesting that fetal programming of 
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HPA-axis reactivity could constitute a possible pathway of transmission of depression 
susceptibility. It would be of interest to determine whether these early differences in 
stress reactivity pattern persist over time and whether they can predict later outcomes, 
such as later depressive symptoms. 
It is critical to underline the fact that we are not able to rule out the possibility 
that shared genetic factors (or a combination of genetic factors and environmental 
exposure) between mother and child may account for infants’ early differences in 
stress reactivity and may be a possible mechanisms of transmission of susceptibility 
from mother to child (e.g. Dougherty et al., 2010). While it has been shown that the 
effects of prenatal stress on several infant outcomes is at least partially independent of 
genetics (Rice et al., 2010) and may be attributed to environmental factors, future 
studies adopting genetic informative designs are needed to disentangle the unique 
environmental effect of maternal antenatal depression on offspring’s stress reactivity.   
The nature of the in utero biological pathways leading to differences in the 
offspring’s HPA axis stress reactivity following exposure to antenatal depression 
remains to be clarified. We examined the impact of naturally occurring variations in 
maternal stress and immune functioning in late pregnancy on 3-month-olds stress 
reactivity. Notably, maternal prenatal cortisol, sAA and inflammatory markers were not 
significantly associated with infants’ cortisol response to stress, after adjusting for 
maternal age, infant’s gender and postnatal depression. While the current study was 
mostly exploratory with regards to possible effects of maternal antenatal sAA and 
inflammation on child outcomes, as available literature in humans is strikingly limited, 
the lack of an effect of maternal antenatal cortisol on infant HPA-axis stress reactivity 
is unexpected. Indeed, although few reports failed to detect a significant association 
between maternal antenatal cortisol and infant’s cortisol stress reactivity (e.g. 
Tollenaar et al., 2011; Braithwaite et al., 2016), a number of studies shows evidence 
for a positive links (e.g. Davis et al., 2011; Gutteling, De Weerth, & Buitelaar, 2004; 
Gutteling et al., 2005). Methodological differences between studies, including 
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differences in maternal cortisol assessment and gestational timing, may account for 
the conflicting evidence. Additionally, it is possible that small variations in maternal 
cortisol concentrations in a low risk sample of healthy women during the last weeks of 
pregnancy are not capable to significantly affect the fetal developing HPA axis. Or, it is 
also possible that unmeasured postnatal environmental factors might alter the 
unfolding of prenatal processes involved in programming of offspring’s stress-related 
physiology, as initial evidence in humans suggests (e.g. Sharp et al., 2012; Kaplan et 
al., 2009), thus confounding the observed associations.   
Lastly, we did not find any significant association between the maternal 
prenatal variables examined and 3-month-olds’ intensity and duration of behavioral 
distress to the inoculation. This is in contrast with several sources of evidence showing 
a link between either maternal depression  and infant’s behavioral reactivity (e.g. Davis 
et al., 2011; Werner et al., 2007) or maternal cortisol and infant’s behavior in response 
to stress (e.g. De Weerth et al., 2013; Werner et al., 2013b). Inconsistencies might in 
part arise from variability in methods used to evaluate both maternal and infant 
functioning. Additionally, it is possible that little inter-individual variability exists in the 
behavioral response to the first inoculation, with almost all infants displaying a 
significant level of behavioral distress following the shot administration. This is in line 
with findings from Jahromi and colleagues (2004) who reported a decrease in the 
intensity and duration of infants’ distress from 2 to 6 months. While our assessment of 
infants’ behavior was based on observer’s ratings, due to logistical issues related to 
being in the waiting room with other families not involved in the current research, in 
line with prior work (e.g. Jahromi et al., 2004) we were not able to videotape infants’ 
behavior before the inoculation and several minutes after. While the experimenter 
rated the infants before the inoculation as being “quiet” or “distressed”, we did not 
have a proper baseline period that could allow us to model the infant’s trajectory of 
response over time, thus limiting the possibility to detect significant associations 




A number of limitations should be taken into account when interpreting the 
current findings. First, our small sample size limits the statistical power of the findings. 
In addition, our results are based on a low-risk middle-high SES sample of healthy 
women and infants, thus limiting generalizability to different populations. Replication of 
the current findings in different and larger cohorts is needed. Secondly, while the 
assessment of multiple biological markers is a strength of the current study, our 
investigation was limited to one time point in late pregnancy and the observed 
associations might not extend to other gestational times. Prospective studies including 
different gestational windows of exposure, along with multiple stress markers, are 
likely to be particularly informative. Third, as we relied on naturally occurring variations 
in maternal depressive symptoms and associated biological markers, it is difficult to 
disentangle the role of prenatal factors from the effects of other related factors, 
including maternal diet or lifestyle or shared genetic factors that are likely to play a role 
in the “risk” transmission from mother to infant. Nevertheless, a wide range of possible 
confounders such as sociodemographic factors, health and pregnancy-related factors 
were controlled in statistical analyses. Additionally, only healthy pregnant women free 
from any medication, alcohol or smoking use were included. However, genetic factors 
or factors related to changes in diet or lifestyle remain areas for future investigations. 
Similarly, while we controlled for the effects of maternal postnatal depressive 
symptoms, we did not adjust for a number of additional postnatal environmental 
factors, including the quality of mother-child relationship, which is known to affect 
infant development (e.g. Raby et al., 2015). As a sensitive rearing environment has 
been shown to play a role in the link between prenatal adverse exposure and later 
outcomes in offspring (e.g. Grant et al., 2009; Bergman et al., 2010) and the 
assessment of postnatal depressive symptoms is not likely to fully reflect the quality of 
postnatal experience, future studies should explicitly examine the role of maternal 




To sum up, the current study provided support for a specific role of maternal 
antenatal depression in shaping infant temperamental NA and cortisol reactivity to 
stress. Additionally, maternal cortisol and CRP levels in late pregnancy were found to 
contribute in a unique way to 3-month-olds’ cognitive development, while maternal 
antenatal sAA levels appear to be related to infant NA. Taken together, the present 
findings add to growing evidence on the role of prenatal maternal influences on later 
child development, suggesting that the developing fetal brain is particularly sensitive to 
the intrauterine environment and adapts to even relatively small variations in maternal 
stress and inflammatory signals, with consequences that are evident 3 months after 
birth. Findings from the current study encourage further investigation of SNS and IRS 
mechanisms in fetal programming that have been largely neglected until now. 
However, our results do not support the hypothesis that distress-linked variations in 
cortisol, sAA and inflammatory marker levels during pregnancy mediate the effects of 
maternal depression on fetal development. Indeed, we reported only a marginally 
significant association between maternal depressive symptoms and IL-6 levels, that 
interestingly were not found to be related to any of the outcomes evaluated 3 months 
after birth, while no associations between maternal distress and cortisol or sAA or 
CRP levels, in line with several previous reports (e.g. Davis et al., 2011; Bergman et 
al., 2010). While a number of limitations discussed above may partially account for 
these null associations, these findings underscore the needs to explore alternative 
mechanisms of effects, involving for example epigenetics or placental mechanisms of 
regulation, in order to elucidate the full extent of the in-utero pathways leading to 
different developmental trajectories. Moreover, it would be of great interest to evaluate 
whether the observed individual neurodevelopmental differences are stable over time 
and whether they predict later outcomes. It is our purpose to follow up this sample to 
evaluate whether the effects of prenatal maternal influences persist to later ages and 
to examine the role played by postnatal caregiving. A better understanding of the 
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origins and trajectories of early individual differences will be crucial for the design of 






Chapter 6: The role of postnatal maternal care in the 
association between maternal prenatal influences and 





There is mounting evidence that in utero exposure to maternal depression 
during pregnancy can influence fetal development, leading to negative 
neurodevelopmental outcomes in the offspring during infancy and beyond, including 
delayed cognitive development, fearful or reactive temperament and altered stress 
reactivity (e.g. Gentile, 2017). The process through which fetal development is 
perturbed as a consequence of exposure to an altered intrauterine environment has 
often been described as fetal programming (e.g. Barker, 2004; Seckl & Holmes, 2007). 
In particular, it has been proposed that mood-related alterations in the functioning of 
some biological systems, such as the Hypothalamic-Pituitary-Adrenal (HPA) axis, the 
Sympathetic Nervous System (SNS) and the Inflammatory Response Systems (IRS), 
might mediate the observed effects of fetal programming (reviewed in Rakers et al., 
2017). In chapters 4 and 5, we examined the effects of antenatal exposure to 
variations in maternal depressive symptoms, stress and inflammatory biological 
markers on infant’s developmental outcomes soon after birth and at 3 months of age. 
However, considerable evidence suggests that fetal programming of later outcomes 
can be modified by postnatal environmental conditions (O’Donnell & Meaney, 2017), 
thus underscoring the need to account not only for prenatal effects but also for early 




Long-standing evidence within the attachment theory framework and recent 
neuroscience support the fundamental role of a sensitive and responsive caregiver as 
one of the leading forces directing infants’ psychobiological developmental trajectories 
(Tottenham, 2017). The quality of early parental care has been found to predict a 
number of outcomes in children, including socio-emotional and cognitive development 
(e.g. Austin et al., 2017; De Wolff & Van Ijzendoorn, 1997; Gartstein, Hancock, & 
Iverson, 2017; Mills-Koonce et al., 2015). Additionally, considerable evidence supports 
the role of a sensitive and responsive caregiver as an external behavioral and 
physiological regulator throughout the first year of life (Crockenberg & Leerkes, 2004), 
influencing infants’ developing stress response systems (Gunnar, 2017). In particular, 
it has been shown that a sensitive caregiver is able to buffer child’s HPA axis reactivity 
(reviewed in Gunnar & Hostinar, 2015), while disturbances in early care can disrupt 
neuroendocrine stress regulation (Gunnar & Quevedo, 2007), with a non-optimal 
caregiving environment, characterized by low maternal sensitivity, leading to 
exaggerated stress reactivity (Albers et al., 2008; Blair et al., 2008; Hane et al., 2010; 
Blair et al., 2006). The biological embedding of early caregiving experiences within the 
infant’s HPA axis has been proposed as a potential pathway through which the quality 
of caregiving can alter children’s developmental trajectories, reducing or exacerbating 
the risk for psychopathology (e.g. Gunnar & Quevedo, 2007). However, while several 
studies investigating the impact of antenatal depression on child development have 
accounted for the effects of postnatal symptomatology (e.g. O’Donnell et al., 2013), 
the potential role of parenting style, in mediating or moderating antenatal maternal 
influences, has been largely neglected.  
Substantial continuity has been reported in maternal prenatal and postnatal 
depressive symptoms and family disharmony, suggesting that continued exposure to 
adversity might occur (Bekkhus et al., 2011). Additionally, maternal postnatal 
depression has been found to negatively affect maternal caregiving behaviors (e.g. 
Bernard et al., 2018). However, the extent to which poor maternal parenting in the 
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early postnatal period might explain, at least partially, some of the outcomes in the 
offspring that have been traditionally associated with antenatal depression is largely 
unknown (Monk et al., 2012).  
Furthermore, it is still unclear whether the quality of parenting received during 
early development may moderate the effects of prenatal stress exposure on infants’ 
physiological and behavioral outcomes. Evidence from rodent and primate models 
suggest that variations in postnatal caregiving are able to modify the bio-behavioral 
outcomes associated with prenatal stress exposure, by either counteracting the 
detrimental influences of prenatal adversities on offspring development or 
exacerbating the risk of poor outcomes (Francis et al., 2003; Maccari et al., 1995; 
Sanchez, 2006; Sapolsky, 1997; Wakshlak & Marta, 1990).  
For example, it has been shown that postnatal maternal adequate caregiving 
behaviors, such as handling or “licking and grooming”, can reverse offspring increases 
in emotional reactivity (Wakshlak & Marta, 1990), deficits in hippocampal 
neurogenesis (Lemaire et al., 2006), impairment in glucocorticoids feedback (Maccari 
et al., 1995) and morphological and hormonal alterations (Del Cerro et al., 2010) 
associated with prenatal stress exposure. Additionally, initial evidence suggests that 
similar effects might operate in humans too, as shown by studies demonstrating that 
early maternal tactile stimulation, such as maternal stroking, might moderate the 
effects of prenatal stress on children’s physiological and behavioural outcomes (Sharp 
et al., 2012; Sharp et al., 2015; Pickles et al., 2017). However, only a handful of 
prospective studies examined the buffering role of sensitive caregiving in the link 
between prenatal maternal distress, such as depressive or anxiety symptoms, and 
infants’ developmental outcomes, including temperament, cognition and stress 
reactivity.  
A review of the literature yielded only three published studies examining the 
moderating role of postnatal maternal care in the link between self-reported prenatal 
stress and cognitive development, and these provided mixed results. More specifically, 
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Grant and colleagues (2010) found that maternal sensitivity to distress moderated the 
link between prenatal exposure to maternal anxiety disorder and 7-month-olds 
cognitive, but not motor, development in a sample of 77 mother-infant dyads, while 
controlling for postnatal concurrent symptoms. In particular, a positive association 
between maternal sensitivity and cognitive performance among infants prenatally 
exposed to maternal anxiety (N=14), but not among controls (N=63), was reported. In 
contrast, no evidence was found for a moderating role of maternal sensitivity and 
structuring in the link between maternal antenatal objective and subjective stress  and 
30-month-olds cognitive development in a sample of 128 mother-infant dyads from the 
Queensland Flood Study (Austin et al., 2017). Likewise, Bergman and colleagues 
(2008) found that attachment did not moderate the link between maternal antenatal 
stress exposure (as indicated by the number of stressful events experienced during 
pregnancy) and 17-month-olds cognitive development in a sample of 125 mother-
infant dyads. However, considerable differences in infants’ age and “maternal stress” 
phenotype under study makes difficult to compare findings from the above mentioned 
studies.   
Similarly, very few studies investigated whether the quality of maternal 
caregiving was able to moderate the association between prenatal stress and infants’ 
temperament. In particular, Bergman and colleagues (2008) reported that an insecure-
ambivalent attachment pattern exacerbates the link between prenatal stress exposure 
and 17-month-olds’ fearfulness as observed during a standardized laboratory 
assessment. Conversely,Kaplan and collaborators (2009) did not find any significant 
effect of maternal sensitivity in moderating the link between prenatal psychiatric 
diagnosis and maternal report of 4-month-olds’ temperament, although the small 
sample size (N=44) limited the statistical power of the study. 
Furthermore, to our knowledge, only three human studies explored the 
buffering role of maternal sensitive caregiving on infants’ prenatal-stress associated 
stress physiology. In a small prospective study, maternal sensitivity moderated the 
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prenatal effects of maternal psychiatric diagnosis on 4-month-olds’ baseline cortisol 
levels, with maternal sensitivity protecting from elevations in cortisol levels among 
infants of prenatally depressed/anxious mothers (N=19), while no effects were 
reported on infants’ heart rate variability (Kaplan, Evans & Monk, 2009). Grant and 
colleagues (2010) found maternal sensitivity to be associated with lower 7-month-olds’ 
behavioral reactivity to the still-face procedure; and the association was more marked 
in infants of prenatally anxious women (N=16). In contrast, while maternal sensitivity 
independently predicted infant’s cortisol response to the still-face, it did not moderate 
the association between prenatal maternal anxiety and infants’ cortisol reactivity 
(Grant et al., 2009). 
Lastly, despite increasing evidence for a role of maternal antenatal 
disturbances in the functioning of stress-related biological systems in fetal 
programming (e.g. Davis et al., 2011; Giesbrecht et al., 2017; Graham et al., 2017), to 
date only Bergman and colleagues (2010) investigated the extent to which the quality 
of caregiving might moderate the link between maternal antenatal variations in stress 
hormones and child outcomes. Specifically, the authors found that a secure infant-
mother attachment protected from the detrimental effects of prenatal exposure to 
higher levels of cortisol on 17-month-olds’ cognitive functioning.  
 
6.2 Summary and study hypotheses 
While a great deal of research has shown that in utero exposure to maternal 
depression is associated with an increased risk for altered physiological and 
behavioral outcomes in the offspring (reviewed in Gentile, 2017), the extent to which 
prenatal factors and postnatal factors related to the quality of early caregiving interact 
to influence infants’ outcomes remains unknown. In particular, despite the fact that 
antenatal depression is one of the strongest predictor of postpartum depression (e.g. 
Heron et al., 2004) which, in turn, has been related to disturbances in early parenting 
(Easterbrooks, Biesecker, & Lyons-Ruth, 2000; Easterbrooks et al., 2008), studies in 
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the DOHaD field have rarely accounted for the quality of postnatal care. Thus, it is 
unclear whether the quality of postnatal care may explain some of the developmental 
outcomes that have been originally attributed to the intrauterine exposure to antenatal 
depression. Furthermore, while animal models consistently show that postnatal 
maternal care  moderates the impact of antenatal stress exposure on the development 
of the offspring (Weinstock et al., 2017), generalizability of these findings to humans is 
still unknown. A review of the literature yelded only a handful of prospective studies 
examining the role of caregiving in moderating the impact of prenatal maternal stress 
on the offspring’s development (Austin et al., 2017; Bergman et al., 2008; Kaplan et 
al., 2009; Grant et al., 2009; Grant et al., 2010) with large variability in sample sizes, 
infant’s age, measures of maternal stress (i.e. psychiatric diagnosis, self-reported 
stressful life events, subjective and objective stress following exposure to a natural 
disaster) and caregiving (i.e. maternal sensitivity, sensitivity to distress, structuring and 
mother-infant attachment) making difficult to draw any comparisons. Furthermore, 
while Bergman and colleagues (2008) have investigated the moderating role of 
postnatal care in the link between maternal antenatal cortisol and 17-month-olds’ 
cognitive development (Bergman et al., 2008), no studies to date have focused on 
early infancy and have included alternative biological measures of maternal antenatal 
stress, such as salivary alpha amylase (sAA), C-Reactive Protein (CRP) and 
Interleukine-6 (IL-6).  
In chapter 5, we investigated the influences of variations in maternal antenatal 
depressive symptoms, stress and inflammatory markers on 3-month-olds 
neurodevelopmental outcomes, while controlling for postnatal symptomatology. In the 
current study, we aimed to extend research into the effects of antenatal stress by 
exploring the role of the quality of maternal early caregiving, as assessed through the 
Emotional Availability (EA) scales (Biringen, 2008). The EA scales is a well-validated 
instrument that allows to obtain reliable indicators of the quality of mother-child 
relationship and that, compared to other rating systems, emphasizes the emotional 
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feature of the interaction (Biringen et al., 2012), which might be an important aspect to 
consider in mothers experiencing depressive symptoms. Despite being widely used in 
developmental studies, the EA scales are still rarely employed in research within the 
DOHaD field.  
Building upon existing knowledge, we aimed to provide additional empirical 
evidence for a role of maternal EA on 3-month-olds’ developmental outcomes 
independent from prenatal and postnatal depressive symptoms and to investigate the 
interplay among prenatal and postnatal maternal influences in shaping infants’ bio-
behavioral development. For this reason, we examined the independent contribution of 
postnatal maternal EA and the interactive influence with prenatal maternal factors (i.e. 
maternal depressive symptoms, cortisol, sAA, CRP and IL-6) on a broad range of 
infants’ outcomes including stress reactivity, temperament and psychomotor 
development, while controlling for several potential confounders. We evaluate several 
different outcomes tapping into distinct aspects of development in order to test the 
robustness of the effects and evaluate whether prenatal and postnatal factors interact 
in a similar way to influence different developmental outcomes. Additionally, 
considering the strong association between maternal depressive and anxiety 
symptoms, we investigated whether adjusting for maternal anxiety, rather than 
depression, changes the direction and significance of the associations among 
maternal EA and child outcomes and whether maternal antenatal anxiety interact with 
postnatal EA to predict any outcomes in the offspring.  
Based upon the available literature, we hypothesized that maternal EA would 
be associated with several developmental outcomes in offspring and in, particular, we 
expected infants of less emotionally available mothers to show poorer cognitive and 
motor performances, more difficult temperament and greater stress reactivity. 
Furthermore, with respect to the role of maternal caregiving in the DOHaD hypothesis, 
we tested two main hypotheses. First, we hypothesized that women with higher 
prenatal depressive symptoms would show lower levels of maternal EA, as compared 
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to women with lower depressive symptoms, and that this subsequently could mediate 
the effects of antenatal depression on infants’ neurodevelopmental outcomes. 
Secondly, we explored for the first time whether maternal EA would moderate the 
relationship between several indices of prenatal maternal stress (i.e. depressive 
symptoms, cortisol, sAA, CRP and IL-6) and infant outcomes. Due to the limited 
available literature in humans, we made only a very broad a priori hypothesis. In 
particular, we hypothesized that higher maternal EA at 3 months of age would protect 
infants from the negative impact of prenatal stress, while we expected the worst 
outcomes in infants of mothers who showed higher levels of antenatal stress and were 
also less emotionally available at 3 months of age.  
 
6.3 Material and methods 
 
6.3.1 Participants  
One hundred and ten predominantly Italian (97.1%) middle-high class (87.5%) 
primiparous (91.3%) women were recruited between 30-33 gestational weeks at 3 
hospitals in Italy as part of the EDI (Effects of Depression on Infants) study. Women 
with singleton uncomplicated pregnancy, no smoking or drug using and not afflicted by 
any chronic disease or taking any chronic medications were eligible to participate. 
From the initial sample of 110 women, 3 were excluded for reasons related to 
intrauterine death and newborn’s health problems, while 3 women did not attend the 
postnatal session due to logistic reasons (i.e. living too far from the Medea Institute), 
resulting in 104 mother-infant dyads included in the current study. Infants (51% males) 
were mostly born by vaginal delivery (81.7%) and were full term, except for two babies 
born, respectively, at 35 and 36 gestational weeks in good health. Women who were 
excluded from the 12-weeks postnatal phase did not differ from participants on any 




6.3.2 Procedure  
Maternal depressive and anxiety symptoms, biological functioning and 
cognitive function were assessed in late pregnancy (mean gestational age= 34.72; 
SD= 1.14) as described below. Health and pregnancy-related data were also collected 
at that time. The 12-week postnatal assessment included one session for the 
evaluation of infants’ cortisol and behavioral reactivity to the inoculation and a 
subsequent session at the Medea Institute for the assessment of infants’ cognitive and 
motor development and quality of mother-infant relationship. On the same occasion, 
mothers were asked to report on infants’ health, temperament and, once again, on 
their depressive and anxiety symptoms.  
The Ethics Committee of University College London, of Scientific Institute 
Eugenio Medea and of the hospitals and pediatric health centers involved approved 
the study protocol.  
 
6.3.3 Maternal assessment 
Maternal pre- and postnatal depressive and anxiety symptoms. Maternal 
depressive symptoms were evaluated through the Italian version (Benvenuti et al., 
1999) of the Edinburgh Postnatal Depression Scale (EPDS; Cox, Holden, & Sagovsky, 
1987), a 10-items scale widely used to screen for perinatal depression. Items are 
scored on a 4-points Likert scale ranging from 0 to 3, with a maximum score of 30. 
Maternal anxiety symptoms were evaluated through the Italian version (Pedrabissi & 
Santinello, 1989) of the trait anxiety subscale of the State-Trait Anxiety Inventory 
(STAI) (Spielberger, Gorsuch & Lushene, 1970) a 20-item scale generally employed to 
identify symptoms of anxiety as a general trait. Responses are rated on a 4-point 
Likert scale ranging from 1 (not at all) to 4 (very much), with a maximum score of 40. 
Maternal antenatal cognitive function was assessed through the Raven 
Standard Progressive Matrices (RSPM, Raven et al., 1998), a widely employed test 
that evaluate non-verbal general cognitive ability. It consists of 60 multiple choice 
270 
 
items that require participants to identify the missing element that completes a pattern 
within 30 minutes. The RSPM raw scores, as a measure of individual general cognitive 
ability, were employed in the analyses. 
Maternal antenatal biological assessment. Blood samples, available from 94 
women out of 104, were drawn in the morning by venipuncture and kept refrigerated at 
+4° until they reached the Biological Lab of Medea Institute were serum was 
centrifuged, aliquoted, and stored at −80 °C. Biological assay for CRP and IL-6 levels 
were run in duplicate by using Quantikine High Sensitivity ELISA kits (R&D Systems 
Europe, LTD) at LaboSpace in Milan. Intra-assay coefficient of variation (CV) was <6% 
for IL-6 and <3% for CRP, inter-assay CV was <10% for both markers.  
Saliva samples were collected at home on two consecutive days immediately 
upon awakening, 30 minutes post-awakening and before going to bed by passive drool 
(Granger et al., 2007) to provide a general index of diurnal cortisol and sAA functioning 
(O’Donnell et al., 2013). Participants were instructed to record time of collection on a 
diary and asked to avoid eating, tooth-brushing and exercising in the 30 minutes 
before collection and eating a major meal in the hour before the evening sample. As 1 
woman collected the 30 minutes post-waking sample on day 2 more than one hour 
from awakening this sample was excluded from analyses (e.g. O’Donnell, 2013; 
O’Connor, 2014). All saliva samples were stored frozen at -80° until assayed for 
salivary cortisol at the Biological Lab of Medea Institute, using a competitive high 
sensitivity enzyme immunoassay kit (Expanded Range High Sensitivity Cortisol EIA 
Kit, Salimetrics), and for sAA at the Salimetrics Centre of Excellence testing lab at 
Anglia Ruskin University, using a kinetic enzyme assay kit (Salimetrics α-Amylase 
Kinetic Enzyme Assay Kit). All samples from one woman were run in the same assay 
to minimize method variability. Salivary cortisol assays were run in duplicate and 
averaged, except for 2 samples with minimal volume. Average intra- and inter-assay 
coefficients were <6% and <8%, respectively. Results were computed in µg/dl. A 
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random 10% of the sAA assays were run in duplicate to confirm reliability. The intra-
assay coefficient of variation was < 3%. Results were computed in U/mL. 
Maternal postnatal caregiving. The quality of maternal caregiving was 
evaluated through the Emotional Availability (EA) Scales, Infancy/Early Childhood 
Version (4th edition, Biringen, 2008) during a 15 minutes-videotaped free-play session. 
Mothers were left with their 3-month-olds in a room equipped with a standard set of 
age-appropriate toys and were told to interact with their child as they normally would 
do at home. Maternal behaviours towards the child were rated on four dimensions, 
namely: 1) Sensitivity, which refers to the ability to be warm, emotionally connected 
and responsive to the child’s signals; 2) Structuring, which refers to the ability to 
appropriate scaffold and structure the child’s play; 3) Non-intrusiveness, which refers 
to the ability to be available to the child without interfering with the child’s age-
appropriate autonomy and 4) Non-hostility, which refers to non-negative, abrasive, 
impatient or antagonistic style of interaction with the child. Each scale is rated with a 
direct score ranging from 1 (non-optimal) to 7 (optimal), as well as along 7 sub-scales 
generating a total score ranging from 7 to 29. In order to maximize variability in the EA 
scores, the total scores were employed in data analyses, as previously done (Austin et 
al., 2017). Additionally, as the four maternal EA scales were moderately inter-
correlated (rs= 0.73–0.50), they were standardized and summed to create an overall 
index of maternal EA (Cronbach’s α= .85) which also reduces the number of variables 
for analyses, as done in prior work (Taylor-Colls & Fearon, 2015). Two clinical 
psychologists, both trained by Zeynep Biringen and reliable in the use of the EA scale, 
4th Edition, both with the EA’s author, and with each other, coded independently the 
videotaped interactions after the end of data collection. Both raters were blind to all 
prenatal and postnatal data. A subsample of 20 randomly chosen dyads (around 
19.5% of the sample) were coded by both raters. Intra-class correlation (ICC) 




6.3.4 Infant assessment 
Infant temperament was assessed through the 37-items very short form of the 
Infant Behavior Questionnaire (IBQ-R-VSF), a widely employed standardized measure 
designed to evaluate 3 to 12 months infants’ temperament (Putnam et al., 2014). Items 
describing specific infants’ behaviors are rated by the caregiver on a 7-point scale and 
evaluate three broad, empirically derived, temperamental dimensions, namely 
negative affectivity, positive affectivity/surgency, and orienting/regulatory capacity.  
Infant mental and motor development was assessed through a well-
standardized and widely employed developmental assessment, namely the Bayley 
Scales of Infant and Toddler Development – Third Edition (Bayley III, Bayley 2006), 
that was performed by a trained clinical psychologist blind to prenatal data, according 
to the standardized protocol. Age-standardized composite scores for the Cognitive and 
Motor scales were calculated by using test norms (mean= 100; SD= 15).  
Infant behavioral stress reactivity. Infants’ cortisol and behavioural response to 
the inoculation were evaluated during the routine first inoculation visit at 12 weeks of 
age (SD=1.84). Infants were administered two injections (mean duration=1.06 
minutes, SD=00.30) in the thighs and infants’ behaviour was videotaped from the 
undressing before the inoculation until 2 minutes after the last needle was retracted. 
Coding of infant behavioural distress began once the last needle was retracted for a 2 
minutes period at 5-seconds intervals on a 4-point scale (Jahromi et al., 2004) ranging 
from 0 (no vocalization) to 3 (very intense loud crying with a out-of-control quality). The 
predominant (>2.5 seconds) level of intensity during each 5-seconds interval was 
scored. The scores were averaged across intervals to obtain an overall measure of 
intensity of distress, while a measure of overall distress duration was calculated by 
adding the number of intervals during which the infant was distressed (i.e. received a 
rating >0) and multiplying by 5. All videos were coded by a trained graduate student, 
blinded to all prenatal and postnatal study data. Twenty-one percent of the 
observations were coded by an independent trained coder. Intra-class correlation was 
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0.998 (p<.001). Data concerning the inoculation were available for 91 infants out of 
104, as 2 infants’ parents did not consent to the inoculation, while 11 infants were 
vaccinated in a different district from those involved in the project. 
Cortisol collection and assay. Three infants’ saliva samples were collected in 
the waiting room right before entering in the doctor room for the inoculation (baseline) 
and 20 and 40 minutes after the inoculation, through specifically designed swab 
(SalivaBio Infant’s Swab, Salimetrics), and were stored at -80º until assayed for 
cortisol according to the same procedure described for maternal cortisol. With the 
exception of 1 infant who was fed 11 minutes before the first saliva collection, babies 
were not fed in the 30 minutes before the saliva collection (mean time from last 
feeding=102.99 minutes, SD=54.60). Complete cortisol data were available for 78 
infants, while one or two samples were missing for 16 infants. Infants with complete or 
partial data did not differ on any sociodemographic/maternal or infants’ variables or 
situational factors (i.e. time of the day, length of the inoculation, behavioral score). All 
samples from one infant were run in duplicates on the same assay, with the exception 
of 8 samples that were run in singlet due to minimal saliva volume. The average intra- 
and inter-assay coefficients of variance were below 7% and 10%, respectively.  
 
6.3.5 Statistical analyses 
Variables were preliminarily examined for outliers and skewness. Samples 
greater than 3 SD from the mean were removed (n=7 for prenatal cortisol, n=4 for 
sAA, n=3 for prenatal IL-6, n=4 for infants’ cortisol) and variables were natural log (ln) 
transformed to approximate normal distributions. As described in the previous 
chapters, cortisol and sAA values at each time point were averaged across the 2 days 
and mean values were used to calculated four summaries measures of maternal 
cortisol and sAA diurnal functioning, specifically: awakening values, response to 
awakening (calculated by subtracting waking values from the 30min post-waking 
levels), diurnal slope (calculated by subtracting the bedtime values from the waking 
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values) and total diurnal output (calculated as the area under the curve (AUCg) using 
the trapezoid method with respect to the ground, Pruessner et al., 2003). The AUCg 
was calculated for each day separately and as the two values were highly correlated 
across the 2 days (r=.57, p<.001, for cortisol, while r=.75, p<.001 for sAA) the mean of 
the 2 days was used.  
Preliminary Pearson bivariate correlations and univariate analysis of variance 
(ANOVA) were conducted to investigate the effect of maternal, infant or situational 
variables on infants’ outcomes. Subsequent analyses were adjusted for those 
variables that emerged as significantly related to the dependent variables in these 
preliminary analyses.  
Separate hierarchical regression analyses were performed to evaluate the 
impact of maternal EA on infant’s outcomes (i.e. IBQ-R-VSF scales scores, Bayley III 
scales scores and behavioral intensity and duration of distress), while adjusting for 
covariates. Regarding the role of maternal EA in the association between antenatal 
maternal depression and infants’ development, we first employed Pearson bivariate 
correlations to investigate the association between maternal prenatal (and postnatal) 
depressive symptoms and EA score. A full mediation model was tested only when 
significant associations were found between maternal depressive symptoms and EA 
score (the a-path of the mediation model; Baron & Kenny, 1986) and maternal  
depressive symptoms and infants’ outcomes (the c-path of the mediation model; Baron 
& Kenny, 1986). Additional hierarchical regressions models were conducted to 
determine the interactive effects among maternal postnatal EA and prenatal variables 
on infant’s outcomes. Covariates were entered in the first step. Prenatal maternal 
variables were entered in a second step jointly with maternal EA scores, while the 
interacting effect of maternal prenatal and postnatal variables was entered in the last 
step. Similarly, Hierarchical Linear Models (HLMs) were estimated to explore the 
independent influence of maternal EA as well as the interactive influence of antenatal 
and postnatal maternal variables on infants’ cortisol response to the inoculation, while 
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accounting for the hierarchical structure of the data. HLMs were specified at two levels 
where individuals were level 2 and time was level 1. Time was centered at baseline so 
that the model intercept represents the mean cortisol level at baseline. Before fitting 
explanatory models including level-2 predictors, a baseline model of cortisol response 
was fitted, including linear and quadratic slopes for time. A random intercept and a 
random linear slope were included to allow between-person variability. The 
explanatory variables were centered around the grand mean and entered in the model 
one-by-one. Gender was centered at males. Model fit was tested with likelihood 
deviance difference test for nested models. Specifically, variables were kept in the 
model when their presence resulted in a significant (p<.05) reduction of the likelihood 
ratio statistic.  
Maternal depression and anxiety both during pregnancy (r=.66, p<.001) and 
postnatally (r=.58, p<.001) were quite strongly inter-correlated, thus a supplementary 
set of analyses was conducted to evaluate the independent effects of maternal EA 
while controlling for maternal anxiety, rather than depression. Additionally, the 
interactive effect between maternal prenatal anxiety and postnatal EA was tested.  
Statistical analyses were performed using SPSS 24 and MLWiN. 
 
6.3.6 Covariates.  
Several factors known to affect infants’ psychomotor development, 
temperament or stress physiology, such as sociodemographic factors, health-related 
and factors related to the day of inoculation were examined as potential confounders 
of the association between maternal variables and infant’s outcomes.  
Maternal age was significantly associated with infants’ 20-min post-stressor 
cortisol levels (r=.22, p=.04) and females showed marginally higher levels of cortisol at 
the 40-min post stressor collection as compared to males (F(1, 81)=2.98, p=.08). 
Thus, maternal age and infant gender were included as covariates in subsequent 
analyses on stress reactivity. 
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Both gestational age at birth and maternal IQ were significantly associated with 
infants’ cognitive development (respectively, r=.23, p=.02 and r=.24, p=.01) and 
gestational age at birth was significantly related to infants’ PAS scores (r=.28, p=.01). 
In addition, females tended to perform higher on the Motor scale, as compared to 
males (F(1, 101)=3.53, p=.06). Thus, gestational age, gender and maternal IQ (only 
for analyses on psychomotor development) were retained as covariate in the 
subsequent hierarchical linear regression models.  
Lastly, maternal EPDS scores at 3 months were significantly related to infant’s 
NA (r=.31, p=.003) and, marginally, with infants’ 20-min post-stressor cortisol levels 
(r=-.20, p=.06). Thus, maternal postnatal depression was included as a possible 
confounder in all regression and multilevels models. All analyses were also performed 
without including postnatal depression and are reported in the supplementary section.  
 
6.4 Results  
 
6.4.1 Descriptive analyses  
Descriptive statistics for study variables are presented in Table 6.1. Bivariate 
correlations showed no significant associations between maternal EA scores and 
prenatal or postnatal EPDS or STAI scores (range in Pearson rs=.07-13, all ps>.15), 
thus indicating that both antenatal and current depressive/anxiety symptoms were 
unrelated to maternal quality of caregiving, thus precluding further testing of mediation 
hypothesis (Baron & Kenny, 1986). However, there was a significant association 
between maternal EA and prenatal IL-6 levels (r=-.22, p=.04). Additionally, there was a 
significant association between higher maternal EA and both higher infants’ cognitive 
and motor composite scores (respectively, r=.20, p=.04 and r=.28, p=.005), as well as 
between higher EA and lower intensity of infant’s behavioural distress in response to 
the inoculation (r=-.22, p=.04). In contrast, infants’ cortisol levels and temperamental 
traits were not significantly associated with maternal EA scales scores (all ps>.05). 
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Table 6.1 – Descriptive statistics for study variables at the prenatal and postnatal 
assessment 
Study Variable Mean SD Range 
Prenatal    
Maternal cortisol (µg/dl)    
Waking 0.38 0.13 0.13-0.83 
Waking +30’  0.50 0.15 0.10-0.91 
Bedtime 0.18 0.06 0.01-0.41 
Maternal sAA (U/ml)    
Waking 69.89 64.68 3.00-463.84 
Waking +30’  48.33 38.65 2.80-190.10 
Bedtime 97.90 80.39 3.28-562.71 
Maternal CRP (ng/ml) 3749.60 2714.57 480.04-11179.80 
Maternal IL-6 (pg/ml) 1.69 1.03 0.48-6.47 
Maternal depression 
(EPDS) 
5.34 4.33 0-19 
Maternal anxiety (STAI-T) 36.32 9.07 21-63 
Postnatal    
Cognitive composite score 102.36 10.81 75-125 
Motor composite score 99.73 8.14 85-121 
NA 3.46 0.88 1.58-5.42 
PAS 3.87 0.76 2.30-5.54 
ORC 5.60 0.57 4.30-6.75 
Behavioral response to 
stress  
1.39 0.78 0.25-3.00 
Infants’ cortisol (µg/dl)    
Baseline  0.31 0.23 0.03-1.10 
20-min post-stressor  0.78 0.35 0.01-1.86 
40-min post-stressor 0.47 0.25 0.11-1.37 
Maternal sensitivity 22.23 3.32 15-29 
Maternal structuring 23.06 2.81 14-29 
Maternal non-intrusiveness 22.09 4.07 13-29 






6.4.2 Independent effects of maternal EA scores on infant’s outcomes 
As shown in Table 6.2, multiple hierarchical regression analyses revealed 
significant associations between maternal EA scores and infant motor development, 
after controlling for infant’s gender, gestational age, maternal IQ, prenatal and 
postnatal depression. Specifically, higher maternal EA was significantly associated 
with higher infants’ motor scores at 3 months (β=.27, t=2.77, p=.007), while the 
association between maternal EA scores and infant cognitive development was not 
significant (p=.085).  
Table 6.2 – Hierarchical linear regression analyses for the independent effects of 
maternal EA on infants’ cognitive and motor outcomes, adjusted for covariates 
 Cognitive scores Motor scores 
 β p β p 
Step 1     
Gestational Age .22 .03 .26 .01 
Maternal IQ .22 .03 .01 .94 
Gender .13 .18 .20 .05 
Prenatal EPDS -.13 .29 .04 .75 
Postnatal EPDS  .12 .31 .13 .19 
ΔR
2
 for step 1 .12 .02 .13 .03 
Fmodel 2.68 .03 2.67 .03 
Step 2     
Maternal EA .17 .09 .27 .01 
ΔR
2
 for step2 .03 .09 .07 .01 
Fmodel 2.78 .01 3.67 .003 
 
Furthermore, as presented in Table 6.3, HLMs revealed a significant effect of 
maternal EA on both the linear and quadratic slopes of infants’ cortisol response (both 
ps=.04), while controlling for relevant covariates. Specifically, as shown in Figure 6.1, 
lower maternal EA was associated with 3-month-olds’ greater cortisol reactivity, as 
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indicated by a steeper linear and quadratic slope of cortisol response. However, 
maternal EA was not significantly associated with cortisol baseline levels (p>.05). The 
inclusion of maternal EA significantly improved the model fit over the baseline model 
(deviance difference (3)=8.1 p=.04).  
Lastly, there were no significant associations between maternal EA scales 
scores and any temperamental dimension as well as infant intensity and duration of 
behavioral distress in response to the inoculation, after adjusting for covariates (all 
ps>.05). 
 
Table 6.3 – HLM for the independent effects of maternal EA on infants’ cortisol 
response, adjusted for covariates. 
 Cortisol response 
 Estimate (SE) p 
Fixed effects   
Intercept 0.262 (0.022) <.001 
Maternal Age 0.005 (0.003) .13 
Prenatal EPDS 0.034 (0.021) .11 
Postnatal EPDS -0.029 (0.020) .15 
Maternal EA 0.002 (0.005) .79 
Linear 0.021 (0.002) <.001 
Maternal EA -0.001 (0.000) .04 
Quadratic -0.000 (0.000) <.001 
Maternal EA  0.000 (0.000) .04 
Random effects   
Level 2 (individual)   
Intercept variance 0.009(0.004) .05 
Linear slope variance 0.000 (0.000) .02 
Intercept/Linear slope covariance -0.000(0.000) .19 
Level 1 (occasions)   




Figure 6.1 – Averaged cortisol values before and after the inoculation for infants of 




6.4.3 Interactive effects between prenatal maternal variables and postnatal EA 
scores on infant’s outcomes 
 
In Chapter 5, the independent effects of antenatal maternal influences (i.e. 
depressive symptoms and biological markers) on infant psychomotor development, 
temperament and stress reactivity was evaluated in separate hierarchical regression 
or hierarchical linear models, as appropriate. We now extend those models to include 
both the independent effects of maternal EA and the interactive effects with the 
maternal prenatal variables above mentioned, in order to evaluate the moderating role 
of maternal postnatal EA in the association between maternal prenatal influences and 
infant outcomes, while controlling for possible confounders. Our interest was primarily 
in the interaction terms.  
 
6.4.3.1 Motor and cognitive development  
Hierarchical regression analyses showed no significant interaction between 
maternal prenatal variables (i.e. depressive symptoms, cortisol, sAA, CRP and IL-6) 
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and postnatal EA scores on infant cognitive and motor development, after adjusting for 
covariates. In contrast, as shown in Table 6.4, the main effects of prenatal maternal 
cortisol AUCg and CRP levels on cognitive development, already outlined in Chapter 
5, remain significant even when maternal EA was included in the model. 
 
Table 6.4 – Hierarchical linear regression analyses for the interactive effects between 
maternal postnatal EA and, respectively, prenatal cortisol and CRP  levels on infants’ 
cognitive scores. 
 Cort AUCg CRP 
 β P β p 
Step 1     
Gender .15 .13 .10 .37 
Gestational Age .21 .04 .20 .07 
Maternal IQ .22 .03 .17 .13 
Postnatal EPDS  .13 .27 .14 .29 
Prenatal EPDS -.14 .26 -.14 .31 
ΔR
2
 for step 1 .13 .03 .09 .15 
Fmodel 2.68 .03 1.65 .15 
Step 2     
Prenatal biological predictor -.37 <.001 -.21 .04 
Maternal EA .16 .09 .21 .05 
ΔR
2
 for step 2 .15 <.001 .11 .01 
Fmodel 4.90 <.001 2.56 .02 
Step 3     
Maternal EA X Biological 
predictor 
.09 .34 -.19 .10 
ΔR
2
 for step 3 .01 .34 .03 .08 






6.4.3.2 Temperament and behavioral distress in response to stress  
None of the interaction coefficients between maternal prenatal variables and 
postnatal EA predicting temperamental scores was statistically significant (all ps>.05), 
after adjusting for infant’s gender, gestational age and postnatal depression. In 
contrast, the main effects of maternal prenatal depressive symptoms and maternal 
sAA response to awakening on infants’ NA scores, already reported in Chapter 5, 
remain significant after adjusting for postnatal EA. Specifically, higher depressive 
symptoms and greater morning sAA decline after awakening were associated with 
infants’ higher scores on NA (respectively, β=.37, t= 2.97, p<.01 and β=-.31, t= -3.14, 
p<.01).  
Similarly, there were no significant interaction between maternal prenatal 
variables and postnatal EA scores in predicting infant’s intensity and duration of 
behavioral distress in response to the inoculation, after controlling for infant’s gender, 
maternal age and postnatal depression.  
 
6.4.3.3 Cortisol response to stress 
As shown in Table 6.5, there was a significant three-way interaction among 
maternal prenatal cortisol AUCg, maternal EA at 3 months and both the linear and 
quadratic slopes of time (p<.05) on infants’ cortisol levels, after controlling for maternal 
age, infant’s gender, postnatal and prenatal depression. Specifically, as illustrated in 
Figure 6.2, at higher levels of maternal prenatal cortisol (+1SD), there was a significant 
association between maternal EA and infant’s cortisol reactivity (for both linear and 
quadratic slopes p<.01), with lower levels of maternal EA being associated with 
greater cortisol reactivity. In addition, at higher level of maternal EA (+1SD), there 
were no differences in infants’ cortisol response to the inoculation depending on levels 
of prenatal maternal cortisol (p=.26), while at lower levels of maternal EA (-1SD), 
infants prenatally exposed to higher maternal cortisol levels showed a significantly 
steeper linear and quadratic slopes (both ps<.05). The overall improvement of the 
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model fit over the baseline model was significant (deviance difference (9)=17.24, 
p=.05).  
 
Table 6.5– Full prediction model for the independent and interactive effects of maternal 




 Cortisol Response 
 Estimate (SE) p 
Fixed effects   
Intercept 0.268 (0.023) <.001 
Maternal Age 0.005 (0.003) 0.18 
Postnatal EPDS -0.040 (0.021) 0.06 
Prenatal EPDS  0.046 (0.023) 0.04 
Maternal EA 0.000 (0.005) 0.98 
Prenatal Cortisol AUCg -0.000 (0.000) 0.15 
Prenatal Cortisol AUCg X Maternal EA 0.000 (0.000) 0.80 
Linear 0.027 (0.023) 0.07 
Maternal EA 0.003 (0.002) 0.15 
Prenatal Cortisol AUCg 0.000 (0.000) 0.19 
Prenatal Cortisol AUCg X Maternal EA -0.000 (0.000) 0.04 
Quadratic -0.000 (0.000) 0.07 
Maternal EA -0.000 (0.000) 0.15 
Prenatal Cortisol AUCg -0.000 (0.000) 0.27 
Prenatal Cortisol AUCg X Maternal EA 0.000 (0.000) 0.05 
Random effects   
Level 2 (individual)   
Intercept variance 0.009(0.004) 0.04 
Linear slope variance 0.000(0.000) 0.01 
Intercept/Linear slope    
covariance 
-0.000(0.000) 0.15 
Level 1 (occasions)   
Intercept variance 0.016(0.003) <.001 
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Figure 6.2 – Averaged cortisol values before and after the inoculation for infants of 
higher (+1 SD) and lower (-1SD) emotionally available mothers jointly with higher (+1 SD) 
and lower (-1SD) maternal antenatal cortisol, after adjusting for covariates. 
 
 
No significant interaction between postnatal EA scores and all other prenatal 
variables (i.e. maternal depressive symptoms, sAA, IL-6 and CRP levels) on infant 
cortisol response was found. Additionally, the effects of maternal prenatal variables, 
including maternal depressive symptoms, on infant cortisol reactivity, were no longer 
significant once maternal EA scores were included in the model. 
 
6.4.4 Supplementary analyses 
 
A supplementary set of analyses was run to evaluate the effects of maternal 
EA on infants’ outcomes while controlling for maternal anxiety, rather than depression. 
The analyses yielded comparable results with maternal EA remaining a significant 
predictor of infants’ motor outcomes (β=.26, t=2.74, p=.007) and cortisol response to 
the inoculation (for both linear and quadratic slopes, ps=.04), while no significant 
associations between maternal EA and infants’ temperamental or behavioral stress 
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scores were found (all ps>.05). Similarly, the three-way interaction among maternal 
prenatal cortisol AUCg, maternal EA at 3 months and both the linear and quadratic 
slopes of time on infants’ cortisol levels remain significant (both p=.05), after 
controlling for maternal anxiety rather than depression. Lastly, no significant interaction 
between maternal prenatal anxiety and postnatal EA on any outcomes examined (all 
ps>.05) was found. 
Furthermore, as multicollinearity could be an issue, all models were re-run 
without including postnatal depression as a covariate. Results showed that adjusting 
for maternal depressive symptoms at 3 months did not affect the statistical significance 
of the associations between maternal EA and infants’ outcomes previously described. 
The only exception concerns the association between maternal EA and infants’ 
cognitive scores that reached the statistical significance (β=.20, t=2.07, p=.04) once 




The current study was aimed at investigating the effects of maternal postnatal 
caregiving on infants’ early bio-behavioral development, as well as the possible role of 
variations in early maternal care in the association among maternal prenatal influences 
(i.e. depressive symptoms and stress-related biology) and 3-month-olds outcomes. As 
expected, maternal Emotional Availability (EA) emerged as a significant predictor of 
infant’s motor development and stress reactivity at 3 months of age. However, contrary 
to our predictions, maternal EA was not associated with infants’ early cognitive 
development and temperament. Concerning the role of maternal EA in the 
associations between prenatal maternal influences and infants’ neurodevelopment, no 
support for a mediating role of maternal caregiving in the observed associations was 
found. In contrast, the current study provided novel evidence for a role of maternal EA 
in moderating the association between prenatal maternal cortisol and cortisol stress 
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reactivity in a low risk sample of healthy women and infants. These results were 
independent of prenatal and postnatal depressive or anxiety symptoms.  
 
6.5.1 Psychomotor development  
The current findings provide partial support for the hypothesized association 
between maternal postnatal EA and infant’s psychomotor development in healthy full-
term 3-month-old babies. As predicted, higher maternal EA was associated with 
enhanced motor development and the association remained significant when 
controlling for infant’s sex, gestational age, maternal IQ, prenatal and postnatal 
maternal depression. In contrast, the association between maternal sensitivity and 3-
month-olds’ cognitive performance, although in the expected direction, did not reach 
the statistical significance when the model was adjusted for postnatal maternal 
depression.  
The fundamental role of the caregiver in supporting infant development is one 
of the central tenets of attachment theory and empirical evidence suggests that 
maternal sensitivity, defined as the ability to respond in a timely and appropriate 
manner to the child’s signals, is a robust predictor of several developmental outcomes 
(e.g. Kok et al., 2013; Leigh, Nievar, & Nathans, 2011; Verhage et al., 2016). However, 
the role of parenting in fostering motor development has been less investigated. In 
particular, while a number of studies examined the role of parenting on motor 
development in samples at risk for poor developmental outcomes, such as preterm or 
very-low-birth-weight infants (Forcada-Guex et al., 2006; Grunau, 2009; Sansavini et 
al., 2015; Treyvaud et al., 2009), studies on normative samples of typically developing 
children are lacking. To our knowledge, our study is among the first to report an 
association between maternal postnatal EA and early infant’s motor development in a 
sample of healthy full-term babies. This finding is in line with accumulating evidence 
showing that even normal variation in the quality of mother-infant relationship might 
influence infant brain development (e.g. Rayson et al., 2017; Taylor-Colls & Pasco 
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Fearon, 2015) and it is particularly relevant because, across the first year of life, motor 
development play a crucial role in fostering babies’ daily interactions and directly 
influence all other domains of development, with important implications for the child’s 
overall functioning (Karasik, Tamis‐LeMonda, & Adolph, 2011; Leonard & Hill, 2014). 
However, it is important to note that the correlational nature of these findings, does not 
allow to establish causality and direction of this relationship. In particular, it has been 
suggested that children’s characteristics may affect maternal styles of interaction 
(Sameroff & Fiese, 2000). For example, a child who has developmental delays, 
including in the motor domain which play a fundamental role in sustaining mother-child 
interactions at the very early stages of life, may discourage maternal attempts to 
initiate interaction or compromise maternal interactional style as a reaction to her 
child’s abilities, resulting in less optimal mother-child interaction (Wheeler, Hatton, 
Reichardt, & Bailey, 2007). Nonetheless, it is noteworthy that the present result is in 
line with experimental studies showing an effect of interventions aimed at promoting 
sensitive and supportive parenting in improving several domains of children's 
development (Landry, Smith, & Swank, 2006; Morrison et al., 2014), including the 
motor domain (e.g. Natrasony & Teitelbaum, 2016), as well as with studies on adopted 
children showing that foster-reared children showed less mental and motor delay in 
the first year of life as compared to orphanage-reared children (Miller et al., 2005). 
Additionally, while it has been shown that the development of reflexes mainly depends 
on a neurophysiological maturation of the central nervous system, reach-to-grasp 
movements, shared attention for an object, as well as gross-motor milestones are 
strongly influenced by environmental differences in stimulations, such as those 
provided by the caregiver (Zoia et al., 2013). Thus, we might hypothesize that highly 
emotionally available mothers provide an optimal stimulating and positive interactive 
environment that facilitates infants’ physical exploration of the surroundings and 
engagement in rewarding exchanges that could foster infant’s motor development from 
the very beginning of life. As consistent inter-individual variability in the acquisition of 
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motor milestones has been reported (Camaioni & Di Blasio, 2002), it would be 
important to evaluate whether the observed association would persist later in 
development and whether maternal EA at 3 months of age might predict later 
developmental trajectories.  
The lack of a significant association between maternal EA and 3-month-olds 
cognitive performance is in contrast with our expectations and with previous findings 
(e.g. Austin et al., 2017; Firk et al., 2018; Mills-Koonce et al., 2015; van Bakel & 
Riksen-Walraven, 2002). We might hypothesize that this reflects a lack of power and 
that a larger sample size would have the statistical power to detect smaller effects than 
the current study was able to (and indeed the association was significant in the non-
adjusted model). However, it is also possible that the influence of maternal EA we 
reported on motor outcomes might be observed on cognitive performance as the 
children age. In line with this hypothesis, Mills-Koonce and colleagues (2015) reported 
modest correlations between sensitive parenting at 6 months and concurrent infants’ 
cognitive ability, but larger correlations at 24 months. Similarly, Firk and colleagues 
(2018) found a significant association between maternal sensitivity and cognitive 
development at 21 months, but not at 5 or 14 months and Grunau and colleagues 
(2010) reported a significant effect of parenting on cognitive development at 18 
months but not at 8 months in a sample of preterm infants. This is also in line with 
research on developmental risk factors which show that cognitive delays among high-
risk children are not apparent until late toddlerhood (Black, Hess, & Berenson-Howard, 
2000; Mackner, Black, & Starr, 2003). Thus, we might speculate that different sensitive 
windows of higher plasticity to environmental influences might underline the 
development in motor and cognitive development, with the quality of postnatal rearing 
experience appearing to play a greater role in the gradual acquisition of motor skills 
rather than in the cognitive domain at 3 months of age. A follow-up assessment at 
older ages when cognitive and motor skills are more developed and differentiated 
might revealed different findings. 
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Furthermore, differently from our initial hypothesis, we did not find any 
evidence for a moderating effect of maternal EA in the link between maternal prenatal 
factors and infants’ psychomotor development. In contrast, the negative association 
between infant’s cognitive outcomes and both maternal prenatal cortisol and CRP 
levels remain significant even after the inclusion of postnatal maternal EA. This result 
is in contrast with findings from Bergman and colleagues (2010) which reported a 
significant moderating effect of child-mother attachment in the association between 
prenatal cortisol exposure and 17-month-old infant’s cognitive development, with 
higher prenatal maternal cortisol being significantly associated with poorer cognitive 
outcomes only in insecurely-attached children. Replication of these results in different 
and larger samples are needed before interpretation of these findings can be made. 
However, considerable methodological differences, particularly in the assessment of 
the quality of mother-child interaction and, importantly, in child’s age might explain the 
lack of consistency. For example, it has been hypothesized that cognitive development 
in the first stages of life appears much more biologically determined and less 
permeable to postnatal environmental influences, while during the second year of life 
children appear to benefit more from enriching environments (Black et al., 2000). 
However, findings are only preliminary and further research is needed to understand 
how early caregiving experiences may modify the bio-behavioral outcomes associated 
with prenatal stress exposure. 
Lastly, it is noteworthy that no associations between maternal EA scores and 
either prenatal or postnatal depression and anxiety symptoms were found in the 
current study. As mothers in the study were a community low-risk sample, with high 
levels of education and socio-economic status, the lack of important differences in 
maternal EA between mother with higher and lower prenatal depressive symptoms is 
not totally unexpected (e.g. De Weerth et al., 2003; Endendjik et al., 2005). Indeed, 
while the use of a low-risk sample has the potential to limit confounding influences of 
additional risk factors associated with psychosocial adversity (e.g. teenage 
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motherhood, unemployment, financial problems etc.), it is possible that this may have 
constrained the range in maternal EA. In line with this hypothesis, reduced maternal 
EA has been found in depressed mothers (e.g. Easterbrooks, Bureau & Lyons-Ruth, 
2012; Trapolini et al., 2008; Easterbrook, Biesecker, & LyonsRuth, 2000) and in 
mothers with depression in remission (Kluczniok et al., 2016) from high-risk samples 
such as low-income mothers (e.g. Easterbrooks 2000; 2012) or mothers being referred 
to parent-craft centre for support after the delivery (e.g. Trapolini et al., 2008). In 
contrast, studies on low-risk samples, such as work from Endendijk and colleagues 
(2005), reported no impact of maternal depressive symptomatology on EA scores and 
failed to support a mediation role of maternal parenting in the link between antenatal 
depression/anxiety and child outcomes, consistently with the current findings. 
Interestingly, aspects of maternal prenatal physiology related to inflammation, as 
indexed by higher IL-6 levels, were weakly associated with reduced postnatal maternal 
EA. Despite these findings require further replication in larger samples, they are in line 
with several animal studies that showed less optimal mothering behaviors in prenatally 
stressed dams as compared to controls (Bosch et al., 2007; Meek et al., 2001; Pardon 
et al., 2000; Patin et al., 2002) leading to the hypothesis that alterations in maternal 
behaviors might explain, at least partially, the adverse outcomes in pups born from 
prenatally stressed dams. However, it is important to note that in the current study no 
significant associations between maternal IL-6 levels during pregnancy and infants’ 
neurodevelopmental outcomes at 3 months of age were found, thus precluding further 
testing of a mediation model. Additionally, the association between maternal CRP 
levels and infants’ cognitive development remains significant after controlling for 
postnatal EA. Thus, we found no support for a maternal EA-mediated pathway from 




6.5.2 Temperament  
Contrary to our initial hypothesis, we found no evidence for an association 
between maternal EA and early infants’ temperamental traits, as well as no significant 
interactive effects between prenatal and postnatal maternal variables in shaping 3-
month-olds’ temperament, after adjusting for covariates.  
Traditionally, temperamental traits are believed to be relatively stable individual 
differences in the domains of affectivity, activity, attention levels and self-regulation 
(Shiner et al., 2012), that are biologically driven and become more open to 
environmental influences later in development. The lack of an association between 
maternal EA and infants’ temperament, at least at 3 months of age, is consistent with 
this view and it is in line with few available studies reporting no associations between 
maternal sensitivity and infants’ early temperamental traits (e.g. Kaplan et al., 2009; 
Thomas et al., 2017). Similarly, significant association between maternal sensitivity 
and maternal reports of infants’ temperament at 9-12 month of age, but not at a 
younger age, has been reported (Kivijärvi et al., 2005; Seifer et al., 1996). We might 
speculate that, while early temperamental differences are rather independent of the 
quality of postnatal maternal care, they might be open to postnatal shaping later 
across the first year of age. Alternatively, methodological issues related to the sample 
size or the use of maternal reports of infant’s temperament rather than observative 
measures might explain the null findings.  
In addition, maternal EA was not found to moderate the link between prenatal 
maternal influences and infant’s temperament. In contrast, both antenatal maternal 
depression and sAA response to awakening were observed to contribute in a unique 
and independent way to predict infants’ negative affectivity scores, after adjusting for 
confounders and for maternal EA. This is in line with findings from Kaplan and 
colleagues (2009) that did not observe any significant effect of maternal sensitivity in 
moderating the link between prenatal psychiatric diagnosis and 4-month-olds’ 
temperament. In contrast, Bergman and colleagues (2008) showed that Insecure-
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Ambivalent mother-child attachment, accentuated the link between antenatal stress 
and 17-month-olds’ fearfulness. However, methodological differences in the age range 
and in the assessment of temperament (i.e. self-reports versus observation) and 
quality of care (i.e. maternal EA versus attachment) makes difficult to compare results. 
Despite further replication is needed before the significance of the current results can 
be discussed, we might hypothesize that the interactive effects between prenatal and 
postnatal maternal factors on infant temperament might be delayed in its effects and 
be revealed later in development. Additionally, it is also possible that factors that were 
not examined nor controlled as part of the current investigation may play a more 
critical role in shaping infants’ temperament, such as genetics. There is growing 
evidence for the influence of specific polymorphisms on individual differences in 
temperament which suggest that temperament should be considered, at least partially, 
under genetic control (reviewed in Papageorgiou & Ronald, 2013). We might 
hypothesize that pleiotropic genetic effects might account for the observed association 
between prenatal maternal factors and infant’s negative affectivity. Future studies are 
needed to elucidate the complex interplay among genetic, prenatal and postnatal 
environmental influences that are likely to determine the final outcome.  
 
6.5.3 Stress reactivity  
Although all infants, as a whole, displayed the expected cortisol response to 
the inoculation procedure (Gunnar et al., 2009), maternal EA appeared as a significant 
independent predictor of infant’s cortisol reactivity at 3 months of age. In line with our 
predictions, we found that infants of less emotionally available mothers showed a 
greater cortisol response to the immunization as compared to infants of more sensitive 
mothers. In contrast, no effects of maternal EA on infant’s intensity and duration of 
behavioral distress was found. Furthermore, we provided novel evidence for an 
interactive effect between maternal prenatal cortisol and postnatal EA on infants’ 
cortisol response to the inoculation, suggesting an interplay between prenatal and 
293 
 
postnatal environmental factors in shaping individual variability in stress reactivity with 
important theoretical and clinical implications.  
The association between higher maternal EA and lower infant cortisol reactivity 
is in line with our hypothesis and consistent with previous work both in animals and 
humans showing that sensitive and responsive caregivers are able to buffer the 
physiological stress response (e.g. Grant et al., 2009; Gunnar et al., 1996; Levine, 
1994; Nachmias et al.,1996; Suomi, 1991; Spangler & Grossman, 1999), reducing 
activity of stress-mediating biological systems, including the HPA axis. In particular, 
while during the first 3 months of life the HPA axis is highly reactive to a variety of 
stressors (Gunnar, Talge, & Herrera, 2009), it has been shown that it is also during 
this period that maternal caregiving behaviors appear to shape infants’ developing 
stress regulation (e.g. Albers et al., 2008) and, by the end of the first year of life, a 
secure mother-child attachment relationship becomes a powerful stress-buffering 
agent (reviewed in Gunnar, 2017). The mechanisms underlying parental stress 
buffering during infancy are still to be fully elucidated and include the possibility that 
early in development the presence of a sensitive caregiver directly controls regions 
that regulate stress such as the hypothalamus to prevent the beginning of the HPA-
axis hormonal cascade (Gunnar & Hostinar, 2015) or stimulates oxytocin release 
which has inhibitory effects on the HPA-axis (Heinrichs et al., 2003; Hostinar, Sullivan, 
& Gunnar, 2014). We might speculate that in infants of less emotionally available 
mothers, the parental stress buffering is less effective and, although the mother is 
present, these children display stronger elevations in cortisol in response to stress as 
a result. As impaired stress buffering is considered one possible mechanism through 
which early adverse experiences “get under the skin” and influence stress-related 
physiology (Hostinar, Sullivan, & Gunnar, 2014), the current findings could indicate 
one way in which very early experiences with the caregiver might shape the 
developing stress response systems with possible long-term implications.  
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However, because the current findings are correlational, it is difficult to 
establish the direction of the influence between infants’ reactivity and maternal 
sensitivity. For example, we might hypothesize that more “reactive” infants or infants 
who get more “easily” stressed are also infants who might challenge the ability of a 
caregiver to remain emotionally available. However, it is important to note that 
maternal behaviors and infants’ stress response were observed during different 
situations and, in particular, maternal EA was coded during a free-play session which 
should be a less challenging and more usual situation for a caregiver to handle as 
compared to the inoculation procedure. Additionally, as discussed in the previous 
paragraph, we found no evidence for an association between maternal reports of 
infants’ temperament and EA scores, in line with previous reports (e.g. Kaplan, Evans, 
& Monk, 2008; Hane & Fox, 2006). Thus, the alternative hypothesis that infant’s 
characteristics, such as a difficult temperament, constrains the quality of mothers’ 
caregiving seems less likely in the current sample.  
Alternatively, maternal EA might influence maternal soothing behaviors during 
the inoculation procedure which, in turn, might influence infants’ stress reactivity. 
However, it is noteworthy that we did not report any significant association between 
maternal EA and infants’ behavioral intensity and duration of distress to the 
inoculation, whereas maternal soothing behaviors are usually found to predict infants’ 
behavioral response to the vaccination (e.g. Cohen, 2002; Jahromi, Putnam, & Stifter, 
2004). On the one hand, it is possible that methodological reasons, including the lack 
of a baseline period of behavioral observation, might have limited our ability to capture 
the trajectory of infant’s behavioral response to stress and possible associations with 
maternal EA. Nonetheless, the current results are in line with previous reports 
suggesting a dissociation between the physiological and behavioral levels of response 
to stress related to the sensitivity of a caregiver. In particular, it has been shown that 
while a sensitive caregiver is able to buffer the infant’s HPA axis, this does not prevent 
the child from showing elevations in levels of behavioral distress in response to a 
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stressor (Gunnar et al., 1996; Nachmias et al., 1996). This dissociation is thought to 
have a functional role as it allows infants to experience and communicate distress to 
caregivers in a way that elicit help and care, without experiencing concurrent possible 
detrimental elevations in cortisol levels (Gunnar et al., 2015). 
Lastly, we cannot rule out unmeasured confounding or third variables that 
might influence the observed association between maternal EA and infants’ cortisol 
reactivity, including pleiotropic effects whereby shared genetic factors influences both 
maternal sensitivity and infants’ stress reactivity.   
Interestingly, in line with our exploratory hypothesis, the quality of maternal 
caregiving emerged as a significant moderator of the association between prenatal 
maternal cortisol and infant’s cortisol reactivity. Specifically, while maternal prenatal 
cortisol diurnal levels alone were not associated with 3-month-olds stress reactivity, a 
different picture appeared when the interactive effects between maternal prenatal 
cortisol levels and postnatal EA were examined. In particular, the magnitude of the 
association between maternal parenting behaviors and cortisol reactivity depended 
upon maternal prenatal cortisol levels, so that maternal EA was significantly related to 
infants’ cortisol response only at higher levels of maternal prenatal cortisol. In addition, 
high maternal EA buffered the negative association between prenatal maternal cortisol 
and infant’s cortisol reactivity. Specifically, while we reported a significant association 
between maternal antenatal cortisol and greater cortisol response to the inoculation 
among infants of less emotionally available mothers, the association became non-
significant among infants of highly sensitive mothers.  
Despite increasing evidence for a role of a sensitive caregiver as an early 
external regulator of the offspring’s HPA axis and, in parallel, mounting data on the 
effects of prenatal maternal cortisol in shaping the development of fetal stress 
physiology, the extent to which maternal prenatal cortisol and postnatal care have 
interactive organizational effects on the offspring’s HPA axis reactivity in humans 
remains unclear. The current study is among the first to suggest that the processes 
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leading to associations between prenatal maternal cortisol and offspring’s stress 
reactivity might be over–ridden by postnatal environmental factors such as high levels 
of maternal EA in a low risk sample. Further replication in larger and different sample 
is needed. However, our findings are consistent with evidence from animal models 
(e.g. Francis et al., 2003; Maccari et al., 1995; Sanchez, 2006; Sapolsky, 1997; 
Wakshlak & Weinstock, 1990) and with initial evidence in humans suggesting an 
interplay between prenatal stress influences and postnatal maternal sensitivity in 
shaping offspring’s stress-related physiology. In particular, Kaplan and colleagues 
(2008) reported that maternal sensitivity moderates the impact of prenatal psychiatric 
diagnosis on 4-month-olds’ resting cortisol levels, with infants of women with an 
antenatal diagnosis showing higher cortisol levels only if they received less sensitive 
parenting. However, although infant cortisol was measured in a laboratory session, it 
was assessed only once and not in response to a stressor, thus can only partially 
inform about the interactive influence of prenatal and postnatal maternal factors on 
infants’ stress reactivity. In contrast, in the study by Grant and colleagues (2009) 
maternal sensitivity was not found to moderate the association between prenatal 
maternal anxiety and infant’s cortisol reactivity to the still-face procedure at 7 months 
of age. Instead, prenatal anxiety and maternal sensitivity were found to contribute 
independently and in an additive manner to infant cortisol response. However, none of 
these studies included measures of maternal cortisol during pregnancy which is 
thought to represent one of the primaries in utero mediating mechanisms of 
programming of fetal stress reactivity. Although we did not report a main effect for 
prenatal maternal cortisol on 3-month-olds cortisol reactivity, the significant interaction 
we observed among prenatal cortisol and postnatal EA is consistent with the growing 
body of evidence suggesting that the combination of multiple factors, rather than a 
single one, is more likely to be involved in determining psychobiological developmental 
trajectories (e.g., Appleyard et al., 2005). It could be speculated that poor parenting, as 
indicated by low maternal EA, might exacerbate the negative association between 
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maternal prenatal cortisol and infants’ stress reactivity, leading to greater cortisol 
reactivity to the stress of inoculation in infants prenatally exposed to higher levels of 
cortisol. This is in line with a “multiple hit” or “cumulative stress” hypothesis suggesting 
that adverse experience during sensitive periods early in life might predispose 
individuals to be more vulnerable to aversive challenges later in life in a cumulative 
manner (Nederhof & Schmidt, 2012).  
Interestingly, the magnitude of the link between maternal EA and infants’ 
cortisol reactivity that we observed in the whole sample, was found to depend upon 
the levels of maternal diurnal cortisol during pregnancy with a significant association 
between variations in maternal EA and stress reactivity reported only among infants 
prenatally exposed to higher levels of maternal cortisol. These novel findings are in 
line with the notion that individuals might differ in their susceptibility to environmental 
influences that has been proposed by several theoretical models such as the 
diathesis–stress (Monroe & Simons, 1991; Zuckerman, 1999) or dual-risk models 
(Sameroff, 1983), Belsky’s (2005; 1997), differential susceptibility hypothesis and 
Boyce & Ellis (2005) biological sensitivity to context. Further research is needed to 
elucidate the underlying mechanisms, however, it could be speculated that infants of 
prenatally “stressed” women might be particularly affected by variations in maternal 
care because of a genetic predisposition (e.g. Belsky & Pluess, 2009). Or, we might 
hypothesize that the exposure to an altered intrauterine environment characterized by 
higher levels of maternal cortisol, could increase the sensitivity of the developing 
individual to environmental influences and make those infants more vulnerable to the 
effects of variations in postnatal environment, in line with the hypothesis that prenatal 
experience could programme humans postnatal plasticity and adaptation to 





The current findings should be regarded in light of several limitations. First, the 
moderate sample size might have limited our statistical power to detect significant 
interactions. Second, besides maternal EA, additional postnatal environmental factors 
may moderate the association between maternal prenatal stress and differences in 
psychomotor development, temperament and stress regulation, which were not 
addressed in the current study. For example, factors related to paternal caregiving 
which have been shown to buffer negative effects of maternal interactive behaviors 
(Malmberg et al., 2016; Mills-Koonce et al., 2015). Similarly, alternative explanations, 
including genetics, need to be considered when interpreting the current findings and, 
equally important, the observational nature of the design does not allow to establish 
causality or directions of the observed associations. Third, as the current sample 
consists of middle-class, well-educated women, future studies should examine 
whether the current findings generalize to mothers from more disadvantaged socio-
economic samples or high-risk samples. For example, the lack of variance in 
demographics as well as the low rate of women at risk for depression might have 
constrained the range in maternal EA scores and explain, at least in part, the lack of 
association between maternal symptoms of distress and EA scores which is often 
found (e.g. Easterbrooks, Bureau & Lyons Ruth, 2012). Fourth, it is possible that the 
early assessment of healthy full-term infants at 3 months of age might have limited the 
variability in outcomes such as cognitive scores or temperamental traits thus making 
difficult to detect significant effects that might emerged later in development. It is our 
aim to follow up the current cohort of infants to evaluate whether maternal EA, both 






The current findings extend animal research into the biological impact of early 
maternal care by suggesting that naturally occurring variations in maternal EA are 
significantly associated with individual differences in early motor development and 
stress regulation in a low risk sample. In particular, data seems to indicate that highly 
emotionally available mothers, characterized by a sensitive, structuring, non-intrusive, 
and non-hostile style of caregiving, provide an optimal context for early brain 
maturation, fostering motor development and contributing to the shaping of physiologic 
regulation to future stressors. 
Furthermore, the current findings raise an important theoretical and 
methodological issue, indicating that research into biological mechanisms involved in 
programming of bio-behavioral development needs to account not only for prenatal 
effects but also for the influence of early caregiving experiences, as variations in 
postnatal care may alter the unfolding of prenatal programming. In particular, our 
results suggest that the vulnerability related to exposure to higher prenatal maternal 
cortisol, either mediated by genetic factors or by in utero mechanisms, might be 
opened to postnatal shaping by maternal EA, thus supporting the need of a 
comprehensive model of early-life programming.  
Equally important, from a clinical perspective, the data highlights the 
importance of maternal EA, and especially in situations of high stress in pregnancy, for 
later development in young children. Findings suggest that infants exposed to higher 
levels of prenatal maternal cortisol might benefit more from high maternal EA to 
support the development of their stress regulation abilities. Thus, postnatal 
interventions aimed at enhancing maternal EA might be particularly beneficial for 
women experiencing higher stress levels during pregnancy in order to improve their 
children’s developmental outcomes.  
Future studies addressing the moderating and mediating influences of 
postnatal maternal caregiving in the link between antenatal adversity and child 
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outcomes are expected to provide insights into the mechanisms through which 
antenatal exposure to maternal depression might affect children outcomes, as well as 
contribute to identify potential targets for interventions through which the long-term 













Chapter 7: General Discussion 
 
The developmental roots of mental illness can often be traced to early life 
(Grossman et al., 2003; Gunnar & Quevedo, 2007; Schlotz & Phillips, 2009), yet it is 
still unclear how early environmental exposures influence later health outcomes and 
susceptibility to disease. The prenatal period is a time of exceptionally rapid growth 
and brain development including neurogenesis, neuronal differentiation, 
synaptogenesis and myelination (Grossman et al., 2003), which make the fetus 
particularly susceptible to environmental influences with potentially long-lasting 
consequences (Gluckman et al., 2007). In the past decades, a tremendous amount 
has been learned about the organizational influence of maternal antenatal stress on 
the developing fetus, yet there is still a great deal that is not understood.  
The current thesis builds on and extends research into the effects of antenatal 
stress in humans by adopting a multi-systems approach, that involves the assessment 
of different indices of maternal antenatal stress (i.e. depressive/anxiety symptoms, 
stress hormones and inflammatory markers), and by taking the role of postnatal 
maternal care into account.  We used a prospective longitudinal design and 
demonstrated that antenatal depressive symptoms, but not anxiety, were associated 
with an altered stress-related physiology (i.e. diurnal cortisol and inflammation) in late 
pregnancy and independently predicted higher infant negative affectivity (NA) at three 
months of age. In addition, we provided evidence that variations in maternal stress-
related biology during pregnancy were independently associated with physiological 
and behavioural outcomes in offspring. Lastly, we found the first evidence in humans 
that the impact of antenatal maternal cortisol on infant cortisol reactivity to stress may 
be moderated by the quality of the mother-infant relationship. Our results are in 
keeping with the hypothesis that maternal antenatal stress signals can exert a 
programming effect on offspring’s bio-behavioral development and that the impact is 
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partially dependent on the quality of the early rearing environment. This chapter 
describes and discusses the main findings, reviews limitations of the studies included 
in the current dissertation and puts forward suggestions for future research. 
 
7.1 Main findings 
 
7.1.1 Maternal stress-related biology and depressive symptoms during the perinatal 
period 
In line with our predictions, higher depressive symptoms during pregnancy 
were associated with higher Interleukine-6 (IL-6) levels, and an altered cortisol diurnal 
pattern, as indexed by lower morning cortisol levels (i.e. at waking and 30 minutes 
after) and a flatter diurnal decline, while adjusting for potential confounders. In contrast 
with our initial hypothesis, however, no significant associations were found in the early 
postpartum period. Furthermore, exploratory analyses indicate that anxiety, but not 
depressive, symptoms were associated with an altered sAA diurnal profile and that the 
interplay between inflammatory and stress markers during pregnancy might be 
different in women with higher depressive symptoms.  
Evidence exists of an altered diurnal cortisol pattern in clinically depressed 
(O’Connor et al., 2014) or minority high-stressed (Suglia et al., 2010) pregnant women; 
likewise, an association between depressive symptoms and elevations in circulating 
IL-6 levels has been reported in samples of low-income high-psychosocial risk 
(Cassidy-Bushrow et al., 2012; Christian et al., 2009) and clinically depressed (Haeri 
et al., 2013; S. Osborne et al., 2018b) pregnant women. The current findings support 
and extend those studies by showing that antenatal depressive symptoms, even 
without meeting the full criteria for a clinical diagnosis, are associated with an altered 
stress-related physiology in a low-risk community sample of healthy pregnant women. 
These results converge with evidence of depression as a dimensional “trait” in the 
general population, rather than a discrete entity, with a continuous measure of risk 
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underlying the clinical phenotype (e.g. Wray et al., 2018). It is important to note that 
composite measures of diurnal cortisol, such as the overall diurnal cortisol output, as 
indexed by the Area Under the Curve (AUCg), were not significantly associated with 
depressive symptoms. One methodological implication is that a detailed 
characterization of the diurnal pattern, both through multiple sampling and 
sophisticated analytical techniques such as hierarchical linear models (HLMs), is 
needed in order to detect reliable associations between psychosocial stress measures 
and subtle disturbances in diurnal cortisol profile that would be undetectable 
otherwise, especially in late pregnancy and in non-clinical low risk sample. Indeed, as 
cortisol levels increase (e.g. Allolio et al., 1990) and maternal HPA-axis becomes 
gradually less responsive to stress as pregnancy advances (Kammerer et al., 2002), 
the association between maternal distress and cortisol might become more difficult to 
detect; this might be particularly true in low risk samples not exposed to excessive 
stressors (O’ Connor et al., 2014). 
The pathways underlying the observed associations are still to be understood.  
First of all, it has been suggested that depression and either inflammation or cortisol 
dysregulation share a common genetic background. In particular, genetic variants 
related to increased immune responses have been more frequently found in 
depressed patients (reviewed in Barnes, Mondelli, & Pariante, 2017). Similarly, 
glucocorticoid receptor polymorphisms were found to be associated both with an 
altered HPA axis function, with the occurrence of depression and response to 
antidepressants treatment (reviewed in Spijker & van Rossum, 2009). 
Secondly, both the HPA axis and the Inflammatory Response System (IRS) 
have been shown to be extremely responsive to environmental adversities 
(Baumeister, Lightman, & Pariante, 2014) and it has been proposed that early adverse 
experiences, including intra-uterine ones, might affect their functioning and confer 
vulnerability for the development of mental health problems later in life (Pariante et al., 
2017). For example, childhood trauma has been associated with increased 
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inflammation (see meta-analyses by Baumeister et al., 2016) as well as with a 
dysregulation of the HPA axis (Heim et al., 2008). Similarly, heightened inflammation 
has been found in young adults prenatally exposed to maternal depression (Plant et 
al., 2016), while a flatter cortisol diurnal slope was found in adolescents prenatally 
exposed to maternal anxiety (O’Connor et al., 2005), thus raising important questions 
concerning the intergenerational transmission of the risk for depression. In this view, it 
is important to note that depression is often conceptualized as a stress-related 
disorder, with adverse experiences and stressful life events influencing the onset and 
course of the symptomatology in humans (e.g. Pine et al., 2002; Kessler, 1997; 
Kendler et al., 1999). As both the HPA axis and the IRS are considered candidate 
mechanisms through which stress can “get under the skin” to affect mental and 
physical outcomes, current findings, despite observational in nature, could indicate 
possible biological pathways underlying the effects of stress on mental health 
outcomes. In particular, an alteration of the diurnal cortisol pattern (i.e. lower morning 
cortisol output and a flatter diurnal slope) could represent a promising candidate 
mechanism for explaining associations between psychosocial stress and mental health 
outcomes. Interestingly, while traditionally stress is thought to trigger an activation of 
the HPA axis, it is now clear that it could both increase and decrease HPA activity 
depending on several features of the stressor, including time (Miller et al., 2007). 
Meta-analytical evidence indicate that while the beginning of a stressor is associated 
with a greater activity of the HPA-axis, over time, there is a counter-regulatory 
response that leads to a rebound of cortisol output below normal, as indicated by lower 
morning levels, daily output etc. (Miller et al., 2007). Furthermore, there is now 
increasing evidence that a flatter diurnal cortisol decline can represent a biological 
marker of stress exposure (e.g. O’Connor et al., 2014, O’ Donnell et al., 2013) and a 
recent meta-analysis provides evidence of an association between a flatter diurnal 
cortisol slope and a number of poorer mental and physical outcomes, including 
depression (Adam et al., 2017), thus suggesting that diurnal cortisol slopes might 
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represent a biological correlate of physical and emotional health. Likewise, it is now 
clear that psychosocial stress can activate the inflammatory response systems, 
leading to increased levels of pro-inflammatory cytokines, acute phase proteins, such 
as CRP, or other inflammatory markers (Segerstrom & Miller, 2007) and it has been 
proposed that, besides the HPA-axis, inflammatory pathways could represent a 
mechanism for the effect of stress on mental health outcomes that deserve further 
investigation (Miller & Raison, 2016). However, it is important to emphasize once 
again that the current findings were correlational and causative pathways cannot be 
established. Future research is needed to establish whether the changes we observed 
in the HPA axis and IRS functioning of women with higher depressive symptoms 
during pregnancy might represent a mechanism by which depressive states emerge or 
an effect of emerging depressive symptoms.  
Importantly, the inflammatory response system and the HPA axis exhibit 
bidirectional links and function in a complex interdependent manner over time. Thus, 
abnormal inflammation or dysregulation of the HPA axis has the potential to disrupt 
this circuit, carrying potentially adverse consequences for mental and physical health. 
Our exploratory analyses provide evidence of a positive association between maternal 
IL-6 levels and both higher diurnal salivary alpha amylase (sAA) and, to a lesser 
extent, cortisol concentrations in women with higher depressive symptoms during 
pregnancy. While increased inflammation together with hyperactivity of the HPA axis 
activity have been often reported in depressed patients outside the perinatal period 
and is considered suggestive of glucocorticoid resistance (Pariante et al., 2017), the 
interplay among stress hormones and inflammation during pregnancy is still largely 
unexplored. Our initial findings are in line with our exploratory hypothesis and with the 
only two existing studies showing an impairment of the negative feedback relationship 
between cortisol and pro-inflammatory cytokines during pregnancy in high-risk 
samples (Corwin et al., 2013; Walsh et al., 2016), suggesting that bidirectional stress-
immune interactions offer a promising avenue for future endeavor.   
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The current study did not find any substantial evidence of an association 
between diurnal sAA levels and depressive symptoms during pregnancy. In contrast, 
maternal antenatal anxiety symptoms were significantly associated with an altered 
sAA diurnal pattern, as indicated by lower sAA levels at awakening and a flatter 
decline in sAA levels 30 minutes after awakening, in line with few reports of an 
alteration of sympathetic function in prenatally anxious women (e.g. (Field et al., 2004; 
Field et al., 2006; Giesbrecht et al., 2013). These findings indicate that, despite being 
comorbid, maternal depression and anxiety during late pregnancy may differ in some 
respects in their underlying biology, raising important issues with regards to possible 
mechanisms involved in fetal programming and challenging the general notion that 
different forms of maternal antenatal stress are reliably associated with increased 
glucocorticoids levels. Replication of this finding, particularly with larger samples and 
those containing more clinical depressed or anxious individuals would be invaluable. 
The lack of association between maternal depressive symptoms and diurnal 
cortisol or inflammatory markers levels soon after delivery is unexpected, although it is 
in line with some studies that failed to find any significant association between 
maternal depression and either cortisol (reviewed in Garcia-Leal et al., 2017) or 
circulating levels of inflammatory markers (e.g. Corwin et al., 2015; Skalkidou et al., 
2009) in the immediate postpartum period. On the one hand, these null findings might 
be related to limited statistical power, as the sample size at the postnatal phase was 
decreased (N=89 women of the initial 110 included). Alternatively, it can be 
hypothesized that the considerable elevations in both stress hormones and 
inflammatory markers in response to labor and delivery might mask the association 
with postpartum depressive symptoms, so that a major event would be needed to raise 




7.1.2 Maternal depressive symptoms and infants’ outcomes 
As hypothesized, higher maternal antenatal depressive symptoms were 
significantly associated with greater infants’ negative affectivity (NA) at 3 months of 
age. This association was specific for maternal depression, rather than anxiety, and 
remained significant after controlling for postnatal symptomatology and maternal care. 
Conversely, the hypothesized association among maternal depressive symptoms 
during pregnancy and 3-month-olds’ cortisol stress reactivity, outlined in Chapter 5, 
became non-significant once accounting for the quality of maternal care (Chapter 6). 
Furthermore, in contrast with our initial predictions, no associations were found 
between maternal depressive symptoms during late pregnancy and either infant’s birth 
outcomes or cognitive and motor development.  
Findings of an association between prenatal exposure to maternal depression 
and infants’ NA, defined as the individual propensity in experiencing negative 
emotions, are in line with several studies (Austin et al., 2005; Davis et al., 2007; Huot 
et al., 2004; Rouse & Goodman, 2014). As high NA levels represent  a key 
temperamental risk factor for later internalizing and externalizing symptoms, including 
anxiety and depression (e.g. Gartstein, Putnam, & Rothbart, 2012; Sayal et al., 2014), 
the observed association might indicate a possible early pathway from antenatal 
exposure to maternal depression to children’s later behavioral maladjustment. 
However, as the reliance on maternal reports for both the independent (i.e. depressive 
symptoms) and dependent (i.e. infant’s NA) variables produces shared method 
variance and potentially leads to an overestimation of the effects of antenatal maternal 
depression on child temperament, the current findings are to be interpreted with 
caution.  
The mechanisms underlying the association between antenatal maternal 
depression and infants’ NA are still to be elucidated. On the one hand, bidirectional 
evocative effects might occur with either postnatal maternal depression negatively 
affecting infant temperament or infant difficult temperament having a negative impact 
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on maternal psychological state, or both. However, it is noteworthy that the effects of 
maternal antenatal depressive symptoms remained significant even after controlling 
for maternal postnatal mood and quality of caregiving, thus suggesting that these 
postnatal environmental factors cannot fully account for this result. Heritability might be 
one plausible explanation, with infants of mothers reporting greater depressive 
symptoms during pregnancy inheriting a predisposition to experience greater NA (L. 
Schumann et al., 2017), which is then expected to interact over time with 
environmental factors, such as postnatal maternal depression, through complex Gene 
x Environment interplays (Gartstein et al., 2012; Rothbart et al., 2011). Furthermore, 
intrauterine mechanisms of fetal programming might explain the observed associations 
with maternal antenatal depression influencing fetal development through intrauterine 
biological mechanisms, involving for example stress hormones (e.g. Braithwaithe et 
al., 2017; Davis et al., 2007) or inflammatory pathways (Gustaffson et al., 2018), and 
leading to greater infant NA. This latter possibility will be further discussed in the 
following section.  
While maternal antenatal depressive symptoms predicted individual differences 
in 3-month-olds’ cortisol stress reactivity, with infants prenatally exposed to higher 
maternal depression displaying a slower cortisol recovery after the inoculation, 
unexpectedly, the association was no longer significant when adjusting for maternal 
postnatal emotional availability (EA). This suggests that maternal antenatal depression 
does not account for significant unique variance in cortisol reactivity when EA was 
included in the model. The literature concerning an association between maternal 
antenatal depression and children cortisol reactivity is mixed, with either positive (e.g. 
Brennan et al., 2008; Swales et al., 2018) or negative (e.g. Vedhara et al., 2012; 
Waters et al., 2013) or null associations (e.g. Braithwaite, Murphy, & Ramchandani, 
2016; Davis et al., 2011) being reported. The current findings might indicate that the 
quality of maternal postnatal caregiving represents a stronger predictor of infants’ 
cortisol stress reactivity, as compared to antenatal maternal depression. It can be 
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hypothesized that antenatal depression represents a distal marker of adversity, as 
compared to infants’ proximal interactive experiences with the caregiver, which are 
known to play a key role in the development of the stress-response systems (Hostinar 
& Gunnar, 2013). From a methodological perspective, the current findings highlight the 
importance of including measures of infants’ postnatal early environment, along with 
prenatal ones, when investigating processes involved in early programming, as a 
failure to account for postnatal factors, particularly related to early caregiving, might 
confound the observed associations and lead to erroneous conclusions. Interestingly, 
maternal antenatal depressive symptoms were not found to predict cortisol stress 
reactivity among healthy full-term neonates at birth, thus largely independently from 
postnatal influences, in line with findings from Davis and colleagues (2011). More 
studies evaluating infants soon after birth are needed to replicate our and Davis and 
colleagues’ (2011) findings. However, taken together the current results did not 
provide evidence for a prenatal effect of maternal depressive symptoms, independent 
from postnatal factors, in influencing infants’ stress reactivity from birth to three months 
of age in line with the results of a recent systematic review (Bleker et al., 2018) and 
suggest that inadequate control of postnatal factors related to the quality of maternal 
care might, at least partially, account for inconsistencies in the literature.  
The lack of effects of maternal depressive symptoms during late pregnancy on 
infants’ birth outcomes and cognitive development at 3 months is somewhat 
unexpected. Meta-analytical findings indicate a negative association between clinically 
significant levels of maternal depression during pregnancy and infants’ weight at birth 
(Grote et al., 2010; Jarde et al., 2016). However, it is important to note that the 
association was weaker in low-risk samples and becomes non-significant when using 
a continuous measure of depression, such as the EPDS (Grote et al., 2010; Alder et 
al., 2007), or adjusting for relevant covariates, such as gestational age (Accort et al., 
2015). Similarly, a number of large studies reported a link between maternal 
depression during pregnancy and lower cognitive development in infants ranging from 
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18 months of age to 8 years-old (Evans et al., 2012; Koutra et al., 2013; Lin et al., 
2017), although the opposite association (DiPietro et al., 2006; Sandman, Davis, & 
Glynn, 2012) or null association between antenatal depression and infants’ cognitive 
and motor scores from 6 to 78 months in equally methodologically rigorous studies 
have also been reported (Bandoli et al., 2016; Osborne et al., 2018b; Santucci et al., 
2014).  Although these null findings might be reliable, alternative explanations are also 
possible, including the limited sample size, which might have reduced the chance to 
detect a true effect, or the possibility that mild levels of maternal depression might 
have little effect on the developing foetus, as compared to more extreme exposures 
(Grote et al., 2010; Vedhara et al., 2012; Waters et al., 2014). Additionally, we cannot 
rule out that the exclusion of pregnant women with chronic medical problems or 
obstetric complications, resulting in a highly selected sample, might have biased the 
observed associations, particularly with respect to birth outcomes. It is also possible 
that the effects of prenatal maternal depression on offspring’s stress reactivity and 
cognitive development might emerge later in development. A follow-up of the current 
cohort will provide further insight around this issue.  
 
7.1.3 Maternal stress-related biology and infants’ outcomes 
As discussed in the following sections, findings from the current thesis provide 
further support for an association between maternal prenatal diurnal cortisol and 
individual differences in infants’ stress reactivity and cognitive development, in line 
with our predictions. Furthermore, the results add to the limited literature on alternative 
biological mechanisms involved in fetal programming, by highlighting significant 
associations between variations in markers of maternal SNS (i.e. sAA) and IRS (i.e. C-
Reactive Protein (CRP) and IL-6) functioning and infants’ outcomes in a low-risk 
sample of mother-infant dyads. Lastly, we provided the first evidence in humans that 
the association between antenatal maternal cortisol and infants’ stress reactivity can 
be over-ridden by sensitive maternal caregiving.  
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7.1.3.1 Maternal cortisol and infants’ outcomes  
Cortisol has been the most studied candidate mediator of maternal antenatal 
stress on fetal development, yet there are still several lacunae as regards the impact 
of antenatal cortisol on child development (see Zijlmans et al., 2015 for a review).  In 
line with our hypothesis, maternal cortisol diurnal levels during pregnancy were 
associated with  infants’ stress reactivity and cognitive development. These results 
were independent from prenatal and postnatal depressive symptoms and adjusted for 
a number of covariates. However, contrary to our predictions, we failed to detect any 
association between maternal antenatal cortisol and infants’ birth outcomes and 
temperament.  
The association between variations in maternal diurnal cortisol during 
pregnancy and offspring’s stress reactivity is one of the major positive findings of the 
current dissertation. Specifically, at birth, a flatter infant cortisol response to the heel-
stick was associated with a higher maternal cortisol awakening response (CAR) during 
pregnancy, while greater infant behavioural reactivity was related to a flatter maternal 
diurnal cortisol slope, supporting a role for variations in maternal diurnal cortisol 
rhythm during late pregnancy, largely independent from postnatal environmental 
influences, in influencing offspring’s stress reactivity, in line with few initial evidence 
(de Weerth, Buitelaar, & Beijers, 2013; Giesbrecht et al., 2017; Osborne et al., 2018). 
Additionally, at three months of age, we reported a significant association between 
antenatal maternal diurnal cortisol and greater cortisol response to the inoculation 
among infants of less emotionally available mothers. These findings suggest an 
interplay among prenatal and postnatal maternal influences in shaping offspring stress 
reactivity with important conceptual and methodological implications.  
First, the current findings suggest that variations in maternal diurnal cortisol 
during pregnancy are associated with altered patterns of stress reactivity in the 
offspring’s at birth and that these effects are likely to persist until 3 months of age if the 
infant is postnatally exposed to a less sensitive rearing environment. These results are 
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consistent with the hypothesis, mainly based on animal models, that the effects of 
prenatal stress exposure might arise from an alteration of the foetal stress response 
systems (see Glover et al., 2010) that might carry possible long-lasting effects on how 
the brain will respond physiologically and behaviourally to stress and enhance the risk 
of developing later psychopathology, such as mood or anxiety disorders (Tarullo & 
Gunnar, 2006; Gunnar & Vazques 2001; Heim & Nemeroff, 2001). Furthermore, the 
current results indicate that postnatal environmental adversity, such as poor parenting, 
may exacerbate the negative association between maternal antenatal cortisol and 
infants’ stress reactivity, in line with a “multiple hit” or “cumulative stress” hypothesis 
(Nederhof & Schmidt, 2012). Mechanisms for the effects of maternal postnatal care in 
the link between prenatal cortisol exposure and infants’ stress reactivity will be fully 
discussed in section 7.1.3.4.  
Secondly, it is noteworthy that variations in maternal diurnal cortisol pattern 
during pregnancy were associated with a dampened infant cortisol reactivity (though 
an amplified behavioral response to stress) at birth and with a greater cortisol reactivity 
at three months of age in infants of less sensitive mothers. Although replication in 
larger and different samples is needed, we might speculate that neurodevelopmental 
physiological changes in HPA axis responsivity occurring across the first year of age 
might play a role in the observed pattern of association. In particular, it has been 
shown that the effects of similar stressors, such as painful procedures, in inducing a 
cortisol response depend strongly upon the child’s age, with a normative decrease in 
cortisol reactivity to painful stimuli with increasing months of age (Jansen et al., 2010). 
Thus, we might speculate that infants of mothers showing altered cortisol diurnal 
pattern during pregnancy might failed to demonstrate the expected substantial 
increase in cortisol concentrations after the heel-stick at birth. In contrast, they might 
exhibit a stronger response than expected to the inoculation at a later developmental 
age, when the HPA axis responsivity begins to decrease, if they do not benefit from a 
stress-buffering mother-child relationship.   
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Beyond the effects on offspring stress reactivity, in line with our hypothesis, 
higher levels of maternal diurnal cortisol in late pregnancy were associated with 
infants’ lower cognitive scores at 3 months of age, after accounting for several 
confounders, including the quality of postnatal care. This finding is in line with a 
number of studies in humans (e.g. Bergman et al., 2010; Lewinn et al., 2009) and 
substantial data from animal models (reviewed in Owen, Andrews, & Matthews, 2005), 
linking prenatal exposure to either endogenous or synthethic glucocorticoids and 
poorer cognitive performance. 
Taken together, the current findings indicate an association between maternal 
antenatal diurnal cortisol and physiological, behavioral and cognitive outcomes in the 
offspring, possibly suggesting that an alteration in maternal diurnal cortisol levels 
during pregnancy represent a broad risk factor for later infant development. However, 
it is essential to emphasize that the correlational nature of the current findings does 
not allow us to draw causal conclusions and that the pathways possibly underlying the 
observed associations are still to be clarified. On the one hand, genetic or epigenetic 
mechanisms might account for the observed associations (e.g. Van Hulle et al., 2012). 
On the other hand, in light of the widespread observed effects of maternal antenatal 
cortisol on offspring development, it is tempting to interpret the current findings as 
suggestive of a role of maternal diurnal cortisol in influencing fetal brain development, 
leading to later altered biological and behavioral stress reactivity and cognitive 
development. Future studies should examine whether this might be the case and 
possible mechanisms underlying the impact of maternal cortisol on fetal brain 
development. In particular, future investigation should determine whether alterations in 
maternal diurnal cortisol during pregnancy might result in fetal cortisol overexposure. 
As the expression of the 11β-HSD2 placental enzyme has been found to be reduced 
in the last stages of gestation (Murphy et al., 2006), it is possible that even mild 
elevations in maternal cortisol in late pregnancy might affect fetal brain development. 
Notably, both the hippocampus, crucially involved in cognition, and the HPA axis are 
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particularly sensitive to excessive levels of glucocorticoids (Noorlander et al., 2006; 
Owen et al., 2005), this fact might account for the widespread effects of cortisol on 
different domains of child development. Alternatively, maternal cortisol might influence 
fetal brain development indirectly, by affecting vessel tone and possibly leading to 
reduced utero-placental blood flow, with long-term consequences on 
neurodevelopmental outcomes (Rakers et al., 2017).   
Lastly, contrary to what we expected, we did not find any significant association 
between maternal antenatal diurnal cortisol and both infants’ temperament and birth 
outcomes. These null findings deserve further replication in order to elucidate whether 
they are veridical or might be related to methodological issues. However, they are in 
line with the results of a recent literature review (Zijlmans et al., 2015) showing that no 
evidence exists for an association between maternal cortisol levels during gestation 
and maternal report of children’s temperament and with a number of large studies in 
humans finding no significant associations between maternal cortisol and birth 
outcomes after adjusting for covariates, such as gestational age (e.g. Goedhart et al., 
2010; Li et al., 2012). It is noteworthy that despite models were adjusted for infants’ 
gender, we did not examine how infants’ gender interact with antenatal cortisol 
exposure to determine the observed outcomes. As initial evidence exists for gender 
differences in the link between maternal antenatal cortisol and both infants’ 
temperament (Braithwaite et al., 2017a) and birth outcomes (Sandman et al., 2013; 
Clifton et al., 2010), this remains an important area for future research.  
 
7.1.3.2 Maternal sAA and infants’ outcomes 
The role of antenatal maternal sAA, a non-invasive biomarker of SNS, in fetal 
programming is just beginning to be investigated. Exploratory analyses in the current 
dissertation provide preliminary evidence of an association between diurnal patterns of 
maternal sAA during late pregnancy and both infants weight at birth and NA at 3 
months of age, independent from prenatal and postnatal depressive symptoms and 
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from several confounders. In contrast, no significant associations were detected 
among antenatal sAA levels and stress reactivity or cognitive outcomes.  
Findings of a positive association between antenatal maternal sAA levels at 
awakening and throughout the day and infants’ birth weight are partially in line with 
results from the only available study on the link among maternal antenatal sAA and 
birth outcomes (Giesbrecht et al., 2015). We speculated that heightened maternal sAA 
levels might reflect an upregulation of the SNS with advancing gestation to sustain 
maternal and fetal energetic demands, however this hypothesis needs to be explicitly 
tested in future research. Furthermore, a greater maternal sAA decline after 
awakening was related to higher infants NA scores at 3 months of age, after adjusting 
for covariates and accounting for the quality of postnatal maternal care. The influence 
of maternal antenatal sAA levels during pregnancy on infants’ temperament has been 
evaluated in only one study reporting significant sex-dimorphic associations between 
maternal sAA diurnal levels and 2-month-olds negative emotionality (i.e. high levels of 
maternal sAA being marginally associated with reduced negative emotionality in 
males; Braithwaithe et al., 2017).  
Literature on a possible role of sAA in the DOHaD hypothesis is very limited 
and our understanding of the role of alternatives to HPA-axis mediated mechanisms in 
fetal programming is still patchy, thus limiting possible interpretation of the current 
findings. While sAA is thought to provide a reliable index of the SNS functioning (U. M. 
Nater & Rohleder, 2009), studies on sAA during pregnancy are limited (Giesbrecht et 
al., 2013; Giesbrecht et al., 2015; Nierop et al., 2006). Thus, it is currently unclear 
what sAA levels assessed during pregnancy could actually reflect. For example, an 
increased SNS activity during pregnancy causes an increase in vasoconstriction and a 
reduction of placental perfusion, however, the association between maternal prenatal 
sAA levels and foetal blood flow has never been examined. The preliminary and 
correlational nature of the current findings require caution in interpretation. However, 
taken together these initial results point to maternal antenatal sAA as a promising 
316 
 
marker for research into early programming of later health and behavioral outcomes. 
In addition, from a methodological perspective, they converge with the current findings 
on the effects of cortisol on child outcomes to underscore the importance of diurnal 
assessment of stress biomarkers, as a failure to do so might lead to miss possible 
significant associations between maternal physiology and child outcomes.  
 
7.1.3.3 Maternal inflammation and infants’ outcomes  
Literature on the effects of maternal inflammation during pregnancy on 
offspring outcomes in humans is very limited. Although observational epidemiological 
studies report that maternal inflammatory response to infections during pregnancy is 
associated with increased risk of neuropsychiatric disorders, such as schizophrenia, in 
the resulting offspring (Estes & McAllister 2016), the extent to which there is a 
programming effect of maternal antenatal cytokines is unknown.  
The current study is among a small number of other very recent reports 
prospectively examining the association between maternal inflammatory markers 
during pregnancy and early neurodevelopmental outcomes (Osborne et al., 2018; 
Gustaffson et al., 2018; Rasmussen et al., 2018; Graham et al., 2017). Our exploratory 
analyses indicated that maternal antenatal IL-6 levels were negatively associated with 
head circumference at birth, while maternal prenatal CRP concentrations were 
negatively associated with infants’ cognitive scores at 3 months of age in a low risk 
sample of healthy women and infants. These associations were not confounded by 
maternal BMI, infant’s gender and gestational age and were independent from 
maternal depressive symptoms and from the quality of postnatal maternal care. In 
contrast, we did not observe any significant association among maternal inflammation 
and infants’ stress reactivity and temperament.  
The association between higher prenatal maternal IL-6 levels and smaller head 
circumference at birth, which is considered a marker for intrauterine brain development 
(Broekman et al., 2009b), is a novel finding. Instead, findings of an association among 
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higher maternal CRP levels during pregnancy and lower 3-month-olds’ cognitive 
scores converge with the modest available evidence in humans indicating an 
association between maternal inflammation during pregnancy and offspring 
neurodevelopment across the first year of age (Osborne et al., 2018; Rasmussen et 
al., 2018). Despite the fact that the observational nature of the current study does not 
allow us to draw causal inferences, taken together our findings are consistent with 
results from animal studies (e.g. Meyer et al., 2006) and with very recent evidence 
from brain imaging studies in human infants (Grahman et al., 2017; Rasmussen et al., 
2018) suggesting a role of maternal inflammation in affecting fetal growth and neural 
development, although the in utero pathways are still to be clarified.   
IL-6 and CRP are both considered biomarkers of chronic or systemic low-grade 
inflammation (Rohleder, Aringer, & Boentert, 2012) and, as expected, in the current 
sample were moderately correlated. However, it is unclear why different associations 
with child outcomes were detected for IL-6 or CRP levels. Differences might be related 
to methodological or limited statistical power issues or, might also be suggestive of 
distinct inflammatory pathways involved in fetal programming. IL-6 has been proposed 
as a key biological mediator of environmental conditions on the developing fetal brain 
(Entringer, Buss, & Wadhwa, 2015), being able to cross both the placental and blood–
brain barriers (Banks, Kastin, & Gutierrez, 1994; Zaretsky et al., 2004) and possibly 
directly influencing the fetal brain development (Boulanger, 2009; Deverman & 
Patterson, 2009; Smith et al., 2007). Alternatively, elevated levels of maternal IL-6 
might indicate an imbalance of pro-inflammatory and anti-inflammatory influences 
(Kamimura, Ishihara, & Hirano, 2003) which has been proposed as one possible 
mechanism related to the effects of maternal antenatal inflammation on fetal brain 
development (Meyer et al., 2008). While CRP is often considered as a proxy for IL-6 
(S. Black, Kushner, & Samols, 2004), evidence suggests that elevations in CRP itself 
can affect fetal development through several pathways. For example, heightened 
maternal CRP levels could interfere with fetal growth and brain development by 
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contributing to vascular and placental dysfunction (Ernst et al., 2011) or by directly 
altering offspring’s synaptic connectivity (Canetta et al., 2014; Stephan, Barres, & 
Stevens, 2012). Lastly, higher CRP levels may indicate poor maternal health (Wium-
Andersen & Nielsen, 2013), which can themselves influences offspring’s brain 
development and behavioral outcomes (Chittleborough, Lawlor, & Lynch, 2012; O’Neil 
et al., 2014) and, therefore, account for the current findings. Alternatively, hereditary 
transmission might explain the observed associations, with mother-infants shared 
genes accounting for variation in both maternal inflammation and offspring’s outcomes 
though pleiotropic effects. Additionally, epigenetic mechanisms could mediate the 
impact of prenatal maternal inflammation on fetal brain development with potentially 
long-lasting effects, as suggested by results of animal studies (Kundakovic & Jaric, 
2017). 
We did not find any evidence of a significant association between maternal 
antenatal inflammation and both infants’ stress reactivity and temperament after 
adjusting for covariates. While animal findings suggest a possible role of maternal pro-
inflammatory cytokines during pregnancy in the development of fetal stress response 
systems (e.g. Dahlgren et al., 2006; Samuelsson et al., 2006), existing evidence in 
humans is only preliminary. Osborne and colleagues (2018) very recently reported a 
positive unadjusted correlation between specific maternal inflammatory markers, 
namely IL-10, TNFα and VEGF, but not IL-6, and 12-month-olds’ cortisol stress 
reactivity in a sample of clinically depressed pregnant women and healthy controls. 
Furthermore, Gustaffson and colleagues (2018) found that maternal antenatal pro-
inflammatory cytokines (indexed though a latent variable including IL-6, TNF-α, and 
monocyte chemoattractant protein-1) mediated the association between prenatal 
depressive symptoms and maternal, but not observed, ratings of negative affect in 6-
month-olds in a sample of pregnant women at risk for attention-deficit/hyperactivity 
disorder. Despite the possibility that the current null findings concerning temperament 
and stress regulation might be an issue of power, it is noteworthy that the current 
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sample size is slightly higher than the ones in the above mentioned studies (N=87 in 
Osborne et al., 2018; N=62 for Gustaffson et al., 2018). Alternatively, methodological 
heterogeneity in the composition of the samples and in infants’ ages might account for 
different results. Lastly, maternal stress, rather than inflammatory, mediators might be 
more closely involved in influencing fetal development of stress regulation. 
Nonetheless, it is important to emphasize that we are at the very beginning of our 
understanding of the role of maternal inflammation in fetal programming of later health 
and mental outcomes. Future studies are needed in humans to investigate the 
association among direct measures of inflammatory markers and outcomes in the 
offspring and unravel the specific in utero inflammatory pathways involved in fetal 
brain development.  
 
7.1.3.4 The moderating role of maternal postnatal care  
 
Animal studies have consistently shown that the processes leading to the 
negative link between prenatal stress exposure and bio-behavioral outcomes in 
offspring can be over–ridden by postnatal environmental factors (e.g. Maccari et al., 
1995; Wakshlak & Weinstock, 1990). Results from the current thesis provide the first 
evidence in humans indicating that the effects of maternal antenatal cortisol on 3-
month-olds cortisol stress reactivity is eliminated by sensitive maternal caregiving, as 
measured through the Emotional Availability (EA) Scales (Biringen et al., 2008). 
Specifically, in line with our broad hypothesis, higher levels of maternal cortisol during 
pregnancy were associated with infants’ greater cortisol response to the inoculation 
only among infants of less emotionally available mothers, while the association 
became non-significant among infants of highly sensitive mothers. Furthermore, the 
magnitude of the association between maternal EA and infants’ cortisol reactivity 
depended upon maternal prenatal cortisol levels, in line with the emerging notion that 
prenatal experiences could modify individual susceptibility to postnatal environmental 
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influences (Pluess & Belsky, 2011). Contrary to our predictions, however, maternal EA 
did not moderate the link between prenatal maternal influences and infants’ cognitive 
development or temperament. Furthermore, we did not find evidence for a role of 
maternal EA in mediating the effects of antenatal maternal depression on infants’ 
outcomes.  
From a methodological point of view, results from the current dissertation 
emphasize the strong need for models of fetal programming to account for the 
influence of postnatal care. While a considerable number of studies within the DOHaD 
field control for the influence of postnatal maternal symptomatology, which is thought 
to represent a proxy of postnatal environment, current findings indicate that postnatal 
symptoms of distress are not necessarily associated with the quality of maternal 
caregiving in a low risk sample. Furthermore, a failure to include measures of maternal 
care might lead to misleading findings. Indeed, in the current sample, measures of 
antenatal cortisol alone were no longer associated with infants’ pattern of stress 
reactivity at three months of age, although the picture was somewhat different once 
the interactive effects between maternal prenatal cortisol and postnatal EA were taken 
into account.  
The lack of association between maternal EA and either prenatal or postnatal 
depressive or anxiety symptoms we reported in the current study is potentially 
surprising. However, it should be noted that mothers in the study consisted of a 
community low-risk sample, mostly middle-high class, married and well educated. 
Thus, it is possible that the characteristics of the sample might have constrained the 
range in maternal EA. In line with this hypothesis, no differences in maternal EA 
between mother with higher and lower prenatal depressive symptoms have been 
reported in low risk samples (e.g. De Weerth et al., 2003; Endendjik et al., 2005), while 
reduced maternal EA in depressed mothers from high risk samples has often been 
reported (e.g. Easterbrooks, Bureau & Lyons-Ruth, 2012; Trapolini et al., 2008; 
Easterbrook, Biesecker, & LyonsRuth, 2000; Kluczniok et al., 2016). 
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The mechanisms underlying the moderating effects of maternal postnatal care 
in the link between prenatal cortisol exposure and infants’ stress reactivity are still to 
be uncovered. Strong evidence across species indicates that caregiving experiences 
can affect emotional behaviour and physiology by influencing the neural circuits 
underlying emotion regulation and stress reactivity (Callaghan & Tottenham, 2015; 
Tottenham, 2015). In particular, the presence of a sensitive caregiver is hypothesized 
to act as an external regulator that buffer infants’ neural, endocrine and behavioral 
responses to stress (Gunnar & Donzella, 2002; Gunnar et al., 2015) by suppressing 
the hormonal cascade leading to elevations in glucocorticoids and inducing greater 
prefrontal cortex regulation of the amygdala (Moriceau & Sullivan, 2006; Gee et al., 
2016). Thus, early in development, caregivers are believed to operate fairly directly on 
the neural circuits underlying emotional and stress reactivity and influence their 
development (Tottenham et al., 2017; Gee et al., 2014), although the quality of 
caregiving matter. For example, pioneer studies have shown that the maternal 
presence can buffer infant’s HPA axis reactivity for secure but not insecure attachment 
(Nachmias et al., 1996). We might speculate that the maternal “buffering power” is less 
effective in infants of less emotionally available mothers thus exacerbating the 
association between prenatal cortisol exposure and stress reactivity and leading to 
enhanced cortisol response to the inoculation. Additional mechanisms for the buffering 
effects of positive caregiving on infants’ stress reactivity might involve oxytocin, which 
is known to have behavioral and physiological stress-attenuating effects, including 
inhibitory effects on the HPA-axis stress reactivity (Heinrichs et al., 2003). While 
oxytocin is known to play a role in social interactions, recent work indicates that this 
hormone responds to the quality of these interactions. For example, increases in 
infants’ salivary oxytocin following parent-infant interaction have been found to be 
positively related to levels of tactile contact with the parent, parent-child affect 
synchrony and infants’ social engagement (Feldman et al., 2010). We might speculate 
that adverse early caregiving, as indicated by low levels of maternal EA, might 
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negatively affect infants’ HPA axis responsiveness, thus aggravating the impact of 
antenatal cortisol exposure, by impairing the ability of the oxytocin system to regulate 
cortisol stress reactivity, in line with animal evidence (Hostinar et al., 2014) and 
preliminary evidence in human adults (Meinlschmidt and Heim, 2007). Lastly, 
epigenetic mechanisms are an additional pathway through which early caregiving 
experiences can shape stress regulation abilities and interact with prenatal exposures. 
In particular, the work of the group led by Michael Meaney on rodent models has 
shown that maternal adequate caregiving stimulation (i.e. licking and grooming) over 
the first days of life reduce HPA-axis stress reactivity and anxiety-like behaviors in the 
pups by increasing the glucocorticoid receptor (GR) gene expression, mainly through 
the demethylation of the GR gene in the hippocampus of the offspring (Weaver et al., 
2004). In humans early maternal postnatal stroking was found to buffer the association 
between prenatal maternal depression/anxiety and negative outcomes in the offspring 
(Sharp et al., 2012; 2014; Pickles et al., 2017), with initial evidence suggesting that 
these effects might be mediated by epigenetic mechanisms involving the reduction of 
the GR gene methylation (Murgatroyd et al., 2015). It is noteworthy that these studies 
focused on the ability of low-grade components of caregiving, such as tactile 
stimulation, to reverse the effects of antenatal stress and did not include measure of 
maternal caregiving. Future studies should investigate whether maternal EA or 
sensitive caregiving can exert similar epigenetic effects on infants’ developing neural 
and endocrine system. Lastly, it is important to emphasize that, as the current findings 
are correlational, it is difficult to establish the direction of the association between 
infant’s stress reactivity and maternal EA. Thus, while maternal caregiving is known to 
play a role in shaping the infants’ stress response systems, it is also true that infants’ 
characteristics, such as being more “reactive”, “easily stressed” or “difficult to soothe” 




While mechanisms underlying the effects of maternal postnatal EA in the link 
between antenatal cortisol exposure and infant’s stress reactivity are still to be 
elucidated, these results contradict deterministic views of fetal programming, 
supporting the notion that the sensitive window for early life programming of later 
health and mental outcomes extends well beyond the prenatal period with important 
clinical implications. In particular, as attachment-based intervention has been proved 
to be successful in improving maternal EA (e.g. Ziv, Kaplan & Vezan, 2016), this can 
be thought of as a target of clinical intervention with women experiencing emotional 
distress during pregnancy. 
Lastly, the lack of a moderating effect of maternal EA in the link between 
maternal prenatal factors and infants’ psychomotor development or temperament is in 
contrast with our exploratory hypothesis. One previous study reported a significant 
moderating effect of child-mother attachment in the association between antenatal 
maternal stress and 17-month-old infant’s cognitive development (Bergman et al., 
2010) and fearfulness (Bergman et al., 2008). It can be speculated that both cognitive 
development and temperament early in life might be more biologically determined and 
less permeable to postnatal environmental influences (Black et al., 2000) and that the 
moderating effects of maternal postnatal care in the link between prenatal stress and 
child’s outcomes might be revealed later in development. However, findings are only 
preliminary and further research is needed to understand the complex interplay 




The interpretation of findings from the current thesis should be cautious due to 
several limitations that have been already discussed within each chapter but are now 
briefly summarized.  
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First, data are based on a healthy and relatively high SES well-educated 
community sample and levels of self-reported depressive or anxiety symptoms were 
relatively low, as would be expected in a community sample. It is worth noting, 
however, that the prevalence of women at risk for depression according to the EPDS 
cut-off, was similar to that noticed in earlier studies employing the same instrument 
and cut-off (e.g. Johnson et al., 2012) and in line with the general prenatal prevalence 
of these symptoms (e.g. Bennett et al., 2004). In addition, the use of a structured 
diagnostic interview to exclude other psychiatric disorders, jointly with a perinatal-
specific depression questionnaire, strengthens our results. The rationale for focusing 
on a low risk sample is based on the evidence that maternal prenatal stress effects are 
not generally limited to extreme stress levels or clinically diagnosed mental illness. 
Rather, they have often been found in unselected community samples and appear to 
occur across the whole normative range of distress that women might experience at 
some time during their pregnancies (reviewed in Madigan et al., 2018; Talge, Neal, & 
Glover, 2007; Van den Bergh et al., 2017). In addition, very little is known about the 
role of naturally occurring variations in maternal stress and inflammatory signals on 
offspring’s normative neurodevelopment. Thus, a better understanding of the complex 
mechanisms underlying early programming of typical development in a healthy low risk 
sample might represent the first step before applying this knowledge to investigate 
prenatal programming of abnormal development in high risk samples. Furthermore, 
the use of a low risk sample has the potential to limit confounding influences of 
additional risk factors associated with psychosocial adversity (e.g. teenage 
motherhood, unemployment, financial problems etc.), thus possibly leading to fairly 
conservative associations. Findings obtained from a low-risk sample could provide 
“control” data for a future comparison with similar work on high risk samples. 
Nevertheless, the generalizability of the current results to high psychosocial risk or 
clinical populations is limited. Although it is tempting to imagine that findings would be 
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more profound among a sample of clinically depressed women, this remains an open 
question for future investigation.  
Second, although the sample size was of necessity limited because, as 
described in Chapter 2, only healthy pregnant women not taking any chronic 
medication and with no pregnancy complications or medical conditions were included, 
a larger sample size would have allowed more power to detect small effects. 
Additionally, while a highly selected sample is appropriate for a psychobiological study 
in order to limit possible conditions that might themselves be associated with an 
altered functioning of the biological systems examined, it can also limit the 
generalizability of findings. Furthermore, as previously reported (Egliston et al., 2007), 
obtaining sufficient saliva volumes from newborns was a challenge, thus leading to a 
more limited sample size for cortisol analyses. HLMs were employed in order to 
maximize the number of infants included in the final analyses and obtain reliable 
estimates of effects despite missing values for one or more time-points. The results of 
a post-hoc power analysis calculated using G*power 3.0.10 suggest that for detecting 
medium sized effects, hierarchical linear regressions for the effects of prenatal 
maternal factors (i.e. depressive/anxiety symptoms, diurnal cortisol and sAA 
measures, inflammatory markers) on infants’ outcomes had a power estimate ranging 
from .94 to .97. Therefore, the current sample size can be considered adequate for 
testing our hypotheses. This is also in line with results of a recent meta-analysis 
indicating a minimum sample size of N=60, based on the observed associations, in 
order to detect significant associations between maternal cortisol in the third trimester 
and infants’ birth outcomes, while testing for 8 potential covariates (Cherak et al., 
2018).  For what concerns HLMs for the effects of prenatal maternal factors on infants’ 
cortisol reactivity, we estimated that with the current sample size and 80% power, we 
were able to detect effects ranging from r=.18 to r=.22, while we would have miss 
effects smaller than this. Thus, it is important to emphasize once again that 
conclusions that can be drawn from the current study are to be regarded as 
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preliminary and require replication in different and larger cohorts.  
Third, while the current study’s impact comes from the simultaneous measures 
of several self-reported, observational and biological measures from both mothers and 
infants over repeated occasions, this brings the potential confounder of multiple 
comparisons (i.e. increase in the probability to observe associations that result only 
from chance - false positives - as the number of statistical comparison increases). 
While a standard practice is to adjust the threshold for statistical significance according 
to the number of pairwise tests performed, for example using the well-known 
Bonferroni correction (Dunn, 1961), these methods may result in overly conservative 
conclusions and are not free of criticisms (e.g. Nakagawa et al., 2004; Rothman, 1990; 
Perneger, 1998; Feise, 2002; Gelman et al., 2012; Altenhouse et al., 2016). For 
example, while adjusting the α levels for each test performed is effective in limiting 
Type I errors (i.e. rejection of the null hypothesis when the null hypothesis is true), it 
inevitably leads to an increase in the number of Type II errors (i.e. true effects that are 
discarded because they do not pass this threshold) and thus to too many false-
negatives. This might be problematic in exploratory studies that, by nature, are more 
concerned of not missing on something potentially interesting and hence limiting Type 
II error. Additionally, more detailed researches (i.e. including and measuring more 
variables) have less probability of finding significant results and, thus, are more 
penalized by multiple comparisons corrections (Moran et al., 2003); not to mention the 
growing concern that these methods might lead to selective reporting and lack of 
scientific transparency (Fortsmeier et al., 2017). Furthermore, there is currently limited 
agreement concerning the choice of the number of tests that must be adjusted for and 
this is often a spurious decision (Altenhouse et al., 2016). In particular, it is not clear 
whether preliminary analyses should be included or not. As several preliminary 
analyses were run in each chapters to examine potential confounders of the observed 
associations, determine the number of actual comparisons made was problematic. 
Thus, given the exploratory nature of this study and the fact that in several cases we 
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do not have a priori specific hypothesis concerning the effects, we made no statistical 
adjustments for multiple comparisons (e.g. Ravicz et al., 2015; Okun et al., 2013). 
Instead, as recommended by some authors (e.g. Nakagawa et al., 2004), we reported 
all exact p values and stated all the comparisons made in order to allow the reader to 
interpret the results accordingly and evaluate the relative weight of the conclusions. A 
subsequent study with pre-planned hypotheses should be conducted to confirm the 
observed associations. 
Fourth, the focus of the current dissertation was on the effects of late 
pregnancy exposure, thus the current findings might not generalize to different 
gestational windows. Furthermore, we cannot determine whether the observed 
associations are specific to the third trimester or might be the result of a continuous 
prenatal exposure. However, our results, particularly concerning the association 
between maternal antenatal influences and offspring’s stress reactivity, are consistent 
with studies suggesting a stronger and specific effect of prenatal stress exposure in 
late pregnancy as compared to earlier exposure (e.g. Davis et al., 2011; Vedhara et 
al., 2012). 
Fifth, maternal salivary samples were collected at home and despite 
considerable efforts being made to assure compliance with the protocol, this was not 
objectively measured. However, it is noteworthy that Okun and colleagues (2010) 
reported excellent concordance rates between objective and self-report measures of 
sample collection times during pregnancy. In addition, the expected typical diurnal 
patterns in salivary cortisol and sAA was found, thus suggesting that, as a whole, 
women were likely to have complied with the saliva sampling protocol.  
Sixth, due to the observational nature of the design, it is difficult to disentangle 
the role of prenatal factors from the effects of other related factors, including maternal 
diet or lifestyle or shared genetic effect that are likely to play a role in the “risk” 
transmission from mother to infant. A wide range of possible confounders such as 
sociodemographic factors, health and pregnancy-related factors were controlled in 
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statistical analyses. Additionally, only healthy pregnant women free from any 
medication, alcohol or smoking use were included. However, genetic factors or factors 
related to changes in diet or lifestyle remain areas for future investigations.  
 
7.3 Contribution to the DOHaD hypothesis 
 
The current dissertation sought to extend existing literature on the DOHaD 
hypothesis by adopting a novel multi-systems approach, involving a comprehensive 
assessment of maternal antenatal psychological and biological influences, and taking 
into account the role of postnatal maternal care, in the effort to shed light on the 
mechanisms underlying the link between maternal antenatal depressive symptoms 
and infants’ bio-behavioral development. Based on the hypotheses stated in Chapter 
1, three major positive findings were obtained. First, results show new evidence in a 
low-risk sample that women with higher depressive symptoms, but not anxiety, during 
pregnancy have an altered cortisol diurnal pattern and increased levels of 
inflammation. Second, findings indicate that variations in maternal diurnal cortisol 
during pregnancy are associated with early infants’ stress reactivity and cognitive 
development and, third, that maternal sensitive caregiving can reverse some of these 
effects. Furthermore, our exploratory analyses add to the limited literature on 
alternative biological mechanisms involved in fetal programming by showing that 
markers of maternal IRS and SNS functioning during pregnancy are associated with 
infants’ outcomes. Contrary to our predictions, however, maternal depressive 
symptoms was significanty associated only with 3-month-olds NA, while no 
associations were found with infants’ birth outcomes, stress reactivity and cognitive 
development once the models were adjusted for postnatal maternal symptoms and 
caregiving. Likewise, unexpectedly, maternal diurnal cortisol was not related to infants’ 
birth outcomes and temperament. Furthermore, maternal sensitive caregiving, as 
assessed through the EA scales, was not related to maternal antenatal or postnatal 
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depressive symptoms. Reasons for these null findings have been already discussed 
previously and included, among others, the low-risk and highly selected nature of the 
sample, the limited statistical power to detect small effects, the gestational window 
under examination and a failure to account for sex differences or other relevant factors 
such as genetics.  
Findings from the current dissertation are relevant to the field of child 
development, developmental psychopathology and psychoneuroendocrinology and 
make a contribution to the literature in the DOHaD hypothesis in several ways.   
First, findings indicate that antenatal maternal depressive symptoms, even 
without meeting the full criteria for a clinical diagnosis, are associated with an altered 
stress-related physiology. With respect to the DOHaD hypothesis, these results further 
corroborate the notion that maternal antenatal depression might have a detectable 
impact on fetal development even at subclinical levels (O’Donnell & Meaney, 2017), 
and encourage further investigation into the effects of maternal depression across the 
whole spectrum of symptom severity. In addition, as meta-analytical findings from 
Valkanova and colleagues (2013) indicates that in non-pregnant adults higher CRP 
and IL-6 levels precede the development of major depression, while a cortisol flatter 
diurnal decline is increasingly regarded as a general marker of stress exposure (e.g. 
O’ Donnell et al., 2013), the current findings lead the way for future studies into the 
identification of “early risk” biomarkers that might aid in the development of prevention 
strategies and, once an etiological pathway to depressive symptoms has been 
established, be feasible intervention target.  
Second, the observed associations among maternal depressive symptoms and 
both biological alterations during pregnancy and infants’ outcomes (i.e. heightened 
infant NA) were specific for depression. In contrast, maternal anxiety symptoms were 
related to an altered sAA diurnal rhythm during pregnancy and predicted poorer 
infants’ cognitive performances at three months of age. Considering the high rate of 
comorbidity (Falah-Hassani et al., 2017) and proportion of shared genetic factors that 
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influence these two conditions (Middledorp et al., 2005), marked differences in the 
association between anxiety or depression and maternal physiology or child outcomes 
are quite unexpected. Methodological issues might account for these conflicting 
findings. For example, while the EPDS inquiries about the past week, the STAI-T 
investigates a “trait” measure of anxiety that refers to general functioning. However, it 
is important to mention that comparable results were found when using the “state” 
measure of the questionnaire that assess transient anxiety. There are also theoretical 
explanations for the differential association between prenatal depression versus 
anxiety and child outcomes. Indeed, while within the literature concerning the DOHaD 
hypothesis, maternal antenatal depression and anxiety are often considered 
psychological markers of the same underlying construct of “antenatal stress”, current 
findings suggest that their biological underpinnings are to some extent different and, 
thereby, they possibly affect fetal development in different ways. A limited number of 
studies has examined both antenatal anxiety and depression in the same sample and 
conflicting findings have been reported. Few studies indicate that maternal depression, 
rather than anxiety, was more strongly associated with infants’ outcomes (Madigan et 
al., 2018; Lin et al., 2017; Barker et al., 2011), while a handful of others found that 
prenatal anxiety symptoms, rather than depression, have a stronger effect on infants’ 
development (Grant et al., 2009; O’Connor et al., 2002; 2003; 2005; Ibanez et al., 
2015). While more studies are needed to determine the prenatal risk phenotype that 
might be more implicated in child development, our findings demonstrate that an 
accurate psychological and biological characterization of the type of antenatal stress 
under investigation is pivotal in order to advance understanding of the biological 
mechanisms underlying fetal programming, in line with the recent general call within 
the field of the DOHaD hypothesis (Graignic-Philippe et al., 2014; O’Donnell & 
Meaney, 2017). 
Third, in line with the DOHaD hypothesis, small variations in maternal mood, 
stress hormones and inflammatory markers in late pregnancy were all associated with 
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a number of neurodevelopmental outcomes in offspring. However, we did not find 
support for a role of maternal stress-related biological alterations in mediating the 
effects of antenatal depression/anxiety on offspring outcomes. Rather, variations in 
levels of maternal depression, anxiety, stress hormones and inflammatory markers 
during pregnancy appear to exert an effect on offspring outcomes through 
independent and different pathways. This underscores the importance of combining 
both subjective and objective measures of maternal antenatal stress experience. 
Additionally, our initial evidence is possibly suggestive of specific associations 
between distinct antenatal influences and specific outcomes. Specifically, while 
maternal depressive symptoms were associated with heightened infant NA, which is 
considered a marker of risk for later mental health problems (e.g. Sayla et al., 2014), 
inflammatory pathways appeared to be more implicated in outcomes related to brain 
and cognitive development, while glucocorticoids showed more widespread effects on 
stress reactivity and cognitive development. However, it is crucial to emphasize once 
again, that, although findings of a prospective association between maternal antenatal 
influences and offspring’s outcomes are in the expected direction and it is tempting to 
interpret them as suggestive of causative biological pathways, they are only supported 
by correlational analyses. Thus, as for any observed association, they could be the 
result of random error, bias or unmeasured confounding, or they may be the result of a 
true causal effect of prenatal exposure. Further replication and validation in larger 
samples are required.  
Fourth, consistently with the DOHaD hypothesis, the observed associations 
mostly support an effect of antenatal maternal influences independent from the 
postnatal environment. First of all, findings of an association among maternal prenatal 
cortisol or inflammation and altered outcomes soon at birth reinforce the idea that 
programming effects might occur in utero. Secondly, the opportunity to control for both 
postnatal maternal symptomatology and caregiving, allows to obtain statistically 
independent estimates of prenatal effects on 3-month-olds outcomes. Future studies 
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should investigate the extent to which the observed associations are independent from 
genetic influences, which are likely to confound the associations among prenatal 
factors and child outcomes, by adopting genetically informed designs (Rice et al., in 
press).     
Fifth, there has been surprisingly little emphasis on the role of postnatal 
environment in research on the DOHaD hypothesis. This dissertation provides the first 
human evidence that postnatal positive caregiving, as indicated by high maternal EA, 
eliminates the effects of prenatal cortisol exposure on infants’ stress reactivity. This 
result provides a major translation of animal findings showing that a sensitive 
caregiving environment can reverse the effects of neurobiological vulnerability (e.g. 
Francis, Diorio, Plotsky, & Meaney, 2002) and extends research on the DOHaD 
hypothesis and, more generally, on the biological impact of early caregiving 
experiences. From a methodological-conceptual point of view, our findings offer insight 
into the inconsistent pattern of results that have been observed across previous 
studies assessing the association between prenatal cortisol exposure and infant 
cortisol reactivity (reviewed in Zijlmans et al., 2015). Indeed, while we did not detect 
any main effect of antenatal maternal cortisol on 3-month-olds’ stress reactivity in the 
whole sample, we did report a positive association among infants of less emotionally 
available mothers. The current results underscore the need for research into 
mechanisms involved in early life programming of later risk for physical and mental 
health to account for the role of postnatal caregiving experiences which are likely to 
alter the unfolding of prenatal processes. From a clinical perspective, if the current 
findings are replicated, they suggest that the quality of maternal caregiving should be a 
major target for intervention, especially among prenatally stressed mothers. The lack 
of moderating effects of maternal EA in the link between prenatal maternal stress 
signals and both infants’ temperament and cognitive development deserve further 
investigation, although it might indicate that the effects of maternal care in buffering 
prenatal influences vary depending on the nature of the outcome investigated. 
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Sixth, our findings support the emerging view that various forms of prenatal 
adversity may increase the sensitivity of the developing organism to the influences of 
the postnatal environment (Pluess & Belsky, 2011), as a significant association 
between maternal EA and infants’ stress reactivity was reported only among infants 
prenatally exposed to higher cortisol levels. This hypothesis has been only rarely 
addressed within the DOAhD field. Initial studies showed that the effects of 
environmental factors, such as socio-economic status, maternal care or breastfeeding, 
on a number of neurodevelopmental outcomes in the offspring are greater among low 
as compared to normal birth weight (Buss et al., 2007, Jefferis et al., 2022, Kelly et al., 
2001, Bonhert et al., 2008, Tully et al., 2004, Anderson et al., 1999). Furthermore, it 
has been shown that the effects of socio-economic status on long-term memory are 
greater among infants prenatally treated with synthethic glucocorticoids (Grant et al., 
2015). However, to our knowledge, this is the first study to indicate that prenatal 
exposure to endogenous maternal cortisol might alter infants’ susceptibility to the 
quality of maternal care. The possibility that the quality of in utero environment might 
influence, at least in part, the wide diversity among children in the degree to which 
developmental outcomes are influenced by the environment deserves further 
investigation as it holds the potential to inform and improve early interventions 
strategies 
Collectively these findings bring to the forefront a new approach for research 
into the DOHaD hypothesis and represent a step forward in the understanding of early 
programming of both behavioral and biological outcomes by maternal prenatal and 
postnatal influences. 
 
7.4 Future directions 
The studies included in the current thesis have sought to address some of the 
issues outlined in the initial chapter and provide novel contribution to the state-of-a-
science on an important topic concerning the effects of antenatal maternal depression. 
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However, many questions remain unanswered and the current results suggest many 
promising future directions for the study of the DOHaD hypothesis.  
First, while stress-related biological mechanisms possibly involved in fetal 
programming were reviewed and examined separately, they are not likely to be 
alternatives to each other. Future studies on larger samples should address the 
complex bi-directional interplay among stress and inflammatory pathways that is likely 
to underline the effects of antenatal maternal depression on fetal development. In 
addition, we provided very preliminary evidence to suggest that the interaction among 
stress and inflammatory response systems might be altered among women with higher 
depressive symptoms during pregnancy; however, this finding deserves further 
investigation.  
Second, we reported associations among alterations in maternal cortisol 
diurnal rhythm during pregnancy and later patterns of offspring stress reactivity. 
However, as discussed above, the mechanisms underlying this association are still to 
be clarified. In particular, it is unclear whether variations in maternal diurnal cortisol 
profile during pregnancy might actually lead to more cortisol passing through the 
placental barrier to directly affect fetal development. Future studies including more 
direct indexes of fetal intrauterine cortisol exposure such as amniotic fluid cortisol 
(Baibazarova et al., 2013; O’Connor et al., 2013) or cord blood cortisol (Miller et al., 
2005) could provide greater leverage for testing the effects of antenatal cortisol 
exposure.  
Third, future studies exploring the link between antenatal maternal stress and 
inflammatory markers and offspring’s functional and structural alterations of the brain 
represent an important avenue for future research in that they might help to explain the 
pathways underlying the reported associations (e.g. Rasmussen et al., 2018; Buss et 
al., 2012).  
Fourth, while the current thesis outlined significant associations among several 
indices of maternal antenatal stress and infants’ outcomes from birth to three months 
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of age, our findings are limited by the short postnatal follow-up. Thus, it remains 
unknown whether the effects of antenatal maternal stress on later biological, 
behavioral and cognitive outcomes might persist later in development (e.g. O’Donnell 
et al., 2013), change accordingly to the offspring’s age (e.g. Osborne et al., 2018) or 
whether the antenatal stress-related altered outcomes might be predictive of 
subsequent developmental outcomes (e.g. Thomas et al., 2017; Grahman et al., 
2017). Furthermore, the interplay among maternal prenatal and postnatal influences in 
determining offspring outcomes later in development is unknown. To begin to address 
some of these questions, children from the current cohort were re-assessed at 13 
months of age and are being currently re-assessed at approximately 40 months of 
age. While this work goes beyond the current thesis timeframe, the results of these 
later follow-ups will help to shed light on long-lasting effects of antenatal maternal 
stress as well as on the buffering role of postnatal maternal care.  
Fifth, future studies are warranted in order to elucidate the differential effects of 
exposure during different critical periods along gestation by including multiple 
measures of stress and inflammation throughout pregnancy, at least during early, mid- 
and late pregnancy. While a similar approach will be quite expensive and demanding 
for women, it is expected to provide novel data on the most susceptible gestational 
periods for the effects of distinct stress-related mechanisms. In addition, recent 
evidence suggests that changes in cortisol secretion as gestation advances (Davis & 
Sandman, 2010; Davis et al., 2011) are more predictive of later infant development, as 
compared to single cortisol assessment. Thus, repeated biological assessments 
across gestation might help to evaluate the trajectory of change in each biological 
marker levels and better understand possible gestational timing effects.  
Sixth, while the observed associations have been adjusted for infant gender, 
the current sample size did not allow us to directly examine possible gender 
differences in the link between maternal antenatal stress and child outcomes. 
Nevertheless, the possibility that the effects of prenatal stress may be sex-dependent 
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remains an important issue for future research as several lines of evidence converge 
to indicate that that the effects of antenatal stress might differ depending on fetal 
gender. First of all, it has been shown that maternal cortisol secretion during 
pregnancy differs as a function of fetal sex (e.g. Bleker et al., 2017; DiPietro et al., 
2011; Giesbrecht et al., 2015; Hocher et al., 2009; Glynn & Sandman, 2011; Mitchell et 
al., 2017). In line with these findings, in Chapter 3, we reported lower cortisol levels at 
awakening in women carrying female fetuses, relative to males, although fetal sex was 
not found to moderate the association between antenatal maternal depression and the 
diurnal cortisol pattern. Additionally, sex differences in placental function, including 
expression of 11-βHSD2 (Mericq et al., 2009) and glucocorticoid receptors (Saif et al., 
2015), glycemic control and blood pressure have been reported (Hocher et al., 2009; 
Petry et al., 2007). Furthermore, mounting data from animal models and preliminary 
evidence in humans suggest that, while both males and females are susceptible to the 
effects of maternal antenatal stress, the pattern of effects might differ depending on 
fetal sex, resulting in sexually-dimorphic fetal growth strategies and outcomes 
(Sandman, Glynn & Davis, 2013; Glover & Hill, 2012; Van den Bergh et al., 2017). For 
example, preliminary findings in humans suggest that sex moderates the effects of 
prenatal distress on children’s stress reactivity, with males displaying blunted 
response, whereas females showing increase reactivity to stressors (reviewed in 
Carpenter et al., 2017). Interestingly, Giesbrecht and colleagues (2017) reported that 
sex significantly moderated the association between a higher maternal CAR and 3-
month-olds cortisol reactivity to a blood draw in a large sample (N= 236), with males 
showing a flatter response, in line with our findings on the whole sample at birth 
(Chapter 4), and females showing a greater cortisol response. Despite we did not 
examine sex differences in newborns’ cortisol response, the sex ratio in our sample 
slighlty favoured males (51.9%) over females (48.1%), thus it is possible that the 
direction of the observed effect might be partially driven by the composition of our 
sample (Gisebrecht et al., 2017). However, adjusting for sex did not change the 
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direction of the association. Sex differences in the effects of antenatal maternal stress 
might also account for unexpected findings in the current study. For example, in 
contrast with our initial hypothesis, we did not report any significant association 
between antenatal maternal cortisol levels and infants’ NA (Chapter 5). We might 
speculate that a failure to account for sex differences might explain this null finding. 
Indeed, initial evidence indicates that heightened maternal cortisol in pregnancy is 
associated with a more difficult temperament (Sandman et al., 2013; Braithwaithe et 
al., 2017) in females, while opposite effects have been reported in some cases in 
males (e.g. Braithwaithe et al., 2017). As ignoring sex difference essentially takes the 
average of the effects for males and females, in the case they are opposite, this might 
lead to a null overall effect (Gisbrecht et al., 2017). Future studies in larger samples 
should be designed to directly examine sex-dependent processes underpinning the 
effects of prenatal stress on infants’ developmental trajectories, whereby females tend 
to become more reactive to challenge and more anxious, and males become less 
reactive and more aggressive (Glover and Hill, 2012; Sandman et al., 2013). These 
findings may also have relevance to our understanding of sex differences observed in 
the incidence and presentation of psychiatric and stress-related disorders.  
Seventh, studies investigating the interplay among prenatal and postnatal 
maternal influences in determining offspring’s developmental trajectories are scarce. 
We provided novel evidence for a buffering effect of the quality of maternal care in the 
association between antenatal maternal cortisol and infants stress reactivity. However, 
future studies should examine the extent to which other environmental influences, 
such as partner support or positive family functioning, might moderate the association 
between antenatal maternal stress and child outcomes.  
Eighth, the current findings need to be replicated in future studies adopting a 
genetically informed design (Rice et al., 2018) before strong conclusions can be 
drawn. For example, Rice and colleagues (2010) reported significant associations 
between prenatal maternal stress and some indices of later child development (infant 
338 
 
birth weight and conduct problems; though not all e.g. anxiety, ADHD) when using an 
in vitro fertilization-based prenatal cross fostering design which controls for genes 
shared between mother and child. In addition, while a number of genetic variants have 
been found to interact with an adverse early environment to increase vulnerability for 
later depression (e.g. Caspi et al., 2003) or anti-social behaviour (e.g. Taylor & Kim-
Cohen, 2007; Thapar et al., 2005), comparatively, a small number of studies 
(Buchmann et al., 2014; Hill et al., 2013; Pluess et al., 2011; Zohsel et al., 2014) have 
investigated whether these genetic polymorphism might moderate the link between 
prenatal stress exposures and later emotional and behavioural outcomes. This kind of 
studies are expected to provide a valuable contribution to the DOHaD field.  
Lastly, observational studies have inherently limited leverage to test whether 
the effects of prenatal maternal influences on child outcomes is truly causal. Future 
studies should be aimed to provide more experimental evidence in humans. In 
particular, findings from randomized controlled trials on evidence-based intervention to 
reduce antenatal depressive symptoms, hold promise for providing an experimental 
test of the DOHaD hypothesis. More strictly speaking, evidence demonstrating that 
reducing prenatal maternal depressive symptoms has an impact on child biological 
and behavioral outcomes (while controlling for relevant postnatal influences), thereby 
decreasing later risk for psychopathology would provide strong evidence for a true 
antenatal effect of maternal depression with substantial theoretical and clinical 
implications.  
 
7.5 Concluding remarks 
The amount of evidence linking maternal antenatal depression with an 
increased risk of altered biological, behavioral, emotional and cognitive outcomes in 
offspring is now substantial (reviewed in Van den Bergh et al., 2017). Knowledge 
concerning the underlying mechanisms is strikingly much less advanced. The current 
dissertation has addressed an existing gap in the literature by prospectively 
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investigating three stress-related biological pathways possibly underlying fetal 
programming by maternal antenatal depression and by examining the interplay 
between prenatal and postnatal maternal influences. Findings from the current thesis 
represent a first step towards understanding the role of inflammation and stress 
hormones in developmental programming, as well as the buffering role of postnatal 
sensitive caregiving. These are promising and largely unexplored areas for future 
scientific inquiries. Work is needed to elucidate the nature of the in-utero pathways 
leading to the observed associations between maternal antenatal influences and infant 
bio-behavioral outcomes in a normative sample. In addition, we need to understand 
more about gestational ages of sensitivity, sex differences and role of genetics and 
gene-environment interactions.  
From a clinical perspective, the current thesis provides evidence that even 
without meeting full criteria for a clinical diagnosis, maternal depressive symptoms 
during pregnancy are associated with an altered stress-related biology and infant 
outcomes, thus outlining the need for additional attention to maternal mental health 
during the perinatal period. As prevalence estimates suggest that up to 30% of women 
during pregnancy experience depressive symptoms (Bennet et al., 2004; Banti et al. 
2011), the importance of considering maternal mental health as a population health 
issue of high significance cannot be overstated. Maternal depression and anxiety is 
mostly undetected by health practitioners providing perinatal care (Alder et al., 2011). 
In contrast, we proposed that maternal psychological health during pregnancy should 
be addressed as fully as any other medical aspects of antenatal care and that 
midwifes and obstetricians should be trained to detect signs of women distress. 
Pregnant women who present high levels of depressive symptoms should deserve 
careful evaluation and monitoring as they likely represent a vulnerable population who 
may need additional help and support during the transition to parenthood. Paralleling 
to this, more research is needed into psychological interventions effective in reducing 
depressive and anxiety symptoms during pregnancy, as to date preventive antenatal 
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intervention have shown little effect in reducing maternal distress and prenatal 
intervention leads only to a small reduction in symptomatology (see Fontein‐Kuipers et 
al., 2014 meta-analytical findings). For pregnant women who are severely depressed, 
more specialist care, possibly included antidepressants, may be needed.  
Clinical implications of the observed associations among stress and 
inflammatory markers and both antenatal depressive symptoms and child outcomes 
are yet less clear. Future research is needed to understand whether the assessment 
of inflammatory markers into routine clinical practice may aid the development of 
prevention and treatment strategies. For example, inflammation has been found to 
predict response to antidepressants (Cattaneo et al., 2013) and there are evidence to 
suggest that adjunctive anti-inflammatory treatment might be needed in some 
treatment-resistant depression cases (Raison et al., 2013). In light of the demanding 
nature of the assessment of diurnal cortisol, involving multiple samples within the day, 
cortisol diurnal assessment seems a less feasible option to be included in standard 
care and might be offered only to sub-groups of women. There is still a long way to go 
before the assessment of biomarkers of risk for depression can be incorporated in 
routine clinical assessment and be prevention and/or intervention targets. Future 
studies should establish whether the dysregulation of IRS and HPA axis play a 
pathophysiological role in antenatal depression and whether psychological 
interventions for depression lead to changes in cortisol or inflammatory markers 
alongside mood improvements, as there is limited acceptance of pharmacological 
interventions during pregnancy (Goodman, 2009).   
Lastly, findings from the current thesis indicate that whether or not the 
observed association between maternal antenatal cortisol and infant stress reactivity is 
mediated by genetic transmission (e.g. Van Hulle et al., 2012) or by in utero cortisol-
mediated mechanisms (e.g. O’ Donnell et al., 2009), changes in infant stress-related 
systems might be over-ridden by a postnatal sensitive environment, thus extending the 
window of opportunities for preventive interventions beyond the first nine months of 
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life. In contrast, the effects of poor parenting might exacerbate the effects of prenatal 
stress influences contributing to influence later vulnerability for health and mental 
outcomes (Schlotz & Phillips, 2009). Parenting is a challenging task and might become 
even more demanding and overwhelming for women experiencing antenatal distress 
(Easterbrooks et al., 2012). A number of well-validated attachment-based 
interventions, such as the Video-Feedback Intervention to Promote Positive Parenting 
(VIPP; Juffer, Bakermans-Kranenburg, & Van Ijzendoorn, 2012), have been proved to 
be effective in promoting mother-infant relationship, enhancing maternal sensitivity and 
EA, in several context (reviewed in Juffer, Bakermans-Kranenburg, & van IJzendoorn, 
2017) including with depressed mothers (Stein et al., 2018), thus constituing a valid 
option to be offered to antenatally depressed mothers.  
If the current findings are replicated, they suggest that researchers and 
clinicians should join their efforts to find the best way to effectively identify women 
experiencing depressive symptoms during pregnancy and provide them with 
accessible and effective antenatal and postnatal treatment in order to help all mothers 











Aaltonen, R., Heikkinen, T., Hakala, K., Laine, K., & Alanen, A. (2005). Transfer of 
proinflammatory cytokines across term placenta. Obstetrics & Gynecology, 
106(4), 802–807. 
Abbott, R., Whear, R., Nikolaou, V., Bethel, A., Coon, J. T., Stein, K., & Dickens, C. 
(2015). Tumour necrosis factor-α inhibitor therapy in chronic physical illness: A 
systematic review and meta-analysis of the effect on depression and anxiety. 
Journal of Psychosomatic Research, 79(3), 175–184. 
Abe, H., Hidaka, N., Kawagoe, C., Odagiri, K., Watanabe, Y., Ikeda, T., … Ishida, Y. 
(2007). Prenatal psychological stress causes higher emotionality, depression-like 
behavior, and elevated activity in the hypothalamo-pituitary-adrenal axis. 
Neuroscience Research, 59(2), 145–151.  
Abou-Saleh, M. T., Ghubash, R., Karim, L., Krymski, M., & Bhai, I. (1998). Hormonal 
aspects of postpartum depression. Psychoneuroendocrinology, 23(5), 465-475. 
Accortt, E. E., Schetter, C. D., Peters, R. M., & Cassidy-Bushrow, A. E. (2016). Lower 
prenatal vitamin D status and postpartum depressive symptomatology in African 
American women: Preliminary evidence for moderation by inflammatory 
cytokines. Archives of Women’s Mental Health, 19(2), 373–383.  
Adam, E. K., & Kumari, M. (2009). Assessing salivary cortisol in large-scale, 
epidemiological research. Psychoneuroendocrinology, 34(10), 1423–1436.  
Agelink, M. W., Boz, C., Ullrich, H., & Andrich, J. (2002). Relationship between major 
depression and heart rate variability: Clinical consequences and implications for 
antidepressive treatment. Psychiatry Research, 113(1–2), 139–149. 
Aiken, C. E., & Ozanne, S. E. (2014). Transgenerational developmental programming. 
Human Reproduction Update, 20(1), 63–75.  
343 
 
Ainsworth, M. D. S., Blehar, M. C., Waters, E., & Wall, S. (1978). Patterns of 
attachment: Assessed in the strange situation and at home. Hillsdale, NJ: 
Erlbaum. 
Albers, E. M., Marianne Riksen‐Walraven, J., Sweep, F. C. G. J., & Weerth, C. de. 
(2008). Maternal behavior predicts infant cortisol recovery from a mild everyday 
stressor. Journal of Child Psychology and Psychiatry, 49(1), 97–103. 
Alder, J., Fink, N., Bitzer, N., Hosli, I., & Holzgreve, W. (2007). Depression and anxiety 
during pregnancy: A risk factor for obstetric, fetal, and neonatal outcomes. The 
Journal of Maternal-Fetal and Neonatal Medicine, 20, 183–209. 
Alder, J., Fink, N., Urech, C., Hösli, I., & Bitzer, J. (2011). Identification of antenatal 
depression in obstetric care. Archives of Gynecology and Obstetrics, 284(6), 
1403–1409. 
Allister, L., Lester, B. M., Carr, S., & Liu, J. (2001). The effects of maternal depression 
on fetal heart rate response to vibroacoustic stimulation. Developmental 
Neuropsychology, 20(3), 639–651. 
Allolio, B., Hoffmann, J., Linton, E. a, Winkelmann, W., Kusche, M., & Schulte, H. M. 
(1990). Diurnal salivary cortisol patterns during pregnancy and after delivery: 
relationship to plasma corticotrophin-releasing-hormone. Clinical Endocrinology, 
33(2), 279–289.  
Allswede, D. M., Buka, S. L., Yolken, R. H., Torrey, E. F., & Cannon, T. D. (2016). 
Elevated maternal cytokine levels at birth and risk for psychosis in adult offspring. 
Schizophrenia Research, 172(1–3), 41–45. 
Allwood, M. A., Handwerger, K., Kivlighan, K. T., Granger, D. A., & Stroud, L. R. 
(2011). Direct and moderating links of salivary alpha-amylase and cortisol stress-
reactivity to youth behavioral and emotional adjustment. Biological Psychology, 
88(1), 57–64. 
Althouse, A. D. (2016). Adjust for multiple comparisons? It’s not that simple. The 
Annals of thoracic surgery, 101(5), 1644-1645. 
344 
 
American Psychiatric Association (2000). Diagnostic and statistical manual of mental 
disorders (4th ed., Text Revision). Washington, DC. 
Andersen, B. L., Kiecolt-Glaser, J. K., & Glaser, R. (1994). A biobehavioral model of 
cancer stress and disease course. American Psychologist, 49(5), 389. 
Anderson, J.W., Johnstone, B.M., Remley, D.T. (1999). Breast-feeding and cognitive 
development: a meta-analysis. Am J Clin Nutr, 70, 525–535. 
Anderson, S. E., Gooze, R. A., Lemeshow, S., & Whitaker, R. C. (2011). Quality of 
early maternal–child relationship and risk of adolescent obesity. Pediatrics. 
Andersson, L., Sundström-Poromaa, I., Wulff, M., Åström, M., & Bixo, M. (2004). 
Implications of antenatal depression and anxiety for obstetric outcome. Obstetrics 
& Gynecology, 104(3), 467–476. 
Andersson, L., Sundström-Poromaa, I., Wulff, M., Åström, M., & Bixo, M. (2006). 
Depression and anxiety during pregnancy and six months postpartum: A follow-
up study. Acta Obstetricia et Gynecologica Scandinavica, 85(8), 937–944.  
Andrews, M. H., & Matthews, S. G. (2004). Programming of the hypothalamo–
pituitary–adrenal axis: serotonergic involvement. Stress, 7(1), 15–27. 
Appleyard, K., Egeland, B., van Dulmen, M. H. M., & Sroufe, L. A. (2005). When more 
is not better: The role of cumulative risk in child behavior outcomes. Journal of 
Child Psychology and Psychiatry, 46(3), 235–245. 
Ashman, S. B., Dawson, G., & Panagiotides, H. (2008). Trajectories of maternal 
depression over 7 years: Relations with child psychophysiology and behavior and 
role of contextual risks. Development and Psychopathology, 20(1), 55–77.  
Au, B., Smith, K. J., Gariépy, G., & Schmitz, N. (2015). The longitudinal associations 
between C‐reactive protein and depressive symptoms: evidence from the English 
Longitudinal Study of Ageing (ELSA). International Journal of Geriatric 
Psychiatry, 30(9), 976–984. 
Austin, M. P., Christl, B., McMahon, C., Kildea, S., Reilly, N., Yin, C., … King, S. 
(2017). Moderating effects of maternal emotional availability on language and 
345 
 
cognitive development in toddlers of mothers exposed to a natural disaster in 
pregnancy: The QF2011 Queensland Flood Study. Infant Behavior and 
Development, 49(July), 296–309. 
Austin, M. P., Hadzi-Pavlovic, D., Leader, L., Saint, K., & Parker, G. (2005). Maternal 
trait anxiety, depression and life event stress in pregnancy: Relationships with 
infant temperament. Early Human Development, 81(2), 183–190.  
Azak, S., Murison, R., Wentzel-Larsen, T., Smith, L., & Gunnar, M. R. (2013). Maternal 
depression and infant daytime cortisol. Developmental Psychobiology, 55(4), 
334–351.  
Azar, R., & Mercer, D. (2013). Mild depressive symptoms are associated with elevated 
C-reactive protein and proinflammatory cytokine levels during early to 
midgestation: a prospective pilot study. Journal of Women’s Health (2002), 22(4), 
385–389.  
Bagley, S. L., Weaver, T. L., & Buchanan, T. W. (2011). Sex differences in 
physiological and affective responses to stress in remitted depression. Physiology 
and Behavior, 104(2), 180–186.  
Baibazarova, E., Van De Beek, C., Cohen-Kettenis, P. T., Buitelaar, J., Shelton, K. H., 
& Van Goozen, S. H. M. (2013). Influence of prenatal maternal stress, maternal 
plasma cortisol and cortisol in the amniotic fluid on birth outcomes and child 
temperament at 3 months. Psychoneuroendocrinology, 38(6), 907–915.  
Bandoli, G., Coles, C. D., Kable, J. A., Wertelecki, W., Granovska, I. V., Pashtepa, A. 
O., & Chambers, C. D. (2016). Assessing the Independent and Joint Effects of 
Unmedicated Prenatal Depressive Symptoms and Alcohol Consumption in 
Pregnancy and Infant Neurodevelopmental Outcomes. Alcoholism: Clinical and 
Experimental Research, 40(6), 1304–1311.  
Banks, W. A., Kastin, A. J., & Gutierrez, E. G. (1994). Penetration of interleukin-6 
across the murine blood-brain barrier. Neuroscience Letters, 179(1–2), 53–56. 
346 
 
Banti, S., Mauri, M., Oppo, A., Borri, C., Rambelli, C., Ramacciotti, D., … Cassano, G. 
B. (2011). From the third month of pregnancy to 1 year postpartum. Prevalence, 
incidence, recurrence, and new onset of depression. Results from the Perinatal 
Depression-Research & Screening Unit study. Comprehensive Psychiatry, 52(4), 
343–351.  
Bär, K.-J., Greiner, W., Jochum, T., Friedrich, M., Wagner, G., & Sauer, H. (2004). The 
influence of major depression and its treatment on heart rate variability and 
pupillary light reflex parameters. Journal of Affective Disorders, 82(2), 245–252. 
Barker, D. J. (1997). The fetal origins of coronary heart disease. Acta Paediatr Suppl, 
422(6), 78–82.  
Barker, D. J. P. (1995). The fetal and infant origins of disease. European Journal of 
Clinical Investigation, 25(7), 457–463.  
Barker, D. J. P. (2004). The developmental origins of adult disease. Journal of the 
American College of Nutrition, 23(6 Suppl), 588S–595S. 
Barker, D. J., & Osmond, C. (1986). Infant mortality, childhood nutrition, and ischaemic 
heart disease in England and Wales. Lancet (London, England), 1(8489), 1077–
1081. 
Barker, D. J., & Osmond, C. (1988). Low birth weight and hypertension. BMJ (Clinical 
Research Ed.), 297(6641), 134–135.  
Barker, E. D., Jaffee, S. R., Uher, R., & Maughan, B. (2011). The contribution of 
prenatal and postnatal maternal anxiety and depression to child maladjustment. 
Depression and Anxiety, 28(8), 696–702.  
Barker, E. D., Kirkham, N., Ng, J., & Jensen, S. K. G. (2013). Prenatal maternal 
depression symptoms and nutrition, and child cognitive function. The British 
Journal of Psychiatry, 203(6), 417–421. 
Barnes, J., Mondelli, V., & Pariante, C. M. (2017). Genetic Contributions of 
Inflammation to Depression. Neuropsychopharmacology, 42(1), 81–98.  
347 
 
Barnes, L. L. B., Harp, D., & Jung, W. S. (2002). Reliability generalization of scores on 
the Spielberger state-trait anxiety inventory. Educational and Psychological 
Measurement, 62(4), 603–618. 
Baron, R.M., & Kenny, D.A. (1986). The moderator–mediator variable distinction in 
social psychological research: Conceptual, strategic, and statistical 
considerations. Journal of Personality and Social Psychology, 51, 1173–1182. 
Barr, R. (1985). Baby’s Day Diary. Montreal, Quebec. 
Barr, R., Kramer, M. S., Boisjoly, C., McVey-White, L., & Pless, I. B. (1988). Parental 
diary of infant cry and fuss behaviour. Archives of Disease in Childhood, 63(4), 
380–387. 
Barron, W. M., Mujais, S. K., Zinaman, M., Bravo, E. L., & Lindheimer, M. D. (1986). 
Plasma catecholamine responses to physiologic stimuli in normal human 
pregnancy. American Journal of Obstetrics & Gynecology, 154(1), 80–84. 
Barry, R. A., Kochanska, G., & Philibert, R. A. (2008). G × E interaction in the 
organization of attachment: mothers’ responsiveness as a moderator of children’s 
genotypes. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 
49(12), 1313–1320.  
Bassett, J. M., & Hanson, C. (1998). Catecholamines inhibit growth in fetal sheep in 
the absence of hypoxemia. American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology, 274(6), R1536–R1545. 
Bateson, P., Barker, D., Clutton-Brock, T., Deb, D., D’Udine, B., Foley, R. A., … 
Sultan, S. E. (2004). Developmental plasticity and human health. Nature, 
430(6998), 419–421.  
Bauer, A. M., Quas, J. A., & Boyce, W. T. (2002). Associations between physiological 
reactivity and children’s behavior: advantages of a multisystem approach. Journal 
of Developmental and Behavioral Pediatrics : JDBP, 23(2), 102–113. 




Baumeister, D., Akhtar, R., Ciufolini, S., Pariante, C. M., & Mondelli, V. (2016). 
Childhood trauma and adulthood inflammation: A meta-analysis of peripheral C-
reactive protein, interleukin-6 and tumour necrosis factor-α. Molecular Psychiatry, 
21(5), 642–649.  
Baumeister, D., Lightman, S., & Pariante, C. M. (2014). The Interface of Stress and 
the HPA Axis in Behavioural Phenotypes ofMental Illness. Curr Topics Behav 
Neurosci, (18), 13–24. https://doi.org/10.1007/7854 
Bayley, N. (2006). Bayley scales of infants and toddler development (3rd ed.). San 
Antonio, TX US: Harcourt Assessment Inc. 
Bedford, H., Walton, S., & Ahn, J. (2013). Measures of child development: A review. 
Beijers, R., Jansen, J., Riksen-Walraven, M., & de Weerth, C. (2010). Maternal 
Prenatal Anxiety and Stress Predict Infant Illnesses and Health Complaints. 
Pediatrics, 126(2), e401–e409.  
Bekkhus, M., Rutter, M., Barker, E. D., & Borge, A. I. H. (2011). The role of pre- and 
postnatal timing of family risk factors on child behavior at 36 months. Journal of 
Abnormal Child Psychology, 39(4), 611–621.  
Belsky, J. (1997). Theory testing, effect‐size evaluation, and differential susceptibility 
to rearing influence: The case of mothering and attachment. Child Development, 
68(4), 598–600. 
Belsky, J. (2005). Differential susceptibility to rearing influence. Origins of the Social 
Mind: Evolutionary Psychology and Child Development, 139–163. 
Belsky, J., & Pluess, M. (2009). Beyond diathesis stress: Differential susceptibility to 
environmental influences. Psychological Bulletin, 135(6), 885–908.  
Benediktsson, R., Calder, A. A., Edwards, C. R. W., & Seckl, J. R. (1997). Placental 
11β‐hydroxysteroid dehydrogenase: a key regulator of fetal glucocorticoid 
exposure. Clinical Endocrinology, 46(2), 161–166. 
349 
 
Benvenuti, P., Ferrara, M., Niccolai, C., Valoriani, V., & Cox, J. L. (1999). The 
Edinburgh Postnatal Depression Scale: validation for an Italian sample. Journal of 
Affective Disorders, 53(2), 137–141. 
Berger, S., Kliem, A., Yeragani, V., & Bär, K.-J. (2012). Cardio-respiratory coupling in 
untreated patients with major depression. Journal of Affective Disorders, 139(2), 
166–171. 
Bergman, K., Glover, V., Sarkar, P., Abbott, D. H., & O’Connor, T. G. (2010). In utero 
cortisol and testosterone exposure and fear reactivity in infancy. Hormones and 
Behavior, 57(3), 306–312.  
Bergman, K., Sarkar, P., Glover, V., & O’Connor, T. G. (2008). Quality of Child-Parent 
Attachment Moderates the Impact of Antenatal Stress on Child Fearfulness. J 
Child Psychol Psychiatry, 49(10), 1089–1098.  
Bergman, K., Sarkar, P., Glover, V., & O’Connor, T. G. (2010). Maternal Prenatal 
Cortisol and Infant Cognitive Development: Moderation by Infant-Mother 
Attachment. Biol Psychiatry, 67(11), 1026–1032.  
Bergman, K., Sarkar, P., O’Connor, T. G., Modi, N., & Glover, V. (2007). Maternal 
stress during pregnancy predicts cognitive ability and fearfulness in infancy. 
Journal of the American Academy of Child and Adolescent Psychiatry, 46(11), 
1454–1463.  
Bernard, K., Nissim, G., Vaccaro, S., Harris, J. L., & Lindhiem, O. (2018). Association 
between maternal depression and maternal sensitivity from birth to 12 months: a 
meta-analysis. Attachment and Human Development, 00(00), 1–22.  
Betts, K. S., Williams, G. M., Najman, J. M., & Alati, R. (2014). Maternal depressive, 
anxious, and stress symptoms during pregnancy predict internalizing problems in 
adolescence. Depression and Anxiety, 31(1), 9–18.  
Betts, K. S., Williams, G. M., Najman, J. M., & Alati, R. (2015). The relationship 
between maternal depressive, anxious, and stress symptoms during pregnancy 
350 
 
and adult offspring behavioral and emotional problems. Depression and Anxiety, 
32(2), 82–90.  
Biaggi, A., Conroy, S., Pawlby, S., & Pariante, C. M. (2016). Identifying the women at 
risk of antenatal anxiety and depression: A systematic review. Journal of Affective 
Disorders, 191, 62–77.  
Biringen, Z. (2008). Emotional Availability Scales, 4th Edition. Boulder: Colorado State 
University. 
Biringen, Z., Derscheid, D., Vliegen, N., Closson, L., & Easterbrooks, M. A. (2014). 
Emotional availability (EA): Theoretical background, empirical research using the 
EA Scales, and clinical applications. Developmental Review, 34(2), 114–167. 
Bjelanovic, V., Babic, D., Hodzic, D., Bjelanovic, A., Kresic, T., Dugandzic-Simic, A., & 
Oreskovic, S. (2015). Correlation of psychological symptoms with cortisol and 
CRP levels in pregnant women with metabolic syndrome. Psychiatria Danubina, 
27 Suppl 2(1), 578–585.  
Black, M. M., Hess, C. R., & Berenson-Howard, J. (2000). Toddlers from low-income 
families have below normal mental, motor, and behavior scores on the revised 
bayley scales. Journal of Applied Developmental Psychology, 21(6), 655–666.  
Black, S., Kushner, I., & Samols, D. (2004). C-reactive protein. Journal of Biological 
Chemistry, 279(47), 48487–48490. https://doi.org/10.1074/jbc.R400025200 
Blackmore, E. R., Groth, S. W., Chen, D.-G. D., Gilchrist, M. a, O’Connor, T. G., & 
Moynihan, J. a. (2014). Depressive symptoms and proinflammatory cytokines 
across the perinatal period in African American women. Journal of 
Psychosomatic Obstetrics and Gynaecology, 35(1), 8–15.  
Blackmore, E. R., Moynihan, J. A., Rubinow, D. R., & Eva, K. (2011). Psychiatric 
Symptoms and Proinflammatory Cytokines in Pregnancy. Psychosomatic 
Medicine, 73(8), 656–663.  
Blair, C., Granger, D. A., Kivlighan, K. T., Mills-Koonce, R., Willoughby, M., 
Greenberg, M. T., … Family Life Project Investigators. (2008). Maternal and Child 
351 
 
Contributions to Cortisol Response to Emotional Arousal in Young Children From 
Low-Income, Rural Communities. Developmental Psychology, 44(4), 1095–1109.  
Blair, C., Granger, D., Willoughby, M., & Kivlighan, K. (2006). Maternal sensitivity is 
related to hypothalamic‐pituitary‐adrenal axis stress reactivity and regulation in 
response to emotion challenge in 6‐month‐old infants. Annals of the New York 
Academy of Sciences, 1094(1), 263–267. 
Blakeley, P. M., Capron, L. E., Jensen, A. B., O’Donnell, K. J., & Glover, V. (2013). 
Maternal prenatal symptoms of depression and down regulation of placental 
monoamine oxidase A expression. Journal of Psychosomatic Research, 75(4), 
341–345.  
Bleker, L. S., Roseboom, T. J., Vrijkotte, T. G., Reynolds, R. M., & de Rooij, S. R. 
(2017). Determinants of cortisol during pregnancy – The ABCD cohort. 
Psychoneuroendocrinology, 83(April), 172–181.  
Bleker, L.S., van Dammen, L., Leeflang, M.M.G., Limpens, J., Roseboom, T.J., de 
Rooij, S.R. (2018) Hypothalamic-pituitary-adrenal axis and autonomic nervous 
system reactivity in children prenatally exposed to maternal depression: A 
systematic review of prospective studies. Neurosci Biobehav Rev. 2018 Oct 23. 
pii: S0149-7634(17)30750-9. 
Bloch, M., Daly, R. C., & Rubinow, D. R. (2003). Endocrine factors in the etiology of 
postpartum depression. Comprehensive Psychiatry, 44(3), 234–246.  
Bock, J., Murmu, M. S., Biala, Y., Weinstock, M., & Braun, K. (2011). Prenatal stress 
and neonatal handling induce sex-specific changes in dendritic complexity and 
dendritic spine density in hippocampal subregions of prepubertal rats. 
Neuroscience, 193, 34–43.  
Boersma, G. J., & Tamashiro, K. L. (2015). Individual differences in the effects of 
prenatal stress exposure in rodents. Neurobiology of Stress, 1(1), 100–108.  
352 
 
Bohnert, K., & Breslau, N. (2008). Stability of Psychiatric Outcomes of Low Birth 
Weight A Longitudinal Investigation. Archives of General Psychiatry, 65(9), 1080–
1086. 
Bohnert, K.M., Breslau, N. (2008). Stability of psychiatric outcomes of low birthweight: 
a longitudinal investigation. Arch Gen Psychiatry, 65, 1080–1086. 
Bolten, M. I., Wurmser, H., Buske-Kirschbaum, A., Papoušek, M., Pirke, K. M., & 
Hellhammer, D. (2011). Cortisol levels in pregnancy as a psychobiological 
predictor for birth weight. Archives of Women’s Mental Health, 14(1), 33–41.  
Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., Artini, M., … Maes, 
M. (2002). Increased depressive ratings in patients with hepatitis C receiving 
interferon-α–based immunotherapy are related to interferon-α–induced changes 
in the serotonergic system. Journal of Clinical Psychopharmacology, 22(1), 86–
90. 
Booij, S. H., Bos, E. H., Bouwmans, M. E. J., Van Faassen, M., Kema, I. P., 
Oldehinkel, A. J., & De Jonge, P. (2015). Cortisol and α-amylase secretion 
patterns between and within depressed and non-depressed individuals. PLoS 
ONE, 10(7), 1–15.  
Bosch, J. A., de Geus, E. J. C., Veerman, E. C. I., Hoogstraten, J., & Amerongen, A. 
V. N. (2003). Innate secretory immunity in response to laboratory stressors that 
evoke distinct patterns of cardiac autonomic activity. Psychosomatic Medicine, 
65(2), 245–258. 
Bosch, O. J., Müsch, W., Bredewold, R., Slattery, D. A., & Neumann, I. D. (2007). 
Prenatal stress increases HPA axis activity and impairs maternal care in lactating 
female offspring: Implications for postpartum mood disorder. 
Psychoneuroendocrinology, 32(3), 267–278.  
Boufidou, F., Lambrinoudaki, I., Argeitis, J., Zervas, I. M., Pliatsika, P., Leonardou, A. 
A., … Nikolaou, C. (2009). CSF and plasma cytokines at delivery and postpartum 
mood disturbances. Journal of Affective Disorders, 115(1–2), 287–292.  
353 
 
Boulanger, L. M. (2009). Immune Proteins in Brain Development and Synaptic 
Plasticity. Neuron, 64(1), 93–109.  
Boutwell, B. B., Helton, J., Vaughn, M., & Kavish, N. (2017). The Association of 
Externalizing and Internalizing Problems with Indicators of Intelligence in a 
Sample of At-Risk Children. BioRxiv.  
Boyce, W. T., & Ellis, B. J. (2005). Biological sensitivity to context: I. An evolutionary–
developmental theory of the origins and functions of stress reactivity. 
Development and Psychopathology, 17(2), 271–301. 
Brabham, T., Phelka, A., Zimmer, C., Nash, A., López, J. F., & Vázquez, D. M. (2000). 
Effects of prenatal dexamethasone on spatial learning and response to stress is 
influenced by maternal factors. American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology, 279(5), R1899–R1909. 
Braeken, M. A. K. A., Jones, A., Otte, R. A., Widjaja, D., Van Huffel, S., Monsieur, G. 
J. Y. J., … Van den Bergh, B. R. H. (2015). Anxious women do not show the 
expected decrease in cardiovascular stress responsiveness as pregnancy 
advances. Biological Psychology, 111, 83–89.  
Braeken, M. A. K. A., Kemp, A. H., Outhred, T., Otte, R. A., Monsieur, G. J. Y. J., 
Jones, A., & Van Den Bergh, B. R. H. (2013). Pregnant mothers with resolved 
anxiety disorders and their offspring have reduced heart rate variability: 
Implications for the health of children. PLoS ONE, 8(12), 6–12.  
Braithwaite, E. C., Murphy, S. E., & Ramchandani, P. G. (2014). Prenatal risk factors 
for depression: a critical review of the evidence and potential mechanisms. 
Journal of Developmental Origins of Health and Disease, 5(05), 339–350.  
Braithwaite, E. C., Murphy, S. E., & Ramchandani, P. G. (2016a). Effects of prenatal 
depressive symptoms on maternal and infant cortisol reactivity. Archives of 
Women’s Mental Health, 19(4), 581–590.  
354 
 
Braithwaite, E. C., Murphy, S. E., Ramchandani, P. G., & Hill, J. (2017). Associations 
between biological markers of prenatal stress and infant negative emotionality are 
specific to sex. Psychoneuroendocrinology, 86(April), 1–7.  
Braithwaite, E. C., Pickles, A., Sharp, H., Glover, V., O’Donnell, K. J., Tibu, F., & Hill, 
J. (2017). Maternal prenatal cortisol predicts infant negative emotionality in a sex-
dependent manner. Physiology and Behavior, 175, 31–36.  
Braithwaite, E. C., Ramchandani, P. G., Lane, T. A., & Murphy, S. E. (2015). 
Symptoms of prenatal depression are associated with raised salivary alpha-
amylase levels. Psychoneuroendocrinology, 60, 163–172.  
Bränn, E., Papadopoulos, F., Fransson, E., White, R., Edvinsson, Å., Hellgren, C., … 
Skalkidou, A. (2017). Inflammatory markers in late pregnancy in association with 
postpartum depression − a nested case-control study. 
Psychoneuroendocrinology, 79, 146–159.  
Brazelton, T. B., & Nugent, J. K. (1995). Neonatal behavioral assessment scale. 
Cambridge University Press. 
Brennan, P. a, Pargas, R., Walker, E. F., Green, P., & Newport, D. J. (2008). Maternal 
depression and infant cortisol: influences of timing, comorbidity and treatment. J 
Child Psychol Psychiatry, 49(10), 1099–1107. 
Brewster, J. A., Orsi, N. M., Gopichandran, N., McShane, P., Ekbote, U. V, & Walker, 
J. J. (2008). Gestational effects on host inflammatory response in normal and 
pre-eclamptic pregnancies. European Journal of Obstetrics & Gynecology and 
Reproductive Biology, 140(1), 21–26. 
Broekman, B. F. P., Chan, Y.-H., Chong, Y.-S., Quek, S.-C., Fung, D., Low, Y.-L., … 
Saw, S.-M. (2009a). The influence of birth size on intelligence in healthy children. 
Pediatrics, 123(6), e1011-6.  
Bronson, S. L., & Bale, T. L. (2014). Prenatal stress-induced increases in placental 
inflammation and offspring hyperactivity are male-specific and ameliorated by 
maternal antiinflammatory treatment. Endocrinology, 155(7), 2635–2646. 
355 
 
Brouwers, E. P. M., Van Baar, A. L., & Pop, V. J. M. (2001). Maternal anxiety during 
pregnancy and subsequent infant development. Infant Behavior and 
Development, 24(1), 95–106. 
Brown, A. S., & Susser, E. S. (1997). Sex Differences in Prevalence of Congenital 
Neural Defects after Periconceptional Famine Exposure. Epidemiology, 8(1), 55–
58.  
Brown, A. S., Begg, M. D., Gravenstein, S., Schaefer, C. A., Wyatt, R. J., Bresnahan, 
M., … Susser, E. S. (2004). Serologic evidence of prenatal influenza in the 
etiology of schizophrenia. Archives of General Psychiatry, 61(8), 774–780. 
Brunton, P. J. (2010). Resetting the dynamic range of hypothalamic-pituitary-adrenal 
axis stress responses through pregnancy. Journal of Neuroendocrinology, 22(11), 
1198–1213.  
Brunton, P. J., & Russell, J. A. (2008). The expectant brain: Adapting for motherhood. 
Nature Reviews Neuroscience, 9(1), 11–25.  
Buchmann, A. F., Zohsel, K., Blomeyer, D., Hohm, E., Hohmann, S., Jennen-
Steinmetz, C., … Laucht, M. (2014). Interaction between prenatal stress and 
dopamine D4 receptor genotype in predicting aggression and cortisol levels in 
young adults. Psychopharmacology, 231(16), 3089–3097.  
Bufalino, C., Hepgul, N., Aguglia, E., & Pariante, C. M. (2013). The role of immune 
genes in the association between depression and inflammation: A review of 
recent clinical studies. Brain, Behavior, and Immunity, 31, 31–47.  
Buitelaar, J. K., Huizink, A. C., Mulder, E. J., Robles De Medina, P. G., Visser, G. H. 
A., Finch, … De Wied. (2003). Prenatal stress and cognitive development and 
temperament in infants. Neurobiology of Aging, 24(SUPPL. 1), 53–60.  
Buka, S. L., Tsuang, M. T., Torrey, E. F., Klebanoff, M. A., Wagner, R. L., & Yolken, R. 
H. (2001). Maternal cytokine levels during pregnancy and adult psychosis. Brain, 
Behavior, and Immunity, 15(4), 411–420. 
356 
 
Bureau, J.-F., Easterbrooks, M. A., & Lyons-Ruth, K. (2009). Maternal depressive 
symptoms in infancy: Unique contribution to children’s depressive symptoms in 
childhood and adolescence? Development and Psychopathology, 21(2), 519–
537. 
Buschdorf, J. P., & Meaney, M. J. (2011). Epigenetics/programming in the HPA axis. 
Comprehensive Physiology, 6(1), 87–110. 
Buss, C., Davis, E. P., Shahbaba, B., Pruessner, J. C., Head, K., & Sandman, C. A. 
(2012). Maternal cortisol over the course of pregnancy and subsequent child 
amygdala and hippocampus volumes and affective problems. Proceedings of the 
National Academy of Sciences, 201201295. 
Buss, C., Lord, C., Wadiwalla, M., Hellhammer, D. H., Lupien, S. J., Meaney, M. J., & 
Pruessner, J. C. (2007). Maternal Care Modulates the Relationship between 
Prenatal Risk and Hippocampal Volume in Women But Not in Men. Journal of 
Neuroscience, 27(10), 2592–2595.  
Cai, Z., Pan, Z.-L., Pang, Y. I., Evans, O. B., & Rhodes, P. G. (2000). Cytokine 
induction in fetal rat brains and brain injury in neonatal rats after maternal 
lipopolysaccharide administration. Pediatric Research, 47(1), 64. 
Caldji, C., Diorio, J., & Meaney, M. J. (2000). Variations in maternal care in infancy 
regulate the development of stress reactivity. Biological Psychiatry, 48(12), 1164–
1174. 
Callaghan, B. L., & Tottenham, N. (2015). The neuro-environmental loop of plasticity: 
A cross-species analysis of parental effects on emotion circuitry development 
following typical and adverse caregiving. Neuropsychopharmacology, 41(1), 163–
176. 
Camaioni, L., & Di Blasio, P. (2002). Psicologia dello sviluppo. Il mulino. 
Canetta, S., Ph, D., Sourander, A., Surcel, H., Ph, D., Lic, P., … Brown, A. S. (2014). 
Elevated Maternal C-Reactive Protein is Associated with Increased Risk of 
357 
 
Schizophrenia in a National Birth Cohort Sarah. Am J Psychiatry, 171(9), 960–
968.  
Cao, X., Laplante, D. P., Brunet, A., Ciampi, A., & King, S. (2014). Prenatal maternal 
stress affects motor function in 51/2-year-old children: Project Ice Storm. 
Developmental Psychobiology, 56(1), 117–125.  
Capron, L. E., Glover, V., Pearson, R. M., Evans, J., O’Connor, T. G., Stein, A., … 
Ramchandani, P. G. (2015). Associations of maternal and paternal antenatal 
mood with offspring anxiety disorder at age 18 years. Journal of Affective 
Disorders, 187, 20–26.  
Capuron, L., Gumnick, J. F., Musselman, D. L., Lawson, D. H., Reemsnyder, A., 
Nemeroff, C. B., & Miller, A. H. (2002). Neurobehavioral effects of interferon-α in 
cancer patients: phenomenology and paroxetine responsiveness of symptom 
dimensions. Neuropsychopharmacology, 26(5), 643. 
Carpenter, L. L., Gawuga, C. E., Tyrka, A. R., & Price, L. H. (2012). C-reactive protein, 
early life stress, and wellbeing in healthy adults. Acta Psychiatrica Scandinavica, 
126(6), 402–410.  
Carpenter, T., Grecian, S. M., & Reynolds, R. M. (2017). Sex differences in early-life 
programming of the hypothalamic–pituitary–adrenal axis in humans suggest 
increased vulnerability in females: a systematic review. Journal of developmental 
origins of health and disease, 8(2), 244-255. 
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., … 
Braithwaite, A. (2003). Influence of life stress on depression: moderation by a 
polymorphism in the 5-HTT gene. Science, 301(5631), 386–389. 
Cassidy-Bushrow, A. E., Peters, R. M., Johnson, D. A., & Templin, T. N. (2012). 
Association of depressive symptoms with inflammatory biomarkers among 




Catov, J. M., Flint, M., Lee, M. J., Roberts, J. M., & Abatemarco, D. J. (2014). The 
Relationship Between Race, Inflammation and Psychosocial Factors Among 
Pregnant Women. Maternal and Child Health Journal, 19(2), 401–409.  
Cattaneo, A., Gennarelli, M., Uher, R., Breen, G., Farmer, A., Aitchison, K. J., … 
McGuffin, P. (2013). Candidate genes expression profile associated with 
antidepressants response in the GENDEP study: differentiating between baseline 
‘predictors’ and longitudinal ‘targets.’ Neuropsychopharmacology, 38(3), 377. 
Cervoni, J.-P., Thévenot, T., Weil, D., Muel, E., Barbot, O., Sheppard, F., … Di 
Martino, V. (2012). C-reactive protein predicts short-term mortality in patients with 
cirrhosis. Journal of Hepatology, 56(6), 1299–1304. 
Charil, A., Laplante, D. P., Vaillancourt, C., & King, S. (2010). Prenatal stress and 
brain development. Brain Research Reviews, 65(1), 56–79.  
Chase, K. A., Cone, J. J., Rosen, C., & Sharma, R. P. (2016). The value of interleukin 
6 as a peripheral diagnostic marker in schizophrenia. BMC Psychiatry, 16(1), 
152. 
Chatterton Jr, R. T., Vogelsong, K. M., Lu, Y., Ellman, A. B., & Hudgens, G. A. (1996). 
Salivary α‐amylase as a measure of endogenous adrenergic activity. Clinical 
Physiology, 16(4), 433–448. 
Cheeran, M. C.-J., Hu, S., Yager, S. L., Gekker, G., Peterson, P. K., & Lokensgard, J. 
R. (2001). Cytomegalovirus induces cytokine and chemokine production 
differentially in microglia and astrocytes: antiviral implications. Journal of 
Neurovirology, 7(2), 135–147. 
Cheng, C.-Y., & Pickler, R. H. (2010). Maternal psychological well-being and salivary 
cortisol in late pregnancy and early post-partum. Stress and Health: Journal of 
the International Society for the Investigation of Stress, 26(3), 215–224. 
Cheng, Y.-H., Nicholson, R. C., King, B., Chan, E.-C., Fitter, J. T., & Smith, R. (2000). 
Glucocorticoid stimulation of corticotropin-releasing hormone gene expression 
requires a cyclic adenosine 3′, 5′-monophosphate regulatory element in human 
359 
 
primary placental cytotrophoblast cells. The Journal of Clinical Endocrinology & 
Metabolism, 85(5), 1937–1945. 
Cherak, S. J., Giesbrecht, G. F., Metcalfe, A., Ronksley, P. E., & Malebranche, M. E. 
(2018). The effect of gestational period on the association between maternal 
prenatal salivary cortisol and birth weight: A systematic review and meta-analysis. 
Psychoneuroendocrinology, 94(April), 49–62. 
Chiappelli, F., Manfrini, E., Franceschi, C., Cossarizza, A., & Black, K. L. (1994). 
Steroid Regulation of Cytokines. Relevance for TH1‐to‐TH2 Shift? a. Annals of 
the New York Academy of Sciences, 746(1), 204–215. 
Chittleborough, C. R., Lawlor, D. A., & Lynch, J. W. (2012). Prenatal prediction of poor 
maternal and offspring outcomes: implications for selection into intensive parent 
support programs. Maternal and Child Health Journal, 16(4), 909–920. 
Christian, L. M. (2012a). Physiological reactivity to psychological stress in human 
pregnancy: Current knowledge and future directions. Progress in Neurobiology, 
99(2), 106–116. 
Christian, L. M. (2012b). Psychoneuroimmunology in Pregnancy: Immune Pathways 
linking stress with maternal health, adverse birth outcomes and fetal 
development. Neuroscience and Biobehavioral Reviews, 36(1), 350–361.  
Christian, L. M., & Porter, K. (2014). Longitudinal Changes in Serum Proinflammatory 
Markers across Pregnancy and Postpartum: Effects of Maternal Body Mass 
Index. American Journal of Managed Care, 20(11), 887–893.  
Christian, L. M., Franco, A., Glaser, R., & Iams, J. D. (2009). Depressive symptoms 
are associated with elevated serum proinflammatory cytokines among pregnant 
women. Brain, Behavior, and Immunity, 23(6), 750–754.  
Christian, L. M., Franco, A., Iams, J. D., Sheridan, J., & Glaser, R. (2010). Depressive 
symptoms predict exaggerated inflammatory responses to an in vivo immune 
challenge among pregnant women. Brain, Behavior, and Immunity, 24(1), 49–53.  
360 
 
Christian, L. M., Glaser, R., Porter, K., & Iams, J. D. (2013). Stress-Induced 
Inflammatory Responses in Women. Psychosomatic Medicine, 75(7), 658–669.  
Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-
mediated inflammation. The New England Journal of Medicine, 332(20), 1351–
1362.  
Chrousos, G. P., & Kino, T. (2005). Interactive functional specificity of the stress and 
immune responses: the ying, the yang, and the defense against 2 major classes 
of bacteria. The Journal of Infectious Diseases, 192(4), 551–555.  
Cleal, J. K., Poore, K. R., Boullin, J. P., Khan, O., Chau, R., Hambidge, O., … Green, 
L. R. (2007). Mismatched pre- and postnatal nutrition leads to cardiovascular 
dysfunction and altered renal function in adulthood. Proceedings of the National 
Academy of Sciences of the United States of America, 104(22), 9529–9533.  
Clow, A., Hucklebridge, F., Stalder, T., Evans, P., & Thorn, L. (2010). The cortisol 
awakening response: More than a measure of HPA axis function. Neuroscience 
and Biobehavioral Reviews, 35(1), 97–103.  
Coe, C. L., & Lubach, G. R. (2005). Prenatal origins of individual variation in behavior 
and immunity. Neuroscience and Biobehavioral Reviews, 29(1 SPEC. ISS.), 39–
49.  
Cohen, L. L. (2002). Reducing infant immunization distress through distraction. Health 
Psychology, 21(2), 207. 
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & 
Turner, R. B. (2012). Chronic stress, glucocorticoid receptor resistance, 
inflammation, and disease risk. Proceedings of the National Academy of 
Sciences, 109(16), 5995–5999. 
Conradt, E., Hawes, K., Guerin, D., Armstrong, D. A., Marsit, C. J., Tronick, E., & 
Lester, B. M. (2016). The Contributions of Maternal Sensitivity and Maternal 
Depressive Symptoms to Epigenetic Processes and Neuroendocrine Functioning. 
Child Development, 87(1), 73–85.  
361 
 
Copper, R. L., Goldenberg, R. L., Das, A., Elder, N., Swain, M., Norman, G., … Meier, 
A. M. (1996). The preterm prediction study: maternal stress is associated with 
spontaneous preterm birth at less than thirty-five weeks’ gestation. National 
Institute of Child Health and Human Development Maternal-Fetal Medicine Units 
Network. American Journal of Obstetrics and Gynecology, 175(5), 1286–1292. 
Corwin, E. J., & Pajer, K. (2008). The Psychoneuroimmunology of Postpartum 
Depression. Journal of Womens Health, 17(9), 1529–1534. 
Corwin, E. J., Guo, Y., Pajer, K., Lowe, N., McCarthy, D., Schmiege, S., … Stafford, B. 
(2013). Immune dysregulation and glucocorticoid resistance in minority and low 
income pregnant women. Psychoneuroendocrinology, 38(9), 1786–1796.  
Corwin, E. J., Johnston, N., & Pugh, L. (2008). Symptoms of postpartum depression 
associated with elevated levels of interleukin-1 beta during the first month 
postpartum. Biol Res Nurs, 10(2), 128–133. https://doi.org/10/2/128  
Corwin, E. J., Pajer, K., Paul, S., Lowe, N., Weber, M., & Mccarthy, D. O. (2015). 
Bidirectional Psychoneuroimmune Interactions in the Early Postpartum Period 
Influence Risk of Postpartum Depression. Brain, Behavior, and Immunity, 49, 86–
93.  
Cottrell, E. C., & Seckl, J. R. (2009). Prenatal stress, glucocorticoids and the 
programming of adult disease. Frontiers in Behavioral Neuroscience, 
3(September), 1–9.  
Coussons-read, M. E., Lobel, M., Carey, J. C., Kreither, M. O., Anna, D., Argys, L., … 
Cole, S. (2012). The occurrence of preterm delivery is linked to pregnancy- 
specific distress and elevated inflammatory markers across gestation. Brain 
Behavior and Immunity, 26(4), 650–659.  
Coussons-Read, M. E., Okun, M. L., & Nettles, C. D. (2007). Psychosocial stress 
increases inflammatory markers and alters cytokine production across 
pregnancy. Brain, Behavior, and Immunity, 21(3), 343–350.  
362 
 
Coussons-Read, M. E., Okun, M. L., Schmitt, M. P., & Giese, S. (2005). Prenatal 
stress alters cytokine levels in a manner that may endanger human pregnancy. 
Psychosomatic Medicine, 67(4), 625–631.  
Cox, J. L., Holden, J. M., & Sagovsky, R. (1987). Detection of postnatal depression . 
Development of the 10-item Edinburgh Postnatal Depression Scale Detection of 
Postnatal Depression Development of the 10-item Edinburgh Postnatal 
Depression Scale. Br J Psychiatry, 150, 782–786. 
Crockenberg, S. C., & Leerkes, E. M. (2004). Infant and maternal behaviors regulate 
infant reactivity to novelty at 6 months. Developmental Psychology, 40(6), 1123–
1132. 
Crowley, S. K., O’Buckley, T. K., Schiller, C. E., Stuebe, A., Morrow, A. L., & Girdler, 
S. S. (2016). Blunted neuroactive steroid and HPA axis responses to stress are 
associated with reduced sleep quality and negative affect in pregnancy: A pilot 
study. Psychopharmacology, 233(7), 1299–1310. 
Cubała, W. J., Landowski, J., Wielgomas, B., & Czarnowski, W. (2014). Low baseline 
salivary 3-methoxy-4-hydroxyphenylglycol (MHPG) in drug-na??ve patients with 
short-illness-duration first episode major depressive disorder. Journal of Affective 
Disorders, 161, 4–7.  
Curry, A. E., Vogel, I., Skogstrand, K., Drews, C., Schendel, D. E., Flanders, W. D., … 
Thorsen, P. (2008). Maternal plasma cytokines in early- and mid-gestation of 
normal human pregnancy and their association with maternal factors. Journal of 
Reproductive Immunology, 77(2), 152–160 
Czarkowska-Paczek, B., Bartlomiejczyk, I., Gabrys, T., Przybylski, J., Nowak, M., & 
Paczek, L. (2005). Lack of relationship between interleukin-6 and CRP levels in 
healthy male athletes. Immunology Letters, 99(1), 136–140. 
D’Alessandro, S., Curbelo, H. M., Tumilasci, O. R., Tessler, J. A., & Houssay, A. B. 
(1989). Changes in human parotid salivary protein and sialic acid levels during 
pregnancy. Arch Oral Biol, 34(10), 829–831.  
363 
 
D’Anna-Hernandez, K. L., Hoffman, M. C., Zerbe, G. O., Coussons-Read, M., Ross, R. 
G., & Laudenslager, M. L. (2012). Acculturation, maternal cortisol, and birth 
outcomes in women of Mexican descent. Psychosomatic Medicine, 74(3), 296–
304.  
Dahlgren, J., Samuelsson, A.-M., Jansson, T., & Holmäng, A. (2006). Interleukin-6 in 
the maternal circulation reaches the rat fetus in mid-gestation. Pediatric 
Research, 60(2), 147. 
Dancause, K. N., Laplante, D. P., Fraser, S., Brunet, A., Ciampi, A., Schmitz, N., & 
King, S. (2012). Prenatal exposure to a natural disaster increases risk for obesity 
in 5(1/2)-year-old children. Pediatric Research, 71(1), 126–131.  
Dancause, K. N., Laplante, D. P., Oremus, C., Fraser, S., Brunet, A., & King, S. 
(2011). Disaster-related prenatal maternal stress influences birth outcomes: 
project Ice  Storm. Early Human Development, 87(12), 813–820.  
Dantzer, R., & Kelley. K.W. (2007). Twenty Years of research on cytokine-induced 
sickness behavior. Brain Behavior and Immunity, 21(2), 153–160.  
Darnaudery, M., & Maccari, S. (2008). Epigenetic programming of the stress response 
in male and female rats by prenatal restraint stress. Brain Research Reviews, 
57(2), 571–585.  
Davis, E. P., & Sandman, C. A. (2010). The timing of prenatal exposure to maternal 
cortisol and psychosocial stress is associated with human infant cognitive 
development. Neuroscience and Biobehavioral Reviews, 29(1), 3–14. 
Davis, E. P., & Sandman, C. A. (2012a). Prenatal psychobiological predictors of 
anxiety risk in preadolescent children. Psychoneuroendocrinology, 37(8), 1224–
1233.  
Davis, E. P., & Schetter, C. D. (2004). Prenatal Maternal Anxiety and Depression 
Predict Negative Behavioral Reactivity in Infancy and Depression Predict 
Negative Behavioral Reactivity in Infancy, 6(January 2017), 319–331.  
364 
 
Davis, E. P., Glynn, L. M., Schetter, C. D., Hobel, C., Chicz-Demet, A., & Sandman, C. 
A. (2005). Corticotropin-releasing hormone during pregnancy is associated with 
infant temperament. Developmental Neuroscience, 27(5), 299–305.  
Davis, E. P., Glynn, L. M., Schetter, C. D., Hobel, C., Chicz-Demet, A., & Sandman, C. 
A. (2007). Prenatal Exposure to Maternal Depression and Cortisol Influences 
Infant Temperament. Journal of the American Academy of Child & Adolescent 
Psychiatry, 46(6), 737–746.  
Davis, E. P., Glynn, L. M., Waffarn, F., & Sandman, C. A. (2011). Prenatal maternal 
stress programs infant stress regulation. Journal of Child Psychology and 
Psychiatry and Allied Disciplines, 52(2), 119–129. 
Davis, E. P., Head, K., Buss, C., & Sandman, C. A. (2017). Prenatal maternal cortisol 
concentrations predict neurodevelopment in middle childhood. 
Psychoneuroendocrinology, 75, 56–63.  
Davis, E. P., Sandman, C. A., Buss, C., Wing, D. A., & Head, K. (2013). Fetal 
glucocorticoid exposure is associated with preadolescent brain development. 
Biological Psychiatry, 74(9), 647–655. 
Davis, E. P., Townsend, E. L., Gunnar, M. R., Georgieff, M. K., Guiang, S. F., 
Ciffuentes, R. F., & Lussky, R. C. (2004). Effects of prenatal betamethasone 
exposure on regulation of stress physiology in healthy premature infants. 
Psychoneuroendocrinology, 29(8), 1028–1036.  
Davis, E. P., Townsend, E. L., Gunnar, M. R., Guiang, S. F., Lussky, R. C., Cifuentes, 
R. F., & Georgieff, M. K. (2006). Antenatal betamethasone treatment has a 
persisting influence on infant HPA axis regulation. Journal of Perinatology, 26(3), 
147–153. https://doi.org/10.1038/sj.jp.7211447 
Davis, E. P., Waffarn, F., & Sandman, C. A. (2011). Prenatal treatment with 
glucocorticoids sensitizes the hpa axis response to stress among full-term infants. 
Developmental Psychobiology, 53(2), 175–183.  
365 
 
Davis, E. P., Waffarn, F., Uy, C., Hobel, C. J., Glynn, L. M., & Sandman, C. A. (2009). 
Effect of prenatal glucocorticoid treatment on size at birth among infants born at 
term gestation. Journal of Perinatology, 29(11), 731. 
De Bruijn, A. T. C. E., van Bakel, H. J. A., & van Baar, A. L. (2009). Sex differences in 
the relation between prenatal maternal emotional complaints and child outcome. 
Early Human Development, 85(5), 319–324.  
De Bruijn, A. T. C. E., Van Bakel, H. J. A., Wijnen, H., Pop, V. J. M., & Van Baar, A. L. 
(2009). Prenatal maternal emotional complaints are associated with cortisol 
responses in toddler and preschool aged girls. Developmental Psychobiology, 
51(7), 553–563.  
de Kloet, E. R. (1991). Brain corticosteroid receptor balance and homeostatic control. 
Front. Neuroendocrinol., 12, 95–164. 
de Kloet, E. R., & Sarabdjitsingh, R. A. (2008). Everything has rhythm: focus on 
glucocorticoid pulsatility. Endocrinology, 149(7), 3241–3243. 
de Kloet, E. R., Oitzl, M. S., & Joëls, M. (1999). Stress and cognition: are 
corticosteroids good or bad guys? Trends in Neurosciences, 22(10), 422–426. 
De Kloet, E. R., Sibug, R. M., Helmerhorst, F. M., & Schmidt, M. (2005). Stress, genes 
and the mechanism of programming the brain for later life. Neuroscience and 
Biobehavioral Reviews, 29(2), 271–281.  
De Rezende, M. G., Garcia-Leal, C., De Figueiredo, F. P., Cavalli, R. D. C., 
Spanghero, M. S., Barbieri, M. A., … Del-Ben, C. M. (2016). Altered functioning 
of the HPA axis in depressed postpartum women. Journal of Affective Disorders, 
193, 249–256.  
De Weerth, C., & Buitelaar, J. K. (2005). Physiological stress reactivity in human 
pregnancy - A review. Neuroscience and Biobehavioral Reviews, 29(2), 295–312.  
De Weerth, C., Buitelaar, J. K., & Beijers, R. (2013). Infant cortisol and behavioral 
habituation to weekly maternal separations: Links with maternal prenatal cortisol 
and psychosocial stress. Psychoneuroendocrinology, 38(12), 2863–2874.  
366 
 
De Weerth, C., Van Hees, Y., & Buitelaar, J. K. (2003). Prenatal maternal cortisol 
levels and infant behavior during the first 5 months. Early Human Development, 
74(2), 139–151.  
De Wolff, M. S., & Van Ijzendoorn, M. H. (1997). Sensitivity and attachment: A 
meta‐analysis on parental antecedents of infant attachment. Child Development, 
68(4), 571–591. 
Del Cerro, M. C. R., Perez-Laso, C., Ortega, E., Martín, J. L. R., Gomez, F., Perez-
Izquierdo, M. A., & Segovia, S. (2010). Maternal care counteracts behavioral 
effects of prenatal environmental stress in female rats. Behavioural Brain 
Research, 208(2), 593–602. 
Del Giudice, M., Ellis, B. J., & Shirtcliff, E. A. (2011). The adaptive calibration model of 
stress responsivity. Neuroscience & Biobehavioral Reviews, 35(7), 1562–1592. 
Deligiannidis, K. M., Kroll-Desrosiers, A. R., Svenson, A., Jaitly, N., Barton, B. A., Hall, 
J. E., & Rothschild, A. J. (2016). Cortisol response to the Trier Social Stress Test 
in pregnant women at risk for postpartum depression. Archives of Women’s 
Mental Health, 19(5), 789–797.  
Della Vedova, A. M. (2014). Maternal psychological state and infant’s temperament at 
three months. Journal of Reproductive and Infant Psychology, 32(5), 520–534. 
Desai, M., Gayle, D., Babu, J., & Ross, M. G. (2005). Programmed obesity in 
intrauterine growth-restricted newborns: modulation by newborn nutrition. 
American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 288(1), R91–R96. 
Deverman, B. E., & Patterson, P. H. (2009). Cytokines and CNS Development. 
Neuron, 64(1), 61–78.  
Dhabhar, F. S. (2002). Stress-induced augmentation of immune function—the role of 
stress hormones, leukocyte trafficking, and cytokines. Brain, Behavior, and 
Immunity, 16(6), 785–798. 
367 
 
Dickerson, P. A., Lally, B. E., Gunnel, E., Birkle, D. L., & Salm, A. K. (2005). Early 
emergence of increased fearful behavior in prenatally stressed rats. Physiology & 
Behavior, 86(4), 586–593. 
Diego, M. a., Field, T., Hernandez-Reif, M., Cullen, C., Schanberg, S., & Kuhn, C. 
(2004). Prepartum, Postpartum, and Chronic Depression Effects on Newborns. 
Psychiatry, 67(1), 63–80.  
Diego, M. A., Field, T., Hernandez-Reif, M., Schanberg, S., Kuhn, C., & Gonzalez-
Quintero, V. H. (2009). Prenatal depression restricts fetal growth. Early Human 
Development, 85(1), 65–70. https://doi.org/10.1016/j.earlhumdev.2008.07.002 
Diego, M. A., Jones, N. A., Field, T., Hernandez-Reif, M., Schanberg, S., Kuhn, C., & 
Gonzalez-Garcia, A. (2006). Maternal psychological distress, prenatal cortisol, 
and fetal weight. Psychosomatic Medicine, 68(5), 747–753.  
Dieter, J. N. I., Emory, E. K., Johnson, K. C., & Raynor, B. D. (2008). Maternal 
depression and anxiety effects on the human fetus: preliminary findings and 
clinical implications. Infant Mental Health Journal: Official Publication of The 
World Association for Infant Mental Health, 29(5), 420–441. 
Dimidjian, S., & Goodman, S. (2009). Nonpharmacological Intervention and Prevention 
Strategies for Depression during Pregnancy and the Postpartum. Clinical 
Obstetrics and Gynecology, 52(3), 498. 
Dindo, L., Elmore, A., O’Hara, M., & Stuart, S. (2017). The comorbidity of Axis I 
disorders in depressed pregnant women. Archives of Women’s Mental Health, 
20(6), 757–764.  
DiPietro, J. A., Costigan, K. A., & Gurewitsch, E. D. (2005). Maternal 
psychophysiological change during the second half of gestation. Biological 
Psychology, 69(1 SPEC. ISS.), 23–38.  
Dipietro, J. A., Costigan, K. A., & Sipsma, H. L. (2008). Continuity in self-report 
measures of maternal anxiety, stress, and depressive symptoms from pregnancy 
368 
 
through two years postpartum. Journal of Psychosomatic Obstetrics & 
Gynecology, 29(2), 115–124.  
DiPietro, J. A., Costigan, K. A., Kivlighan, K. T., Chen, P., & Mark, L. (2011). Maternal 
salivary cortisol differs by fetal sex during the second half of pregnancy, 36(4), 
588–591.  
DiPietro, J. A., Novak, M., Costigan, K. A., Atella, L., & Reusing, S. (2006). Maternal 
Psychological Distress during Pregnancy in Relation to Child Development at Age 
Two. Child Development, 77(3), 573–587. 
Ditzen, B., Ehlert, U., & Nater, U. M. (2014). Associations between salivary alpha-
amylase and catecholamines - A multilevel modeling approach. Biological 
Psychology, 103(1), 15–18.  
Dole, N., Savitz, D. A., Hertz-Picciotto, I., Siega-Riz, A. M., McMahon, M. J., & 
Buekens, P. (2003). Maternal stress and preterm birth. American Journal of 
Epidemiology, 157(1), 14–24. 
Doornbos, B., Fekkes, D., Tanke, M. A. C., de Jonge, P., & Korf, J. (2008). Sequential 
serotonin and noradrenalin associated processes involved in postpartum blues. 
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32(5), 1320–
1325.  
Dougherty, L. R., Klein, D. N., Congdon, E., Canli, T., & Hayden, E. P. (2010). 
Interaction between 5-HTTLPR and BDNF Val66Met polymorphisms on HPA axis 
reactivity in preschoolers. Biological Psychology, 83(2), 93–100. 
Dougherty, L. R., Klein, D. N., Durbin, C. E., Hayden, E. P., & Olino, T. M. (2010). 
Temperamental positive and negative emotionality and children’s depressive 
symptoms: A longitudinal prospective study from age three to age ten. Journal of 
Social and Clinical Psychology, 29(4), 462–488. 
Dougherty, L. R., Klein, D. N., Olino, T. M., Dyson, M., & Rose, S. (2009). Increased 
waking salivary cortisol and depression risk in preschoolers: The role of maternal 
369 
 
history of melancholic depression and early child temperament. Journal of Child 
Psychology and Psychiatry, 50(12), 1495–1503. 
Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, 
K. L. (2010). A Meta-Analysis of Cytokines in Major Depression. Biological 
Psychiatry, 67(5), 446–457.  
Drake, A. J., & Walker, B. R. (2004). The intergenerational effects of fetal 
programming: non-genomic mechanisms for the inheritance of low birth weight 
and cardiovascular risk. Journal of Endocrinology, 180(1), 1–16. 
Du Clos, T. W., & Mold, C. (2004). C-reactive protein: an activator of innate immunity 
and a modulator of adaptive immunity. Immunologic Research, 30(3), 261–277.  
Dunn, A. J., & Swiergiel, A. H. (2005). Effects of interleukin-1 and endotoxin in the 
forced swim and tail suspension tests in mice. Pharmacology Biochemistry and 
Behavior, 81(3), 688–693. 
Dunn, A. J., Swiergiel, A. H., & de Beaurepaire, R. (2005). Cytokines as mediators of 
depression: what can we learn from animal studies? Neuroscience & 
Biobehavioral Reviews, 29(4–5), 891–909. 
Dunn, O. J. (1961). Multiple comparisons among means. Journal of the American 
Statistical Association, 56, 52–64.  
Dušková, M., Hruškovičová, H., Šimůnková, K., Starka, L., & Pařízek, A. (2014). The 
effects of smoking on steroid metabolism and fetal programming. The Journal of 
Steroid Biochemistry and Molecular Biology, 139, 138–143. 
Dziegielewska, K. M., Møller, J. E., Potter, A. M., Ek, J., Lane, M. A., & Saunders, N. 
R. (2000). Acute-phase cytokines IL-1β and TNF-α in brain development. Cell 
and Tissue Research, 299(3), 335–345. 
Easterbrooks, M. A., Bureau, J. F., & Lyons-Ruth, K. (2012). Developmental correlates 
and predictors of emotional availability in mother-child interaction: A longitudinal 
study from infancy to middle childhood. Development and Psychopathology, 
24(1), 65–78.  
370 
 
Easterbrooks, M.A., Biesecker, G., & Lyons-Ruth, K. (2000). Infancy predictors of 
emotional availability in middle childhood: The roles of attachment security and 
maternal depressive symptomatology. Attachment & Human Development, 2(2), 
170–187. 
Eberhart-Phillips, J. E., Frederick, P. D., Baron, R. C., & Mascola, L. (1993). Measles 
in pregnancy: a descriptive study of 58 cases. Obstetrics and Gynecology, 82(5), 
797–801. 
Edvinsson, A., Brann, E., Hellgren, C., Freyhult, E., White, R., Kamali-Moghaddam, 
M., … Sundstrom-Poromaa, I. (2017). Lower inflammatory markers in women 
with antenatal depression brings the M1/M2 balance into focus from a new 
direction. Psychoneuroendocrinology, 80, 15–25.  
Edwards, L. J., & McMillen, I. C. (2002). Impact of maternal undernutrition during the 
periconceptional period, fetal number, and fetal sex on the development of the 
hypothalamo-pituitary adrenal axis in sheep during late gestation. Biology of 
Reproduction, 66(5), 1562–1569. 
Egliston, K.-A., McMahon, C., & Austin, M.-P. (2007). Stress in pregnancy and infant 
HPA axis function: conceptual and methodological issues relating to the use of 
salivary cortisol as an outcome measure. Psychoneuroendocrinology, 32(1), 1–
13.  
Ehlert, U., Erni, K., Hebisch, G., & Nater, U. (2006). Salivary α-amylase levels after 
yohimbine challenge in healthy men. The Journal of Clinical Endocrinology & 
Metabolism, 91(12), 5130–5133. 
Ehlert, U., Patalla, U., Kirschbaum, C., Piedmont, E., & Hellhammer, D. H. (1990). 
Postpartum blues: Salivary cortisol and psychological factors. Journal of 
Psychosomatic Research, 34(3), 319–325.  
Ekelund, C. K., Vogel, I., Skogstrand, K., Thorsen, P., Hougaard, D. M., Langhoff-
Roos, J., & Jacobsson, B. (2008). Interleukin-18 and interleukin-12 in maternal 
371 
 
serum and spontaneous preterm delivery. Journal of Reproductive Immunology, 
77(2), 179–185. 
El Marroun, H., White, T., Verhulst, F. C., & Tiemeier, H. (2014). Maternal use of 
antidepressant or anxiolytic medication during pregnancy and childhood 
neurodevelopmental outcomes: a systematic review. European Child & 
Adolescent Psychiatry, 23(10), 973–992. 
Elenkov, I. J. (2008). Neurohormonal-cytokine interactions: Implications for 
inflammation, common human diseases and well-being. Neurochemistry 
International, 52(1), 40–51.  
Elenkov, I. J., & Chrousos, G. P. (2002). Stress hormones, proinflammatory and 
antiinflammatory cytokines, and autoimmunity. Annals of the New York Academy 
of Sciences, 966(1), 290–303. 
Elenkov, I. J., & Chrousos, G. P. (2006). Stress system - Organization, physiology and 
immunoregulation. NeuroImmunoModulation, 13(5–6), 257–267.  
Elenkov, I. J., Wilder, R. L., Bakalov, V. K., Link, A. A., Dimitrov, M. A., Fisher, S., … 
Chrousos, G. P. (2001). IL-12, TNF-α, and hormonal changes during late 
pregnancy and early postpartum: implications for autoimmune disease activity 
during these times. The Journal of Clinical Endocrinology & Metabolism, 86(10), 
4933–4938. 
Ellis, B. J., & Giudice, M. Del. (2018). Developmental Adaptation to Stress: An 
Evolutionary Perspective. Annual Review of Psychology, (August 2018), 1–34.  
El-Sheikh, M., Erath, S. A., Buckhalt, J. A., Granger, D. A., & Mize, J. (2008). Cortisol 
and children’s adjustment: the moderating role of sympathetic nervous system 
activity. Journal of Abnormal Child Psychology, 36(4), 601–611.  
Emde, R. N., & Easterbrooks, M. A. (1985). Assessing emotional availability in early 
development. In Early identification of children at risk (pp. 79–101). Springer. 
372 
 
Emory, E. K., & Dieter, J. N. (2006). Maternal depression and psychotropic medication 
effects on the human fetus. Annals of the New York Academy of Sciences, 
1094(1), 287–291. 
Endendijk, J. J., Atce, D. B., van Bakel, H. J. A., Wijnen, H., Pop, V. J., & Van Baar, A. 
L. (2005). Maternal interaction quality moderates effects of prenatal maternal 
emotional symptoms on girls ’ internalizing problems. Infant Mental Health 
Journal, 38(5), 1–10.  
Engel, S. M., Berkowitz, G. S., Wolff, M. S., & Yehuda, R. (2005). Psychological 
trauma associated with the World Trade Center attacks and its effect on 
pregnancy outcome. Paediatric and Perinatal Epidemiology, 19(5), 334–341.  
Engert, V., Vogel, S., Efanov, S. I., Duchesne, A., Corbo, V., Ali, N., & Pruessner, J. C. 
(2011). Investigation into the cross-correlation of salivary cortisol and alpha-
amylase responses to psychological stress. Psychoneuroendocrinology, 36(9), 
1294–1302.  
Entringer, S., Buss, C., & Wadhwa, P. D. (2015). Prenatal stress, development, health 
and disease risk: A psychobiological perspective—2015 Curt Richter Award 
Paper. Psychoneuroendocrinology, 62, 366–375. 
Entringer, S., Buss, C., Rasmussen, J. M., Lindsay, K., Gillen, D. L., Cooper, D. M., & 
Wadhwa, P. D. (2017). Maternal cortisol during pregnancy and infant adiposity: A 
prospective investigation. Journal of Clinical Endocrinology and Metabolism, 
102(4), 1366–1374.  
Entringer, S., Buss, C., Shirtcliff, E. A., Cammack, A. L., Yim, I. S., Chicz-DeMet, A., 
… Wadhwa, P. D. (2010). Attenuation of maternal psychophysiological stress 
responses and the maternal cortisol awakening response over the course of 
human pregnancy. Stress, 13(3), 258–268. 
Erickson, K., Thorsen, P., Chrousos, G., Grigoriadis, D. E., Khongsaly, O., McGregor, 
J., & Schulkin, J. (2001). Preterm birth: Associated neuroendocrine, medical, and 
373 
 
behavioral risk factors. Journal of Clinical Endocrinology and Metabolism, 86(6), 
2544–2552.  
Erni, K., Shaqiri, L., La Marca, R., Zimmermann, R., & Ehlert, U. (2012). 
Psychobiological effects of prenatal glucocorticoid exposure in 10-year-old-
children. Frontiers in Psychiatry, 3, 104. 
Ernst, G. D. S., de Jonge, L. L., Hofman, A., Lindemans, J., Russcher, H., Steegers, E. 
A. P., & Jaddoe, V. W. V. (2011). C-reactive protein levels in early pregnancy, 
fetal growth patterns, and the risk for neonatal complications: the Generation R 
Study. American Journal of Obstetrics and Gynecology, 205(2), 132-e1. 
Ershler, W. B., & Keller, E. T. (2000). Age-associated increased interleukin-6 gene 
expression, late-life diseases, and frailty. Annual Review of Medicine, 51(1), 245–
270. 
Essex, M. J., Shirtcliff, E. A., Burk, L. R., Ruttle, P. L., Klein, M. H., Slattery, M. J., ... & 
Armstrong, J. M. (2011). Influence of early life stress on later hypothalamic–
pituitary–adrenal axis functioning and its covariation with mental health 
symptoms: a study of the allostatic process from childhood into 
adolescence. Development and psychopathology, 23(4), 1039-1058. 
Estes, M. L., & Mcallister, A. K. (2016). Maternal immune activation: implications for 
neuropsychiatric disorders. Science, 353(6301), 772–777.  
Evans, J., Melotti, R., Heron, J., Ramchandani, P., Wiles, N., Murray, L., & Stein, A. 
(2012). The timing of maternal depressive symptoms and child cognitive 
development: A longitudinal study. Journal of Child Psychology and Psychiatry 
and Allied Disciplines, 53(6), 632–640.  
Evans, L. M., Myers, M. M., & Monk, C. (2008). Pregnant women’s cortisol is elevated 
with anxiety and depression — but only when comorbid. Archives of Women’s 
Mental Health, 11(3), 239–248.  
374 
 
Falah-Hassani, K., Shiri, R., & Dennis, C. L. (2017). The prevalence of antenatal and 
postnatal co-morbid anxiety and depression: A meta-analysis. Psychological 
Medicine, 47(12), 2041–2053.  
Favaro, A., Tenconi, E., Degortes, D., Manara, R., & Santonastaso, P. (2015). Neural 
correlates of prenatal stress in young women. Psychological Medicine, 45(12), 
2533–2543. 
Feise, R.J. (2002). Do multiple outcome measures require p-value adjustment?. BMC 
Med Res Methodol., 2(1), 8. 
Feksi, A., Harris, B., Walker, R. F., Riad-Fahmy, D., & Newcombe, R. G. (1984). 
‘Maternity blues’ and hormone levels in saliva. Journal of Affective Disorders (Vol. 
6).  
Feldman, R., Gordon, I., & Zagoory-Sharon, O. (2010). The cross-generation 
transmission of oxytocin in humans. Hormones and behavior, 58(4), 669-676. 
Felten, S. Y., & Felten, D. L. (1994). Neural-immune interactions. Progress in Brain 
Research, 100, 157–162. 
Fernandes, M., Stein, A., Srinivasan, K., Menezes, G., & Ramchandani, P. G. (2014). 
Foetal exposure to maternal depression predicts cortisol responses in infants: 
Findings from rural South India. Child: Care, Health and Development, 41(5), 
677–686.  
Fichter, M. M., Quadflieg, N., Fischer, U. C., & Kohlboeck, G. (2010). Twenty‐five‐year 
course and outcome in anxiety and depression in the Upper Bavarian 
Longitudinal Community Study. Acta Psychiatrica Scandinavica, 122(1), 75–85. 
Field, T., Diego, M., & Hernandez-Reif, M. (2004). Prenatal depression effects on the 
fetus and newborn. Infant Behavior and Development, 29(3), 445–455.  
Field, T., Diego, M., & Hernandez-Reif, M. (2009). Infants of Depressed Mothers Are 
Less Responsive To Faces and Voices: A Review. Infant Behavior and 
Development, 32(3), 239–244. 
375 
 
Field, T., Diego, M., Hernandez-Reif, M., Deeds, O., Holder, V., Schanberg, S., & 
Kuhn, C. (2009). Depressed pregnant black women have a greater incidence of 
prematurity and low birthweight outcomes. Infant Behavior and Development, 
32(1), 10–16.  
Field, T., Diego, M., Hernandez-reif, M., Figueiredo, B., Ascencio, A., Schanberg, S., & 
Kuhn, C. (2011). Comorbid Depression and Anxiety Effects on Pregnancy and 
Neonatal Outcome, 33(1), 1–14. 
https://doi.org/10.1016/j.infbeh.2009.10.004.Comorbid 
Field, T., Diego, M., Hernandez‐Reif, M., Schanberg, S., Kuhn, C., Yando, R., & 
Bendell, D. (2003). Pregnancy anxiety and comorbid depression and anger: 
effects on the fetus and neonate. Depression and Anxiety, 17(3), 140–151. 
Field, T., Diego, M., Hernandez-Reif, M., Vera, Y., Gil, K., Schanberg, S., … 
Gonzalez-Garcia, A. (2004). Prenatal maternal biochemistry predicts neonatal 
biochemistry. International Journal of Neuroscience, 114(8), 933–945.  
Field, T., Fox, N. A., Pickens, J., & Nawrocki, T. (1995). Relative right frontal EEG 
activation in 3-to 6-month-old infants of" depressed" mothers. Developmental 
Psychology, 31(3), 358. 
Field, T., Hernandez-Reif, M., Diego, M., Schanberg, S., & Kuhn, C. (2006). Stability of 
mood states and biochemistry across pregnancy. Infant Behavior and 
Development, 29(2), 262–267. https://doi.org/10.1016/j.infbeh.2005.12.009 
Figueiredo, B., & Costa, R. (2009). Mother’s stress, mood and emotional involvement 
with the infant: 3 months before and 3 months after childbirth. Archives of 
Women’s Mental Health, 12(3), 143–153.  
Figueiredo, B., Pinto, T. M., Pacheco, A., & Field, T. (2017). Fetal heart rate variability 
mediates prenatal depression effects on neonatal neurobehavioral maturity. 
Biological Psychology, 123, 294–301.  
Firk, C., Konrad, K., Herpertz-Dahlmann, B., Scharke, W., & Dahmen, B. (2018). 
Cognitive development in children of adolescent mothers: The impact of 
376 
 
socioeconomic risk and maternal sensitivity. Infant Behavior and Development, 
50(February), 238–246.  
First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B. W., Davies, M., Borus, J., … 
Rounsaville, B. (1995). The structured clinical interview for DSM-III-R personality 
disorders (SCID-II). Part II: Multi-site test-retest reliability study. Journal of 
Personality Disorders, 9(2), 92–104. 
First, M., Spitzer, R., Gibbon, M., & Williams, J. (2002). Structured Clinical Interview 
for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P). 
New York: Biometrics Research. 
Fontein‐Kuipers, Y. J., Nieuwenhuijze, M. J., Ausems, M., Budé, L., & de Vries, R. 
(2014). Antenatal interventions to reduce maternal distress: a systematic review 
and meta‐analysis of randomised trials. BJOG: An International Journal of 
Obstetrics & Gynaecology, 121(4), 389–397. 
Forcada-Guex, M., Pierrehumbert, B., Borghini, A., Moessinger, A., & Muller-Nix, C. 
(2006). Early Dyadic Patterns of Mother-Infant Interactions and Outcomes of 
Prematurity at 18 Months. Pediatrics, 118(1), e107–e114.  
Forstmeier, W., Wagenmakers, E. J., & Parker, T. H. (2017). Detecting and avoiding 
likely false‐positive findings–a practical guide. Biological Reviews, 92(4), 1941-
1968. 
Fox, N. A., & Davidson, R. J. (1986). Taste-elicited changes in facial signs of emotion 
and the asymmetry of brain electrical activity in human newborns. 
Neuropsychologia, 24(3), 417–422. 
Francis, D. D., Diorio, J., Plotsky, P. M., & Meaney, M. J. (2002). Environmental 
enrichment reverses the effects of maternal separation on stress reactivity. 
Journal of Neuroscience, 22(18), 7840–7843. 
Francis, D. D., Szegda, K., Campbell, G., Martin, W. D., & Insel, T. R. (2003). 




Franke, K., Van Den Bergh, B. R. H., de Rooij, S. R., Roseboom, T. J., Nathanielsz, P. 
W., Witte, O. W., & Schwab, M. (n.d.). Effects of Prenatal Stress on Structural 
Brain Development and Aging in Humans. Neurosci Biobehav Rev, 1–24. 
Fransson, E., Dubicke, A., Bystr??m, B., Ekman-Ordeberg, G., Hjelmstedt, A., & 
Lekander, M. (2012). Negative Emotions and Cytokines in Maternal and Cord 
Serum at Preterm Birth. American Journal of Reproductive Immunology, 67(6), 
506–514.  
Frasch, M. G., Lobmaier, S., Stampalija, T., Desplats, P., Pallarés, M. E., Pastor, V., 
… Antonelli, M. (2018). Non-invasive biomarkers of fetal brain development 
reflecting prenatal stress: an integrative multi-scale multi-species perspective on 
data collection and analysis. Neuroscience & Biobehavioral Reviews, (May).  
Freeman, M. P. (2007). Antenatal depression: navigating the treatment dilemmas. 
American Journal of Psychiatry, 164(8), 1162–1165. 
Fries, A. B. W., Shirtcliff, E. A., & Pollak, S. D. (2008). Neuroendocrine dysregulation 
following early social deprivation in children. Developmental Psychobiology: The 
Journal of the International Society for Developmental Psychobiology, 50(6), 588-
599. 
Fujiwara, T., Barr, R. G., Brant, R., & Barr, M. (2011). Infant distress at five weeks of 
age and caregiver frustration. Journal of Pediatrics, 159(3), 425–430.e2.  
Gage, S. H., Munafò, M. R., & Davey Smith, G. (2016). Causal Inference in 
Developmental Origins of Health and Disease (DOHaD) Research. Annual 
Review of Psychology, 67(1), 567–585.  
Galazios, G., Tsoulou, S., Zografou, C., Tripsianis, G., Koutlaki, N., Papazoglou, D., … 
Liberis, V. (2011). The role of cytokines IL-6 and IL-8 in the pathogenesis of 




García-Blanco, A., Diago, V., Serrano De La Cruz, V., Hervás, D., Cháfer-Pericás, C., 
& Vento, M. (2017). Can stress biomarkers predict preterm birth in women with 
threatened preterm labor? Psychoneuroendocrinology, 83(January), 19–24.  
Garcia-Leal, C., De Rezende, M. G., Corsi-Zuelli, F. M. das G., De Castro, M., & Del-
Ben, C. M. (2017). The functioning of the hypothalamic-pituitary-adrenal (HPA) 
axis in postpartum depressive states: a systematic review. Expert Review of 
Endocrinology & Metabolism, 12(5), 341–353.  
Garstein, M. ., & Marmion, J. (2008). Fear And Positive Affectivity In Infancy: 
Convergence/Discrepancy Between Parent-Report And Laboratory-Based 
Indicators. Infant Behav Dev, 31(2), 227–238.  
Gartstein, M. A., Hancock, G. R., & Iverson, S. L. (2017). Positive Affectivity and Fear 
Trajectories in Infancy: Contributions of Mother-Child Interaction Factors. Child 
Development, 00(0), 1–16.  
Gartstein, M. A., Putnam, S. P., & Rothbart, M. K. (2012). Etiology of preschool 
behavior problems: Contributions of temperament attributes in early childhood. 
Infant Mental Health Journal, 33(2), 197–211. 
Gavin, N. I., Gaynes, B. N., Lorh, K. N., Meltzer-Brody, S., Gartlehner, G., & Swinson, 
T. (2005). Perinatal depression: A systematic review of prevalence and incidence. 
Obstetrics and Gynecology, 106(5), 1071–1083.  
Gee, D. G. (2016). Sensitive periods of emotion regulation: influences of parental care 
on frontoamygdala circuitry and plasticity. New directions for child and adolescent 
development, 2016(153), 87-110. 
Gee, D. G., Gabard-Durnam, L., Telzer, E. H., Humphreys, K. L., Goff, B., Shapiro, M., 
... & Tottenham, N. (2014). Maternal buffering of human amygdala-prefrontal 
circuitry during childhood but not during adolescence. Psychological 
science, 25(11), 2067-2078. 
379 
 
Gelman, A., Hill, J., & Yajima, M. (2012). Why we (usually) don't have to worry about 
multiple comparisons. Journal of Research on Educational Effectiveness, 5(2), 
189-211. 
Genest, J. (2010). C-reactive protein: risk factor, biomarker and/or therapeutic target? 
Canadian Journal of Cardiology, 26, 41A–44A. 
Gentile, S. (2017). Untreated depression during pregnancy: Short- and long-term 
effects in offspring. A systematic review. Neuroscience, 342, 154–166.  
Gerardin, P., Wendland, J., Bodeau, N., Galin, A., Bialobos, S., Tordjman, S., … 
Cohen, D. (2011). Depression during pregnancy: Is the developmental impact 
earlier in boys? A prospective case-control study. Journal of Clinical Psychiatry, 
72(3), 378–387.  
Giannakoulopoulos, X., Teixeira, J., Fisk, N., & Glover, V. (1999). Human fetal and 
maternal noradrenaline responses to invasive procedures. Pediatric Research.  
Giesbrecht, G. F., Campbell, T., Letourneau, N., Kaplan, B. J., Field, C. J., Dewey, D., 
… Singhal, N. (2015). Sexually dimorphic adaptations in basal maternal stress 
physiology during pregnancy and implications for fetal development. 
Psychoneuroendocrinology, 56, 168–178.  
Giesbrecht, G. F., Campbell, T., Letourneau, N., Kooistra, L., & Kaplan, B. (2012). 
Psychological distress and salivary cortisol covary within persons during 
pregnancy. Psychoneuroendocrinology, 37(2), 270–279.  
Giesbrecht, G. F., Granger, D. A., Campbell, T., & Kaplan, B. (2013). Salivary alpha-
amylase during pregnancy: Diurnal course and associations with obstetric history, 
maternal demographics, and mood. Developmental Psychobiology, 55(2), 156–
167.  
Giesbrecht, G. F., Letourneau, N., Campbell, T. S., & Team, A. P. O. and N. S. (2017). 
Sexually dimorphic and interactive effects of prenatal maternal cortisol and 
psychological distress on infant cortisol reactivity. Development and 
Psychopathology, 29(3), 805–818.  
380 
 
Gillespie, S., Porter, K., & Christian, L. (2016). Adaptation of the inflammatory immune 
response across pregnancy and postpartum in Black and White women. J 
Reprod Immunol., 114(0), 27–31.  
Gilman, S. C., Fischer, G. J., Biersner, R. J., Thornton, R. D., & Miller, D. A. (1979). 
Human parotid gland alpha-amylase secretion as a function of chronic hyperbaric 
exposure. Naval Submarine Medical Research Lab Groton Ct. 
Gimeno, D., Kivimäki, M., Brunner, E. J., Elovainio, M., De Vogli, R., Steptoe, A., … 
Marmot, M. G. (2009). Associations of C-reactive protein and interleukin-6 with 
cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. 
Psychological Medicine, 39(3), 413–423. 
Gitau, R., Cameron, A., Fisk, N. M., & Glover, V. (1998). Fetal exposure to maternal 
cortisol. Lancet (London, England), 352(9129), 707–708.  
Gitau, R., Fisk, N. M., Teixeira, J. M. A., Cameron, A., & Glover, V. (2001). Fetal 
hypothalamic-pituitary-adrenal stress responses to invasive procedures are 
independent of maternal responses. Journal of Clinical Endocrinology and 
Metabolism, 86(1), 104–109.  
Glover, V. (2011). Annual research review: Prenatal stress and the origins of 
psychopathology: An evolutionary perspective. Journal of Child Psychology and 
Psychiatry, 52(4), 356–367.  
Glover, V. (2014). Maternal depression, anxiety and stress during pregnancy and child 
outcome; What needs to be done. Best Practice and Research: Clinical 
Obstetrics and Gynaecology, 28(1), 25–35.  
Glover, V., & Hill, J. (2012). Sex differences in the programming effects of prenatal 
stress on psychopathology and stress responses: an evolutionary perspective. 
Physiology & Behavior, 106(5), 736–740. 
Glover, V., O’Connor, T. G., & O’Donnell, K. (2010). Prenatal stress and the 




Glover, V., O’Connor, T. G., Heron, J., & Golding, J. (2004). Antenatal maternal 
anxiety is linked with atypical handedness in the child. Early Human 
Development, 79(2), 107–118.  
Gluckman, P. D. (2008). Effect of In Utero and Early Life Conditions on Adult Health 
and Disease. The New England Journal of Medicine, 359(1), 61–73.  
Gluckman, P. D., Hanson, M. A., & Beedle, A. S. (2007). Early life events and their 
consequences for later disease: a life history and evolutionary perspective. 
American Journal of Human Biology : The Official Journal of the Human Biology 
Council, 19(1), 1–19. 
Gluckman, P. D., Hanson, M. A., & Spencer, H. G. (2005). Predictive adaptive 
responses and human evolution. Trends in Ecology and Evolution, 20(10), 527–
533.  
Glynn, L. M., & Sandman, C. A. (2014). Evaluation of the Association Between 
Placental Corticotrophin-Releasing Hormone and Postpartum Depressive 
Symptoms. Psychosomatic Medicine, 76(5), 355–362.  
Glynn, L. M., Davis, E. P., & Sandman, C. A. (2013). New insights into the role of 
perinatal HPA-axis dysregulation in postpartum depression. Neuropeptides, 
47(6), 363–370.  
Glynn, L. M., Howland, M. A., Sandman, C. A., Davis, E. P., Phelan, M., Baram, T. Z., 
& Stern, H. S. (2018). Prenatal maternal mood patterns predict child 
temperament and adolescent mental health. Journal of Affective Disorders, 
228(June 2017), 83–90.  
Godoy, L. D., Rossignoli, M. T., Delfino-Pereira, P., Garcia-Cairasco, N., & de Lima 
Umeoka, E. H. (2018). A Comprehensive Overview on Stress Neurobiology: 
Basic Concepts and Clinical Implications. Frontiers in Behavioral Neuroscience, 
12(July), 127.  
382 
 
Goedhart, G., Vrijkotte, T. G. M., Roseboom, T. J., van der Wal, M. F., Cuijpers, P., & 
Bonsel, G. J. (2010). Maternal cortisol and offspring birthweight: Results from a 
large prospective cohort study. Psychoneuroendocrinology, 35(5), 644–652.  
Golan, H. M., Lev, V., Hallak, M., Sorokin, Y., & Huleihel, M. (2005). Specific 
neurodevelopmental damage in mice offspring following maternal inflammation 
during pregnancy. Neuropharmacology, 48(6), 903–917.  
Gold, P. W., & Chrousos, G. P. (2002). Organization of the stress system and its 
dysregulation in melancholic and atypical depression: high vs low CRH/NE 
states. Molecular Psychiatry, 7(3), 254. 
Goldberg, S., Levitan, R., Leung, E., Masellis, M., Basile, V. S., Nemeroff, C. B., & 
Atkinson, L. (2003). Cortisol concentrations in 12-to 18-month-old infants: stability 
over time, location, and stressor. Biological Psychiatry, 54(7), 719–726. 
Goldman-Mellor, S., Brydon, L., & Steptoe, A. (2010). Psychological distress and 
circulating inflammatory markers in healthy young adults. Psychological Medicine, 
40(12), 2079–2087. 
Goldstein, D. S., Eisenhofer, G., & Kopin, I. J. (2003). Sources and significance of 
plasma levels of catechols and their metabolites in humans. Journal of 
Pharmacology and Experimental Therapeutics, 305(3), 800–811. 
Goldstein, H. (2011). Multilevel statistical models (Vol. 922). John Wiley & Sons. 
Goodman, J. H., & Tyer-Viola, L. (2010). Detection, treatment, and referral of perinatal 
depression and anxiety by obstetrical providers. Journal of Women’s Health 
(2002), 19(3), 477–490.  
Gordis, E. B., Granger, D. A., Susman, E. J., & Trickett, P. K. (2006). Asymmetry 
between salivary cortisol and α-amylase reactivity to stress: Relation to 
aggressive behavior in adolescents. Psychoneuroendocrinology, 31(8), 976–987. 
Gover, A., Chau, V., Miller, S. P., Brant, R., Mcfadden, D. E., Poskitt, K. J., … Grunau, 
R. E. (2013). Prenatal and postnatal inflammation in relation to cortisol levels in 
383 
 
preterm infants at 18 months corrected age. Journal of Perinatology, 33(8), 647–
651.  
Graham, A. M., Rasmussen, J. M., Rudolph, M. D., Heim, C. M., Gilmore, J. H., 
Styner, M., … Buss, C. (2017). Maternal Systemic Interleukin-6 During Pregnancy 
Is Associated With Newborn Amygdala Phenotypes and Subsequent Behavior at 
2 Years of Age. Biological Psychiatry, 83(2), 109–119.  
Graignic-Philippe, R., Dayan, J., Chokron, S., Jacquet, A. Y., & Tordjman, S. (2014). 
Effects of prenatal stress on fetal and child development: A critical literature 
review. Neuroscience and Biobehavioral Reviews, 43, 137–162.  
Grandjean, P., & Landrigan, P. J. (2014). Neurobehavioural effects of developmental 
toxicity. The Lancet Neurology, 13(3), 330–338. 
Granger, D. A., Kivlighan, K. T., Fortunato, C., Harmon, A. G., Hibel, L. C., Schwartz, 
E. B., & Whembolua, G. L. (2007). Integration of salivary biomarkers into 
developmental and behaviorally-oriented research: Problems and solutions for 
collecting specimens. Physiology and Behavior, 92(4), 583–590.  
Grant, K. A., McMahon, C., Austin, M. P., Reilly, N., Leader, L., & Ali, S. (2009). 
Maternal prenatal anxiety, postnatal caregiving and infants’ cortisol responses to 
the still-face procedure. Developmental Psychobiology, 51(8), 625–637.  
Grant, K. A., McMahon, C., Reilly, N., & Austin, M. P. (2010a). Maternal sensitivity 
moderates the impact of prenatal anxiety disorder on infant mental development. 
Early Human Development, 86(9), 551–556.  
Grant, K. A., Sandman, C. A., Wing, D. A., Dmitrieva, J., & Davis, E. P. (2015). 
Prenatal Programming of Postnatal Susceptibility to Memory Impairments: A 
Developmental Double Jeopardy. Psychological Science, 26(7), 1054–1062.  
Grant, K.-A., McMahon, C., Reilly, N., & Austin, M.P. (2010). Maternal sensitivity 
moderates the impact of prenatal anxiety disorder on infant responses to the still-
face procedure. Infant Behavior and Development, 33(4), 453–462. 
384 
 
Groeneweg, F. L., Karst, H., de Kloet, E. R., & Joëls, M. (2012). Mineralocorticoid and 
glucocorticoid receptors at the neuronal membrane, regulators of nongenomic 
corticosteroid signalling. Molecular and Cellular Endocrinology, 350(2), 299–309. 
Groer, M. E., Jevitt, C., & Ji, M. (2015). Immune Changes and Dysphoric Moods 
Across the Postpartum. American Journal of Reproductive Immunology, 73(3), 
193–198.  
Groer, M. W., & Davis, M. W. (2006). Cytokines, infections, stress, and dysphoric 
moods in breastfeeders and formula feeders. JOGNN - Journal of Obstetric, 
Gynecologic, and Neonatal Nursing, 35(5), 599–607.  
Groer, M. W., & Morgan, K. (2007). Immune, health and endocrine characteristics of 
depressed postpartum mothers. Psychoneuroendocrinology, 32(2), 133–139.  
Grossman, A. W., Churchill, J. D., Mckinney, B. C., Kodish, I. M., Otte, S. L., & 
Greenough, W. T. (2003). Experience effects on brain development: possible 
contributions to psychopathology. Journal of Child Psychology and Psychiatry, 
1(44), 33–63. 
Grote, N., Bridge, J., Gavin, A., Melville, J., Iyengar, S., & Katon, W. (2010). A meta-
analysis of depression during pregnancy and the risk of preterm birth, low birth 
weight and intrauterine growth restriction. Arch Gen Psychiatry, 67(10), 1012–
1024.  
Grunau, R. E. (2009). Neonatal pain, parenting stress and interaction, in relation to 
cognitive and motor development at 8 and 18 months in preterm infants. Pain, 
143(1–2), 138–146.  
Gu, W., & Jones, C. T. (1986). The effect of elevation of maternal plasma 
catecholamines on the fetus and placenta of the pregnant sheep. Journal of 
Developmental Physiology, 8(3), 173–186. 
Gunnar, M. R. (1992). Reactivity of the hypothalamic-pituitary-adrenocortical system to 
stressors in normal infants and children. Pediatrics, 90(3), 491–497. 
385 
 
Gunnar, M. R. (2017). Social Buffering of Stress in Development: A Career 
Perspective. Perspectives on Psychological Science, 12(3), 355–373.  
Gunnar, M. R., & Donzella, B. (2002). Social regulation of the cortisol levels in early 
human development. Psychoneuroendocrinology, 27(1–2), 199–220.  
Gunnar, M. R., & Hostinar, C. E. (2015). The Social Buffering of the Hypothalamic-
Pituitary- Adrenocortical Axis in Humans: Developmental and Experiential 
Determinants. Soc Neurosci, 10(5), 479–488.  
Gunnar, M. R., & Vazquez, D. M. (2001). Low cortisol and a flattening of expected 
daytime rhythm: Potential indices of risk in human development. Development 
and Psychopathology, 13(3), 515–538.  
Gunnar, M. R., Brodersen, L., Nachmias, M., Buss, K., & Rigatuso, J. (1996). Stress 
reactivity and attachment security. Developmental Psychobiology, 29(3), 191–
204.  
Gunnar, M. R., Hostinar, C. E., Sanchez, M. M., Tottenham, N., & Sullivan, R. M. 
(2015). Parental buffering of fear and stress neurobiology: Reviewing parallels 
across rodent, monkey, and human models. Social Neuroscience, 10, 474–478. 
Gunnar, M. R., Talge, N. M., & Herrera, A. (2009). Stressor paradigms in 
developmental studies: What does and does not work to produce mean increases 
in salivary cortisol. Psychoneuroendocrinology, 34(7), 953–967.  
Gunnar, M., & Quevedo, K. (2007). The Neurobiology of Stress and Development. 
Annual Review of Psychology, 58(1), 145–173.  
Gunnar, M.R., Donzella, B. Social regulation of the cortisol levels in early human 
development. Psychoneuroendocrinology. 2002; 27(1–2):199–220 
Gustafsson, H. C., Grieve, P. G., Werner, E. A., Desai, P., & Monk, C. (2018). 
Newborn electroencephalographic correlates of maternal prenatal depressive 
symptoms. Journal of Developmental Origins of Health and Disease, 1–5.  
386 
 
Gustafsson, H. C., Sullivan, E. L., Nousen, E. K., Sullivan, C. A., Huang, E., Rincon, 
M., … Loftis, J. M. (2018). Maternal Prenatal Depression Predicts Infant Negative 
Affect via Maternal Inflammatory Cytokine Levels. Brain Behavior and Immunity.  
Gutteling, B. M., De Weerth, C., & Buitelaar, J. K. (2004). Maternal prenatal stress and 
4-6 year old children’s salivary cortisol concentrations pre- and post-vaccination. 
Stress, 7(4), 257–260. 
 Gutteling, B. M., De Weerth, C., & Buitelaar, J. K. (2005). Prenatal stress and 
children’s cortisol reaction to the first day of school. Psychoneuroendocrinology, 
30(6), 541–549.  
Guven, M. A., Coskun, A., Ertas, I. E., Aral, M., Zencırcı, B., & Oksuz, H. (2009). 
Association of maternal serum CRP, IL-6, TNF-α, homocysteine, folic acid and 
vitamin b12 levels with the severity of preeclampsia and fetal birth weight. 
Hypertension in Pregnancy, 28(2), 190–200. 
Haeri, S., Baker, A. M., & Ruano, R. (2013). Do pregnant women with depression have 
a pro-inflammatory profile? Journal of Obstetrics and Gynaecology Research, 
39(5), 948–952.  
Hagberg, H., Mallard, C., & Jacobsson, B. (2005). Role of cytokines in preterm labour 
and brain injury. BJOG: An International Journal of Obstetrics & Gynaecology, 
112, 16–18. 
Hales, C. N., & Barker, D. J. (1992). Type 2 (non-insulin-dependent) diabetes mellitus: 
the thrifty phenotype hypothesis. Diabetologia, 35(7), 595–601. 
Handley, S. l. (1980). Cortisol and Puerperal, 498–509. 
Hane, A. A., & Fox, N. A. (2006). Natural variations in maternal caregiving of human 
infants influence stress reactivity. Psychological Science, 17(6), 550–556. 
Hane, A., Henderson, H., Fox, N. A., & Reeb-Sutherland, B. C. (2010). Ordinary 
Variations in Human Maternal Caregiving in Infancy and Biobehavioral 
Development in Early Childhood: A Follow-up Study. Developmental 
Psychobiology, 52(6), 558–567.  
387 
 
Hanisch, U. K. (2002). Microglia as a source and target of cytokine activities in the 
brain. In Microglia in the regenerating and degenerating central nervous system 
(pp. 79–124). Springer. 
Hanson, M. A., & Gluckman, P. D. (2008). Developmental origins of health and 
disease: new insights. Basic & Clinical Pharmacology & Toxicology, 102(2), 90–
93.  
Hanson, M. A., & Gluckman, P. D. (2014). Early Developmental Conditioning of Later 
Health and Disease: Physiology or Pathophysiology? Physiological Reviews, 
94(4), 1027–1076.  
Harmon, A. G., Hibel, L. C., Rumyantseva, O., & Granger, D. A. (2007). Measuring 
salivary cortisol in studies of child development: watch out—what goes in may not 
come out of saliva collection devices. Developmental Psychobiology: The Journal 
of the International Society for Developmental Psychobiology, 49(5), 495–500. 
Harris, B., Lovett, L., Newcombe, R. G., Read, G. F., Walker, R., & Riad-fahmy, D. 
(1994). Maternity blues and major endocrine changes: Cardiff puerperal mood 
and hormone study II. Br Med, 308(6934), 949–953. 
Harris, B., Lovett, L., Smith, J., Read, G., Walker, R., & Newcombe, R. (1996). Cardiff 
puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks 
postpartum, and its hormonal correlates across the peripartum period. The British 
Journal of Psychiatry, 168(6), 739–744.  
Harville, E. E., Xiong, X., & Buekens, P. (2010). Disasters and Perinatal Health: A 
Systematic Review. Obstetrics & Gynecology Survey, 65(11), 713–728.  
Harville, E. W., Savitz, D. A., Dole, N., Herring, A. H., & Thorp, J. M. (2009). Stress 
Questionnaires and Stress Biomarkers during Pregnancy. Journal of Women’s 
Health, 18(9), 1425–1433.  
Hay, D. F., Pawlby, S., Waters, C. S., & Sharp, D. (2008). Antepartum and postpartum 
exposure to maternal depression: Different effects on different adolescent 
388 
 
outcomes. Journal of Child Psychology and Psychiatry and Allied Disciplines, 
49(10), 1079–1088. 
Hay, D. F., Waters, C. S., Perra, O., Pawlby, S., & Sharp, D. (2010). Mothers’ 
Antenatal Depression and Their Children’s Antisocial Outcomes. Child 
Development, 81(1), 149–165. 
Hayes, L., Goodman, S. H., & Carlson, E. (2013). Maternal antenatal depression and 
infant disorganized attachment at 12 months. Attachment and Human 
Development, 15(2), 133–153.  
Heard, E., & Martienssen, R. A. (2014). Transgenerational Epigenetic Inheritance: 
myths and mechanisms. Cell, 157(1), 95–109.  
Heim, C., Newport, D. J., Mletzko, T., Miller, A. H., & Nemeroff, C. B. (2008). The link 
between childhood trauma and depression: Insights from HPA axis studies in 
humans. Psychoneuroendocrinology, 33(6), 693–710.  
Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support 
and oxytocin interact to suppress cortisol and subjective responses to 
psychosocial stress. Biological psychiatry, 54(12), 1389-1398. 
Helbig, A., Kaasen, A., Malt, U. F., & Haugen, G. (2013). Does antenatal maternal 
psychological distress affect placental circulation in the third trimester? PLoS 
One, 8(2), e57071. 
Hellgren, C., Åkerud, H., Skalkidou, A., & Sundström-Poromaa, I. (2013). Cortisol 
awakening response in late pregnancy in women with previous or ongoing 
depression. Psychoneuroendocrinology, 38(12), 3150–3154.  
Hellhammer, D. H., Wüst, S., & Kudielka, B. M. (2009). Salivary cortisol as a 
biomarker in stress research. Psychoneuroendocrinology, 34(2), 163–171.  
Heron, J., O’Connor, T. G., Evans, J., Golding, J., & Glover, V. (2004). The course of 
anxiety and depression through pregnancy and the postpartum in a community 
sample. Journal of Affective Disorders, 80(1), 65–73.  
389 
 
Heuvel, M. I. Van Den, Assen, M. A. L. M. Van, Glover, V., Claes, S., & Bergh, B. R. 
H. Van Den. (2018). Associations between maternal psychological distress and 
salivary cortisol during pregnancy : A mixed-models approach. 
Psychoneuroendocrinology, 96(May), 52–60.  
Hill, J., Breen, G., Quinn, J., Tibu, F., Sharp, H., & Pickles, A. (2013). Evidence for 
interplay between genes and maternal stress in utero: Monoamine oxidase A 
polymorphism moderates effects of life events during pregnancy on infant 
negative emotionality at 5weeks. Genes, Brain and Behavior, 12(4), 388–396. 
Himes, K. P., & Simhan, H. N. (2011). Plasma corticotropin-releasing hormone and 
cortisol concentrations and perceived stress among pregnant women with 
preterm and term birth. American Journal of Perinatology, 28(06), 443–448. 
Hocher, B., Chen, Y.P., Schlemm, L., Burdack, A., Li, J., Halle, H., Pfab, T., Kalk, P., 
Lang, F., Godes, M. (2009). Fetal sex determines the impact of maternal 
PROGINS progesterone receptor polymorphism on maternal physiology during 
pregnancy. Pharmacogenet. Genomics, 19, 710- 718. 
Hollingshead, A. B. (1957). Two factor index of social position. Yale University Press, 
New Haven. 
Holsboer, F. (2000). The corticosteroid receptor hypothesis of depression. 
Neuropsychopharmacology, 23(5), 477. 
Holzman, C., Senagore, P., Tian, Y., Bullen, B., Devos, E., Leece, C., … Sapkal, A. 
(2009). Maternal catecholamine levels in midpregnancy and risk of preterm 
delivery. American Journal of Epidemiology, 170(8), 1014–1024.  
Horowitz, M. A., Zunszain, P. A., Anacker, C., Musaelyan, K., & Pariante, C. M. 
(2013). Glucocorticoids and inflammation: A double-headed sword in 
depression?: How do neuroendocrine and inflammatory pathways interact during 
stress to contribute to the pathogenesis of depression? Inflammation in 
Psychiatry, 28, 127–143.  
390 
 
Hostinar, C. E., & Gunnar, M. R. (2013). Future Directions in the Study of Social 
Relationships as Regulators of the HPA Axis across Development. J Clin Child 
Adolesc Psychol, 42(4), 564–575.  
Hostinar, C. E., Sullivan, R. M., & Gunnar, M. R. (2014). Psychobiological Mechanisms 
Underlying the Social Buffering of the HPA Axis: A Review of Animal Models and 
Human Studies across Development. Psychological Bulletin, 140(1), 1–47.  
Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-
reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Medicine, 71(2), 
171–186.  
Hruschka, D. J., Kohrt, B. A., & Worthman, C. M. (2005). Estimating between- and 
within-individual variation in cortisol levels using multilevel models. 
Psychoneuroendocrinology, 30(7), 698–714.  
Hsiao, E. Y., & Patterson, P. H. (2012). Placental regulation of maternal‐fetal 
interactions and brain development. Developmental Neurobiology, 72(10), 1317–
1326. 
Huang, H. (2010). Structure of the fetal brain: what we are learning from diffusion 
tensor imaging. The Neuroscientist, 16(6), 634–649. 
Huang, H., Zhang, J., Wakana, S., Zhang, W., Ren, T., Richards, L. J., … van Zijl, P. 
C. M. (2006). White and gray matter development in human fetal, newborn and 
pediatric brains. Neuroimage, 33(1), 27–38. 
Huber, T. J., Issa, K., Schik, G., & Wolf, O. T. (2006). The cortisol awakening response 
is blunted in psychotherapy inpatients suffering from depression. 
Psychoneuroendocrinology, 31(7), 900–904. 
Huizink, A. C., Dick, D. M., Sihvola, E., Pulkkinen, L., Rose, R. J., & Kaprio, J. (2007). 
Chernobyl exposure as stressor during pregnancy and behavior in adolescent 
offspring, 116(6), 438–446. 
391 
 
Huizink, A. C., Menting, B., De Moor, M. H. M., Verhage, M. L., Kunseler, F. C., 
Schuengel, C., & Oosterman, M. (2017). From prenatal anxiety to parenting 
stress: a longitudinal study. Archives of Women’s Mental Health, 20(5), 663–672.  
Huizink, A. C., Mulder, E. J. H., & Buitelaar, J. K. (2004). Prenatal stress and risk for 
psychopathology: specific effects or induction of general susceptibility? 
Psychological Bulletin, 130(1), 115–142.  
Huizink, A. C., Robles de Medina, P. G., Mulder, E. J. H., Visser, G. H. a, & Buitelaar, 
J. K. (2003). Stress during pregnancy is associated with developmental outcome 
in infancy. Journal of Child Psychology and Psychiatry, 44(6), 810–818.  
Huot, R. L., Brennan, P. A., Stowe, Z. N., Plotsky, P. M., & Walker, E. F. (2004). 
Negative affect in offspring of depressed mothers is predicted by infant cortisol 
levels at 6 months and maternal depression during pregnancy, but not 
postpartum. Annals of the New York Academy of Sciences, 1032, 234–236.  
Huxley, R., Neil, A., & Collins, R. (2002). Unravelling the fetal origins hypothesis : is 
there really an inverse association between birthweight and subsequent blood 
pressure ?, 360, 659–665. 
Ibanez, G., Bernard, J. Y., Rondet, C., Peyre, H., Forhan, A., Kaminski, M., & Saurel-
Cubizolles, M. J. (2015). Effects of antenatal maternal depression and anxiety on 
children’s early cognitive development: A prospective Cohort study. PLoS ONE, 
10(8), 1–16.  
Iliadis, S. I., Comasco, E., Sylvén, S., Hellgren, C., Poromaa, I. S., & Skalkidou, A. 
(2015). Prenatal and postpartum evening salivary cortisol levels in association 
with peripartum depressive symptoms. PLoS ONE, 10(8), 1–21.  
Ishitobi, Y., Akiyoshi, J., Tanaka, Y., Ando, T., Okamoto, S., Kanehisa, M., … Kodama, 
K. (2010). Elevated salivary α-amylase and cortisol levels in unremitted and 
remitted depressed patients. International Journal of Psychiatry in Clinical 
Practice, 14(4), 268–273.  
392 
 
Ising, M., Horstmann, S., Kloiber, S., Lucae, S., Binder, E. B., Kern, N., … Holsboer, F. 
(2007). Combined dexamethasone/corticotropin releasing hormone test predicts 
treatment response in major depression - a potential biomarker? Biological 
Psychiatry, 62(1), 47–54.  
Iwata, M., Ota, K. T., & Duman, R. S. (2013). The inflammasome: Pathways linking 
psychological stress, depression, and systemic illnesses. Brain, Behavior, and 
Immunity, 31, 105–114. https://doi.org/10.1016/j.bbi.2012.12.008 
Jahromi, L. B., Putnam, S. P., & Stifter, C. A. (2004). Maternal regulation of infant 
reactivity from 2 to 6 months. Developmental Psychology, 40(4), 477–487.  
Jansen, J., Beijers, R., Riksen-Walraven, M., & de Weerth, C. (2010). Cortisol 
reactivity in young infants. Psychoneuroendocrinology, 35(3), 329–338.  
Jarcho, M. R., Slavich, G. M., Tylova-Stein, H., Wolkowitz, O. M., & Burke, H. M. 
(2013). Dysregulated diurnal cortisol pattern is associated with glucocorticoid 
resistance in women with major depressive disorder. Biological Psychology, 
93(1), 150–158.  
Jarde, A., Morais, M., Kingston, D., Giallo, R., MacQueen, G. M., Giglia, L., … 
McDonald, S. D. (2016). Neonatal outcomes in women with untreated antenatal 
depression compared with women without depression: A systematic review and 
meta-analysis. JAMA Psychiatry, 73(8), 826–837.  
Jefferis, B.J., Power, C., Hertzman, C. (2002). Birth weight, childhood socio- economic 
environment, and cognitive development in the 1958 British birth cohort study. 
BMJ, 325-305. 
Joëls, M., & Baram, T. Z. (2009). The neuro-symphony of stress. Nature Reviews 
Neuroscience, 10(6), 459. 
Joëls, M., Sarabdjitsingh, R. A., & Karst, H. (2012). Unraveling the time domains of 
corticosteroid hormone influences on brain activity: rapid, slow, and chronic 
modes. Pharmacological Reviews, 64(4), 901–938. 
393 
 
Johnson, E. O., Kamilaris, T. C., Chrousos, G. P., & Gold, P. W. (1992). Mechanisms 
of stress: a dynamic overview of hormonal and behavioral homeostasis. 
Neuroscience & Biobehavioral Reviews, 16(2), 115–130. 
Johnson, J. D., O’Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. 
(2002). Prior stressor exposure sensitizes LPS-induced cytokine production. 
Brain, Behavior, and Immunity, 16(4), 461–476. 
Johnson, M., Schmeid, V., Lupton, S. J., Austin, M.-P., Matthey, S. M., Kemp, L., … 
Yeo, A. E. (2012). Measuring perinatal mental health risk. Archives of Women’s 
Mental Health, 15(5), 375–386.  
Johnstone, J. F., Bocking, A. D., Unlugedik, E., & Challis, J. R. G. (2005). The effects 
of chorioamnionitis and betamethasone on 11β, hydroxysteroid dehydrogenase 
types 1 and 2 and the glucocorticoid receptor in preterm human placenta. Journal 
of the Society for Gynecologic Investigation, 12(4), 238–245. 
Jones, C. T., & Robinson, R. O. (1975). Plasma catecholamines in foetal and adult 
sheep. The Journal of Physiology, 248(1), 15–33. 
Jones, N. A., Field, T., Fox, N. A., Davalos, M., Lundy, B., & Hart, S. (1998). EEC 
Asymmetry vagal tone Brazelton maternal depression. Infant Behavior & 
Development, 21(3), 537–541.  
Jones, N. A., Field, T., Fox, N. A., Lundy, B., & Davalos, M. (1997). EEG activation in 
1-month-old infants of depressed mothers. Development and Psychopathology, 
9(3), 491–505. 
Juffer, F., Bakermans-Kranenburg, M. J., & van IJzendoorn, M. H. (2017). Pairing 
attachment theory and social learning theory in video-feedback intervention to 
promote positive parenting. Current Opinion in Psychology, 15, 189–194.  
Juffer, F., Bakermans-Kranenburg, M. J., & Van Ijzendoorn, M. H. (2012). Promoting 
positive parenting: An attachment-based intervention. Routledge. 
Jung, C., Ho, J. T., Torpy, D. J., Rogers, A., Doogue, M., Lewis, J. G., … Inder, W. J. 
(2011). A longitudinal study of plasma and urinary cortisol in pregnancy and 
394 
 
postpartum. The Journal of Clinical Endocrinology & Metabolism, 96(5), 1533–
1540. 
Juruena, M. F., Bocharova, M., Agustini, B., & Young, A. H. (2018). Atypical 
depression and non-atypical depression: Is HPA axis function a biomarker? A 
systematic review. Journal of affective disorders, 233, 45-67. 
Kaaja, R. J., Moore, M. P., Yandle, T. G., Ylikorkala, O., Frampton, C. M., & Nicholls, 
M. G. (1999). Blood pressure and vasoactive hormones in mild preeclampsia and 
normal pregnancy. Hypertension in Pregnancy, 18(2), 173–187. 
Kamimura, D., Ishihara, K., & Hirano, T. (2003). IL-6 signal transduction and its 
physiological roles: the signal orchestration model. In Reviews of physiology, 
biochemistry and pharmacology (pp. 1–38). Springer. 
Kammerer, M., Adams, D., Castelberg Bv, B. von, & Glover, V. (2002). Pregnant 
women become insensitive to cold stress. BMC Pregnancy and Childbirth, 2(1), 
8.  
Kammerer, M., Taylor, A., & Glover, V. (2006). The HPA axis and perinatal 
depression: A hypothesis. Archives of Women’s Mental Health, 9(4), 187–196.  
Kantonen, T., Karlsson, L., Nolvi, S., Karukivi, M., Tolvanen, M., & Karlsson, H. (2015). 
Maternal alexithymic traits, prenatal stress, and infant temperament. Infant 
Behavior and Development, 41, 12–16. 
Kaplan, L. A., Evans, L., & Monk, C. (2008). Effects of mothers’ prenatal psychiatric 
status and postnatal caregiving on infant biobehavioral regulation: can prenatal 
programming be modified? Early Human Development, 84(4), 249–256. 
Kapoor, A., Petropoulos, S., & Matthews, S. G. (2008). Fetal programming of 
hypothalamic–pituitary–adrenal (HPA) axis function and behavior by synthetic 
glucocorticoids. Brain Research Reviews, 57(2), 586–595. 
Karasik, L. B., Tamis‐LeMonda, C. S., & Adolph, K. E. (2011). Transition from crawling 




Karlsson, L., Nousiainen, N., Scheinin, N. M., Maksimow, M., Salmi, M., Lehto, S. M., 
& Tolvanen, M. (2016). Cytokine profile and maternal depression and anxiety 
symptoms in mid-pregnancy — the FinnBrain Birth Cohort Study. Archives of 
Women’s Mental Health.  
Katz, E. R., Stowe, Z. N., Newport, D. J., Kelley, M. E., Pace, T. W., Cubells, J. F., & 
Binder, E. B. (2012). Regulation of mRNA expression encoding chaperone and 
co-chaperone proteins of the glucocorticoid receptor in peripheral blood: 
association with depressive symptoms during pregnancy. Psychological 
Medicine, 42(05), 943–956.  
Keenan, K., Grace, D., & Gunthorpe, D. (2003). Examining Stress Reactivity in 
Neonates : Relations between Cortisol and Behavior. Child Development, 74(6), 
1930-42 
Kelly, Y. J., Nazroo, J. Y., McMunn, A., Boreham, R., & Marmot, M. (2001). Birthweight 
and behavioural problems in children: A modifiable effect? International Journal of 
Epidemiology, 30(1), 88–94.  
Kelly, Y.J., Nazroo, J.Y., McMunn, A., et al (2001). Birthweight and behavioural 
problems in children: a modifiable effect? Int J Epidemiol, 30, 88–94. 
Kendall-Tackett, K. (2007). A new paradigm for depression in new mothers: the central 
role of inflammation and how breastfeeding and anti-inflammatory treatments 
protect maternal mental health. International Breastfeeding Journal, 2(1), 6.  
Kendler, K. S., Karkowski, L. M., & Prescott, C. A. (1999). Causal relationship between 
stressful life events and the onset of major depression. American Journal of 
Psychiatry, 156(6), 837-841. 
Kennedy, B., Dillon, E., Mills, P. J., & Ziegler, M. G. (2001). Catecholamines in human 
saliva. Life Sciences, 69(1), 87–99. 
Kessler, R. C. (1997). The effects of stressful life events on depression. Annual review 
of psychology, 48(1), 191-214. 
396 
 
Kessler, R. C. (2003). Epidemiology of women and depression. Journal of Affective 
Disorders, 74(1), 5–13.  
Khalife, N., Glover, V., Taanila, A., Ebeling, H., Järvelin, M.-R., & Rodriguez, A. 
(2013). Prenatal glucocorticoid treatment and later mental health in children and 
adolescents. PloS One, 8(11), e81394. 
Khashan, A. S., Abel, K. M., McNamee, R., Pedersen, M. G., Webb, R. T., Baker, P. 
N., … Mortensen, P. B. (2008). Higher risk of offspring schizophrenia following 
antenatal maternal exposure to severe adverse life events. Archives of General 
Psychiatry, 65(2), 146–152. 
Kianbakht, S., Mashhadi, E., Jamillian, H. R., & Ghazavi, A. (2013). Immune 
phenomena in neonates of women with depression during pregnancy: a case-
control study. The Journal of Maternal-Fetal & Neonatal Medicine, 26(6), 608–
610.  
Kiecolt-Glaser, J. K., Preacher, K. J., MacCallum, R. C., Atkinson, C., Malarkey, W. B., 
& Glaser, R. (2003). Chronic stress and age-related increases in the 
proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences, 
100(15), 9090–9095. 
Kim, H. G., Mandell, M., Crandall, C., Kuskowski, M. A., Dieperink, B., & Buchberger, 
R. L. (2006). Antenatal psychiatric illness and adequacy of prenatal care in an 
ethnically diverse inner-city obstetric population. Archives of Women’s Mental 
Health, 9(2), 103–107. 
King, S., Dancause, K., Turcotte-Tremblay, A.-M., Veru, F., & Laplante, D. P. (2012). 
Using Natural Disasters to Study the Effects of Prenatal Maternal Stress on Child 
Health and Development. Birth Defects Research Part C: Embryo Today: 
Reviews, 96(4), 273–288.  
King, S., Kildea, S., Austin, M. P., Brunet, A., Cobham, V. E., Dawson, P. A., … Yong 
Ping, E. (2015). QF2011: A protocol to study the effects of the Queensland flood 
397 
 
on pregnant women, their pregnancies, and their children’s early development. 
BMC Pregnancy and Childbirth, 15(1).  
King, S., Mancini-Marie, A., Brunet, A., Walker, E., Meaney, M. J., & Laplante, D. P. 
(2009). Prenatal maternal stress from a natural disaster predicts dermatoglyphic 
asymmetry in humans. Development and Psychopathology, 21(2), 343–353.  
Kinney, D. K., KM, M., Crowley, D., & Miller, A. (2008). Prenatal stress and risk for 
autism. Neurosci Biobehav Rev, 32(8), 1519–1532.  
Kirkpatrick, R. M., McGue, M., Iacono, W. G., Miller, M. B., & Basu, S. (2014). Results 
of a “GWAS Plus:” General cognitive ability is substantially heritable and 
massively polygenic. PloS One, 9(11), e112390. 
Kitchener, P., Di Blasi, F., Borrelli, E., & Piazza, P. V. (2004). Differences between 
brain structures in nuclear translocation and DNA binding of the glucocorticoid 
receptor during stress and the circadian cycle. European Journal of 
Neuroscience, 19(7), 1837–1846. 
Kivijärvi, M., Räihä, H., Kaljonen, A., Tamminen, T., & Piha, J. (2005). Infant 
temperament and maternal sensitivity behavior in the first, 421–428. 
Kivlighan, K. T., DiPietro, J. A., Costigan, K. A., & Laudenslager, M. L. (2008). Diurnal 
rhythm of cortisol during late pregnancy: Associations with maternal 
psychological well-being and fetal growth. Psychoneuroendocrinology, 33(9), 
1225–1235.  
Klinkenberg, A. V, Nater, U. M., Nierop, A., Bratsikas, A., Zimmermann, R., & Ehlert, 
U. (2009). Heart rate variability changes in pregnant and non‐pregnant women 
during standardized psychosocial stress1. Acta Obstetricia et Gynecologica 
Scandinavica, 88(1), 77–82. 
Kluczniok, D., Sc, M., Boedeker, K., Ph, D., Fuchs, A., Sc, M., … Bermpohl, F. (2016). 
Emotional Availability In Mother – Child Interaction : The Effects Of Maternal 
Depression In Remission And Additional, 657(November 2015), 648–657.  
398 
 
Knopik, V. S., Marceau, K., Palmer, R. H. C., Smith, T. F., & Heath, A. C. (2016). 
Maternal smoking during pregnancy and offspring birth weight: a genetically-
informed approach comparing multiple raters. Behavior Genetics, 46(3), 353–
364. 
Knorr, U., Vinberg, M., Kessing, L. V., & Wetterslev, J. (2010). Salivary cortisol in 
depressed patients versus control persons: A systematic review and meta-
analysis. Psychoneuroendocrinology, 35(9), 1275–1286.  
Knuesel, I., Chicha, L., Britschgi, M., Schobel, S. A., Bodmer, M., Hellings, J. A., … 
Prinssen, E. P. (2014). Maternal immune activation and abnormal brain 
development across CNS disorders. Nature Reviews. Neurology, 10(11), 643–
660.  
Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & 
Krogh, J. (2014). Effect of anti-inflammatory treatment on depression, depressive 
symptoms, and adverse effects: a systematic review and meta-analysis of 
randomized clinical trials. JAMA Psychiatry, 71(12), 1381–1391. 
Kok, R., Linting, M., Bakermans-Kranenburg, M. J., van Ijzendoorn, M. H., Jaddoe, V. 
W. V., Hofman, A., … Tiemeier, H. (2013). Maternal sensitivity and internalizing 
problems: evidence from two longitudinal studies in early childhood. Child 
Psychiatry and Human Development, 44(6), 751–765.  
Korhonen, M., Luoma, I., Salmelin, R., & Tamminen, T. (2014). Maternal depressive 
symptoms: associations with adolescents’ internalizing and externalizing 
problems and social competence. Nordic Journal of Psychiatry, 68(5), 323–332. 
Kossintseva, I., Wong, S., Johnstone, E., Guilbert, L., Olson, D. M., Mitchell, B. F., … 
Proinflammatory, B. F. M. (2006). Proinflammatory cytokines inhibit human 
placental 11 ␤ -hydroxysteroid dehydrogenase type 2 activity through Ca 2 ϩ and 
cAMP pathways. Am J Physiol Endocrinol Metab, 2, 282–288.  
399 
 
Koutra, K., Chatzi, L., Bagkeris, M., Vassilaki, M., Bitsios, P., & Kogevinas, M. (2013). 
Antenatal and postnatal maternal mental health as determinants of infant 
neurodevelopment at 18 months of age in a mother-child cohort (Rhea Study) in 
Crete, Greece. Social Psychiatry and Psychiatric Epidemiology, 48(8), 1335–
1345. 
Kozhimannil, K. B., Pereira, M. A., & Harlow, B. L. (2009). Association between 
diabetes and perinatal depression among low-income mothers. Jama, 301(8), 
842–847. 
Kudielka, B. M., Hellhammer, D. H., & Wüst, S. (2009). Why do we respond so 
differently? Reviewing determinants of human salivary cortisol responses to 
challenge. Psychoneuroendocrinology, 34(1), 2–18.  
Kuhlman, K. R., Chiang, J. J., Horn, S., & Bower, J. E. (2017). Developmental 
psychoneuroendocrine and psychoneuroimmune pathways from childhood 
adversity to disease. Neuroscience and Biobehavioral Reviews, 80(May), 166–
184.  
Kumpel, B. M., & Manoussaka, M. S. (2012). Placental immunology and maternal 
alloimmune responses. Vox Sanguinis, 102(1), 2–12. 
Kundakovic, M., & Jaric, I. (2017). The epigenetic link between prenatal adverse 
environments and neurodevelopmental disorders. Genes, 8(3).  
Kurki, T., Hiilesmaa, V., Raitasalo, R., Mattila, H., & Ylikorkala, O. (2000). Depression 
and anxiety in early pregnancy and risk for preeclampsia. Obstetrics & 
Gynecology, 95(4), 487–490. 
Kuzawa, C. W., Fried, R. L., Borja, J. B., & McDade, T. W. (2017). Maternal pregnancy 
C-reactive protein predicts offspring birth size and body composition in 
metropolitan Cebu, Philippines. Journal of Developmental Origins of Health and 
Disease, 8, 1–8.  
400 
 
Kuzmicki, M., Telejko, B., Szamatowicz, J., Zonenberg, A., Nikolajuk, A., Kretowski, 
A., & Gorska, M. (2009). High resistin and interleukin-6 levels are associated with 
gestational diabetes mellitus. Gynecological Endocrinology, 25(4), 258–263. 
La Rocca, C., Carbone, F., Longobardi, S., & Matarese, G. (2014). The immunology of 
pregnancy: regulatory T cells control maternal immune tolerance toward the 
fetus. Immunology Letters, 162(1), 41–48. 
Lahti, M., Savolainen, K., Tuovinen, S., Pesonen, A.-K., Lahti, J., Heinonen, K., … 
Räikkönen, K. (2017). Maternal Depressive Symptoms During and After 
Pregnancy and Psychiatric Problems in Children. Journal of the American 
Academy of Child & Adolescent Psychiatry, 56(1), 30–39.e7.  
Lamers, F., Vogelzangs, N., Merikangas, K. R., De Jonge, P., Beekman, A. T. F., & 
Penninx, B. (2013). Evidence for a differential role of HPA-axis function, 
inflammation and metabolic syndrome in melancholic versus atypical depression. 
Molecular Psychiatry, 18(6), 692. 
Lancaster, C. A., Gold, K. J., Flynn, H. A., Yoo, H., Marcus, S. M., & Davis, M. M. 
(2010). Risk factors for depressive symptoms during pregnancy: a systematic 
review. Am J Obstet Gynecol, 202(1), 5–14.  
Landry, S. H., Smith, K. E., & Swank, P. R. (2006). Responsive parenting: establishing 
early foundations for social, communication, and independent problem-solving 
skills. Developmental Psychology, 42(4), 627. 
Langer-Gould, A., Garren, H., Slansky, A., Ruiz, P. J., & Steinman, L. (2002). Late 
pregnancy suppresses relapses in experimental autoimmune encephalomyelitis: 
Evidence for a suppressive pregancy-related serum factor. The Journal of 
Immunology, 169(2), 1084–1091. 
Langley-Evans, S. C. (2006, February). Developmental programming of health and 
disease. The Proceedings of the Nutrition Society. England. 
Langley-Evans, S. C., Phillips, G. J., Benediktsson, R., Gardner, D. S., Edwards, C. R. 
W., Jackson, A. A., & Seckl, J. R. (1996). Protein intake in pregnancy, placental 
401 
 
glucocorticoid metabolism and the programming of hypertension in the rat. 
Placenta, 17(2), 169–172. 
Laplante, D. P., Barr, R. G., Brunet, A., Galbaud du Fort, G., Meaney, M. L., Saucier, 
J.-F., … King, S. (2004). Stress during pregnancy affects general intellectual and 
language functioning in  human toddlers. Pediatric Research, 56(3), 400–410.  
Laplante, D. P., Brunet, A., & King, S. (2016). The effects of maternal stress and 
illness during pregnancy on infant temperament: Project Ice Storm. Pediatric 
Research, 79(1–1), 107–113.  
Latendresse, G., Ruiz, R. J., & Wong, B. (2013). Psychological distress and SSRI use 
predict variation in inflammatory cytokines during pregnancy. Open J Obstet 
Gynecol, 3(1A), 184–191.  
Laucht, M., Esser, G., & Schmidt, M. H. (1997). Developmental outcome of infants 
born with biological and psychosocial risks. Journal of Child Psychology and 
Psychiatry, 38(7), 843–853. 
Laurent, H. K., Leve, L. D., Neiderhiser, J. M., Natsuaki, M. N., Shaw, D. S., Harold, G. 
T., & Reiss, D. (2013). Effects of prenatal and postnatal parent depressive 
symptoms on adopted child HPA regulation: Independent and moderated 
influences. Developmental Psychology, 49(5), 876. 
Le Strat, Y., Dubertret, C., & Le Foll, B. (2011). Prevalence and correlates of major 
depressive episode in pregnant and postpartum women in the United States. 
Journal of Affective Disorders, 135(1–3), 128–138. 
Lebel, C., Walton, M., Letourneau, N., Giesbrecht, G. F., Kaplan, B. J., & Dewey, D. 
(2016). Prepartum and Postpartum Maternal Depressive Symptoms Are Related 
to Children’s Brain Structure in Preschool. Biological Psychiatry, 80(11), 859–
868.  
Lederman, R. P., Lederman, E., Work, B. A., & McCann, D. S. (1989). Plasma 
epinephrine, norepinephrine, and cortisol of multigravidas in pregnancy and labor 
402 
 
and in umbilical cord arteries after delivery. Journal of Psychosomatic Obstetrics 
& Gynecology, 10(1), 57–69. 
Lee, Y. B., Nagai, A., & Kim, S. U. (2002). Cytokines, chemokines, and cytokine 
receptors in human microglia. Journal of Neuroscience Research, 69(1), 94–103. 
Leech, S. L., Larkby, C. A., Day, R., & Day, N. L. (2006). Predictors and correlates of 
high levels of depression and anxiety symptoms among children at age 10. 
Journal of the American Academy of Child and Adolescent Psychiatry, 45(2), 
223–230.  
Leerkes, E. M., Blankson, A. N., & O’Brien, M. (2009). Differential effects of maternal 
sensitivity to infant distress and nondistress on social‐emotional functioning. Child 
Development, 80(3), 762–775. 
Leigh, B., & Milgrom, J. (2008). Risk factors for antenatal depression, postnatal 
depression and parenting stress. BMC Psychiatry, 8(1), 24. 
Leigh, P., Nievar, M. A., & Nathans, L. (2011). Maternal Sensitivity and Language in 
Early Childhood: A Test of the Transactional Model. Perceptual and Motor Skills, 
113(1), 281–299.  
Leis, J. A., Heron, J., Stuart, E. A., & Mendelson, T. (2014). Associations between 
maternal mental health and child emotional and behavioral problems: Does 
prenatal mental health matter? Journal of Abnormal Child Psychology, 42(1), 
161–171.  
Lemaire, V., Lamarque, S., Le Moal, M., Piazza, P. V., & Abrous, D. N. (2006). 
Postnatal Stimulation of the Pups Counteracts Prenatal Stress-Induced Deficits in 
Hippocampal Neurogenesis. Biological Psychiatry, 59(9), 786–792.  
Leonard, H. C., & Hill, E. L. (2014). The impact of motor development on typical and 
atypical social cognition and language: A systematic review. Child and 
Adolescent Mental Health, 19(3), 163–170. 
Leung, E., Tasker, S. L., Atkinson, L., Vaillancourt, T., Schulkin, J., & Schmidt, L. A. 
(n.d.). Perceived Maternal Stress During Pregnancy and Its Relation to Infant 
403 
 
Stress Reactivity at 2 Days and 10 Months of Postnatal Life. Clinical Pediatrics, 
49(2), 158–165.  
Levine, S. (1994). The Ontogeny of the Hypothalamic‐Pituitary‐Adrenal Axis. The 
Influence of Maternal Factors a. Annals of the New York Academy of Sciences, 
746(1), 275–288. 
Levitan, R. D., Vaccarino, F. J., Brown, G. M., & Kennedy, S. H. (2002). Low-dose 
dexamethasone challenge in women with atypical major depression: pilot study. 
Journal of Psychiatry and Neuroscience, 27(1), 47. 
Lewinn, K. Z., Stroud, L. R., Molnar, B. E., Ware, J. H., Koenen, K. C., & Buka, S. L. 
(2009). Elevated maternal cortisol levels during pregnancy are associated with 
reduced childhood IQ. International Journal of Epidemiology, 38(6), 1700–1710.  
Li, J., Wang, Z.-N., Chen, Y.-P., Dong, Y.-P., Shuai, H.-L., Xiao, X.-M., … Hocher, B. 
(2012). Late gestational maternal serum cortisol is inversely associated with fetal 
brain growth. Neuroscience & Biobehavioral Reviews, 36(3), 1085–1092.  
Licht, C. M., de Geus, E. J., Zitman, F. G., Hoogendijk, W. J., van Dyck, R., & Penninx, 
B. W. (2008). Association between major depressive disorder and heart rate 
variability in the Netherlands Study of Depression and Anxiety (NESDA). Arch 
Gen Psychiatry, 65(12), 1358–1367.  
Lin, Y., Xu, J., Huang, J., Jia, Y., Zhang, J., Yan, C., & Zhang, J. (2017). Effects of 
prenatal and postnatal maternal emotional stress on toddlers’ cognitive and 
temperamental development. Journal of Affective Disorders, 207, 9–17.  
Lindsay, J. R., & Nieman, L. K. (2005). The hypothalamic-pituitary-adrenal axis in 
pregnancy: challenges in disease detection and treatment. Endocrine Reviews, 
26(6), 775–799. 
Littel, R. C., Milliken, G. A., Stroup, W. W., & Wolfinger, R. D. (n.d.). SAS system for 
mixed models. 1996. Cary, NC: SAS Institute. 
404 
 
Liu, H., Zhang, Y., Gao, Y., & Zhang, Z. (2016). Elevated levels of Hs-CRP and IL-6 
after delivery are associated with depression during the 6 months post partum. 
Psychiatry Research, 243, 43–48.  
Liu, Y., Ho, R. C. M., & Mak, A. (2012). Interleukin (IL)-6, tumour necrosis factor alpha 
(TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with 
major depressive disorder: A meta-analysis and meta-regression. Journal of 
Affective Disorders, 139(3), 230–239.  
Liukkonen, T., Räsänen, P., Jokelainen, J., Leinonen, M., Järvelin, M.-R., Meyer-
Rochow, V. B., & Timonen, M. (2011). The association between anxiety and C-
reactive protein (CRP) levels: results from the Northern Finland 1966 birth cohort 
study. European Psychiatry, 26(6), 363–369. 
Lokensgard, J. R., Hu, S., Sheng, W., Cox, D., Cheeran, M. C.-J., & Peterson, P. K. 
(2001). Robust expression of TNF-α, IL-1β, RANTES, and IP-10 by human 
microglial cells during nonproductive infection with herpes simplex virus. Journal 
of Neurovirology, 7(3), 208–219. 
Lommatzsch, M., Hornych, K., Zingler, C., Schuff-Werner, P., Höppner, J., & Virchow, 
J. C. (2006). Maternal serum concentrations of BDNF and depression in the 
perinatal period. Psychoneuroendocrinology, 31(3), 388–394.  
Loomans, E. M., Der Stelt, O. van, Van Eijsden, M., Gemke, R. J. B. J., Vrijkotte, T., & 
den Bergh, B. R. H. V. (2011). Antenatal maternal anxiety is associated with 
problem behaviour at age five. Early Human Development, 87(8), 565–570.  
Lopez-Duran, N. L., Kovacs, M., & George, C. J. (2009). Hypothalamic–pituitary–
adrenal axis dysregulation in depressed children and adolescents: A meta-
analysis. Psychoneuroendocrinology, 34(9), 1272–1283. 
Lorenz, K. (1935). Der kunpan in der umwelt des vogels. Der artgenosse als 




Luby, J. L., Mrakotsky, C., Heffelfinger, A., Brown, K., & Spitznagel, E. (2004). 
Characteristics of depressed preschoolers with and without anhedonia: evidence 
for a melancholic depressive subtype in young children. American Journal of 
Psychiatry, 161(11), 1998–2004. 
Luby, J.L.,Heffelinger, A., Mrakotsky, C., Brown, K., , … Spitznagel, E. (2003). 
Alterations in stress cortisol reactivity in depressed preschoolers relative to 
psychiatric and no-disorder comparison groups. Archives of General Psychiatry, 
60(12), 1248–1255.  
Lucassen, P. J., Bosch, O. J., Jousma, E., Krömer, S. A., Andrew, R., Seckl, J. R., & 
Neumann, I. D. (2009). Prenatal stress reduces postnatal neurogenesis in rats 
selectively bred for high, but not low, anxiety: possible key role of placental 
11β‐hydroxysteroid dehydrogenase type 2. European Journal of Neuroscience, 
29(1), 97–103. 
Luiza, J. W., Gallaher, M. J., & Powers, R. W. (2015). Urinary cortisol and depression 
in early pregnancy: role of adiposity and race. BMC Pregnancy and Childbirth, 15, 
30.  
Lundy, B. L., Jones, N. A., Field, T., Nearing, G., Davalos, M., Pietro, P., … Kuhn, C. 
(1999). Prepartum depression effects on neonates. Infant Behavior and 
Development, 22(1), 121–137.  
Luoma, I., Tamminen, T., Kaukonen, P., Laippala, P., Puura, K., Salmelin, R., & 
Almqvist, F. (2001). Longitudinal study of maternal depressive symptoms and 
child well-being. Journal of the American Academy of Child and Adolescent 
Psychiatry, 40(12), 1367–1374.  
Lupien, S. J., McEwen, B. S., Gunnar, M. R., & Heim, C. (2009). Effects of stress 
throughout the lifespan on the brain, behaviour and cognition. Nature Reviews 
Neuroscience, 10(6), 434–445.  
Lupien, S. J., Parent, S., Evans, A. C., Tremblay, R. E., Zelazo, P. D., Corbo, V., … 
Séguin, J. R. (2011). Larger amygdala but no change in hippocampal volume in 
406 
 
10-year-old children exposed to maternal depressive symptomatology since birth. 
Proceedings of the National Academy of Sciences, 108(34), 14324–14329. 
Lutgendorf, S. K., Garand, L., Buckwalter, K. C., Reimer, T. T., Hong, S.-Y., & 
Lubaroff, D. M. (1999). Life stress, mood disturbance, and elevated interleukin-6 
in healthy older women. Journals of Gerontology Series A: Biomedical Sciences 
and Medical Sciences, 54(9), M434–M439. 
Maccari, S., Darnaudery, M., Morley-Fletcher, S., Zuena, A. R., Cinque, C., & Van 
Reeth, O. (2003). Prenatal stress and long-term consequences: Implications of 
glucocorticoid hormones. Neuroscience and Biobehavioral Reviews, 27(1–2), 
119–127.  
Maccari, S., Krugers, H. J., Morley-Fletcher, S., Szyf, M., & Brunton, P. J. (2014). The 
consequences of early-life adversity: Neurobiological, behavioural and epigenetic 
adaptations. Journal of Neuroendocrinology, 26(10), 707–723.  
Maccari, S., Piazza, P. V, Kabbaj, M., Barbazanges,  a, Simon, H., & Le Moal, M. 
(1995). Adoption reverses the long-term impairment in glucocorticoid feedback 
induced by prenatal stress. The Journal of Neuroscience : The Official Journal of 
the Society for Neuroscience, 15(1 Pt 1), 110–116.  
Maccari, S., Polese, D., Reynaert, M. L., Amici, T., Morley-Fletcher, S., & Fagioli, F. 
(2017). Early-life experiences and the development of adult diseases with a focus 
on mental illness: The Human Birth Theory. Neuroscience, 342, 232–251.  
Mackner, L. M., Black, M. M., & Starr  Raymond H, J. (2003). Cognitive development 
of children in poverty with failure to thrive: a prospective study through age 6. 
Journal of Child Psychology and Psychiatry, 44(5), 743–751. 
Macko, A. R., Yates, D. T., Chen, X., Shelton, L. A., Kelly, A. C., Davis, M. A., … 
Limesand, S. W. (2016). Adrenal demedullation and oxygen supplementation 
independently increase glucose-stimulated insulin concentrations in fetal sheep 
with intrauterine growth restriction. Endocrinology, 157(5), 2104–2115. 
407 
 
Madigan, S., Oatley, H., Racine, N., Fearon, R. M. P., Schumacher, L., Akbari, E., … 
Tarabulsy, G. M. (2018). A Meta-Analysis of Maternal Prenatal Depression and 
Anxiety on Child Socio-Emotional Development. Journal of the American 
Academy of Child & Adolescent Psychiatry.  
Maes, M., Lin, A. H., Ombelet, W., Stevens, K., Kenis, G., De Jongh, R., … Bosmans, 
E. (2000a). Immune activation in the early puerperium is related to postpartum 
anxiety and depressive symptoms. Psychoneuroendocrinology, 25(2), 121–137.  
Maes, M., Lin, A., Ombelet, W., Stevens, K., Kenis, G., De Jongh, R., … Bosmans, E. 
(2000b). Immune activation in the early puerperium is related to postpartum 
anxiety and depressive symptoms. Psychoneuroendocrinology, 25(2), 121–137.  
Magiakou, M. a, Mastorakos, G., Rabin, D., Margioris,  a N., Dubbert, B., Calogero,  a 
E., … Chrousos, G. P. (1996). The maternal hypothalamic-pituitary-adrenal axis 
in the third trimester of human pregnancy. Clinical Endocrinology, 44(4), 419–
428. 
Mairesse, J., Lesage, J., Breton, C., Bréant, B., Hahn, T., Darnaudéry, M., … Vieau, 
D. (2007). Maternal stress alters endocrine function of the feto-placental unit in 
rats. American Journal of Physiology-Endocrinology and Metabolism, 292(6), 
E1526–E1533. 
Majzoub, J. A., & Karalis, K. P. (1999). Placental corticotropin-releasing hormone: 
function and regulation. American Journal of Obstetrics and Gynecology, 180(1), 
S242–S246. 
Makhseed, M., Raghupathy, R., Azizieh, F., Farhat, R., Hassan, N., & Bandar, A. 
(2000). Circulating cytokines and CD30 in normal human pregnancy and 
recurrent spontaneous abortions. Human Reproduction (Oxford, England), 15(9), 
2011–2017. 
Malmberg, L., Lewis, S., West, A., Murray, E., Sylva, K., & Stein, A. (2016). The 
influence of mothers’ and fathers’ sensitivity in the first year of life on children’s 
408 
 
cognitive outcomes at 18 and 36 months. Child: Care, Health and Development, 
42(1), 1–7. 
Mandal, M., Donnelly, R., Elkabes, S., Zhang, P., Davini, D., David, B. T., & Ponzio, N. 
M. (2013). Maternal immune stimulation during pregnancy shapes the 
immunological phenotype of offspring. Brain, Behavior, and Immunity, 33, 33–45. 
Manoharan, A., Rajkumar, R. P., Shewade, D. G., Sundaram, R., Muthuramalingam, 
A., & Paul, A. (2016). Evaluation of interleukin‐6 and serotonin as biomarkers to 
predict response to fluoxetine. Human Psychopharmacology: Clinical and 
Experimental, 31(3), 178–184. 
Manyonda, I. T., Slater, D. M., Fenske, C., Hole, D., Choy, M. Y., & Wilson, C. (1998). 
A role for noradrenaline in pre‐eclampsia: towards a unifying hypothesis for the 
pathophysiology. BJOG: An International Journal of Obstetrics & Gynaecology, 
105(6), 641–648. 
Marchand, A., Juster, R. P., Lupien, S. J., & Durand, P. (2016). Psychosocial 
determinants of diurnal alpha-amylase among healthy Quebec workers. 
Psychoneuroendocrinology, 66, 65–74.  
Marcus, S. (2009). Depression during pregnancy: rates, risks, and consequences - 
motherisk update 2008. Can J Clin Pharmacol, 16(1), e15-22.  
Markert, U. R., Morales-Prieto, D. M., & Fitzgerald, J. S. (2011). Understanding the link 
between the IL-6 cytokine family and pregnancy: implications for future 
therapeutics. Expert Review of Clinical Immunology, 7(5), 603–609. 
Marsland, A. L., Walsh, C., Lockwood, K., & John-henderson, N. A. (2017). The effects 
of acute psychological stress on circulating and stimulated inflammatory markers: 
A systematic review and meta- analysis. Brain Behavior and Immunity, 64, 208–
219.  
Marzi, M., Vigano,  a, Trabattoni, D., Villa, M. L., Salvaggio,  a, Clerici, E., & Clerici, M. 
(1996). Characterization of type 1 and type 2 cytokine production profile in 
409 
 
physiologic and pathologic human pregnancy. Clinical and Experimental 
Immunology, 106(1), 127–133.  
Mastorakos, G., & Ilias, I. (2003). Maternal and fetal hypothalamic-pituitary-adrenal 
axes during pregnancy and postpartum. Annals of the New York Academy of 
Sciences, 997, 136–149.  
Mastorci, F., Vicentini, M., Viltart, O., Manghi, M., Graiani, G., Quaini, F., … Sgoifo, A. 
(2009). Long-term effects of prenatal stress: changes in adult cardiovascular 
regulation  and sensitivity to stress. Neuroscience and Biobehavioral Reviews, 
33(2), 191–203.  
Mattes, E., McCarthy, S., Gong, G., van Eekelen, J. A. M., Dunstan, J., Foster, J., & 
Prescott, S. L. (2009). Maternal mood scores in mid-pregnancy are related to 
aspects of neonatal immune function. Brain, Behavior, and Immunity, 23(3), 380–
388.  
McCalla, C. O., Nacharaju, V. L., Muneyyirci-Delale, O., Glasgow, S., & Feldman, J. G. 
(1998). Placental 11β-hydroxysteroid dehydrogenase activity in normotensive and 
pre-eclamptic pregnancies. Steroids, 63(10), 511–515. 
McGowan, P. O., & Matthews, S. G. (2018). Prenatal stress, glucocorticoids, and 
developmental programming of the stress response. Endocrinology, 159(1), 69–
82.  
McLean, M., & Smith, R. (2001). Corticotrophin-releasing hormone and human 
parturition. Reproduction, 121(4), 493–501. 
Meaney, M. J. (2001). Maternal care, gene expression, and the transmission of 
individual differences in stress reactivity across generations. Annual Review of 
Neuroscience, 24, 1161–1192.  
Meek, L. R., Dittel, P. L., Sheehan, M. C., Chan, J. Y., & Kjolhaug, S. R. (2001). 
Effects of stress during pregnancy on maternal behavior in mice. Physiology & 
Behavior, 72(4), 473–479. 
410 
 
Meinlschmidt, G., Heim, C. (2007). Sensitivity to intranasal oxytocin in adult men after 
early parental separation. Biol. Psychiatry 61, 1109–1111. 
Melville, J. L., Gavin, A., Guo, Y., Fan, M.-Y., & Katon, W. J. (2010). Depressive 
disorders during pregnancy: prevalence and risk factors in a large urban sample. 
Obstetrics and Gynecology, 116(5), 1064–1070.  
Mercer, B. M., Thorp, J. M., Sullivan, M. J. O., Ramin, M., Carpenter, M. W., Rouse, D. 
J., & Sibai, B. (2010). Risk Factors for Preterm Birth < 32 Weeks and. Health 
(San Francisco), 27(8), 631–640.  
Mericq V, Medina P, Kakarieka E, et al. (2009). Differences in expression and activity 
of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of 
term pregnancies according to birth weight and gender. Eur J Endocrinol., 161, 
419–425. 
Merlot, E., Couret, D., & Otten, W. (2008). Prenatal stress, fetal imprinting and 
immunity. Brain, Behavior, and Immunity, 22(1), 42–51.  
Metcalfe, N. B., & Monaghan, P. (2001). Compensation for a bad start: Grow now, pay 
later? Trends in Ecology and Evolution, 16(5), 254–260.  
Meyer, U., Feldon, J., Schedlowski, M., & Yee, B. K. (2006). Immunological stress at 
the maternal–foetal interface: A link between neurodevelopment and adult 
psychopathology. Brain, Behavior, and Immunity, 20(4), 378–388.  
Meyer, U., Nyffeler, M., Yee, B. K., Knuesel, I., & Feldon, J. (2008). Adult brain and 
behavioral pathological markers of prenatal immune challenge during 
early/middle and late fetal development in mice. Brain, Behavior, and Immunity, 
22(4), 469–486. 
Michael, A. E., & Papageorghiou, A. T. (2008). Potential significance of physiological 
and pharmacological glucocorticoids in early pregnancy. Human Reproduction 
Update, 14(5), 497–517. 
411 
 
Middeldorp, C.M., Cath, D.C., Van Dyck, R., Boomsma, D.I. (2005). The co-morbidity 
of anxiety and depression in the perspective of genetic epidemiology. A review of 
twin and family studies. Psychol Med. 35(5), 611–24. . 
Milgrom, J., Holt, C., Holt, C. J., Ross, J., Ericksen, J., & Gemmill, A. W. (2015). 
Feasibility study and pilot randomised trial of an antenatal depression treatment 
with infant follow-up. Archives of Women’s Mental Health, 18(5), 717–730.  
Miller, A. H., & Raison, C. L. (2015). Are anti-inflammatory therapies viable treatments 
for psychiatric disorders? where the rubber meets the road. JAMA Psychiatry, 
72(6), 527–528. 
Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: from 
evolutionary imperative to modern treatment target. Nature Reviews Immunology, 
16(1), 22–34. 
Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and Its Discontents: The 
Role of Cytokines in the Pathophysiology of Major Depression. Biological 
Psychiatry, 65(9), 732–741. 
Miller, A. R., Barr, R. G., & Eaton, W. O. (1993). Crying an Motor Behavior of Six-
Week-Old Infants and Postpartum Maternal Mood. Pediatrics, 92(4), 551 LP-558.  
Miller, G. E., Chen, E., & Zhou, E. S. (2007). If it goes up, must it come down? Chronic 
stress and the hypothalamic-pituitary-adrenocortical axis in 
humans. Psychological bulletin, 133(1), 25. 
Miller, G. E., Cohen, S., & Ritchey, A. K. (2002). Chronic psychological stress and the 
regulation of pro-inflammatory cytokines: A glucocorticoid-resistance model. 
Health Psychology, 21(6), 531–541.  
Miller, G. E., Culhane, J., Grobman, W., Simhan, H., Williamson, D. E., Adam, E. K., 
… Borders, A. (2017). Mothers’ childhood hardship forecasts adverse pregnancy 
outcomes: Role of inflammatory, lifestyle, and psychosocial pathways. Brain, 
Behavior, and Immunity, 65, 11–19.  
412 
 
Miller, G. E., Miller, G. E., Blackwell, E., & Blackwell, E. (2006). Turning Up the Heat. 
Heart Disease, 15(6), 269–272.  
Miller, L., Chan, W., Comfort, K., & Tirella, L. (2005). Health of children adopted from 
Guatemala: comparison of orphanage and foster care. Pediatrics, 115(6), e710–
e717. 
Miller, N. M., Fisk, N. M., Modi, N., & Glover, V. (2005). Stress responses at birth: 
determinants of cord arterial cortisol and links with cortisol response in infancy. 
BJOG: An International Journal of Obstetrics & Gynaecology, 112(7), 921–926. 
Mills-Koonce, W. R., Willoughby, M. T., Zvara, B., Barnett, M., Gustafsson, H., Cox, M. 
J., & Investigators,  the F. L. P. K. (2015). Mothers’ and Fathers’ Sensitivity and 
Children’s Cognitive Development in Low-Income, Rural Families. J Appl Dev 
Psychol, 38, 1–10.  
Mina, T. H., Räikkönen, K., Riley, S. C., Norman, J. E., & Reynolds, R. M. (2015). 
Maternal distress associates with placental genes regulating fetal glucocorticoid 
exposure and IGF2: Role of obesity and sex. Psychoneuroendocrinology, 59, 
112–122.  
Mitchell, A. M., Palettas, M., & Christian, L. M. (2017). Fetal sex is associated with 
maternal stimulated cytokine production, but not serum cytokine levels, in human 
pregnancy. Brain, behavior, and immunity, 60, 32-37. 
Mizokami, T., Wu Li, A., El-Kaissi, S., & Wall, J. R. (2004). Stress and thyroid 
autoimmunity. Thyroid, 14(12), 1047–1055. 
Moghaddam Banaem, L., Mohamadi, B., Asghari Jaafarabadi, M., & Aliyan 
Moghadam, N. (2012). Maternal serum C‐reactive protein in early pregnancy and 
occurrence of preterm premature rupture of membranes and preterm birth. 
Journal of Obstetrics and Gynaecology Research, 38(5), 780–786. 
Monaghan, P., & Haussmann, M. F. (2015). The positive and negative consequences 
of stressors during early life. Early Human Development, 91(11), 643–647. 
413 
 
Monk, C., Fifer, W. P., Myers, M. M., Bagiella, E., Duong, J. K., Chen, I. S., … 
Altincatal, A. (2011). Effects of maternal breathing rate, psychiatric status, and 
cortisol on fetal heart rate. Developmental Psychobiology, 53(3), 221–233.  
Monk, C., Newport, D. J., Korotkin, J. H., Long, Q., Knight, B., & Stowe, Z. N. (2012). 
Uterine blood flow in a psychiatric population: Impact of maternal depression, 
anxiety, and psychotropic medication. Biological Psychiatry, 72(6), 483–490.  
Monk, C., Sloan, R. P., Myers, M. M., Ellman, L., Werner, E., Jeon, J., … Fifer, W. P. 
(2004). Fetal heart rate reactivity differs by women’s psychiatric status: An early 
marker for developmental risk? Journal of the American Academy of Child and 
Adolescent Psychiatry, 43(3), 283–290.  
Monk, C., Spicer, J., & Champagne, F. A. (2012). Linking prenatal maternal adversity 
to developmental outcomes in infants : The Role of Epigenetic Pathways. Dev 
Psychopathol., 24(4), 1361–1376.  
Monroe, S. M., & Simons, A. D. (1991). Diathesis-stress theories in the context of life 
stress research: implications for the depressive disorders. Psychological Bulletin, 
110(3), 406. 
Mor, G., Cardenas, I., Abrahams, V., & Guller, S. (2011). Inflammation and pregnancy: 
the role of the immune system at the implatation site, 1221(1), 80–87.  
Moran, M. D. (2003). Arguments for rejecting the sequential Bonferroni in ecological 
studies. Oikos, 100(2), 403-405. 
Moret, C., & Briley, M. (2011). The importance of norepinephrine in depression. 
Neuropsychiatric Disease and Treatment, 7(SUPPL.), 9–13.  
Morgan, C. D., Sandler, M., & Panigel, M. (1972). Placental transfer of catecholamines 
in vitro and in vivo. American Journal of Obstetrics & Gynecology, 112(8), 1068–
1075. 
Moriceau, S., & Sullivan, R. M. (2006). Maternal presence serves as a switch between 
learning fear and attraction in infancy. Nature Neuroscience, 9(8), 1004–1006. 
414 
 
Morilak, D. A., Barrera, G., Echevarria, D. J., Garcia, A. S., Hernandez, A., Ma, S., & 
Petre, C. O. (2005). Role of brain norepinephrine in the behavioral response to 
stress. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29(8), 
1214–1224. 
Morrison, J., Pikhart, H., Ruiz, M., & Goldblatt, P. (2014). Systematic review of 
parenting interventions in European countries aiming to reduce social inequalities 
in children ’ s health and development. BMC Public Health, 14(1040), 1–13. 
Moss, K. M., Simcock, G., Cobham, V., Kildea, S., Elgbeili, G., Laplante, D. P., & King, 
S. (2017). A potential psychological mechanism linking disaster-related prenatal 
maternal stress with child cognitive and motor development at 16 months: The 
QF2011 Queensland Flood Study. Developmental Psychology, 53(4), 629–641.  
Mousa, A., SeigerA, Kjaeldgaard, A., & Bakhiet, M. (1999). Human first trimester 
forebrain cells express genes for inflammatory and anti-inflammatory cytokines. 
Cytokine, 11(1), 55–60. 
Muhammad, A., & Kolb, B. (2011). Mild prenatal stress-modulated behavior and 
neuronal spine density without affecting amphetamine sensitization. 
Developmental Neuroscience, 33(2), 85–98.  
Murgatroyd, C., Quinn, J. P., Sharp, H. M., Pickles, A., & Hill, J. (2015). Effects of 
prenatal and postnatal depression, and maternal stroking, at the glucocorticoid 
receptor gene. Translational psychiatry, 5(5), e560. 
Murphy, V. E., & Clifton, V. L. (2003). Alterations in human placental 11beta-
hydroxysteroid dehydrogenase type 1 and 2 with gestational age and labour. 
Placenta, 24(7), 739–744. 
Murphy, V. E., Gibson, P. G., Giles, W. B., Zakar, T., Smith, R., Bisits, A. M., … 
Clifton, V. L. (2003). Maternal asthma is associated with reduced female fetal 




Murphy, V. E., Smith, R., Giles, W. B., & Clifton, V. L. (2006). Endocrine regulation of 
human fetal growth: the role of the mother, placenta, and fetus. Endocrine 
Reviews, 27(2), 141–169. 
Murray, D., & Cox, J. L. (1990). Screening for depression during pregnancy with the 
edinburgh depression scale (EDDS). Journal of Reproductive and Infant 
Psychology, 8(2), 99–107.  
Murray, L., Halligan, S. L., Goodyer, I., & Herbert, J. (2010). Disturbances in early 
parenting of depressed mothers and cortisol secretion in offspring: a preliminary 
study. Journal of Affective Disorders, 122(3), 218–223. 
Mychasiuk, R., Gibb, R., & Kolb, B. (2011). Prenatal bystander stress induces 
neuroanatomical changes in the prefrontal cortex and hippocampus of developing 
rat offspring. Brain Research, 1412, 55–62.  
Nachmias, M., Gunnar, M., Mangelsdorf, S., Parritz, R. H., & Buss, K. (1996). 
Behavioral inhibition and stress reactivity: The moderating role of attachment 
security. Child development, 67(2), 508-522. 
Nakagawa, S. (2004). A farewell to Bonferroni: the problems of low statistical power 
and publication bias. Behavioral ecology, 15(6), 1044-1045. 
Nakamura, T., Matsumine, A., Matsubara, T., Asanuma, K., Uchida, A., & Sudo, A. 
(2012). Clinical significance of pretreatment serum C‐reactive protein level in soft 
tissue sarcoma. Cancer, 118(4), 1055–1061. 
Nater, U. M., & Rohleder, N. (2009). Salivary alpha-amylase as a non-invasive 
biomarker for the sympathetic nervous system: Current state of research. 
Psychoneuroendocrinology, 34(4), 486–496.  
Nater, U. M., La Marca, R., Florin, L., Moses, A., Langhans, W., Koller, M. M., & 
Ehlert, U. (2006). Stress-induced changes in human salivary alpha-amylase 




Nater, U. M., Rohleder, N., Schlotz, W., Ehlert, U., & Kirschbaum, C. (2007). 
Determinants of the diurnal course of salivary alpha-amylase. 
Psychoneuroendocrinology, 32(4), 392–401.  
Natrasony, C., & Teitelbaum, D. (2016). Watch Me Move: A Program For Parents of 
Young Children With Gross-Motor Delays. Physical and Occupational Therapy in 
Pediatrics, 36(4), 388–400.  
Nederfors, T., & Dahlöf, C. (1996). Effects on salivary flow rate and composition of 
withdrawal of and re‐exposure to the β1‐selective antagonist metoprolol in a 
hypertensive patient population. European Journal of Oral Sciences, 104(3), 262–
268. 
Nederhof, E., & Schmidt, M. V. (2012). Physiology & Behavior Mismatch or cumulative 
stress : Toward an integrated hypothesis of programming effects. Physiology & 
Behavior, 106(5), 691–700.  
Nelson, K. B., & Willoughby, R. E. (2000). Infection, inflammation and the risk of 
cerebral palsy. Current Opinion in Neurology, 13(2), 133–139. 
Nelson, K. B., & Willoughby, R. E. (2002). Overview: infection during pregnancy and 
neurologic outcome in the child. Mental Retardation and Developmental 
Disabilities Research Reviews, 8(1), 1–2. 
Netsi, E., Evans, J., Wulff, K., O’Mahen, H., & Ramchandani, P. G. (2015). Infant 
outcomes following treatment of antenatal depression: Findings from a pilot 
randomized controlled trial. Journal of Affective Disorders, 188, 252–256.  
NI Dieter  Maria Hernandez-Reif, Nancy A. Jones, JP Lecanuet, FA Salman, 
Mercedes Redzepi, J, T. F. (2001). Maternal depression and increased fetal 
activity. Journal of Obstetrics and Gynaecology, 21(5), 468–473. 
Nierop, A., Bratsikas, A., Klinkenberg, A., Nater, U. M., Zimmermann, R., & Ehlert, U. 
(2006). Prolonged salivary cortisol recovery in second-trimester pregnant women 
and attenuated salivary a-amylase responses to psychosocial stress in human 
417 
 
pregnancy. Journal of Clinical Endocrinology and Metabolism, 91(4), 1329–1335. 
h 
Nierop, A., Bratsikas, A., Zimmermann, R., & Ehlert, U. (2006). Are stress-induced 
cortisol changes during pregnancy associated with postpartum depressive 
symptoms? Psychosomatic Medicine, 68(6), 931–937.  
Nikolaos, B., Marina, E., Christos, T., Sotirios, K., Eleftheria, T., & Charalambos, P. 
(2016). Assessment of intelligence with Raven and WAIS in patients with 
psychosis, (August), 72–74. 
Nilsonne, G., Lekander, M., Åkerstedt, T., Axelsson, J., & Ingre, M. (2016). Diurnal 
variation of circulating interleukin-6 in humans: A meta-analysis. PLoS ONE, 
11(11), 1–17.  
Nisell, H., Hjemdahl, P., & Linde, B. (1985). Cardiovascular responses to circulating 
catecholamines in normal pregnancy and in pregnancy‐induced hypertension. 
Clinical Physiology, 5(5), 479–493. 
Nomura, Y., Finik, J., Salzbank, J., Ly, J., Huynh, N., Davey, T., … Daniel, R. (2014). 
The Effects of Preeclampsia on Perinatal Risks and Infant Temperaments Among 
Mothers With Antenatal Depression. Psychology Research, 4(6). 
Noorlander, C. W., De Graan, P. N. E., Middeldorp, J., Van Beers, J., & Visser, G. H. 
A. (2006). Ontogeny of hippocampal corticosteroid receptors: effects of antenatal 
glucocorticoids in human and mouse. Journal of Comparative Neurology, 499(6), 
924–932. 
Norhayati, M. N., Nik Hazlina, N. H., Asrenee, A. R., & Wan Emilin, W. M. A. (2015). 
Magnitude and risk factors for postpartum symptoms: A literature review. Journal 
of Affective Disorders, 175, 34–52.  
Noto, Y., Sato, T., Kudo, M., Kurata, K., & Hirota, K. (2005). The relationship between 
salivary biomarkers and state-trait anxiety inventory score under mental 
arithmetic stress: a pilot study. Anesthesia & Analgesia, 101(6), 1873–1876. 
418 
 
Nulman, I., Koren, G., Rovet, J., Barrera, M., Pulver, A., Streiner, D., & Feldman, B. 
(2012). Neurodevelopment of children following prenatal exposure to venlafaxine, 
selective serotonin reuptake inhibitors, or untreated maternal depression. 
American Journal of Psychiatry, 169(11), 1165–1174 10p. 
O' Connor, T. G. , Heron, J., Golding, J., Beveridge, M., & Glover, V. T. E. (2002). 
Maternal antenatal anxiety and children ’ s behavioural / emotional problems at 4 
years : Report from the Avon Longitudinal Study of Parents and Children Maternal 
antenatal anxiety and children ’ s behavioural / emotional problems at 4 years 
Report from. The British Journal of Psychiatry, 180, 502–508.  
O’Brien, T. C., Mustanski, B. S., Skol, A., Cook, E. H., & Wakschlag, L. S. (2013). Do 
dopamine gene variants and prenatal smoking interactively predict youth 
externalizing behavior? Neurotoxicology and Teratology, 40, 67–73.  
O’Connor, T. G., Ben-Shlomo, Y., Heron, J., Golding, J., Adams, D., & Glover, V. 
(2005). Prenatal anxiety predicts individual differences in cortisol in pre-
adolescent children. Biological Psychiatry, 58(3), 211–217.  
O’Connor, T. G., Bergman, K., Sarkar, P., & Glover, V. (2013). Prenatal cortisol 
exposure predicts infant cortisol response to acute stress. Developmental 
Psychobiology, 55(2).  
O’Connor, T. G., Heron, J., & Glover, V. (2002). Antenatal anxiety predicts child 
behavioral/emotional problems independently of postnatal depression. Journal of 
the American Academy of Child and Adolescent Psychiatry, 41(12), 1470–1477.  
O’Connor, T. G., Monk, C., & Fitelson, E. M. (2014). Practitioner Review: Maternal 
mood in pregnancy and child development - Implications for child psychology and 
psychiatry. Journal of Child Psychology and Psychiatry and Allied Disciplines, 
55(2), 99–111.  
O’Connor, T. G., Tang, W., Gilchrist, M. A., Moynihan, J. A., Pressman, E. K., & 
Blackmore, E. R. (2014). Diurnal cortisol patterns and psychiatric symptoms in 
pregnancy: Short-term longitudinal study. Biological Psychology, 96(1), 35–41.  
419 
 
O’Donnell, K. J., & Meaney, M. J. (2017). Fetal origins of mental health: The 
developmental origins of health and disease hypothesis. American Journal of 
Psychiatry, 174(4), 319–328. 
O’Donnell, K. J., Bugge Jensen, A., Freeman, L., Khalife, N., O’Connor, T. G., & 
Glover, V. (2012). Maternal prenatal anxiety and downregulation of placental 11β-
HSD2. Psychoneuroendocrinology, 37(6), 818–826.  
O’Donnell, K. J., Glover, V., Barker, E. D., & O’Connor, T. G. (2014). The persisting 
effect of maternal mood in pregnancy on childhood psychopathology. 
Development and Psychopathology, 26(2), 393–403. 
O’Donnell, K. J., Glover, V., Jenkins, J., Browne, D., Ben-Shlomo, Y., Golding, J., & 
O’Connor, T. G. (2013). Prenatal maternal mood is associated with altered 
diurnal cortisol in adolescence. Psychoneuroendocrinology, 38(9), 1630–1638.  
O’Donnell, K., O’Connor, T. G., & Glover, V. (2009). Prenatal stress and 
neurodevelopment of the child: Focus on the HPA axis and role of the placenta. 
Developmental Neuroscience, 31(4), 285–292.  
O’Keane, V., Lightman, S., Patrick, K., Marsh, M., Papadopoulos, A. S., Pawlby, S., … 
Moore, R. (2011). Changes in the maternal hypothalamic-pituitary-adrenal axis 
during the early puerperium may be related to the postpartum “blues.” Journal of 
Neuroendocrinology, 23(11), 1149–1155.  
O’Leary, U., Rusch, K. M., & Guastello, S. J. (1991). Estimating age‐stratified WAIS‐R 
IQS from scores on the raven’s standard progressive matrices. Journal of Clinical 
Psychology, 47(2), 277–284. 
O’Neil, A., Itsiopoulos, C., Skouteris, H., Opie, R. S., McPhie, S., Hill, B., & Jacka, F. 
N. (2014). Preventing mental health problems in offspring by targeting dietary 
intake of pregnant women. BMC Medicine, 12(1), 208. 
Obel, C., Hedegaard, M., Henriksen, T. B., Secher, N. J., Olsen, J., & Levine, S. 
(2005). Stress and salivary cortisol during pregnancy. 
Psychoneuroendocrinology, 30(7), 647–656.  
420 
 
Oberlander, T. F., Weinberg, J., Papsdorf, M., Grunau, R., Misri, S., & Devlin, A. M. 
(2008). Prenatal exposure to maternal depression, neonatal methylation of 
human glucocorticoid receptor gene (NR3C1) and infant cortisol stress 
responses. Epigenetics, 3(2), 97–106.  
Ohno, Y., Kitamura, H., Takahashi, N., Ohtake, J., Kaneumi, S., Sumida, K., … 
Shibasaki, S. (2016). IL-6 down-regulates HLA class II expression and IL-12 
production of human dendritic cells to impair activation of antigen-specific CD4+ T 
cells. Cancer Immunology, Immunotherapy, 65(2), 193–204. 
Okano, & Nomura. (1992). Endocrine Study of Ti-Ie Maternity Blues, 932, 921–932. 
Okun, M. L., Krafty, R. T., Buysse, D. J., Monk, T. H., Reynolds III, C. F., Begley, A., & 
Hall, M. (2010). What constitutes too long of a delay? Determining the cortisol 
awakening response (CAR) using self-report and PSG-assessed wake time. 
Psychoneuroendocrinology, 35(3), 460–468. 
Okun, M. L., Luther, J. F., Wisniewski, S. R., & Wisner, K. L. (2013a). Disturbed sleep 
and inflammatory cytokines in depressed and nondepressed pregnant women: 
An exploratory analysis of pregnancy outcomes. Psychosomatic Medicine, 75(7), 
670–681.  
Olson, S. L., Sameroff, A. J., Kerr, D. C. R., Lopez, N. L., & Wellman, H. M. (2005). 
Developmental foundations of externalizing problems in young children: The role 
of effortful control. Development and Psychopathology, 17(1), 25–45. 
Osborne, L. M., & Monk, C. (2013). Perinatal depression-The fourth inflammatory 
morbidity of pregnancy?. Theory and literature review. 
Psychoneuroendocrinology, 38(10), 1929–1952. 
Osborne, S., Biaggi, A., Chua, T. E., Du Preez, A., Hazelgrove, K., Nikkheslat, N., … 
Pariante, C. M. (2018). Antenatal depression programs cortisol stress reactivity in 
offspring through increased maternal inflammation and cortisol in pregnancy: The 




Otte, C., Hinkelmann, K., Moritz, S., Yassouridis, A., Jahn, H., Wiedemann, K., & 
Kellner, M. (2010). Modulation of the mineralocorticoid receptor as add-on 
treatment in depression: a randomized, double-blind, placebo-controlled proof-of-
concept study. Journal of Psychiatric Research, 44(6), 339–346. 
Owen, D., Andrews, M. H., & Matthews, S. G. (2005). Maternal adversity, 
glucocorticoids and programming of neuroendocrine function and behaviour. 
Neuroscience & Biobehavioral Reviews, 29(2), 209–226. 
Pace, T. W. W., Hu, F., & Miller, A. H. (2007). Cytokine-effects on glucocorticoid 
receptor function: Relevance to glucocorticoid resistance and the 
pathophysiology and treatment of major depression. Brain, Behavior, and 
Immunity, 21(1), 9–19.  
Pace, T. W. W., Mletzko, T. C., Alagbe, O., Musselman, D. L., Nemeroff, C. B., Miller, 
A. H., & Heim, C. M. (2006). Increased stress-induced inflammatory responses in 
male patients with major depression and increased early life stress. American 
Journal of Psychiatry, 163(9), 1630–1633. 
Pacheco, A., & Figueiredo, B. (2012). Mother’s depression at childbirth does not 
contribute to the effects of antenatal depression on neonate’s behavioral 
development. Infant Behavior and Development, 35(3), 513–522.  
Palma-Gudiel, H., Córdova-Palomera, A., Leza, J. C., & Fananás, L. (2015). 
Glucocorticoid receptor gene (NR3C1) methylation processes as mediators of 
early adversity in stress-related disorders causality: a critical review. 
Neuroscience & Biobehavioral Reviews, 55, 520–535. 
Papageorgiou, K. A., & Ronald, A. (2013). “He who sees things grow from the 
beginning will have the finest view of them” A systematic review of genetic 




Pardon, M.-C., Gérardin, P., Joubert, C., Pérez-Diaz, F., & Cohen-Salmon, C. (2000). 
Influence of prepartum chronic ultramild stress on maternal pup care behavior in 
mice. Biological Psychiatry, 47(10), 858–863. 
Pariante, C. M. (2017). Why are depressed patients inflamed? A reflection on 20 years 
of research on depression, glucocorticoid resistance and inflammation. European 
Neuropsychopharmacology, 27(6), 554–559.  
Parry, B. L., Sorenson, D. L., Meliska, C. J., Basavaraj, N., Zirpoli, G. G., Gamst, A., & 
Hauger, R. (2003). Hormonal Basis of Mood and Postpartum Disorders. Current 
Women’s Health Reports, 3(July), 230–235. 
Patin, V., Lordi, B., Vincent, A., Thoumas, J. ., Vaudry, H., & Caston, J. (2002). Effects 
of prenatal stress on maternal behavior in the rat. Developmental Brain 
Research, 139(1), 1–8.  
Pauli-Pott, U., Mertesacker, B., & Beckmann, D. (2004). Predicting the development of 
infant emotionality from maternal characteristics. Development and 
Psychopathology, 16(1), 19–42. 
Pawlby, S., Hay, D. F., Sharp, D., Waters, C. S., & O’Keane, V. (2009). Antenatal 
depression predicts depression in adolescent offspring: Prospective longitudinal 
community-based study. Journal of Affective Disorders, 113(3), 236–243.  
Pawlby, S., Hay, D., Sharp, D., Cerith S, W., & Pariante, C. M. (2011). Antenatal 
depression and offspring psychopathology: The influence of childhood 
maltreatment. British Journal of Psychiatry, 199(2), 106–112.  
Pearson, R. M., Evans, J., Kounali, D., Lewis, G., Heron, J., Ramchandani, P., … 
Stein,  a. (2013). Maternal depression during pregnancy and the postnatal period: 
risks and possible mechanisms for offspring depression at 18 years. JAMA 
Psychiatry, 70(12), 1312–1319.  
Pedersen, C. A., Stern, R. A., Pate, J., Senger, M. A., Bowes, W. A., & Mason, G. A. 
(1993). Thyroid and adrenal measures during late pregnancy and the puerperium 
423 
 
in women who have been major depressed or who become dysphoric 
postpartum. Journal of Affective Disorders, 29(2–3), 201–211.  
Pedrabissi, L., & Santinello, M. (1989). Inventario per l’ansia di «Stato» e di «Tratto»: 
nuova versione italiana dello STAI Forma Y: Manuale. Firenze: Organizzazioni 
Speciali, 44. 
Peer, M., Soares, C., Levitan, R., Streiner, D., & Steiner, M. (2013). Antenatal 
Depression in a Multi-Ethnic , Community Sample of Canadian ... 
CanJPsychiatry, 58(10), 579–587. 
Perneger, T. V. (1998). What's wrong with Bonferroni adjustments. BMI, 316(7139), 
1236-1238. 
Perry, V. H., Nicoll, J. A. R., & Holmes, C. (2010). Microglia in neurodegenerative 
disease. Nature Reviews Neurology, 6(4), 193. 
Petraglia, F., Florio, P., Nappi, C., & Genazzani, A. R. (1996). Peptide signaling in 
human placenta and membranes: autocrine, paracrine, and endocrine 
mechanisms. Endocrine Reviews, 17(2), 156–186.  
Petraglia, F., Potter, E., Cameron, V. A., Sutton, S., Behan, D. P., Woods, R. J., … 
Vale, W. (1993). Corticotropin-releasing factor-binding protein is produced by 
human placenta and intrauterine tissues. The Journal of Clinical Endocrinology & 
Metabolism, 77(4), 919–924. 
Petraglia, F., Sutton, S., Vale, W., & Plotsky, P. (1987). Corticotropin-releasing factor 
decreases plasma luteinizing hormone levels in female rats by inhibiting 
gonadotropin-releasing hormone release into hypophysial-portal circulation. 
Endocrinology, 120(3), 1083–1088. 
Petry, C. J., Ong, K. K., & Dunger, D. B. (2007). Does the fetal genotype affect 
maternal physiology during pregnancy?. Trends in molecular medicine, 13(10), 
414-421. 
Piazze, J., Ruozi-Berretta, A., Di Cioccio, A., & Anceschi, M. (2005). Neonatal length 
and cranial circumference are reduced in human pregnancies at term after 
424 
 
antepartum administration of betamethasone. Journal of Perinatal Medicine, 
33(5), 463–464. 
Pickles, A., Sharp, H., Hellier, J., & Hill, J. (2017). Prenatal anxiety, maternal stroking 
in infancy, and symptoms of emotional and behavioral disorders at 3.5 years. 
European Child and Adolescent Psychiatry, 26(3), 325–334. 
https://doi.org/10.1007/s00787-016-0886-6 
Pine, D. S., Cohen, P., Johnson, J. G., & Brook, J. S. (2002). Adolescent life events as 
predictors of adult depression. Journal of affective disorders, 68(1), 49-57. 
Plant, D. T., Barker, E. D., Waters, C. S., Pawlby, S., & Pariante, C. M. (2013). 
Intergenerational transmission of maltreatment and psychopathology: The role of 
antenatal depression. Psychological Medicine, 43(3), 519–528.  
Plant, D. T., Pawlby, S., Sharp, D., Zunszain, P. A., & Pariante, C. M. (2016). Prenatal 
maternal depression is associated with offspring inflammation at 25 years: a 
prospective longitudinal cohort study. Translational Psychiatry, 6(11), e936-8.  
Plotsky, P. M., & Meaney, M. J. (1993). Early, postnatal experience alters 
hypothalamic corticotropin-releasing factor (CRF) mRNA, median eminence CRF 
content and stress-induced release in adult rats. Molecular Brain Research, 
18(3), 195–200. 
Pluess, M., & Belsky, J. (2011). Prenatal programming of postnatal plasticity? 
Development and Psychopathology, 23(1), 29–38.  
Pluess, M., Bolten, M., Pirke, K.-M., & Hellhammer, D. (2010). Maternal trait anxiety, 
emotional distress, and salivary cortisol in pregnancy. Biological Psychology, 
83(3), 169–175.  
Pluess, M., Velders, F. P., Belsky, J., Van IJzendoorn, M. H., Bakermans-Kranenburg, 
M. J., Jaddoe, V. W. V., … Tiemeier, H. (2011). Serotonin transporter 
polymorphism moderates effects of prenatal maternal anxiety on infant negative 
emotionality. Biological Psychiatry, 69(6), 520–525.  
425 
 
Ponirakis, A., Susman, E. J., & Stifter, C. A. (1998). Negative emotionality and cortisol 
during adolescent pregnancy and its effects on infant health and autonomic 
nervous system reactivity. Developmental Psychobiology: The Journal of the 
International Society for Developmental Psychobiology, 33(2), 163–174. 
Ponzio, N. M., Servatius, R., Beck, K., Marzouk, A., & Kreider, T. I. M. (2007). 
Cytokine levels during pregnancy influence immunological profiles and 
neurobehavioral patterns of the offspring. Annals of the New York Academy of 
Sciences, 1107(1), 118–128. 
Poole, J. A., & Claman, H. N. (2004). Immunology of pregnancy. Clinical Reviews in 
Allergy & Immunology, 26(3), 161–170. 
Posner, J., Cha, J., Roy, A. K., Peterson, B. S., Bansal, R., Gustafsson, H. C., … 
Monk, C. (2016). Alterations in amygdala-prefrontal circuits in infants exposed to 
prenatal maternal depression. Translational Psychiatry, 6(11), e935-8.  
Pringle, K. G., Rae, K., Weatherall, L., Hall, S., Burns, C., Smith, R., … Blackwell, C. 
C. (2015). Effects of maternal inflammation and exposure to cigarette smoke on 
birth weight and delivery of preterm babies in a cohort of Indigenous Australian 
women. Frontiers in Immunology, 6(MAR), 1–7.  
Pruessner, J. C., Kirschbaum, C., Meinlschmid, G., & Hellhammer, D. H. (2003). Two 
formulas for computation of the area under the curve represent measures of total 
hormone concentration versus time-dependent change. 
Psychoneuroendocrinology, 28(7), 916–931. 
Pruessner, J. C., Wolf, O. T., Hellhammer, D. H., Buske-Kirschbaum, A., Von Auer, K., 
Jobst, S., … Kirschbaum, C. (1997). Free cortisol levels after awakening: a 
reliable biological marker for the assessment of adrenocortical activity. Life 
Sciences, 61(26), 2539–2549. 
Putnam, S. P., Helbig, A. L., Gartstein, M. A., Rothbart, M. K., & Leerkes, E. (2014). 
Development and assessment of short and very short forms of the infant behavior 
questionnaire-revised. Journal of Personality Assessment, 96(4), 445–458.  
426 
 
Qiu, A., Anh, T. T., Li, Y., Chen, H., Rifkin-Graboi, A., Broekman, B. F. P., … Meaney, 
M. J. (2015). Prenatal maternal depression alters amygdala functional 
connectivity in 6-month-old infants. Translational Psychiatry, 5(2).  
Qiu, A., Shen, M., Buss, C., Chong, Y. S., Kwek, K., Saw, S. M., … Meaney, M. J. 
(2017). Effects of Antenatal Maternal Depressive Symptoms and Socio-Economic 
Status on Neonatal Brain Development are Modulated by Genetic Risk. Cerebral 
Cortex, 27(5), 3080–3092.  
Qiu, C., Williams, M. A., Calderon-Margalit, R., Cripe, S. M., & Sorensen, T. K. (2009). 
Preeclampsia risk in relation to maternal mood and anxiety disorders diagnosed 
before or during early pregnancy. American Journal of Hypertension, 22(4), 397–
402. 
Quarini, C., Pearson, R. M., Stein, A., Ramchandani, P. G., Lewis, G., & Evans, J. 
(2016). Are female children more vulnerable to the long-term effects of maternal 
depression during pregnancy? Journal of Affective Disorders, 189.  
Quas, J. A., Hong, M., Alkon, A., & Boyce, W. T. (2000). Dissociations between 
psychobiologic reactivity and emotional expression in children. Developmental 
Psychobiology, 37(3), 153–175. 
Raby, K. L., Roisman, G. I., Fraley, R. C., & Simpson, J. A. (2015). The enduring 
predictive significance of early maternal sensitivity: Social and academic 
competence through age 32 years. Child Development, 86(3), 695–708. 
Radesky, J. S., Zuckerman, B., Silverstein, M., Rivara, F. P., Barr, M., Taylor, J. A., … 
Barr, R. G. (2013). Inconsolable Infant Crying and Maternal Postpartum 
Depressive Symptoms. Pediatrics, 131(6), e1857–e1864.  
Rahman, A., Malik, A., Sikander, S., Roberts, C., & Creed, F. (2008). Cognitive 
behaviour therapy-based intervention by community health workers for mothers 
with depression and their infants in rural Pakistan: a cluster-randomised 
controlled trial. The Lancet, 372(9642), 902–909. 
427 
 
Räikkönen, K., Pesonen, A. K., O’Reilly, J. R., Tuovinen, S., Lahti, M., Kajantie, E., … 
Reynolds, R. M. (2015). Maternal depressive symptoms during pregnancy, 
placental expression of genes regulating glucocorticoid and serotonin function 
and infant regulatory behaviors. Psychological Medicine, 45(15), 3217–3226.  
Räikkönen, K., Seckl, J. R., Heinonen, K., Pyhälä, R., Feldt, K., Jones, A., … 
Järvenpää, A.-L. (2010). Maternal prenatal licorice consumption alters 
hypothalamic–pituitary–adrenocortical axis function in children. 
Psychoneuroendocrinology, 35(10), 1587–1593. 
Raison, C. L., & Miller, A. H. (2003). When not enough is too much: the role of 
insufficient glucocorticoid signaling in the pathophysiology of stress-related 
disorders. The American Journal of Psychiatry, 160(9), 1554–1565.  
Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., 
… Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor 
antagonist infliximab for treatment-resistant depression: the role of baseline 
inflammatory biomarkers. JAMA Psychiatry, 70(1), 31–41. 
Rakers, F., Bischoff, S., Schiffner, R., Haase, M., Rupprecht, S., Kiehntopf, M., … 
Schwab, M. (2015). Role of catecholamines in maternal-fetal stress transfer in 
sheep. American Journal of Obstetrics and Gynecology, 213(5), 684.e1-9.  
Rakers, F., Rupprecht, S., Dreiling, M., Bergmeier, C., Witte, O. W., & Schwab, M. 
(2017). Transfer of maternal psychosocial stress to the fetus. Neuroscience and 
Biobehavioral Reviews, in press. https://doi.org/10.1016/j.neubiorev.2017.02.019 
Rantakallio, P., Jones, P., Moring, J., & Von Wendt, L. (1997). Association between 
central nervous system infections during childhood and adult onset schizophrenia 
and other psychoses: a 28-year follow-up. International Journal of Epidemiology, 
26(4), 837–843. 
Rash, J. A., Thomas, J. C., Campbell, T. S., Letourneau, N., Granger, D. A., 
Giesbrecht, G. F., … Singhal, N. (2016). Developmental origins of infant stress 
428 
 
reactivity profiles: A multi-system approach. Developmental Psychobiology, 58(5), 
578–599.  
Rasmussen, J. M., Graham, A. M., Entringer, S., Gilmore, J. H., Styner, M., Fair, D. A., 
… Buss, C. (2018). Maternal Interleukin-6 concentration during pregnancy is 
associated with variation in frontolimbic white matter and cognitive development 
in early life. NeuroImage, (April), 1–11.  
Ratnayake, U., Quinn, T., Walker, D. W., & Dickinson, H. (2013). Cytokines and the 
neurodevelopmental basis of mental illness. Frontiers in Neuroscience, 7(7 OCT), 
1–9.  
Raudenbush, S. W., & Bryk, A. S. (2002). Hierarchical linear models: Applications and 
data analysis methods (Vol. 1). Sage. 
Ravelli, A. C., van der Meulen, J. H., Michels, R. P., Osmond, C., Barker, D. J., Hales, 
C. N., & Bleker, O. P. (1998). Glucose tolerance in adults after prenatal exposure 
to famine. Lancet (London, England), 351(9097), 173–177. 
Raven, J. C., & Court, J. H. (1998). Raven’s progressive matrices and vocabulary 
scales. Oxford pyschologists Press. 
Rayson, H., Bonaiuto, J. J., Ferrari, P. F., & Murray, L. (2017). Early maternal 
mirroring predicts infant motor system activation during facial expression 
observation. Scientific Reports, 7(1), 1–11.  
Redshaw, M., & Henderson, J. (2013). From antenatal to postnatal depression: 
associated factors and mitigating influences. Journal of Women’s Health, 22(6), 
518–525. 
Reynolds, R. M. (2013a). Glucocorticoid excess and the developmental origins of 
disease: Two decades of testing the hypothesis - 2012 Curt Richter Award 
Winner. Psychoneuroendocrinology, 38(1), 1–11.  
Reynolds, R. M. (2013b). Programming Effects of Glucocorticoids. Clinical Obstetrics 
and Gynecology, 56(3), 602–609. 
429 
 
Rezaie, P., Dean, A., Male, D., & Ulfig, N. (2004). Microglia in the cerebral wall of the 
human telencephalon at second trimester. Cerebral Cortex, 15(7), 938–949. 
Rice, D., & Barone, S. (2000). Critical Periods of Vulnerability for the Developing 
Nervous System : Evidence from Humans and Animal Models Birth _. 
Enviornmental Health Perspectives, 108(3). 
Rice, F., Harold, G. T., Boivin, J., Van Den Bree, M., Hay, D. F., & Thapar, A. (2010). 
The links between prenatal stress and offspring development and 
psychopathology: Disentangling environmental and inherited influences. 
Psychological Medicine, 40(2), 335–342.  
Rice, F., Jones, I., & Thapar, A. (2007). The impact of gestational stress and prenatal 
growth on emotional problems in offspring: A review. Acta Psychiatrica 
Scandinavica, 115(3), 171–183. 
Rice, F., Langley, K., Woodford, C., Davey-Smith, G., & Thapar, A. (in press.). 
Identifying the contribution of prenatal risk factors to offspring development and 
psychopathology: what designs to use and a critique of literature on maternal 
smoking and stress in pregnancy. Development and Psychopathology. 
Rifkin-Graboi, A., Bai, J., Chen, H., Hameed, W. B. R., Sim, L. W., Tint, M. T., … Qiu, 
A. (2013). Prenatal maternal depression associates with microstructure of right 
amygdala in neonates at birth. Biological Psychiatry, 74(11), 937–944.  
Rijlaarsdam, J., van IJzendoorn, M. H., Verhulst, F. C., Jaddoe, V. W. V, Felix, J. F., 
Tiemeier, H., & Bakermans-Kranenburg, M. J. (2017). Prenatal stress exposure, 
oxytocin receptor gene (OXTR) methylation, and child autistic traits: The 
moderating role of OXTR rs53576 genotype. Autism Research : Official Journal of 
the International Society for Autism Research, 10(3), 430–438.  
Robertson, E., Grace, S., Wallington, T., & Stewart, D. E. (2004). Antenatal risk factors 
for postpartum depression: A synthesis of recent literature. General Hospital 
Psychiatry, 26(4), 289–295.  
430 
 
Rode, J. L., & Kiel, E. J. (2016). The mediated effects of maternal depression and 
infant temperament on maternal role. Archives of Women’s Mental Health, 19(1), 
133–140. 
Roelfsema, V., Gunn, A. J., Fraser, M., Quaedackers, J. S., & Bennet, L. (2005). 
Cortisol and ACTH responses to severe asphyxia in preterm fetal sheep. 
Experimental Physiology, 90(4), 545–555. 
Rohleder, N. (2012). Acute and chronic stress induced changes in sensitivity of 
peripheral inflammatory pathways to the signals of multiple stress systems - 2011 
Curt Richter Award Winner. Psychoneuroendocrinology, 37(3), 307–316.  
Rohleder, N., Aringer, M., & Boentert, M. (2012). Role of interleukin-6 in stress, sleep, 
and fatigue. Annals of the New York Academy of Sciences, 1261(1), 88–96.  
Rohleder, N., Nater, U. M., Wolf, J. M., Ehlert, U., & Kirschbaum, C. (2004). 
Psychosocial stress‐induced activation of salivary alpha‐amylase: an indicator of 
sympathetic activity? Annals of the New York Academy of Sciences, 1032(1), 
258–263. 
Roomruangwong, C., Kanchanatawan, B., Sirivichayakul, S., Mahieu, B., Nowak, G., & 
Maes, M. (2017). Lower Serum Zinc and Higher CRP Strongly Predict Prenatal 
Depression and Physio-somatic Symptoms, Which All Together Predict Postnatal 
Depressive Symptoms. Molecular Neurobiology, 54(2), 1500–1512.  
Ross, K. M. K., Miller, G., Culhane, J., Grobman, W., Simhan, H. N., Wadhwa, P. D., 
… Borders, A. (2016). Patterns of peripheral cytokine expression during 
pregnancy in two cohorts and associations with inflammatory markers in cord 
blood. American Journal of Reproductive Immunology, 76(5), 406–414.  
Ross, L. E., Grigoriadis, S., Mamisashvili, L., Koren, G., Steiner, M., Dennis, C.-L., … 
Mousmanis, P. (2011). Quality assessment of observational studies in psychiatry: 
an example from perinatal psychiatric research. International Journal of Methods 
in Psychiatric Research, 20(4), 224–234.  
431 
 
Rothbart, M. K. (1991). Temperament. In Explorations in temperament (pp. 61–74). 
Springer. 
Rothbart, M. K., Sheese, B. E., Rueda, M. R., & Posner, M. I. (2011). Developing 
Mechanisms of Self-Regulation in Early Life. Emotion Review, 3(2), 207–213.  
Rothenberger, S. E., Resch, F., Doszpod, N., & Moehler, E. (2011a). Prenatal stress 
and infant affective reactivity at five months of age. Early Human Development, 
87(2), 129–136.  
Rothenberger, S. E., Resch, F., Doszpod, N., & Moehler, E. (2011b). Prenatal stress 
and infant affective reactivity at five months of age. Early Human Development, 
87(2), 129–136.  
Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern epidemiology. 
Rothman, K.J. (1990). No adjustments are needed for multiple comparisons. 
Epidemiology, 1, 43–46. 
Rouse, M. H., & Goodman, S. H. (2014). Perinatal depression influences on infant 
negative affectivity: Timing, severity, and co-morbid anxiety. Infant Behavior and 
Development, 37(4), 739–751.  
Ruiz, R. J., Fullerton, J., Brown, C. E. L., & Schoolfield, J. (2001). Relationships of 
Cortisol, Perceived Stress, Genitourinary Infections, and Fetal Fibronectin to 
Gestational Age at Birth. Biological Research For Nursing, 3(1), 39–48.  
Rusterholz, C., Hahn, S., & Holzgreve, W. (2007). Role of placentally produced 
inflammatory and regulatory cytokines in pregnancy and the etiology of 
preeclampsia. Seminars in Immunopathology, 29(2), 151–162.  
Saif, Z., Hodyl, N. A., Stark, M. J., Fuller, P. J., Cole, T., Lu, N., & Clifton, V. L. (2015). 
Expression of eight glucocorticoid receptor isoforms in the human preterm 
placenta vary with fetal sex and birthweight. Placenta, 36(7), 723-730. 
Saito, S., Umekage, H., Sakamoto, Y., Sakai, M., Tanebe, K., Sasaki, Y., & Morikawa, 
H. (1999). Increased T‐helper‐1‐type immunity and decreased T‐helper‐2‐type 
432 
 
immunity in patients with preeclampsia. American Journal of Reproductive 
Immunology, 41(5), 297–306. 
Salacz, P., Csukly, G., Haller, J., & Valent, S. (2012). Association between subjective 
feelings of distress, plasma cortisol, anxiety, and depression in pregnant women. 
European Journal of Obstetrics Gynecology and Reproductive Biology, 165(2), 
225–230.  
Salaria, S., Chana, G., Caldara, F., Feltrin, E., Altieri, M., Faggioni, F., … Everall, I. P. 
(2006). Microarray analysis of cultured human brain aggregates following cortisol 
exposure: Implications for cellular functions relevant to mood disorders. 
Neurobiology of Disease, 23(3), 630–636.  
Salvolini, E., Di Giorgio, R., Curatola,  a, Mazzanti, L., & Fratto, G. (1998). Biochemical 
modifications of human whole saliva induced by pregnancy. British Journal of 
Obstetrics and Gynaecology, 105(6), 656–660. 
Sameroff, A. J. (1983). Developmental systems: Contexts and evolution. In P. Mussen 
(Ed.), Handbook of Child Psychology. New York, NY: Wiley, 1, 237–294. 
Sameroff, A. J., & Fiese, B. H. (2000). Transactional regulation: The developmental 
ecology of early intervention. Handbook of Early Childhood Intervention, 2, 135–
159. 
Samuelsson, A. M., Öhrn, I., Dahlgren, J., Eriksson, E., Angelin, B., Folkow, B., & 
Holmäng, A. (2004). Prenatal exposure to interleukin-6 results in hypertension 
and increased hypothalamic-pituitary-adrenal axis activity in adult rats. 
Endocrinology, 145(11), 4897–4911.  
Samuelsson, A.-M., Jennische, E., Hansson, H.-A., & Holmang, A. (2006). Prenatal 
exposure to interleukin-6 results in inflammatory neurodegeneration in 
hippocampus with NMDA/GABAA dysregulation and impaired spatial learning. 
American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 290(5), R1345–R1356. 
433 
 
Sanchez, M. M. (2006). The impact of early adverse care on HPA axis development: 
nonhuman primate models. Hormones and Behavior, 50(4), 623–631. 
Sandman, C. A., Buss, C., Head, K., & Davis, E. P. (2015). Fetal exposure to maternal 
depressive symptoms is associated with cortical thickness in late childhood. 
Biological Psychiatry, 77(4), 324–334.  
Sandman, C. A., Davis, E. P., & Glynn, L. M. (2012). Prescient Human Fetuses Thrive. 
Psychol Sci., 23(1), 93–100.  
Sandman, C. A., Glynn, L., Schetter, C. D., Wadhwa, P., Garite, T., Chicz-DeMet, A., 
& Hobel, C. (2006). Elevated maternal cortisol early in pregnancy predicts third 
trimester levels of placental corticotropin releasing hormone (CRH): Priming the 
placental clock. Peptides, 27(6), 1457–1463. 
Sansavini, A., Zavagli, V., Guarini, A., Savini, S., Alessandroni, R., & Faldella, G. 
(2015). Dyadic co-regulation, affective intensity and infant’s development at 12 
months: A comparison among extremely preterm and full-term dyads. Infant 
Behavior and Development, 40, 29–40 
Santucci, A. K., Singer, L. T., Wisniewski, S. R., Luther, J. F., Eng, H. F., Dills, J. L., … 
Wisner, K. L. (2014). Impact of prenatal exposure to serotonin reuptake inhibitors 
or maternal major depressive disorder on infant developmental outcomes. The 
Journal of Clinical Psychiatry, 75(10), 1088–1095.  
Sapolsky, R. M. (1997). The trouble with testosterone. Springer. 
Sarkar, P., Bergman, K., Fisk, N. M., O’Connor, T. G., & Glover, V. (2007). Ontogeny 
of foetal exposure to maternal cortisol using midtrimester amniotic fluid as a 
biomarker. Clinical Endocrinology, 66(5), 636–640. 
Sarkar, S., Tsai, S.-W., Nguyen, T. T., Plevyak, M., Padbury, J. F., & Rubin, L. P. 
(2001). Inhibition of placental 11beta -hydroxysteroid dehydrogenase type 2 by 
catecholamines via alpha -adrenergic signaling. American Journal of Physiology: 
Regulatory, Integrative, and Comparative Physiology, 281(January), R1966-1974.  
434 
 
Sawchenko, P. E., Brown, E. R., Chan, R. K. W., Ericsson, A., Li, H.-Y., Roland, B. L., 
& Kovacs, K. J. (1996). The paraventricular nucleus of the hypothalamus and the 
functional neuroanatomy of visceromotor responses to stress. In Progress in 
brain research (Vol. 107, pp. 201–222).  
Sayal, K., Heron, J., Maughan, B., Rowe, R., & Ramchandani, P. (2014). Infant 
temperament and childhood psychiatric disorder: Longitudinal study. Child: Care, 
Health and Development, 40(2), 292–297.  
Scannapieco, F. A., Torres, G., & Levine, M. J. (1993). Salivary α-amylase: role in 
dental plaque and caries formation. Critical Reviews in Oral Biology & Medicine, 
4(3), 301–307. 
Scheyer, K., & Urizar, G. G. (2016). Altered stress patterns and increased risk for 
postpartum depression among low-income pregnant women. Archives of 
Women’s Mental Health, 19(2), 317–328.  
Schlotz, W., & Phillips, D. I. W. (2009). Fetal origins of mental health: Evidence and 
mechanisms. Brain, Behavior, and Immunity, 23(7), 905–916.  
Schneider, M. L., Roughton, E. C., Koehler, A. J., & Lubach, G. R. (1999). Growth and 
development following prenatal stress exposure in primates: an examination of 
ontogenetic vulnerability. Child Development, 70(2), 263–274. 
Schoof, E., Girstl, M., Frobenius, W., Kirschbaum, M., Repp, R., Knerr, I., … Dötsch, J. 
(2001). Course of placental 11beta-hydroxysteroid dehydrogenase type 2 and 15-
hydroxyprostaglandin dehydrogenase mRNA expression during human gestation. 
European Journal of Endocrinology / European Federation of Endocrine 
Societies, 145, 187–192.  
Schumann, A., Andrack, C., & Bär, K. J. (2017). Differences of sympathetic and 
parasympathetic modulation in major depression. Progress in Neuro-
Psychopharmacology and Biological Psychiatry, 79(July), 324–331.  
435 
 
Schumann, L., Boivin, M., Paquin, S., Lacourse, E., Brendgen, M., Vitaro, F., … Booij, 
L. (2017). Persistence and innovation effects in genetic and environmental factors 
in negative emotionality during infancy: A twin study. PLoS ONE, 12(4), 1–16.  
Schwartz, E. B., Granger, D. A., Susman, E. J., Gunnar, M. R., & Laird, B. (1998). 
Assessing salivary cortisol in studies of child development. Child Development, 
69(6), 1503–1513. 
Schwartz, J., & Morrison, J. L. (2005). Impact and mechanisms of fetal physiological 
programming. American Journal of Physiology. Regulatory, Integrative and 
Comparative Physiology, 288(1), R11-5 
Scrandis, D. A., Langenberg, P., Tonelli, L. H., Sheikh, T. M., Manogura, A. C., 
Alberico, L. a, … Postolache, T. T. (2008). Prepartum Depressive Symptoms 
Correlate Positively with C-Reactive Protein Levels and Negatively with 
Tryptophan Levels: A Preliminary Report. International Journal of Child Health 
and Human Development : IJCHD, 1(2), 167–174.  
Seckl, J. R., & Holmes, M. C. (2007). Mechanisms of disease: Glucocorticoids, their 
placental metabolism and fetal “programming” of adult pathophysiology. Nature 
Clinical Practice Endocrinology and Metabolism, 3(6), 479–488.  
Seckl, J. R., & Meaney, M. J. (2004). Glucocorticoid programming. Annals of the New 
York Academy of Sciences, 1032, 63–84.  
Segerstrom, S. C., & Miller, G. E. (2004). Psychological Stress and the Human 
Immune System: A Meta- Analytic Study of 30 Years of Inquiry. Psychological 
Bulletin, 130(4), 601–630.  
Seifer, R., Schiller, M., Sameroff, A. J., Resnick, S., & Riordan, K. (1996). Attachment, 
maternal sensitivity, and infant temperament during the first year of life. 
Developmental Psychology, 32(1), 12–25.  
Sennstrom, M. B., Ekman, G., Westergren-Thorsson, G., Malmstrom, A., Bystrom, B., 
Endresen, U., … Brauner, A. (2000). Human cervical ripening, an inflammatory 
process mediated by cytokines. Molecular Human Reproduction, 6(4), 375–381. 
436 
 
Seth, S., Lewis, A. J., & Galbally, M. (2016). Perinatal maternal depression and 
cortisol function in pregnancy and the postpartum period: a systematic literature 
review. BMC Pregnancy and Childbirth.  
Seth, S., Lewis, A. J., Saffery, R., Lappas, M., & Galbally, M. (2015). Maternal prenatal 
mental health and placental 11β-HSD2 gene expression: Initial findings from the 
mercy pregnancy and emotionalwellbeing study. International Journal of 
Molecular Sciences, 16(11), 27482–27496.  
Sharp, H., Hill, J., Hellier, J., & Pickles, A. (2015). Maternal antenatal anxiety, 
postnatal stroking and emotional problems in children: Outcomes predicted from 
pre- and postnatal programming hypotheses. Psychological Medicine, 45(2), 
269–283.  
Sharp, H., Pickles, A., Meaney, M., Marshall, K., Tibu, F., & Hill, J. (2012). Frequency 
of Infant Stroking Reported by Mothers Moderates the Effect of Prenatal 
Depression on Infant Behavioural and Physiological Outcomes. PLoS ONE, 
7(10), 1-10. 
Shea, A. K., Streiner, D. L., Fleming, A., Kamath, M. V., Broad, K., & Steiner, M. 
(2007). The effect of depression, anxiety and early life trauma on the cortisol 
awakening response during pregnancy: Preliminary results. 
Psychoneuroendocrinology, 32(8–10), 1013–1020.  
Shelton, M., Schminkey, D., & Groer, M. (2015). Relationships Among Prenatal 
Depression, Plasma Cortisol, and Inflammatory Cytokines. Biol Res Nurs, 17(3), 
295–302.  
Sherer, M. L., Posillico, C. K., & Schwarz, J. M. (2017). An examination of changes in 
maternal neuroimmune function during pregnancy and the postpartum period. 
Brain, Behavior, and Immunity, 66, 201–209.  
Shi, L., Fatemi, S. H., Sidwell, R. W., & Patterson, P. H. (2003). Maternal influenza 
infection causes marked behavioral and pharmacological changes in the 
offspring. Journal of Neuroscience, 23(1), 297–302. 
437 
 
Shimizu, A., Nishiumi, H., Okumura, Y., & Watanabe, K. (2015). Depressive symptoms 
and changes in physiological and social factors 1 week to 4 months postpartum in 
Japan. Journal of Affective Disorders, 179, 175–182.  
Shiner, R. L., Buss, K. A., Mcclowry, S. G., Putnam, S. P., Saudino, K. J., & Zentner, 
M. (2012). What Is Temperament Now? Assessing Progress Temperament 
Research on the Twenty-Fifth Anniversary of Goldsmith et al. Child Development 
Perspectives, 6(4), 436–444.  
Silberg, J. L., San Miguel, V. F., Murrelle, E. L., Prom, E., Bates, J. E., Canino, G., … 
Eaves, L. J. (2005). Genetic and environmental influences on temperament in the 
first year of life: The Puerto Rico Infant Twin Study (PRINTS). Twin Research and 
Human Genetics, 8(4), 328–336. 
Silverman, M. N., & Sternberg, E. M. (2012). Glucocorticoid regulation of inflammation 
and its functional correlates: from HPA axis to glucocorticoid receptor 
dysfunction. Annals of the New York Academy of Sciences, 1261(1), 55–63. 
Silversides, C. K., & Colman, J. M. (2007). Physiological changes in pregnancy. Heart 
Disease in Pregnancy, 2, 6–17. 
Simcock, G., Elgbeili, G., Laplante, D. P., Kildea, S., Cobham, V., Stapleton, H., … 
King, S. (2017). The Effects of Prenatal Maternal Stress on Early Temperament: 
The 2011 Queensland Flood Study. Journal of Developmental and Behavioral 
Pediatrics : JDBP, 38(5), 310–321.  
Simcock, G., Kildea, S., Kruske, S., Laplante, D. P., Elgbeili, G., & King, S. (2018). 
Disaster in pregnancy: midwifery continuity positively impacts infant 
neurodevelopment, QF2011 study. BMC Pregnancy and Childbirth, 18(1), 309. 
https://doi.org/10.1186/s12884-018-1944-5 
Simon, C. D., Adam, E. K., Holl, J. L., Wolfe, K. A., Grobman, W. A., & Borders, A. E. 
B. (2016). Prenatal Stress and the Cortisol Awakening Response in African-
American and Caucasian Women in the Third Trimester of Pregnancy. Maternal 
and Child Health Journal, 20(10), 2142–2149.  
438 
 
Simpson, W., Steiner, M., Coote, M., & Frey, B. N. (2016). Relationship between 
inflammatory biomarkers and depressive symptoms during late pregnancy and 
the early postpartum period: A longitudinal study. Revista Brasileira de 
Psiquiatria, 38(3), 190–196.  
Singer, J. D., Willett, J. B., Singer, J. D., & Willett, J. B. (2003). Doing data analysis 
with the multilevel model for change. Applied Longitudinal Data Analysis: 
Modeling Change and Event Occurrence, 96–97. 
Sjögren, E., Leanderson, P., Kristenson, M., & Ernerudh, J. (2006). Interleukin-6 levels 
in relation to psychosocial factors: studies on serum, saliva, and in vitro 
production by blood mononuclear cells. Brain, Behavior, and Immunity, 20(3), 
270–278. 
Skalkidou, A., Sylvén, S. M., Papadopoulos, F. C., Olovsson, M., Larsson, A., & 
Sundström-Poromaa, I. (2009). Risk of postpartum depression in association with 
serum leptin and interleukin-6 levels at delivery: A nested case-control study 
within the UPPSAT cohort. Psychoneuroendocrinology, 34(9), 1329–1337.  
Skinner, M. K. (2014). A new kind of inheritence. Scientific American, 311(2), 44–51.  
Skogstrand, K., Ekelund, C. K., Thorsen, P., Vogel, I., Jacobsson, B., Nørgaard-
Pedersen, B., & Hougaard, D. M. (2008). Effects of blood sample handling 
procedures on measurable inflammatory markers in plasma, serum and dried 
blood spot samples. Journal of Immunological Methods, 336(1), 78–84.  
Smith, G. D. (2008). Assessing intrauterine influences on offspring health outcomes: 
can epidemiological studies yield robust findings? Basic & Clinical Pharmacology 
& Toxicology, 102(2), 245–256. 
Smith, S. E. P., Li, J., Garbett, K., Mirnics, K., & Patterson, P. H. (2007). Maternal 
immune activation alters fetal brain development through interleukin-6. The 
Journal of Neuroscience : The Official Journal of the Society for Neuroscience, 
27(40), 10695–10702.  
439 
 
Soe, N. N., Wen, D. J., Poh, J. S., Chong, Y. S., Broekman, B. F., Chen, H., … Qiu, A. 
(2018). Perinatal maternal depressive symptoms alter amygdala functional 
connectivity in girls. Human Brain Mapping, 39(2), 680–690.  
Soe, N. N., Wen, D. J., Poh, J. S., Li, Y., Broekman, B. F. P., Chen, H., … Qiu, A. 
(2016). Pre- and post-natal maternal depressive symptoms in relation with infant 
frontal function, connectivity, and behaviors. PLoS ONE, 11(4), 1–17.  
Song, S., Wang, W., & Hu, P. (2009). Famine, death, and madness: schizophrenia in 
early adulthood after prenatal exposure to the Chinese Great Leap Forward 
Famine. Social Science & Medicine (1982), 68(7), 1315–1321.  
Sorrells, S., JR, C., Munhoz, C., & Sapolsky, R. (2016). The Stressed CNS: When 
Glucocorticoids Aggravate Inflammation, 36(5), 1011–1014.  
Spangler, G. (1991). The emergence of adrenocortical circadian function in newborns 
and infants and its relationship to sleep, feeding and maternal adrenocortical 
activity. Early Human Development, 25(3), 197–208. 
Spangler, G., & Grossman, K. (1999). Individual and physiological correlates of 
attachment disorganization in infancy. 
Speirs, R. L., Herring, J., Cooper, W. D., Hardy, C. C., & Hind, C. R. K. (1974). The 
influence of sympathetic activity and isoprenaline on the secretion of amylase 
from the human parotid gland. Archives of Oral Biology, 19(9), 747–752. 
Spielberger, C. D., Gorsuch, R. L., Lushene, R. E., Vagg, P. R., & Jacobs, G. A. 
(1970).State-trait anxiety inventory. Palo Alto. Consulting psychologists press. 
Spijker, A. T., & van Rossum, E. F. C. (2009). Glucocorticoid receptor polymorphisms 
in major depression. Focus on glucocorticoid sensitivity and neurocognitive 
functioning. Annals of the New York Academy of Sciences, 1179, 199–215.  
Spinillo, A., Viazzo, F., Colleoni, R., Chiara, A., Cerbo, R. M., & Fazzi, E. (2004). Two-
year infant neurodevelopmental outcome after single or multiple antenatal 
courses of corticosteroids to prevent complications of prematurity. American 
Journal of Obstetrics and Gynecology, 191(1), 217–224. 
440 
 
St James-Roberts, I., Hurry, J., & Bowyer, J. (1993). Objective confirmation of crying 
durations in infants referred for excessive crying. Archives of Disease in 
Childhood, 68(1), 82–84. 
Stalder, T., Kirschbaum, C., Kudielka, B. M., Adam, E. K., Pruessner, J. C., Wüst, S., 
… Clow, A. (2016). Assessment of the cortisol awakening response : Expert 
consensus guidelines. Psychoneuroendocrinology, 63, 414–432. 
Staneva, A., Bogossian, F., Pritchard, M., & Wittkowski, A. (2015). The effects of 
maternal depression, anxiety, and perceived stress during pregnancy on preterm 
birth: A systematic review. Women and Birth, 28(3), 179–193.  
Steenbergen, M. R., & Jones, B. S. (2002). Modeling multilevel data structures. 
American Journal of Political Science, 218–237. 
Steensberg, A., Fischer, C. P., Keller, C., Moller, K., & Pedersen, B. K. (2003). IL-6 
enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of 
Physiology. Endocrinology and Metabolism, 285(2), E433-7.  
Stein, A., Netsi, E., Lawrence, P. J., Granger, C., Kempton, C., Craske, M. G., … 
Murray, L. (2018). Mitigating the effect of persistent postnatal depression on child 
outcomes through an intervention to treat depression and improve parenting: a 
randomised controlled trial. The Lancet Psychiatry, 5(2), 134–144.  
Stephan, A. H., Barres, B. A., & Stevens, B. (2012). The Complement System: An 
Unexpected Role in Synaptic Pruning During Development and Disease. Annual 
Review of Neuroscience, 35(1), 369–389.  
Steptoe, A., Hamer, M., & Chida, Y. (2007). The effects of acute psychological stress 
on circulating inflammatory factors in humans: A review and meta-analysis. Brain, 
Behavior, and Immunity, 21(7), 901–912. 
Stirrat, L. I., O’Reilly, J. R., Barr, S. M., Andrew, R., Riley, S. C., Howie, A. F., … 
Denison, F. C. (2016). Decreased maternal hypothalamic-pituitary-adrenal axis 
activity in very severely obese pregnancy: associations with birthweight and 
gestation at delivery. Psychoneuroendocrinology, 63, 135–143. 
441 
 
Stonawski, V., Frey, S., Golub, Y., Rohleder, N., Kriebel, J., Goecke, T.W., Fasching, 
P.A., Beckmann, M.W., Kornhuber, J., Kratz, O., Moll, G.H., Heinrich, H., Eichler, 
A. (2019) Associations of prenatal depressive symptoms with DNA methylation of 
HPA axis-related genes and diurnal cortisol profiles in primary school-aged 
children. Dev Psychopathol. ,31(2), 419-431.  
Straley, M. E., Van Oeffelen, W., Theze, S., Sullivan, A. M., O’Mahony, S. M., Cryan, 
J. F., & O’Keeffe, G. W. (2017). Distinct alterations in motor & reward seeking 
behavior are dependent on the gestational age of exposure to LPS-induced 
maternal immune activation. Brain, Behavior, and Immunity, 63, 21–34. 
Straub, R. H., Buttgereit, F., & Cutolo, M. (2005). Benefit of pregnancy in inflammatory 
arthritis. Annals of the Rheumatic Diseases, 64(6), 801–803. 
Stroud, L. R., Papandonatos, G. D., Parade, S. H., Salisbury, A. L., Phipps, M. G., 
Lester, B. M., … Marsit, C. J. (2016). Prenatal Major Depressive Disorder, 
Placenta Glucocorticoid and Serotonergic Signaling, and Infant Cortisol 
Response. Psychosomatic Medicine, 78(9), 979–990.  
Stroustrup, A., Hsu, H.-H., Svensson, K., Schnaas, L., Cantoral, A., González, M. S., 
… Coull, B. A. (2016). Toddler temperament and prenatal exposure to lead and 
maternal depression. Environmental Health, 15(1), 71. 
Suglia, S., Staudenmayer, J., Cohen, S., Bosquet Enlow, M., Rich-Edwards, J., & 
Wright, R. J. (2010). Cumulative Stress and Cortisol Disruption among Black and 
Hispanic Pregnant Women in an Urban Cohort. Psychol Trauma, 2(4), 326–334.  
Suomi, S. J. (1991). Early stress and adult emotional reactivity in rhesus monkeys. 
The Childhood Environment and Adult Disease, 156, 171–183. 
Susman, E. J., Schmeelk, K. H., Worrall, B. K., Granger, D. A., Ponirakis, A., & 
Chrousos, G. P. (1999). Corticotropin-releasing hormone and cortisol: longitudinal 
associations with depression and antisocial behavior in pregnant adolescents. 




Susser, E., Hoek, H., & Brown A. (1998). Neurodevelopmental Disorders after 
Prenatal Famine. American Journal of Epidemiology, 147(3), 213–216.  
Swales, D. A., Winiarski, D. A., Smith, A. K., Stowe, Z. N., Newport, D. J., & Brennan, 
P. A. (2018). Maternal Depression and Cortisol in Early Pregnancy Predict 
Offspring Emotional Reactivity in the Preschool Period, (August 2017).  
Sykes, L., MacIntyre, D. A., Yap, X. J., Teoh, T. G., & Bennett, P. R. (2012). The Th1: 
th2 dichotomy of pregnancy and preterm labour. Mediators of Inflammation, 2012. 
Szegda, K., Markenson, G., Bertone-johnson, E. R., Chasan-, L., & Sciences, H. 
(2014). Depression during pregnancy: a risk factor for adverse neonatal 
outcomes? A critical review of the literature Kathleen. J Matern Fetal Neonatal 
Med, 27(9), 960–967.  
Szelényi, J. (2001). Cytokines and the central nervous system. Brain Research 
Bulletin, 54(4), 329–338. 
Tabachnick, B. G., & Fidell, L. S. (2007). Multilevel linear modeling. Using Multivariate 
Statistics, 781–857. 
Takai, N., Yamaguchi, M., Aragaki, T., Eto, K., Uchihashi, K., & Nishikawa, Y. (2004). 
Effect of psychological stress on the salivary cortisol and amylase levels in 
healthy young adults. Archives of Oral Biology, 49(12), 963–968. 
Talge, N. M., Neal, C., & Glover, V. (2007). Antenatal maternal stress and long-term 
effects on child neurodevelopment: How and why? Journal of Child Psychology 
and Psychiatry and Allied Disciplines, 48(3–4), 245–261.  
Tanaka, T., Narazaki, M., & Kishimoto, T. (2014). IL-6 in Inflammation, Immunity, and 
Disease, 6(Kishimoto 1989), 1–16.  
Tanaka, Y., Ishitobi, Y., Maruyama, Y., Kawano, A., Ando, T., Okamoto, S., … 
Akiyoshi, J. (2012). Salivary alpha-amylase and cortisol responsiveness following 
electrical stimulation stress in major depressive disorder patients. Progress in 
Neuro-Psychopharmacology and Biological Psychiatry, 36(2), 220–224. 
443 
 
Tank, A. W., & Lee Wong, D. (2015). Peripheral and central effects of circulating 
catecholamines. Compr Physiol, 5(1), 1–15. 
Tarabulsy, G. M., Pearson, J., Vaillancourt-Morel, M.-P., Bussières, E.-L., Madigan, S., 
Lemelin, J.-P., … Royer, F. (2014). Meta-analytic findings of the relation between 
maternal prenatal stress and anxiety and child cognitive outcome. Journal of 
Developmental and Behavioral Pediatrics : JDBP, 35(1), 38–43.  
Tarullo, A. R., & Gunnar, M. R. (2006). Child maltreatment and the developing HPA 
axis. Hormones and Behavior, 50(4), 632–639.  
Taylor, A., & Kim-Cohen, J. (2007). Meta-analysis of gene–environment interactions in 
developmental psychopathology. Development and Psychopathology, 19(4), 
1029–1037. 
Taylor, A., Glover, V., Marks, M., & Kammerer, M. (2009). Diurnal pattern of cortisol 
output in postnatal depression. Psychoneuroendocrinology, 34(8), 1184–1188.  
Taylor, A., Littlewood, J., & Adams, D. (1994). Serum Cortisol and Dysphoria Levels 
Are Related in New Mothers to Moods of Elation, 241–247. 
Taylor-Colls, S., & Pasco Fearon, R. M. (2015). The Effects of Parental Behavior on 
Infants’ Neural Processing of Emotion Expressions. Child Development, 86(3), 
877–888.  
Thapar, A., Langley, K., Fowler, T., Rice, F., Turic, D., Whittinger, N., … O’Donovan, 
M. (2005). Catechol O-methyltransferase gene variant and birth weight predict 
early-onset antisocial behavior in children with attention-deficit/hyperactivity 
disorder. Archives of General Psychiatry, 62(11), 1275–1278. 
Tharner, A., Luijk, M. P. C. M., van IJzendoorn, M. H., Bakermans-Kranenburg, M. J., 
Jaddoe, V. W. V, Hofman, A., … Tiemeier, H. (2012). Maternal lifetime history of 
depression and depressive symptoms in the prenatal and early postnatal period 
do not predict infant-mother attachment quality in a large, population-based Dutch 
cohort study. Attachment and Human Development, 14(1), 63–81.  
444 
 
Thayer, K. A., Heindel, J. J., Bucher, J. R., & Gallo, M. A. (2012). Role of 
environmental chemicals in diabetes and obesity: A national toxicology program 
workshop review. Environmental Health Perspectives, 120(6), 779–789.  
Thayer, Z. M., & Kuzawa, C. W. (2014). Early origins of health disparities: Material 
deprivation predicts maternal evening cortisol in pregnancy and offspring cortisol 
reactivity in the first few weeks of life. American Journal of Human Biology, 26(6), 
723– 
Thoma, M. V, Kirschbaum, C., Wolf, J. M., & Rohleder, N. (2012). Acute stress 
responses in salivary alpha-amylase predict increases of plasma norepinephrine. 
Biological Psychology, 91(3), 342–348. 
Thomas, J. C., Letourneau, N., Bryce, C. I., Campbell, T. S., & Giesbrecht, G. F. 
(2017). Biological embedding of perinatal social relationships in infant stress 
reactivity. Developmental Psychobiology, 59(4), 425–435.  
Thompson, L. A., Morgan, G., Unger, C. A., & Covey, L. A. A. (2017). Prenatal 
maternal cortisol measures predict learning and short-term memory performance 
in 3- but not 5-month-old infants. Developmental Psychobiology, 59(6), 723–737.  
Tollenaar, M. S., Beijers, R., Jansen, J., Riksen-Walraven, J. M. A., & De Weerth, C. 
(2011). Maternal prenatal stress and cortisol reactivity to stressors in human 
infants. Stress, 14(1), 53–65. h 
Tottenham, N. (2015). Social scaffolding of human amygdala-mPFC circuit develop- 
ment. Social Neuroscience, 10(5), 489–499 
Tottenham, N. (2017). The Fundamental Role of Early Environments to Developing an 
Emotionally Healthy Brain. Policy Insights from the Behavioral and Brain 
Sciences, 5(1), 98-103. 
Trapolini, T., Ungerer, J. A., & McMahon, C. A. (2008). Maternal depression: Relations 
with maternal caregiving representations and emotional availability during the 
preschool years. Attachment & Human Development, 10(1), 73–90. 
445 
 
Trautman, P., Meyer-Bahlburg, H., Postelnek, J., & New, M. (1995). Effects of early 
prenatal dexamethasone on the cognitive and behavioral development of young 
children: results of a pilot study. Psychoneuroendocrinology, 20(4), 439–449.  
Treyvaud, K., Anderson, V. A., Howard, K., Bear, M., Hunt, R. W., Doyle, L. W., … 
Anderson, P. J. (2009). Parenting Behavior Is Associated With the Early 
Neurobehavioral Development of Very Preterm Children. Pediatrics, 123(2), 555–
561. 
Tse, A. C., Rich-Edwards, J. W., Rifas-Shiman, S. L., Gillman, M. W., & Oken, E. 
(2010). Association of maternal prenatal depressive symptoms with child 
cognition at age 3 years. Paediatric and Perinatal Epidemiology, 24(3), 232–240.  
Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic-pituitary-adrenal axis, 
neuroendocrine factors and stress. Journal of Psychosomatic Research, 53(4), 
865–871. 
Tsubouchi, H., Nakai, Y., Toda, M., Morimoto, K., Chang, Y. S., Ushioda, N., … 
Shimoya, K. (2011). Change of salivary stress marker concentrations during 
pregnancy: Maternal depressive status suppress changes of those levels. Journal 
of Obstetrics and Gynaecology Research, 37(8), 1004–1009. 
Tully, L. A., Arseneault, L., Caspi, A., Moffitt, T. E., & Morgan, J. (2004). Does 
maternal warmth moderate the effects of birth weight on twins’ attention-
deficit/hyperactivity disorder (ADHD) symptoms and low IQ? Journal of 
Consulting and Clinical Psychology, 72(2), 218. 
Tully, L.A., Arseneault, L., Caspi, A., et al (2004). Does maternal warmth moderate the 
effects of birth weight on twins’ attention-deficit/ hyperactivity disorder (ADHD) 
symptoms and low IQ? J Consult Clin Psychol, 72, 218–226. 
Turcotte-Tremblay, A.-M., Lim, R., Laplante, D. P., Kobzik, L., Brunet, A., & King, S. 
(2014). Prenatal maternal stress predicts childhood asthma in girls: project ice 
storm. BioMed Research International, 2014, 201717.  
446 
 
Turner‐Cobb, J. M., Rixon, L., & Jessop, D. S. (2008). A prospective study of diurnal 
cortisol responses to the social experience of school transition in four‐year‐old 
children: Anticipation, exposure, and adaptation. Developmental Psychobiology, 
50(4), 377–389. 
Underwood, L., Waldie, K., D’Souza, S., Peterson, E. R., & Morton, S. (2016). A 
review of longitudinal studies on antenatal and postnatal depression. Archives of 
Women’s Mental Health, 19(5), 711–720.  
Uno, H., Eisele, S., Sakai, A., Shelton, S., Baker, E., DeJesus, O., & Holden, J. (1994). 
Neurotoxicity of glucocorticoids in the primate brain. Hormones and Behavior, 
28(4), 336–348. 
Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013). CRP, IL-6 and depression: A 
systematic review and meta-analysis of longitudinal studies. Journal of Affective 
Disorders, 150(3), 736–744.  
van Bakel, H. J. A., & Riksen-Walraven, J. M. (2002). Parenting and Development of 
One-Year-Olds: Links with Parental, Contextual, and Child Characteristics. Child 
Development, 73(1), 256–273.  
Van Batenburg-Eddes, T., Brion, M. J., Henrichs, J., Jaddoe, V. W. V., Hofman, A., 
Verhulst, F. C., … Tiemeier, H. (2013). Parental depressive and anxiety 
symptoms during pregnancy and attention problems in children: A cross-cohort 
consistency study. Journal of Child Psychology and Psychiatry and Allied 
Disciplines, 54(5), 591–600.  
Van den Bergh, B. R. H. (2011). Developmental programming of early brain and 
behaviour development and mental health: a conceptual framework. 
Developmental Medicine and Child Neurology, 53 Suppl 4, 19–23. 
https://doi.org/10.1111/j.1469-8749.2011.04057.x 
Van Den Bergh, B. R. H., Van Calster, B., Smits, T., Van Huffel, S., & Lagae, L. 
(2008). Antenatal maternal anxiety is related to HPA-axis dysregulation and self-
447 
 
reported depressive symptoms in adolescence: A prospective study on the fetal 
origins of depressed mood. Neuropsychopharmacology, 33(3), 536–545.  
Van den Bergh, B. R. H., van den Heuvel, M. I., Lahti, M., Braeken, M., de Rooij, S. R., 
Entringer, S., … Schwab, M. (2017). Prenatal developmental origins of behavior 
and mental health: The influence of maternal stress in pregnancy. Neuroscience 
and Biobehavioral Reviews, (November) 
Van Dijk, A. E., Van Eijsden, M., Stronks, K., Gemke, R. J. B. J., & Vrijkotte, T. G. M. 
(2012). Prenatal stress and balance of the child’s cardiac autonomic nervous 
system at age 5-6 years. PloS One, 7(1), e30413. 
van Dooren, F. E. P., Schram, M. T., Schalkwijk, C. G., Stehouwer, C. D. A., Henry, R. 
M. A., Dagnelie, P. C., … Sep, S. J. S. (2016). Associations of low grade 
inflammation and endothelial dysfunction with depression–The Maastricht Study. 
Brain, Behavior, and Immunity, 56, 390–396. 
Van Hulle, C., Shirtcliff, E., Lemery-Chalfant, K., & Goldsmith, H. (2012). Genetic and 
environmental influences on individual differences in cortisol level and circadian 
rhythm in middle childhood. Hormones and Behavior, 62(1), 36–42.  
van Stegeren, A., Rohleder, N., Everaerd, W., & Wolf, O. T. (2006). Salivary alpha 
amylase as marker for adrenergic activity during stress: effect of betablockade. 
Psychoneuroendocrinology, 31(1), 137–141. 
Vannuccini, S., Clifton, V. L., Fraser, I. S., Taylor, H. S., Critchley, H., Giudice, L. C., & 
Petraglia, F. (2016). Infertility and reproductive disorders: Impact of hormonal and 
inflammatory mechanisms on pregnancy outcome. Human Reproduction Update, 
22(1),  
Vedhara, K., Metcalfe, C., Brant, H., Crown, A., Northstone, K., Dawe, K., … Smith, G. 
D. (2012). Maternal mood and neuroendocrine programming: effects of time of 
exposure and sex. Journal of Neuroendocrinology, 24(7), 999–1011.  
Veen, G., Giltay, E. J., Licht, C. M. M., Vreeburg, S. A., Cobbaert, C. M., Penninx, B. 
W. J. H., & Zitman, F. G. (2013). Evening salivary alpha-amylase, major 
448 
 
depressive disorder, and antidepressant use in the Netherlands Study of 
Depression and Anxiety (NESDA). Psychiatry Research, 208(1), 41–46. 
https://doi.org/10.1016/j.psychres.2013.03.012 
Veith RC, N, L., O, L., Barnes, R., Raskind, M., Villacres, E., … Halter, J. (1994). 
Sympathetic Nervous System Activity in Major depression. Arch Gen Psychiatry, 
51, 411–422. 
Veith, R. C., Best, J. D., & Halter, J. B. (1984). Dose-dependent suppression of 
norepinephrine appearance rate in plasma by clonidine in man. The Journal of 
Clinical Endocrinology & Metabolism, 59(1), 151–155. 
Velders, F. P., Dieleman, G., Henrichs, J., Jaddoe, V. W. V, Hofman, A., Verhulst, F. 
C., … Tiemeier, H. (2011). Prenatal and postnatal psychological symptoms of 
parents and family functioning:  the impact on child emotional and behavioural 
problems. European Child & Adolescent Psychiatry, 20(7), 341–350.  
Venihaki, M., Carrigan, A., Dikkes, P., & Majzoub, J. A. (2000). Circadian rise in 
maternal glucocorticoid prevents pulmonary dysplasia in fetal mice with adrenal 
insufficiency. Proceedings of the National Academy of Sciences of the United 
States of America, 97(13), 7336–7341.  
Verhage, M. L., Schuengel, C., Madigan, S., Fearon, R. M., Oosterman, M., Cassibba, 
R., …  van IJzendoorn, M. H. (2016). Narrowing the transmission gap: A 
synthesis of three decades of research on intergenerational transmission of 
attachment. Psychological Bulletin, 142(4), 337. 
Verreault, N., Da Costa, D., Marchand, A., Ireland, K., Dritsa, M., & Khalifé, S. (2014). 
Rates and risk factors associated with depressive symptoms during pregnancy 
and with postpartum onset. Journal of Psychosomatic Obstetrics & Gynecology, 
35(3), 84–91. 
Voegtline, K. M., Costigan, K. A., Kivlighan, K. T., Laudenslager, M. L., Henderson, J. 
L., & Dipietro, J. A. (2013). Concurrent levels of maternal salivary cortisol are 
449 
 
unrelated to self-reported psychological measures in low-risk pregnant women. 
Archives of Women’s Mental Health, 16(2), 101–108.  
Vreeburg, Sophie; Hoogendijk, W. (2009). Major Depressive Disorder and 
hypothalamic-pituitary-adrenal axis activity. Arch Gen Psychiatry, 66(6), 617–626. 
Wadhwa, P. D. (2005). Psychoneuroendocrine processes in human pregnancy 
influence fetal development and health. Psychoneuroendocrinology, 30(8), 724–
743.  
Wadhwa, P. D., Buss, C., Entringer, S., & Swanson, J. M. (2009). Developmental 
origins of health and disease: brief history of the approach and current focus on 
epigenetic mechanisms. Seminars in Reproductive Medicine, 27(5), 358–368.  
Waffarn, F., & Davis, E. P. (2012). Effects of antenatal corticosteroids on the 
hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental 
findings and clinical considerations. American Journal of Obstetrics and 
Gynecology, 207(6), 446–454. 
Wakshlak, A., & Weinstock, M. (1990). Neonatal handling reverses behavioral 
abnormalities induced in rats by prenatal stress. Physiology & Behavior, 48(2), 
289–292. 
Walder, D. J., Laplante, D. P., Sousa-Pires, A., Veru, F., Brunet, A., & King, S. (2014). 
Prenatal maternal stress predicts autism traits in 6(1/2) year-old children: Project 
Ice Storm. Psychiatry Research, 219(2), 353–360.  
Waldie, K. E., Peterson, E. R., D’Souza, S., Underwood, L., Pryor, J. E., Carr, P. A., … 
Morton, S. M. B. (2015). Depression symptoms during pregnancy: evidence from 
growing up in New Zealand. Journal of Affective Disorders, 186, 66–73. 
Walsh, K., Basu, A., Werner, E., Lee, S., Feng, T., Osborne, L. M., … Monk, C. 
(2016). Associations Among Child Abuse, Depression, and Interleukin-6 in 
Pregnant Adolescents. Psychosomatic Medicine, (May), 1.  
450 
 
Wapner, R. J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D. J., Spong, C. Y., … 
Caritis, S. N. (2007). Long-term outcomes after repeat doses of antenatal 
corticosteroids. New England Journal of Medicine, 357(12), 1190–1198. 
Waters, C. S., Goozen, S., Phillips, R., Swift, N., Hurst, S. L., Mundy, L., … Hay, D. F. 
(2013). Infants at familial risk for depression show a distinct pattern of cortisol 
response to experimental challenge. Journal of Affective Disorders, 150(3), 955–
960.  
Waters, C. S., Hay, D. F., Simmonds, J. R., & van Goozen, S. H. M. (2014). Antenatal 
depression and children’s developmental outcomes: potential mechanisms and 
treatment options. European Child & Adolescent Psychiatry, 23(10), 957–971.  
Watson, J. B., & Rayner, R. (1920). Conditioned emotional reactions. Journal of 
Experimental Psychology, 3(1), 1–14. https://doi.org/52, 281-302 
Weaver, I. C. G., Cervoni, N., Champagne, F. A., D’Alessio, A. C., Sharma, S., Seckl, 
J. R., … Meaney, M. J. (2004). Epigenetic programming by maternal behavior. 
Nature Neuroscience, 7(8), 847–854. 
Weinstock, M. (2001). Alterations induced by gestational stress in brain morphology 
and behaviour of the offspring. Progress in Neurobiology, 65(5), 427–451. 
Weinstock, M. (2005). The potential influence of maternal stress hormones on 
development and mental health of the offspring. Brain, Behavior, and Immunity, 
19(4), 296–308. 
Weinstock, M. (2007). Gender differences in the effects of prenatal stress on brain 
development and behaviour. Neurochemical Research, 32(10), 1730–1740.  
Weinstock, M. (2008). The long-term behavioural consequences of prenatal stress. 
Neuroscience and Biobehavioral Reviews, 32(6), 1073–1086.  
Weinstock, M. (2017). Prenatal stressors in rodents: Effects on behavior. Neurobiology 
of Stress, 6, 3–13.  
451 
 
Welberg, L. A. M. (2005). Chronic maternal stress inhibits the capacity to up-regulate 
placental 11 -hydroxysteroid dehydrogenase type 2 activity. Journal of 
Endocrinology, 186(3), R7–R12.  
Welberg, L. A., & Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the 
programming of the brain. Journal of Neuroendocrinology, 13(2), 113–128. 
Wen, D. J., Poh, J. S., Ni, S. N., Chong, Y. S., Chen, H., Kwek, K., … Qiu, A. (2017). 
Influences of prenatal and postnatal maternal depression on amygdala volume 
and microstructure in young children. Translational Psychiatry, 7(4).  
Werner, E., Myers, M. M., Fifer, W. P., Cheng, B., Fang, Y., Allen, R., & Monk, C. 
(2007). prenatal predictors of infant temperament. Developmental Psychobiology, 
49(2), 165–171.  
Werner, E., Zhao, Y., Evans, L., Kinsella, M., Kurzius, L., Altincatal, A., … Monk, C. 
(2013). Higher maternal prenatal cortisol and younger age predict greater infant 
reactivity to novelty at 4 months: An observation-based study. Developmental 
Psychobiology, 55(7), 707–718. 
Wetherell, M. A., Crown, A. L., Lightman, S. L., Miles, J. N. V, Kaye, J., & Vedhara, K. 
(2006). The four-dimensional stress test: Psychological, sympathetic–adrenal–
medullary, parasympathetic and hypothalamic–pituitary–adrenal responses 
following inhalation of 35% CO2. Psychoneuroendocrinology, 31(6), 736–747. 
Wheeler, A., Hatton, D., Reichardt, A., & Bailey, D. (2007). Correlates of maternal 
behaviours in mothers of children with fragile X syndrome. Journal of Intellectual 
Disability Research, 51(6), 447–462. 
Wingenfeld, K., Schulz, M., Damkroeger, A., Philippsen, C., Rose, M., & Driessen, M. 
(2010). The diurnal course of salivary alpha-amylase in nurses: an investigation 




Wium-Andersen, M. K., & Nielsen, S. F. (2013). Elevated C-Reactive Protein Levels, 
Psychological Distress, and Depression in 73á131 Individuals. JAMA Psychiatry, 
70(2), 176–184. 
Woody, C. A., Ferrari, A. J., Siskind, D. J., Whiteford, H. A., & Harris, M. G. (2017). A 
systematic review and meta-regression of the prevalence and incidence of 
perinatal depression. Journal of Affective Disorders, 219(April), 86–92.  
Wray, N. R., Ripke, S., Mattheisen, M., Trzaskowski, M., Byrne, E. M., Abdellaoui, A., 
… Andlauer, T. M. F. (2018). Genome-wide association analyses identify 44 risk 
variants and refine the genetic architecture of major depression. Nature Genetics, 
50(5), 668. 
Wyrwoll, C. S., & Holmes, M. C. (2012). Prenatal excess glucocorticoid exposure and 
adult affective disorders: A role for serotonergic and catecholamine pathways. 
Neuroendocrinology, 95(1), 47–55.  
Xiong, X., Harville, E. W., Mattison, D. R., Elkind-Hirsch, K., Pridjian, G., & Buekens, 
P. (2008). Exposure to Hurricane Katrina, post-traumatic stress disorder and birth 
outcomes. The American Journal of the Medical Sciences, 336(2), 111–115.  
Yaka, R., Salomon, S., Matzner, H., & Weinstock, M. (2007). Effect of varied 
gestational stress on acquisition of spatial memory, hippocampal LTP and 
synaptic proteins in juvenile male rats. Behavioural Brain Research, 179(1), 126–
132.  
Yang, E. V., & Glaser, R. (2002). Stress-induced immunomodulation and the 
implications for health. International Immunopharmacology, 2(2–3), 315–324.  
Yang, J., Han, H., Cao, J., Li, L., & Xu, L. (2006). Prenatal stress modifies 
hippocampal synaptic plasticity and spatial learning in  young rat offspring. 
Hippocampus, 16(5), 431–436.  
Yehuda, R., Engel, S. M., Brand, S. R., Seckl, J., Marcus, S. M., & Berkowitz, G. S. 
(2005). Transgenerational effects of posttraumatic stress disorder in babies of 
453 
 
mothers exposed to the World Trade Center attacks during pregnancy. Journal of 
Clinical Endocrinology and Metabolism, 90(7), 4115–4118. 
Yim, I. S., Glynn, L. M., Schetter, C. D., Hobel, C. J., Chicz-DeMet, A., & Sandman, C. 
A. (2009). Elevated Corticotropin-Releasing Hormone in Human Pregnancy 
Increases the Risk of Postpartum Depressive Symptoms. Arch Gen Psychiatry, 
66, 162–169.  
Zaretsky, M. V, Alexander, J. M., Byrd, W., & Bawdon, R. E. (2004). Transfer of 
inflammatory cytokines across the placenta. Obstetrics and Gynecology, 103(3), 
546–550.  
Zijlmans, M. A. C., Riksen-Walraven, J. M., & de Weerth, C. (2015). Associations 
between maternal prenatal cortisol concentrations and child outcomes: A 
systematic review. Neuroscience and Biobehavioral Reviews, 53, 1–24.  
Zohsel, K., Buchmann, A. F., Blomeyer, D., Hohm, E., Schmidt, M. H., Esser, G., … 
Laucht, M. (2014). Mothers’ prenatal stress and their children’s antisocial 
outcomes - A moderating role for the Dopamine D4 Receptor (DRD4) gene. 
Journal of Child Psychology and Psychiatry and Allied Disciplines, 55(1), 69–76.  
Zoia, S., Blason, L., D’Ottavio, G., Biancotto, M., Bulgheroni, M., & Castiello, U. 
(2013). The development of upper limb movements: from fetal to post-natal life. 
PloS One, 8(12), e80876. 
Zorn, J. V., Schür, R. R., Boks, M. P., Kahn, R. S., Joëls, M., & Vinkers, C. H. (2017). 
Cortisol stress reactivity across psychiatric disorders: A systematic review and 
meta-analysis. Psychoneuroendocrinology, 77, 25–36.  
Zuckerman, M. (1999). Diathesis-stress models. In M. Zuckerman, Vulnerability to 

















First and foremost, I want to express my deep gratitude to Prof. Pasco Fearon, my 
supervisor at the UCL, and Dr Alessandra Frigerio, my mentor at the Medea Scientific Institute, 
with whom I have had the privilege to work during this PhD. I want to thank Pasco for being such 
an inspiring example and for his passion for the subject, kindness and support, even when heavily 
burdened by other duties, which has made my PhD a memorable experience. I sincerely hope that 
our collaborative efforts will continue for many years to come. I would like to thank Alessandra, for 
being my professional “secure base” at the Medea Scientific Institute and for enlightening me the 
first glance of research back in 2009. I am deeply grateful for all the help, guidance and 
encouragement since my very first steps as a researcher until today. There is still a long way to go 
for me to become a researcher beyond the PhD but I hope I could always count on your support 
and guidance.  
My sincere thanks also go to Dr. Frances Rice, my subsidiary supervisor, for her insightful 
comments during this PhD and for helping me to develop a critical and independent thought. I will 
never forget these valuable lessons.  
I would like to express my sincere gratitude to Prof. Massimo Molteni, for believing in me 
and pushing me to pursue my professional goals, as well as for providing the laboratory and 
research facilities at the Medea Scientific Institute that make this research possible.  
I gratefully acknowledge the funding sources that sponsored my PhD and the EDI Study. 
My work was supported by a PhD studentship provided by the Stanley Thomas Johnson 
Foundation. Additional funds were provided by Fondazione Banca del Monte di Lombardia and 
Soroptimist Club di Lecco. I would also like to thank the Scientific Institute Eugenio Medea for 
supporting and funding the follow-up phases of the EDI Study.  
I would like to thank Francesca Ciceri (Biological Lab at the Medea Institute) for dealing 
with cortisol analyses and all the members of the Attachment Lab at the Medea Institute, and 
particularly, Nadia Dottori, Enrita Pozzi, Marco Redaelli and Marta Calcinati, for their invaluable 
help in data collection and coding.  
456 
 
A special thanks is extended to all the families and children who participated in this study. 
The opportunity to follow them in the transition to parenthood was an amazing professional and life 
experience.  
I am also extremely grateful to all the hospitals and pediatric health centers involved in data 
collection. In particular, I want to thank Dr. Stefano Norchi and Dr. Daniele Merazzi from Ospedale 
Valduce di Como, Dr. Rinaldo Zanini from Ospedale Mandic di Merate, Dr. Alberto Zanini from 
Ospedale Fatebenefratelli di Erba, Dr.ssa Katia Ascorti from Consultorio La Famiglia di Como, Dr 
Aldo Palumbo from Dipartimento di Prevenzione Medica, ASL di Como and Dr Paola De Grada 
from Dipartimento di Prevenzione Medica, ASL di Lecco for their invaluable support and all the 
midwives and nurses for their help in recruitment and data collection.  
I thank my fellow labmates and colleagues at the Medea Institute for supporting me along 
the way, for the stimulating discussions and lot of coffee in the last four years. 
I would like to thank my parents and sister for all their love and encouragement. You have 
always supported me in all my pursuits and decisions, though hard they could be, and you have 
always been on my side with a slice of cake and a hug that was exactly what I needed in hard 
times.  
Lastly, I thank my beloved husband Ermanno. We have come a long way together and I am 
sometimes still amazed by all the things we have built. Without your love, patience and 
encouragement, these pages would have never been written. And thank you Riccardo, for filling 




















































APPENDIX D: Ad-hoc forms 
 
In what follows are presented the ad-hoc forms employed throughout the current study. 
Specifically, the “Sociodemographic Form” and “Prenatal Form” were employed to collect 
demographic and pregnancy-related data at 34-36 gestational weeks. The “Postnatal Form: Birth” 
was employed to collect delivery and both maternal and infant health-related data at birth. Lastly, 
“The Postnatal Form: 3 months” was used to collect data on infant health at 3 months of age. 
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